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Part I
Introduction

Chapter 1.
General introduction
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1GeNeRal INtRoDUCtIoN
Information on quality of care plays a central role in healthcare nowadays.1 
As a result of the growing demand for health care, increasing costs, and evi-
dence of variation in quality of care, the interest in the quantitative assess-
ment of health care quality has increased.2,3 Furthermore, today’s society 
demands ever more transparency, which requires the health care sector—
as well as other public sectors—to provide insight into their performance. 
Different stakeholders may use quality of care information for different pur-
poses. Health care professionals use it to evaluate their performance in order 
to try to improve quality.4 Government agencies use quality of care informa-
tion to monitor and regulate quality of care, while insurance companies use 
it to select hospitals they want to contract, and patients may use it to com-
pare hospitals in order to make informed treatment decisions. 
As quality of care information is used for such a variety of purposes, it is cru-
cial that quality measures are valid and reliable and actually do represent 
quality of care. However, despite a rapidly growing body of scientific litera-
ture on this topic, there is currently no consensus on how to measure quality 
of care. 
In this thesis we focus on the measurement of quality of hospital care for 
external purposes. Specifically, we will study the reliability and validity of 
‘quality indicators’.
In this chapter some concepts related to this topic will be introduced and 
consequently the specific research questions and content of the rest of the 
thesis will be presented.
12
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meaSURING QUalIty oF HoSPItal CaRe
Various definitions of quality of care have been formulated over the years.3 
One commonly used definition is from the Organisation for Economic Coop-
eration and Development (OECD) (Box 1).5 
Box 1. Dimensions of quality of care
Quality of care can be measured on at least three key dimensions: ef-
fectiveness, person centeredness and safety.6 Effectiveness reflects the 
degree to which processes result error-freely in desired outcomes.7 Person 
centeredness or responsiveness means the degree to which a system func-
tions by placing the patient at the centre of its delivery.6,8 This component 
is often measured in terms of the care, communication and understand-
ing experienced by the patient in the clinician-patient relationship.9,10 The 
degree to which health care processes prevent, and ameliorate adverse 
outcomes, possibly resulting from the health care processes itself, is referred 
to as safety.6,11
Quality of care research has a long history. In the mid-1800s Florence Night-
ingale studied quality of care by assessing mortality and infection rates in 
British military hospitals during the Crimean War. In Austria, Ignaz Semmel-
weis measured and compared mortality rates related to puerperal fever 
between maternity clinics in Vienna (1841-1846).12 In the beginning of the 
20th century, the American physician Ernest Codman introduced a system 
to capture patient outcomes following surgical procedures in US hospitals.13
These quality assessments were all initiated by health care professionals. The 
interest in quality and safety of care revived after the publication of the 
Harvard Medical Practice study in 1991 and the later publication ‘To Err Is 
Human: Building a Safer System’ by the Institute of Medicine in America. 
Since then the importance given to patient safety and quality of care has 
increased. And specifically the demand for quality assurance and transpar-
ency from external stakeholder, such as society and politics, has become 
stronger.1,14-16 Nowadays, information on quality of care is used for internal 
and external purposes. Internal purposes include, for example, the initiation 
and evaluation of quality improvement programs.17 External use of quality 
information involves the public comparison of hospitals based on informa-
tion regarding the hospitals’ quality of care. Such external comparisons may 
lead to quality improvement through selection of the ‘best’ providers by 
patients or payers.17,18
13
1QUalIty INDICatoRS
Quality indicators are measurable aspects of quality and are generally used 
to assess quality of care (Box 2).19
Box 2. Definition of quality indicators
Quality indicators are measurement tools, screens, or flags that are used 
as guides to monitor, evaluate, and improve the quality of patient care, 
clinical support services, and organizational functions that affect patient 
outcomes.20
Following Avedis Donabedian’s framework, quality indicators are often clas-
sified into three types: structure, process and outcome indicators. Examples 
of structure, process and outcome indicators for hospital care are presented 
in Figure 1. Structure indicators define the characteristics of the health sys-
tem or the hospital in which the care is provided,6 such as human resources 
and organizational factors.21 Structure indicators are measured at the pro-
vider or system level. Process indicators can be measured per patient and 
refer to the appropriateness of the delivered care,6 such as guideline adher-
ence. Outcome indicators reflect the end result as a consequence of care,3 
such as clinical care outcomes, adverse events or patient’s satisfaction with 
care. 
Figure 1. Structure, process, outcome model 22
Structure
Nurse-to-bed  
ratio
Hospital patient 
volume
Existence of spe-
cific units (e.g. 
stroke units)
•
•
•
Process
Proportion of  
patients who 
receive  
antibiotic  
prophylaxis  
during hip- 
replacement 
operation
Proportion of 
patients who 
received 
discharge 
instructions
•
•
outcome
Proportion of 
patients who 
died 30 days 
after discharge
Proportion of 
patients who 
had to undergo 
reoperation
Positive 
outcomes as 
perceived and 
reported by 
patients
•
•
•
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outcome indicators
While in the scientific literature no consensus exists on which type of quality 
indicator is best able to assess quality of care,23,24 there is an increasing inter-
est in outcome indicators.25 Outcome indicators are thought to matter most 
to patients and reflect all aspects of care.24 In this thesis we study mainly 
outcome indicators. 
Outcome indicators are usually expressed as a rate or a percentage. Thus 
they consist of a denominator and a numerator. The denominator is the total 
number of patients to which the indicator applies, e.g. all patients admitted 
with diagnosis x. The numerator is the number of patients with the outcome 
of interest, e.g. death within 30 days after admission. Examples of commonly 
used outcome indicators that are studied in this thesis are mortality rates, 
readmission rates and complication rates. These outcome indicators are ex-
pected to reflect—at least to some extent—the quality of care. They are 
attractive because they are very general, and thus applicable to many dif-
ferent patient groups. 
Mortality is a frequently studied outcome indicator as it is the most undesir-
able outcome of care.26 In clinical research, it is considered a ‘hard’ out-
come. In many countries, such as the United Kingdom, the United States, 
Sweden, Canada, France and Australia, mortality is monitored as a mea-
sure of quality of hospital care.27 It is most often defined as death during a 
hospital stay.28,29
Readmissions are of interest as a quality indicator as they incur costs and oc-
cur relatively frequently.30-32 About 20% of hospitalized Medicare patients are 
readmitted within 30 days.33 In several countries readmissions are monitored 
and also used in pay for performance schemes.34 For example, in the US hos-
pitals with unusually high readmission rates are financially penalized.35
Complication rates, such as wound infections or anastomotic leakages, are 
attractive outcome indicators since they are adverse events that are relative-
ly closely related to the care process. In this thesis we will study anastomotic 
leakages, which are among the most severe complications in surgery and 
are associated with increased morbidity, reoperations, and mortality.36,37
In many clinical fields remarkable variation in these patient outcomes across 
hospitals is found, which suggests that there are differences in quality of care 
between hospitals and that there is room for quality improvement.38
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1PSyCHometRIC CRIteRIa oF 
a GooD oUtCome INDICatoR
Using outcome indicators as a measure of quality of processes of hospital 
care requires that differences in outcomes between hospitals represent dif-
ferences in underlying quality of care. Therefore outcome indicators need 
to be evaluated in terms of their psychometric criteria. The required quality 
of an outcome indicator depends on the intended use. The larger the con-
sequences of a specific indicator score—for example, financial penalties for 
hospitals with higher mortality rates—the more certain it needs to be that 
the outcome indicator actually reflects the quality of the delivered care. 
When using quality indicators externally, for comparison between hospitals, 
at least the relevance, reliability, validity, feasibility and usability of an out-
come indicator should be considered (Table 2). 
table 2. Psychometric criteria to evaluate outcome indicators39-42
Relevance  The outcome of interest should occur frequently or should represent an 
  improvement opportunity.
Scientific rigor Reliability The indicator needs to produce the same result on repeated measurement.
 Validity The indicator needs to measure what it claims to measure. Different forms 
  of validity can be distinguished: face validity, content validity, construct 
  validity, and criterion validity.
Feasibility  The data used to calculate the indicator need to be feasible to obtain.
Usability  The indicator should be understood by its intended audience and provide 
  the ability to take action to improve the indicator score (actionability).
In this thesis we concentrate on the scientific rigor of outcome indicators 
for quality of hospital care. We will investigate the reliability and validity of 
various outcome indicators in different disease fields. Furthermore, we will 
study different elements that determine the reliability and validity of an out-
come indicator: data quality, definitions, statistical uncertainty and case-
mix (Table 3). These elements are also represented in the system that is used 
by the Dutch Quality Institute to judge quality indicators.43 Below they will be 
discussed in detail. 
16
table 3. Psychometric criteria to evaluate an outcome indicator studied in 
this thesis
Psychometric characteristic 
Reliability: Data quality: Uniformity in data (collection)
 Definitions: Accuracy of the definition of the numerator and denominator and other 
  data elements that are used to calculate the indicator
 Statistical  Random variation caused by low numbers of patients/outcomes 
 uncertainty:
Validity: Case-mix: Differences in patient populations between hospitals
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1RelIaBIlIty 
Reliability refers to the degree to which an outcome indicator is reproduc-
ible.44 The reproducibility of an outcome indicator is threatened by unsystem-
atic errors, such as low data quality, ambiguous indicator definitions and sta-
tistical uncertainty due to low event rates, which we will study in this thesis. 
Data quality
As mentioned previously, outcome indicators consist of a nominator and de-
nominator that are based on underlying individual patient data. Sometimes 
other data elements are also used to calculate indicator scores, such as 
patient characteristics to adjust for case-mix. In order to calculate reliable 
outcome indicators, the underlying data need to be complete, accurate 
consistent and reproducible.45
Two different types of data sources are generally used to calculate outcome 
indicators: administrative data and clinical data. For our research questions 
on reliability we will focus on administrative data. Although not originally 
set up for this purpose, these data are frequently used to calculate quality 
indicators.46 These data sources are attractive because they include large 
numbers of people (often nationwide), are available in a structured way 
and patient journeys to other institutions can theoretically be followed.47-49
In this thesis we will investigate which aspects of data quality affect the 
reliability of quality indicators for hospital care. We will review the current 
knowledge in the scientific literature, and study the effect of data quality 
empirically by evaluating a hospital quality indicator set of the Dutch Health 
Transparency Program (DHTP), which is based on administrative data. 
Definitions
A second prerequisite for reliable outcome indicators is the clear and unam-
biguous definition of the indicator elements (nominator, denominator and 
other data elements that are used to calculate the indicator such as case-
mix factors).50 Different interpretations of an indicator—for example, which 
patients should be included in the denominator—can significantly alter the 
indicator score, especially when data is self-reported.51 Even if the quality 
of the data is good, if the wrong data elements are delivered, the indicator 
scores become unreliable.
In this thesis we will investigate the clarity of the definitions of currently used 
quality indicators for quality of hospital care by reviewing the scientific lit-
18
erature on the outcome indicator readmission rate in heart failure patients. 
Heart failure is a complex clinical syndrome, of which exercise intolerance 
and fluid retention are typical characteristics.52 In the United States approxi-
mately 500,000 new cases are diagnosed each year and 300,000 people 
die from heart failure annually.53
Approximately 800,000 hospital discharges per year can be attributed to 
heart failure54 and it is a major contributor to the rising healthcare costs. 
More than 25% of patients hospitalized for heart failure are readmitted with-
in 30 days after discharge.55 Therefore readmissions are a highly relevant 
quality indicator for heart failure.56 One of the most important predictors 
associated with adverse outcomes in heart failure patients is symptom sta-
tus, which is difficult to assess, as a limited number of heart failure symptom 
instruments are available.57
Statistical uncertainty
A certain amount of variation in outcomes between hospitals is simply caused 
by chance. The smaller the number of treated patients and/or number of 
outcomes, the larger the impact of chance. As a result, quality of care dif-
ferences may appear bigger than they in reality are.58 Statistical uncertainty 
can be accounted for with so-called random effect regression models. 
In this thesis, we will examine how statistical uncertainty affects the reliability 
of outcome indicators for colon cancer and oesophago-gastric (O-G) can-
cer surgery. We will use two clinical datasets: the Dutch Surgical Colorec-
tal Audit (DSCA) data and the National Oesophago-gastric Cancer Audit 
(NOGCA) database. It is estimated that in 2015 there will be 132,700 new 
cases of colorectal cancer in the United States.59 Almost 90% of colorec-
tal cancers arise from benign, adenomatous polyps lining the wall of the 
bowel. When cancer develops, the polyps grow to a larger size and take on 
a villous appearance or they contain dysplastic cells.60 Surgery is the main 
treatment for colon cancer. Usually the part of the colon affected by the 
tumour is removed as well as close lymph nodes. The two ends of the colon 
are then reconnected. 
The American Cancer Society estimates that in 2015 there will be 93,000 new 
cases of colon cancer in the United States.59 The prognosis for O-G cancer 
patients remains poor with a 5-year survival rate of 5-10% for oesophageal61 
and 10–30% for gastric cancer.62-64 Treatment options are determined by the 
disease stage and patient’s general health. For local disease surgical resec-
tion is regarded as the cornerstone treatment.65
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1For both colon and O-G cancer we will study the most commonly used 
short-term outcome indicators, namely mortality and the surgical compli-
cation anastomotic leakage.
20
ValIDIty
Validity refers to whether an indicator measures what it claims to measure.66 
An outcome indicator is valid if a hospital that delivers good quality of 
care—as represented in structure and process indicators—shows desirable 
outcomes (Figure1).67 
Different forms of validity can be distinguished. Face validity refers to the 
extent to which, subjectively viewed, an indicator measures what it is in-
tended to measure. This is usually determined by expert committees.68 Con-
tent validity represents the extent to which an indicator samples the relevant 
sub-dimensions of quality of hospital care.41,68 Construct validity describes 
the extent to which an indicator correlates with another indicator that aims 
to measure the same underlying construct.68 Criterion validity reflects the 
extent to which an indicator shows agreement with a gold standard of the 
measured domain in quality of care.68 When no gold standard exists, as is 
the case with quality of care, the common approach to measure validity is 
construct validity. Which means for example assessing the correlation be-
tween the process indicator ‘percentage of patients who received antibiot-
ics prior to surgery’ and the outcome indicator ‘postoperative infections’, 
as both indicators aim to measure the underlying quality construct safety 
of surgery. 
The validity of an indicator is threatened by systematic errors. An indicator 
may be reliable, but not valid, for example when there is systematic misclas-
sification. However, if an indicator is not reliable, it cannot have high validity. 
Insufficient case-mix correction, a factor that threatens the validity of out-
come indicators of hospital care, is studied in this thesis. 
Case-mix 
Different patients are seen at different hospitals. For example, for cancer 
surgery high-volume centres or teaching hospitals often treat more difficult 
patients than small or non-teaching hospitals treat.69 Therefore, differences 
in outcome do not only reflect differences in quality of care but also differ-
ences in case-mix. The case-mix differences can be accounted for with a 
‘case-mix correction model’, which is a logistic regression model that es-
timates the probability of the outcome for each patient based on his or 
her characteristics. These expected outcomes can be compared to the ob-
served outcomes. 
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1In this thesis we will investigate the extent to which case-mix correction af-
fects the validity of outcome indicators by reviewing the scientific literature 
and conducting empirical research using the two previously mentioned 
clinical databases: the DSCA on colon cancer and the English audit data 
on O-G cancer. Using these data we will develop a case-mix model to ad-
just for differences in patient characteristics when using outcome indicators 
and we will test the extent of the effect of case-mix correction on the valid-
ity of outcome indicators.
22
aImS aND oUtlINe
The main aim of this thesis is to expand our knowledge on how to measure 
quality of hospital care for external purposes. We will study the reliability and 
validity of outcome indicators. Specifically we will focus on data quality, in-
dicator definitions, statistical uncertainty and case-mix correction.
The specific research questions are:
Which aspects of data quality affect the reliability of quality indicators 
for hospital care? 
How clear are the definitions of currently used quality indicators for hos-
pital care?
To what extent does statistical uncertainty affect the reliability of outcome 
indicators for surgical colon and oesophago-gastric cancer care?
To what extent does case-mix correction affect the validity of outcome 
indicators for surgical colon and oesophago-gastric cancer care?
outline of this thesis
The thesis is structured in five parts with a total of ten chapters. Part I includes 
this general introduction (Chapter 1). 
Part II and III , the main parts of this thesis, include literature reviews and 
empirical studies.
Part II (Chapter 2-4) includes literature studies, systematic reviews and a 
meta-analysis. This part extensively describes the current scientific knowl-
edge on both the reliability and validity of quality indicators for hospital care. 
In Chapter 2 we investigate the evidence on the validity of the outcome 
indicator readmission rates in hospitals in the European context. Chapter 3 
summarizes the problems with the reliability and validity of readmission rates 
as an outcome indicator for quality of hospital care in general. Chapter 4 
focuses specifically on heart failure. 
Part III contains empirical studies on the reliability and validity of quality 
indicators for hospital care. Chapter 5 describes the extent to which data 
quality and indicator computation strategies affect the reliability of hospital 
quality indicators. For this research we use breast cancer and hip replace-
ment indicators from the Dutch Health Care Transparency Program (DHTP) 
and conduct a survey of 42 Dutch hospitals. In Chapter 6 we investigate the 
effect of data quality on the correlation between the indicators within the 
1.
2.
3.
4.
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1hip replacement indicator set of DHTP. Chapter 7 examines the effects of 
statistical uncertainty and case-mix correction on the reliability and validity 
of outcome indicators for the quality of colon cancer resection in the DSCA 
data. In Chapter 8 we develop case-mix correction models for comparing 
30- and 90-day rates for mortality and for anastomotic leakage after 
O-G cancer resections between hospitals in the English audit data. Using 
the same data, Chapter 9 assesses differences in case-mix corrected out-
comes between hospitals and surgeons, as well as the correlation between 
outcomes and the structure indicator volume. 
Table 4 presents an overview of the outcome indicators under investiga-
tion, the clinical fields, the data sources including year and country, and the 
chapter in which the indicator is studied.
table 4. Outcome indicators for the quality of hospital care studied in this 
thesis
Outcome  Clinical field Datasource Country Year  Chapter
indicator
Readmission General Literature International 1999-2010 2
 General Literature International 2001-2013 3
 Heart failure Literature International      /  -2014 4
Relapse Breast cancer Administrative NL 2009-2011  5
Complications Hip and knee replacement Administrative NL 2009-2011 5 and 6
 Colon cancer  Clinical NL 2011-2012  7
 Oesophago-gastric cancer Clinical UK 2011-2013  8 and 9
mortality* Colon cancer Clinical NL 2011-2012  7
 Oesophago-gastric cancer Clinical UK 2011-2013  8 and 9
*postoperative mortality, 30-day mortality, 90-day mortality.
In the General Discussion (Part IV, Chapter 10) the results of the studies in 
the previous chapters are discussed as well as their implications for research 
and policy. 
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aBStRaCt
Background: Quality indicators are increasingly implemented in Europe for 
policy and management purposes. Many of these indicators were initially 
developed and implemented in the USA. However, the suitability of directly 
adopting indicators that have been developed in a different health care 
system can be questioned. Therefore, we investigate the validity behind the 
readmission rate indicator in the European setting.
methods: A systematic literature study was conducted to identify the status 
of scientific research on the validity of this indicator (January 1999 and April 
2010). Descriptive information as well as information on the data source, in-
dicator definition, risk adjustment factors, and conclusions was assessed.
Results: The majority of the 486 included studies focused on the actual use of 
the indicator as an outcome measure in European countries. Only 21 studies 
specifically addressed its validity, or important prerequisites of validity. There 
is little consensus over the timeframe used to calculate the indicator, the 
type of readmission that is included, and the case-mix correction applied.
Conclusions: Despite the increase in Europe of the use of the readmission 
rate as a measure of quality of care, the amount of research performed on 
its validity is scarce. Those studies that report on validity replicate earlier, 
mainly US findings (<1999) of methodological problems and express reserva-
tions on its large-scale use. The readmission rate as an indicator should be 
used with care. Users should address issues related to definition, timeframe 
and case-mix correction as part of the process to enhance validity in the 
European settings.
2
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INtRoDUCtIoN
Recent transformations in European (EU) health care systems, such as the 
change from a government-driven health care to a free market system, ask 
for an objective assessment of the quality of hospital care.1 Performance 
indicators, measurement tools that assess a particular health care structure, 
process or outcome,2 are generally expected to provide such objective as-
sessments of health care quality. However, in order to do so, the structures 
(e.g. organization of care), processes (what has been done to a patient) 
and outcomes (final health status) that are measured should be interrelat-
ed, and should be informative about the same underlying construct. 
An important starting point in quality of care research has its origin in the 
USA in the 1970s. Here, the interest in quality of care increased substantial-
ly when the Healthcare Cost and Utilization Project (HCUP) developed a 
set of health care quality indicators in 1989.3 In those years, a substantial 
amount of knowledge became available on the difficulties that arise when 
developing and maintaining valid and reliable health care quality indica-
tors.4 Ashton et al.5, for example, aimed to resolve the (at that time current) 
controversy in the USA over the validity of early readmissions as a measure 
of quality of care. Despite the results being somewhat conflicting, the sum-
mary odds ratios indicated that the process of medical care does affect the 
risk for readmission within 30 days. It was suggested however to handle the 
reported figures cautiously, as a null effect could not be ruled out. 
In many health care systems the rate of readmissions (RR) to a hospital has 
become a well-known indicator which measures how many patients are re-
admitted to the hospital after they have been discharged. The rationale be-
hind monitoring readmissions is that a readmission is related to substandard 
care. Within the Donabedian model, this indicator can be considered an 
intermediate outcome indicator, as it is a proxy for the rate of adverse events 
or positive outcomes such as increased life expectancy or reduced morbidity 
(genuine outcome indicator). The fact that hospital readmissions are high in 
cost,6 a burden to patients,7 and can be easily computed from routine statis-
tics of administrative databases,8 makes it plausible that readmission scores 
are monitored. Indeed over a decade ago several studies, mostly performed 
in the USA, report that readmissions were valid measures of quality as they 
appear to be largely caused by substandard care received during the prior 
hospitalization.6,9,10-12 However, other studies failed to confirm a valid relation 
between the quality of care and the RR.5,8 In all it seemed that the validity of 
the RR as a measure of health care quality was still debated.
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Within the last decade, Europe followed up on the USA’s example and sev-
eral countries implemented performance indicators that were originally de-
veloped there. Since local health care factors, such as the proximity of the 
hospital and the availability of the beds,13,14 influence the probability of a 
readmission, and the European health care systems are substantially differ-
ent from that of the USA (both at the governmental and hospital level) the 
validity of the RR might be comprised. 
Our aim is to explore the validity behind the RR indicator in the European 
setting. The validity is assessed by looking at the consistency in the use of 
definition of the indicator, the readmission timeframe used and the use of 
case-mix correction.
2
36
metHoDS
Search strategy and selection criteria
A systematic literature search was conducted in the electronic databases 
Medline and PubMed, using the following keywords in various combina-
tions: “re-admission”, “readmission”, “rehospitalisation”, “re-hospitalization” 
and MEDLINE subject heading (MeSH term) “patient readmission”, present 
in either the title and/or the abstract. The search was limited to publications 
from Europe and to the time period from January 1999 to April 2010. An 
English abstract was required to be present in order to be able to include 
or exclude the study. After we screened the abstracts of included studies, 
two groups of articles that differed largely in magnitude were identified: 
(i) studies using the RR as an outcome indicator and (ii) studies testing the 
indicators validity. 
Procedure for classification and evaluation
The classification and evaluation process was performed by two indepen-
dent researchers, who discussed any disagreement. If necessary, a third 
researcher was consulted. From all included articles, the following data 
elements were extracted: Year of publication, country of affiliation of the 
corresponding author and the patient group/disease being focused on. 
Further, we checked whether they define the RR they are focussing at, and 
how they define it. To provide more insight into current opinion on the valid-
ity, we screened the articles focusing on the validity of the quality indicator 
in more depth using information from the title, the abstract and full text. 
The following data elements were abstracted: type of validity investigated, 
study design used, type of data sources, type of case-mix correction and 
the conclusion. We distinguished between three types of validity: (i) face 
validity, the extent to which the measure appears to assess the construct, (ii) 
construct validity, the degree to which the measure reflects the construct 
and is related to other variables in predicted ways, (iii) criterion validity, the 
validity that relates to the ability of a measure to predict an outcome (crite-
rion), this measure ideally gets evaluated against a ‘gold standard’.15
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n = 1062
Total number of articles 
identified in MEDLINE 
and Pub Med for title/
abstract screening
n = 510
Identified abstracts 
considered for inclusion
n = 21
About validity of 
indicator/data source
2
ReSUltS
The search identified 1062 publications (see Figure 1 for flow diagram). After the 
initial screening, 552 articles were excluded on the basis of our inclusion criteria 
or a missing full English text. Of the 207 studies which did not provide full texts, 
most studies were published in Germany (n=55), Spain (n=38), France (n=29) 
and Denmark (n=25). The remaining 510 articles were screened on basis of the 
full text, 24 articles were reclassified. The resulting 486 articles were evaluated 
by the reviewers of which 465 articles focused on the actual use of the indicator 
as an outcome measurement and 21 studies somehow addressed the validity 
of the indicator, see for further bibliometric results Figure 2 A, B and C.
The RR is a poorly defined but increasingly used outcome indicator
Of the 465 articles which use the RR as an outcome measure in their study, 
we found 288 (partly) defining what they mean by RR. 177 studies just stated 
that they used the RR as an outcome measure, without defining it. 263 arti-
Figure 1. Flow diagram of article selection procedure
n = 486
Included articles
n = 552
Excluded (no English full 
text available or based 
on content)
n = 465
About acutal use of the 
indicator
n = 24
Reclassified based on 
full text
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cles out of the 288 defined the timeframe they were investigating, 13 studies 
looked at readmissions within 14 weeks, while 80 studies used the timeframe 
‘within 30 days’. However, most of the articles applied ‘longer than 30 days’ 
(n=166). Those who defined the type of RR (70 studies out of the 288) used 
most often ‘unplanned/emergency readmission’ (n=51). Just 45 studies stat-
ed both, the timeframe and type of readmission they included.
Figure 2. (A) number of publications per country in absolute numbers, (B) 
number of publications per patient group or disease field and (C) number 
of publications per year
publication per country in absolut numbersa
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In the following paragraph, the 21 validity studies that address the quality of 
the indicator will be the topic of discussion. The studies will be discussed in 
regards to the following aspects: definition, type of validity and adjustment 
for case-mix. 
As is described above, 21 European articles could be identified that address 
validity or validity aspects of the RR. Seven studies were included on basis of 
their abstract in which they stated to investigate the validity of the indicator 
by using the term validity or validation.16-22 The rest was identified on basis of 
the full-text information. In that case, the authors inferred the validity topic 
based on whether they questioned validity related factors, such as the influ-
ence of case-mix/ hospital factors, or the influence of different definitions 
on the RR score. 
Data sources used varied. Three validity studies used data from an administra-
tive database. Of those three, one study used the MODCOD system (encoded 
reports), allowing to compute DRGs according to ICD-9-CM codes (CPHA, 
1979) and the UNIDOC system, which is an integrated patient report proces-
sor.23 One study used a hospital information database (PAS)24 and the third used 
the hospital’s ‘Clinicom’ patient administration system with an in-built 28-day 
re-admission search tool.25 Other data source examples are: data collected 
by statistic offices (n=2) 16,17 hospital discharge data (n=1),18 hospital information 
systems (n=1),26 electronic coding systems (n=1),27 and cancer registries (n=1).19 
Two studies did not provide details about the source of the studied data.28,29
40
Different ways to address validity
Diverse aspects of an indicator’s validity can be addressed (such as face-, 
construct-, criterion validity, or validity threatening factors such as the time 
window used, hospital and patient characteristics). The criterion validity of 
an indicator can be addressed by several ways, such as investigating the 
predictability of an outcome indicator, or directly comparing performance 
which is revealed by the performance indicator to a golden standard (ex-
pert judgement of care based on record review).
In our review, we observed in total 14 studies that investigated the validity of 
the RR (13 criterion validity 1 face validity,30 no construct validity study could 
be identified) and five studies that did not specifically investigated or discuss 
valid relations between the RR and other measure of quality of care but inves-
tigated factors that might influence validity (see Table 1 for summary).22,31-34 
The identified criterion studies are discussed below in more detail. Of the 13 
criterion validity studies, 11 studies used expert judgments as a golden stan-
dard. The quality of care was merely judged by whether a readmission was 
unplanned/emergency (n=3),17,23,24 unforeseen and avoidable (n=1)16 could 
be avoided (n=1),18 or unplanned and avoidable (n=3),25,26,35 or was caused 
by a complication that was likely related to the surgery or whether it was 
provoked by the patient himself (n=3).27-29 In two studies, the golden standard 
was provided by either an expert judgment about aspects of quality of care 
based on information from an electronic full text discharge summary,23 or on 
process indicators that were derived from evidence based guidelines and 
were calculated from medical chart information.20 In the latter study, the 
authors specifically stated that these process indicators were used as gold-
en standard. Finally one study validated a National Patient Registry against 
corresponding data from the review of medical records serving as the gold 
standard.19 In regards to the study purpose, four studies were set-up to inves-
tigate whether the indicator is informative of insufficient care,18,20,27,29 or if the 
underlying data source is suitable for calculating the RR (n=9).16,17,19,23-26,28,35 
This paragraph refers to the 11 studies investigating the validity threatening 
factors or the feasibility of the RR.16,17,21,22,27,29,31-34,36 Eight studies16,17,27,29,31-34 investi-
gated validity threatening factors such as the time window used to determine 
the readmissions, and the factors that influence readmissions like patient and 
hospital characteristics. The other three studies merely focused on the feasi-
bility of calculating the indicator,21,36 or on the validity of linking multiple ad-
missions to one patient without the presence of unique patient identifiers.22 
Finally, one study merely discussed general validity issues of the RR.30
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table 1. Validity studies
Validity
type
Face 
Validity 
Criterion 
validity
Conclusionsa
RR is an unsatisfactory per-
formance indicator since it 
seems difficult to select only the 
unplanned and avoidable RAs, 
current health care databases 
are not sufficient to detect RAs 
to other hospitals, and there 
is no uniform time window in 
which RA is measured.
Electronic reports based on di-
agnostic and procedure codes 
alone are not sufficient to distin-
guish planned from unplanned 
RA, automation of detailed (full 
text) clinical databases seems 
promising.
RR is unlikely to be a valid 
outcome indicator, until better 
routine data for standardization 
by case-mix is available
RR is not a valid measure of 
the quality of care for heart 
failure patients; unplanned RAs 
are more strongly associated 
with clinical and demographic 
characteristics than with quality 
of care. Case-mix correction is 
needed
No specific measure for agree-
ment was given. GP’s and 
hospital staff judged most RAs 
to be caused by a relapse or 
complication of index illness. 
Opinions differed most signifi-
cantly when the reason for RAs 
was poor health on discharge 
or inadequate preparation on 
discharge.
Detection of avoidable RA by 
computerized method was 
scientifically sound enough to 
sign quality issues. Medical risk 
adjusters were more important 
than non-medical patient 
characteristics. But RR is sign to 
gather further information from 
medical records, and not for 
public reporting.
Design
Opinion
paper
Retrospective 
case-control 
study
Comparative 
research
Retrospective 
case-control 
study
Observational 
research
Evaluative 
retrospective 
cohort study
Study aim
To discuss of the validity of RR.
(n.a.)
To compare databases to 
determine which information is 
needed to distinguish planned 
from unplanned RA. b,c
To investigate possible factors 
influencing the RR: frequency of 
previous admission and cause 
of RA. c,d
To determine relation between 
early unplanned RAs of heart 
failure patients and suboptimal 
in-hospital care, or whether RA 
relates to clinical and demo-
graphic characteristics of the 
patient. b,c
To compare views of general 
practitioners and hospital staff 
on the reasons for unplanned RA 
of elderly people. d,e
To develop a computerized 
method that is able to detect po-
tentially avoidable hospital RAs 
on basis of routinely collected 
data and to develop a predic-
tion model that adjusts the RR for 
case-mix factors. d,f
author
Clarke, 2004,
UK30
Kossovsky, 
1999, 
Switzerland23
Leng, 1999, 
UK17
Kossovsky, 
2000, 
Switzerland29
Pearson, 
2002, UK28
Halfon, 2002, 
Switzerland26
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Comparing crude rates of RA 
does not quantify number of 
avoidable RAs and is only useful 
as a sign to conduct local stud-
ies to determine avoidable RAs.
No conclusions were drawn 
regarding the possibility to 
distinguish between planned, 
unplanned, avoidable or 
unavoidable. But, RR should be 
monitored regularly, with a time 
frame of 30 days of discharge.
Most RAs are not avoidable thus 
RR cannot be considered valid 
indicators of the quality of care 
for the set of specialties in a gen-
eral hospital, RR depends mainly 
on patients clinical condition 
and is not uniformly defined.
RR, calculated from routinely 
collected data was not a valid 
indicator of the quality of heart 
failure care. Improvement of 
definition and measurement 
methods are needed as well as 
appropriative risk adjustments.
Adjusted rates of potentially 
avoidable RAs are scientifically 
sound enough to warrant their 
inclusion in hospital quality 
surveillance and a high rate 
acts as a signal to hospitals to 
evaluate their practices.
A hospital coded information 
database, may not be accurate 
enough for the calculation of 
unplanned RR as it allows inclu-
sion of unrelated admissions. 
Also, factors like age, sex, history 
of psychiatric disease, number of 
drugs on discharge could not be 
used to predict unplanned RA.
Older patients with more 
complex care needs are more 
likely to be readmitted, rapid 
throughput of patients is not 
associated with RA. RR needs to 
be interpreted with caution; it 
varies with changes in the inclu-
sion criteria. However, on basis 
of expert judgment it appeared 
that most RAs can be avoided 
with better quality care
3 month 
retrospective 
audit
Prospective 
study, 
explorative
Cross-
sectional 
observational 
study
Evaluative, 
retrospective 
cohort study
Evaluative 
retrospective 
cohort study
Retrospective 
audit of case 
note records
Retrospective 
observational 
study.
To examine reasons for RA, 
possible errors in coding and any 
preventable factors in acutely 
readmitted patients. d,f
To measure RR and to qualify 
the RAS as planned, unplanned, 
avoidable or unavoidable. b,f
To identify the frequency and 
characteristics of potentially 
avoidable RAs and to compare 
the quality of care derived from 
RR to the quality of care judged 
by experts. b,g
To measure the validity and 
predictive ability of RA. d,e
To evaluate the usefulness of 
a computerized algorithm to 
identify avoidable RAs on the 
basis of minimum bias, criterion 
validity (expert judgment), and 
measurement precision. d,h
To assess the accuracy of 
hospital unplanned RA data, 
and identify patterns or possible 
causes of unplanned general 
surgical RAs. c,d
To formulate an appropriate 
definition of RA, to investigate 
the demographics and the 
predominant cause of readmit-
ted patients (avoidable RA) and 
to see whether rapid throughput 
is leading to unacceptably high 
RRs. e,i
Courtney, 
2003, UK25
Maurer, 
2004, 
Switzerland35
Jiménez-
Puente, 
2004, Spain18
Luthi, 2004, 
Switzerland20
Halfon, 2006, 
Switzerland16
Adeyemo, 
2007, UK24
Shalchi, 
2009, UK27
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The DCD is a valid method for 
the monitoring of quality of care 
in cholecystectomy, however 
correct coding is important, 
especially with administrative 
data. Length of stay > 3days 
and/or RA were strongly as-
sociated with post-operative 
complications.
RR is susceptible to the choice 
of time interval. The longer the 
time interval, the greater the 
number of unrelated admissions 
included. The optimal cut-off 
point in time is additionally 
dependent on its use.
Adjustment for factors like male 
sex, older age, diagnosis of 
heart failure, COPD or asthma 
and patient socio-economic 
status is necessary. Failure to do 
so may disadvantage hospitals 
serving primarily deprived com-
munities.
To use RR as a valid indicator, 
the score must be corrected for 
substantial over-dispersion by 
using the random effects model.
Emergency RRs after day case 
admissions and after elective 
abdominal hysterectomy are 
suitable comparative measures, 
excluding those records with a 
cancer diagnosis. However, the 
measure should not be used 
to make definitive judgments 
about hospitals.
The external validation pro-
cedure of record linkage is 
feasible, efficient, and informa-
tive about identifying the source 
of errors.
Some support for 28 days as a 
valid time window for conges-
tive heart failure patients. Little 
support for 28 days as a valid 
time window in defining RA for 
patients with COPD and stroke.
Evaluative 
retrospective 
cohort study
Modeling 
approach
Prospective 
observa-
tional cohort 
study
Retrospective 
analysis
Descriptive 
feasibility 
study
Validation of 
probabilistic 
record link-
age
Modeling 
approach
To investigate the validity of 
the Danish Cholecystectomy 
Database (DCD) by evaluating 
the association between PIs cal-
culated from this database and 
post-operative complications. d,e
To demonstrate the effects of dif-
ferent time intervals to calculate 
RR. (under investigation, c)
To examine the effect of patient 
and disease factors on the risk of 
emergency medical RA. b,c
To test different options for 
handling over-dispersion of per-
formance indicators. c,d
To identify suitable outcome 
measures for comparing gyne-
cology performance between 
hospitals. c,d
To describe an efficient, gener-
alizable approach to validate 
probabilistic record linkage re-
sults and to apply this approach 
to validate linkage of admissions 
of newborns. (n.a.)
To develop a modeling ap-
proach to tackle the issue sur-
rounding the appropriate choice 
of a time window as a definition 
of RA. (under investigation, c)
Harboe, 
2009, 
Denmark19
Heggestad, 
2003, 
Norway31
Lyratzo-
poulos, 2005, 
UK33
Spiegel- 
halter, 
200534
Mason, 
2006, UK37
Tromp, 2007, 
The Nether-
lands22
Demir, 2008, 
UK32
Validity 
factors
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The recommended measures 
(RR and mortality rate) should 
not be used to make definitive 
judgments about hospitals, but 
as pointers as to where further 
investigation is needed. They 
minimize case-mix differences 
and have sufficient numbers for 
comparison analyses. Inac-
curate and incomplete coding 
are potential violations of the 
validity of the indicator.
Descriptive 
feasibility 
study
To apply 10 of the AHRQ 
indicators for use in English 
routine hospital admissions data 
as the first step in validation, and 
describe their rates in relation to 
established measures of nega-
tive outcome. c,d
Bottle, 2009, 
UK21
a:Inferences are made when authors do not describe topic clearly. b: Time window larger than within 30 
days. c: Unplanned/emergency readmissions. d: Time window within 30 days. e: All readmissions. f: Un-
planned and avoidable. g: Avoidable readmissions. h:Unforeseen and avoidable. i: Time window within 14 
days. n.a.= not applicable, RR= Readmission Rate, RA=Readmission.
A definition that often lacks precision
The identified studies learned that the time windows and the criteria ‘avoid-
able’ and ‘unplanned’ were the main issues threatening the validity of this 
indicator. It seems that there is a large variability in the time range between 
discharge and readmission as it ranged from ‘14 days’,27 to ‘within 180 days’.18 
The largest number of articles however, calculated readmissions within 30 
days (28 to 30; n=11).16,17,19-21,24-26,28,34,36 The rest used either a time range within 14 
days (n=1),27 or a time frame larger than 31 days (n=5).18,23,29,33,35 From the total 
of 19 applicable studies, 10 defined the readmission as unplanned/emergen-
cy, 17,21,23,24,29,31-34,36 one defined it as avoidable18 three studies used both avoid-
able and unplanned/emergency (see symbols in Table 1).25,26,35
Different options for adjusting to patient and disease characteristics
Six studies examined to what extent patient characteristics, demographical, 
social and medical factors, affected the RR.16,17,27,29,33,34 Two out of them spe-
cifically investigated the increase in risk to be readmitted for various patient 
dependent variables.29,33 First, Kossovsky et al.,29 investigated heart failure 
patients in a case-control design and observed a significant increase of re-
admission risk for: previous diagnosis of heart failure, age, history of cardio 
revascularization. Odds ratio’s varied from 1.14 (poor readiness for discharge) 
to 4.1 (age, for patients > 80). In addition the authors observed an associa-
tion between readiness for discharge and a subsequent early readmission. 
The second one33 conducted a case-control design and observed the fol-
lowing significant predictors of all cause readmission: male sex, age, number 
of coded co morbidities, admission via GP referral (decrease in risk), primary 
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2
diagnosis of heart failure and of chronic obstructive pulmonary disease or 
asthma, and higher level of deprivation. Hazard ratio’s varied from 0.93 (ad-
mission via GP referral) to 1.49 (> 4 coded co morbidities). 
Three studies investigated the possibility to apply satisfactory risk adjustment 
for patient-related factors,16 descriptively compared the rates between differ-
ent medical specialties,17 or statistically compared the rates between medi-
cal and patient characteristics.27 In all, there was some evidence for the in-
fluence of male gender, age, length of stay, previous hospitalization within 6 
months, life threatening diseases that are prone to serious disability or com-
plications (cancer, heart disease, high risk surgery) and disease categories 
such as nephrology and haematology. The last one addressed the effects of 
hospital factors on the variability between unadjusted readmission rates from 
various care institutions (so called over-dispersion), by investigating different 
options to reduce this variability.34
Finally, the resulting two studies investigated the time window to calculate 
the RR. While one study32 used a modelling approach on nationally collected 
hospital data on three disease groups (COPD, stroke and CHF) and Bayesian 
classification to determine an appropriate time window, the other study ap-
plied a conceptual model to analyse all-cause unplanned readmissions (with-
out cancer and obstetrics readmissions) on the basis of the characteristics of 
the risk, or hazard curve.31 Whereas Demir et al.32 observed some support for 
the 28 days time window in congestive heart failure patients, to Heggestad31 
it seems that the time used to calculate the readmission is largely dependent 
upon the reason why the RR is measured.
46
DISCUSSIoN
In short, the aim of this literature review was to investigate the validity behind 
the RR indicator, used within the European health care systems. The results 
revealed a substantial increase of studies reporting on the use of the RR as 
an outcome since 2004, of which the majority of the papers originated from 
the UK. However, the amount of research on the validity of the indicator stays 
relatively behind in comparison with the total increase in studies. Reviewing 
the content of the articles that used the RR but did not investigate its validity 
learned that only a small number specifically defined how the RR was mea-
sured and even a smaller part of the studies used recommended unplanned 
readmissions. Exploring the validity studies, however, learned that the major-
ity cast doubt on its validity in the European setting. The studies highlight sub-
stantial problems with respect to the adjustment of factors that are beyond 
medical control but increase the risk to be admitted, the degree to which 
avoidable readmissions can be accurately detected and the time window 
that is used to detect relevant readmissions. 
limitations
Some limiting aspects of the methods used in our current review require fur-
ther discussion. First, the search was limited to PubMed and Medline, other 
databases were not addressed. Further, in our methods we mentioned that 
papers were excluded not providing English full texts. As such, the total num-
ber of validity studies presented in this literature review is an underestimation 
of the total number. In our opinion, however, the observations reported in 
this review are of a robust character and it seems unlikely that inclusion of 
non-English literature would change the scope and conclusions. Also, as the 
research field of performance indicators is relatively young, sensitive search 
terms are not well established yet. Our experience showed that a combina-
tion of self-entered search terms and selecting relevant MeSH terms revealed 
the most appropriate articles.
the time window needs to be in accordance with the type of disease 
The reported differences in whether RR is valid or not might be explained by 
the various ways that were used to measure the RR (e.g time window used). 
Our review showed similar variety in the use of time windows as the number 
of days between discharge and readmission ranged from 14 days post-dis-
charge, to 180 days. Most validity studies calculate the RR on basis of early 
readmissions within 30 days, whereas the majority of the articles using the 
indicator as an outcome measure use a timeframe > 30 days. According 
to Heggestad,31 it seems that the time used to calculate the readmission is 
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2
largely dependent upon the reason why the RR is measured, and whether it 
is important to have a sensitive or a specific measure. Also, the optimal time 
window is largely dependent on the type of disease the patient was originally 
treated for.32
Readmission needs to be avoidable and unplanned 
Not only the time window varied, the type of readmission that is included 
varied as well, as some counted all and others counted only unplanned re-
admissions. The importance of this distinction is shown in the conflicting results 
regarding the validity of the RR, in studies that included all readmissions com-
pared to those only including unplanned readmissions. Despite the fact that 
unplanned readmissions are more likely to be related to substandard care 
than planned readmissions, our review showed that in European publications 
this distinction is not always made. Perhaps this is caused by the difficulty to 
distinguish between planned and unplanned readmissions. Kossovsky,23 in-
deed, concludes that an administrative database that consists of (discharge) 
diagnosis and procedure codes alone is not sufficient for that purpose. How-
ever, even the inclusion of unplanned readmissions might not be valid as un-
planned readmissions could well be caused by a new infection that is not re-
lated to the previous hospital stay.26 Instead, it is argued to focus on potentially 
avoidable readmissions that are unforeseen at time of discharge. In all, on the 
basis of their literature appraisal, Rumball-Smith and Hider37 recommend that 
the RR can be defined as following: ‘the number of patients who experienced 
unintended, acute readmission or death within 30-days of discharge from the 
index admission, divided by the total number of patients discharged alive 
within the reference pool’ (p.63).
Case-mix factors have to be taken into account
Medical and demographical patient characteristics9 such as the severity and 
complexity of the diagnosis of the readmitted patient, the length of stay,6,13 
and age and socio-economic status, seem to influence the validity of the 
RR as well.38 The number of factors that could potentially affect the RR seems 
numerous, but male sex, age, number of coded co morbidities and the dis-
ease that a patient was treated for are important factors to take into account 
when measuring the RR. 
Conclusion
With this article, we hope to increase the awareness on the methodological 
pitfalls of performance indicators and stimulate research activities on their 
validity in different national set-ups in Europe. Our literature study showed that 
a performance indicator of US origin, such as the RR, is increasingly used in 
48
Europe. However, the amount of research performed on its validity remained 
scarce. Those studies that do report on its validity replicate earlier findings 
from mainly the USA (<1999) of methodological problems such as the lack of 
a uniform definition, the impact of case-mix factors and the questionable reli-
ability of the databases used to compute the RR. 
It seems that a ‘best recipe’ to calculate the RR in a valid way does not exist. 
Clarke (2004) nicely summarizes the challenges that arise when calculating 
the RR. The author suggests stopping using this indicator altogether, particu-
larly when it is calculated from routine data sources and used for the com-
parison of readmission rates between different hospitals on a macro (nation-
al) level. Many databases do not allow for the tracking of patients from one 
hospital to another, as unique patient identifiers are less frequently used within 
the health care context. As a consequence, patients that are readmitted to 
another hospital, something that particularly happens with patients that are 
dissatisfied with the care they received, are missed in the calculation.30 Wal-
raven et al.39 conclude that the true proportion of potentially avoidable read-
missions is simply unclear.
Implications 
The validity of the measure has to be strengthened for its user’s purpose (i.e. 
managers, policy makers, and developers). Moreover, the actual purpose of 
the indicator is important when studying its validity as each type of use (ac-
countability, improvement, consumer information, pay-for-performance) may 
place different demands on the degree of validity.40,41 Further it is suggested 
to pay attention to test and enhance the indicators’ local validity. 
In sum, performance indicators are not those easy obtainable measures of 
health care quality as most users would like them to be. In fact, insufficient 
validity of performance indicators seems to be a more common problem42 
as can be learned from the research field of the Hospitalized Standardized 
Mortality Rates.43
Nevertheless, if the RR is measured as an indicator of quality of care, it is best 
to ensure that these readmissions are related to the index admission, are un-
planned or even better, can be identified as avoidable. Secondly, the time 
window that is used to calculate the readmissions should be adapted to the 
type of care that is investigated and thirdly, the data used for calculating the 
indicator should have undergone reliability analysis. The data quality need to 
be of such high standard that the readmissions can be accurately related to 
an index admission and that patient-specific information is available to adjust 
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2
for patient factors. Only under these circumstances does the RR provide use-
ful information about the quality of care a hospital performs.
Keypoints
Despite the increase (between 1999 and 2009) in the European use of the 
readmission rate as a measure of quality of care in Europe, the amount of 
research performed on its validity remains scarce.
Those studies that do report on the validity of the readmission rate as a 
quality indicator replicate earlier findings from mainly the USA(<1999), of 
methodological problems such as the lack of a uniform definition, the 
impact of case-mix factors and the questionable reliability of the data-
bases used to compute the readmission rate. 
When readmission rates are increasingly used for public reporting or 
performance payment programs, it seems worthwhile investigating their 
local validity before using them on a large scale for management and 
policy purposes. 
Users should address issues related to the indicators’ definition, time-
frame and case-mix correction as part of the process to enhance valid-
ity in the European settings.
•
•
•
50
ReFeReNCeS
1. Mainz J. Defining and classifying clinical indicators for quality improvement. International Journal for 
 Quality in Health Care 2003;15(6): 523-530.
2. Worning AM, Mainz J, Klazinga N, Gotrik JK, Johansen KS. (Policy on quality development for the medi-
cal profession). Ugeskr Laeger 1992; 154:3523-3533.
3. AHRQ Agency for Healthcare Research and Quality. Refinement of the HCUP Quality Indicators: http://
www.ahrq.gov/clinic/epcsums/hcupqisum.htm Accessed (27.11.2010).
4. Brook RH, McGlynn EA, Shekelle PG. Defining and measuring quality of care: a perspective from US 
researchers. Int J Qual Health Care. 2000;12(4):281-295. 
5. Ashton CM, Del Junco DJ, Souchek J, Wray NP, Mansyur CL. The association between the quality of inpa-
tient care and early readmission: a meta-analysis of the evidence. Med Care. 1997; 35(10):1044-1059. 
6. Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L. The association between the quality of inpatient 
care and early readmission. Annals of Internal Medicine. 1995. 122(6): 415- 421.
7. Cakir B, Gammon G. Evaluating readmission rates: how can we improve? South Med Journal. 2010. 
103(11):1079-1083.
8. Ashton CM, Wray NP. A conceptual framework for the study of early readmission as an indicator of qual-
ity of care. Soc. Sci. Med. 1996; 43(11): 1533-1541.
9. Ashton CM, Kuykendall DH, Johnson ML, Wray NP. An empirical assessment of the validity of explicit and 
implicit process-of-care criteria for quality assessment. Med Care. 1999; 37(8):798-808.
10. Wray NP, Peterson NJ, Souchek J, Ashton CM, Hollingsworth JC. Application of an analytic model to 
early readmission rates within the department of veterans affairs. Med Care. 1997;35(8):768-781. 
11. Weissman JS, Ayanian JZ, Chasan-Taber S, et al. Hospital readmission and quality of care. Med Care. 
1999; 37(5):490-501. 
12. Hannan EL, Racz MJ, Walford G., et al. Predictors of readmission for complications of coronary artery 
bypass graft surgery. JAMA 2003;290(6):773-780. 
13. LaVela SL, Smith B, Weaver FM, Miskevics SA. Geographical proximity and health care utilization in vet-
erans with SCI&D in the USA. Social Science & Medicine. 2004:59 (11):2387-2399.
14. Fisher ES, Wennberg JE, Stukel TA, Sharp SM. Hospital readmission rates for cohorts of medicare benefi-
ciaries in boston and new haven. The New England Journal of Medicine. 1994:331(15):989-995. 
15. Romano P. Selecting Indicators for Patient Safety at the Health Systems Level in OECD Countries. 
Summary of recent US experience. 2007. Entered at 22.03.2011: http://www.oecd.org/datao-
ecd/44/29/39495326.pdf
16. Halfon P, Eggli Y, Prêtre-Rohrbach I, Meylan D, Marazzi A, Burnand B. Validation of the potentially avoid-
able hospital readmission rate as a routine indicator of the quality of hospital care. Medical Care 
2006;44(11):972-981. 
17. Leng GC, Walsh D, Fowkes FGR, Swainson CP. Is the emergency readmission rate a valid outcome indi-
cator? Quality in Health Care. 1999;8:234-238. 
18. Jiménez-Puente A, García-Alegría J, Jorge Gómez-Aracena et al. Readmission rate as an indicator 
of hospital performance: The case of Spain. International Journal of Technology Assessment in Health 
Care 2004;20(3):385-391. 
19. Harboe K M, Anthonsen K, Bardram L. Validation of data and indicators in the Danish Cholecystectomy 
Database. International Journal for Quality in Health Care 2009; 21 (3):160-168. 
20. Luthi JC, Burnand B, McClellan WM, Pitts SR, Flanders WD. Is readmission to hospital an indicator of poor 
process of care for patients with heart failure? Qual Saf Health Care 2004;13:46-51. 
21. Bottle A, Aylin P. Application of AHRQ patient safety indicators to English hospital data. Qual Saf Health 
Care 2009; 18(4):303-308.
22. Tromp M, Ravelli ACJ, Méray N, Reitsma JB, Bonsel GJ. An efficient validation method of probabilistic 
record linkage including readmissions and twins. Methods Inf Med 2008;47:356-363. 
23. Kossovsky MP, Sarasin FP, Bolla F, Gaspoz JM, Borst F. Distinction between planned and unplanned read-
missions following discharge from a department of internal medicine. Meth Inform Med 1999;38:140-143.
24. Adeyemo D, Radley S. Unplanned general surgical re-admissions – how many, which patients and why? 
Ann R Coll Surg Engl 2007; 89: 363–367.
C
ha
pt
er
 2
   
Th
e 
va
lid
ity
 o
f t
he
 q
ua
lit
y 
in
d
ic
a
to
r r
ea
d
m
iss
io
n 
ra
te
 in
 th
e 
Eu
ro
p
ea
n 
lit
e
ra
tu
re
51
2
25. Courtney ED, Ankrett S, McCollum PT. 28-Day emergency surgical re-admission rates as a clinical in-
 dicator of performance. AM R Coll Surg Engl 2003;85:75-78. 
26. Halfon P, Eggli Y, Melle G, Chevalier J, Wasserfallen J, Burnand B. Measuring potentially avoidable hos-
pital readmissions. J Clin Epidemiol 2002;55(6):573-587.
27. Shalchi Z, Saso S, Li HK, Rowlandson E, Tennant RC. Factors influencing hospital readmission rates after 
acute medical treatment. Clinical Medicine 2009; 9(5):426-430. 
28. Pearson B, Skelly R, Wileman D, Masud T. Unplanned readmission to hospital: a comparison of the views 
of general practitioners and hospital staff. Age and Ageing 2002; 31: 141-143.
29. Kossovsky MP, Sarasin FP, Perneger TV, Chopard P, Sigaud P, Gaspoz J. Unplanned readmissions of pa-
tients with congestive heart failure: Do they reflect in-hospital quality of care or patient characteristics? 
The American journal of medicine 2000;109:386-390. 
30. Clarke A. Readmission to hospital: a measure of quality or outcome? The value of readmission to hospi-
tal as a quality indicator is still debatable. Qual Saf Health Care 2004;13:10-11.
31. Heggestad T, Lilleeng S E. Measuring readmissions: focus on the time factor. International Journal for 
Quality in Health Care 2003;15(2):147-154.
32. Demir E, Chaussalet TJ, Xie H, Millard PH. Emergency Readmission Criterion: A Technique for Determin-
ing the Emergency Readmission Time Window. IEEE Trans Inf Technol Biomed 2008:12(5);644-649. 
33. Lyratzopoulos G, Havely D, Gemmell I, Cook GA. Factors influencing emergency medical readmission 
risk in a UK district general hospital: A prospective study. BMC Emergency Medicine 2005;21:5:1. 
34. Spiegelhalter DJ. Handling over-dispersion of performance indicators. Qual Saf Health Care 
2005;14:347-351.
35. Maurer PP, Ballmer PE. Hospital readmissions – are they predictable and avoidable? Swiss med wkly 
2004;134:606-611. 
36. Mason A, Goldacre M, Meddings D, Woolfson J. Use of case fatality and readmission measure to com-
pare hospital performance in gynaecology. BJOG 2006;113:695-699.
37. Rumball-Smith J, Hider P. The validity or readmission rate as a marker of the quality of hospital care, and 
a recommendation for its definition. New Zeeland Medical Journal 2009 13; 122: 32-39.
38. Corrigan JM, Martin JB. Identification of factors associated with hospital readmission and development 
of a predictive model. Health Serv Res. 1992; 27(1):82-101. 
39. Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: a 
systematic review. CMAJ. 2011 Apr 19;183(7):391-402. 
40. Pronovost PJ, Goeschel CA. Viewing health care delivery as science: challenges, benefits, and policy 
implications. Health Services Research. 2010;45(5 Pt 2):1508-1522.
41. Klazinga N, Stronks K, Delnoij D, Verhoeff A. Indicators without a cause. Reflections on the development 
and use of indicators in health care from a public health perspective. International Journal for Quality 
in Health Care 2001; 13(6): 433-438
42. Stelfox TH, Straus ES, Nathens A, Bobranska-Artiuch B. Evidence for quality indicators to evaluate adult 
trauma care: A systematic review. Crit Care Med 2011; 39 (4): 1-14.
43. Lingsma HF, Dippel DW, Hoeks SE, Steyerberg EW, Franke CL, van Oostenbrugge RJ, de Jong G, Simoons 
ML, Scholte op Reimer WJ, and The Netherlands Stroke Survey investigators. Variation between hospitals 
in patient outcome after stroke is only partly explained by differences in quality of care: results from the 
Netherlands Stroke Survey. J Neurol Neurosurg Psychiatry 2008; 79:888-894;

Chapter 3.
a systematic review on 
the reliability and validity 
of the quality indicator 
readmission rate
Claudia Fischer, Hester F lingsma, Perla J marang-van de mheen, 
Dionne S Kringos, Niek S Klazinga, ewout W Steyerberg
This article was published as: 
Is the readmission rate a valid quality indicator? A review of the evidence. 
PLoS ONE. 2014; 9(11):e112282.

55
aBStRaCt
Background: Hospital readmission rates are increasingly used for both qual-
ity improvement and cost control. However, the validity of readmission rates 
as a measure of quality of hospital care is not evident. We aimed to give an 
overview of the different methodological aspects in the definition and mea-
surement of readmission rates that need to be considered when interpreting 
readmission rates as a reflection of quality of care.
methods: We conducted a systematic literature review, using the biblio-
graphic databases Embase, Medline OvidSP, Web-of-Science, Cochrane 
central and PubMed for the period of January 2001 to May 2013.
Results: The search resulted in 101 included papers. We found that defini-
tion of the context in which readmissions are used as a quality indicator is 
crucial. This context includes the patient group and the specific aspects of 
care of which the quality is aimed to be assessed. Methodological flaws 
like unreliable data and insufficient case-mix correction may confound the 
comparison of readmission rates between hospitals. Another problem oc-
curs when the basic distinction between planned and unplanned readmis-
sions cannot be made. Finally, the multi-faceted nature of quality of care 
and the correlation between readmissions and other outcomes limit the 
indicator’s validity.
Conclusions: Although readmission rates are a promising quality indicator, 
several methodological concerns identified in this study need to be ad-
dressed, especially when the indicator is intended for accountability or pay 
for performance. We recommend investing resources in accurate data reg-
istration, improved indicator description, and bundling outcome measures 
to provide a more complete picture of hospital care.
3
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INtRoDUCtIoN
Readmissions cause a high burden to healthcare systems and patients. In 
the US nearly 20% of Medicare patients are readmitted within 30 days after 
hospital discharge, associated with an estimated annual cost of 17billion.1 
Readmissions are thought to be related to quality of care, for instance due 
to postoperative complications. As readmissions vary widely across coun-
tries, regions and centers, at least part of them might be avoidable.2-6 As a 
consequence, there is a high interest in the readmission rate as an indicator 
of quality of hospital care. Nevertheless, the actual way this indicator is used 
in different countries varies widely.
In the US, since 2009 all-cause hospital readmission rates for pneumonia, 
congestive heart failure, and acute myocardial infarction are publically 
reported by the Centers for Medicare and Medicaid Services (CMS).7 In 
2010, the Patient Protection and Affordable Care Act (ACA) introduced the 
Hospital Readmissions Reduction Program (HRRP), for cost controlling. The 
program included financial penalties for hospitals having high readmission 
rates, which will be extended in the coming years.8 In the UK, readmission 
rates for specific diseases have been published since 1998 by the National 
Centre for Health Outcomes Development (NCHOD) to improve quality.9 It 
was found that the crude emergency readmission rate had increased from 
about 8% in 1998 to about 10% in 2006.9 In response, the NHS started a new 
regulation for reimbursement payments in 2011: hospitals receive no reim-
bursement for emergency readmissions within 30 days of discharge follow-
ing an elective admission. All other emergency readmissions are reimbursed 
for only 25%.10 Since the year 2006 also the Australian government monitors 
28-day readmission rates to gain more insight in quality of care.11
Readmissions are used for different aims, such as cost control or as balanc-
ing measure for length of hospital stay or other outcome measures. However, 
in recent years the focus has primarily been on using it as an easily available 
measure of the quality of hospital care. Despite its use by policymakers for 
both quality improvement and cost control, the validity of readmission rates 
as a measure of quality of hospital care is not evident.12
However, in order to consider a quality indicator to evaluate care for ex-
ternal purposes it needs to fulfill certain criteria in regards to its reliability 
and validity. An indicator needs to show relevance, based on its impact on 
health, its importance for policy and its susceptibility to being influenced by 
the health care system. The assessment of an indicator needs to be feasible. 
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3
The data needed to calculate an indicator need to be available, reliable 
and need to be seen in relation to the burden of reporting. Further, an in-
dicator needs to show scientific soundness.13 In the case of the readmission 
rate, this suggests, that readmissions are determined by quality of hospital 
care, measured by structures and processes. This implies that we are inter-
ested in avoidable readmissions.
 
We aim to give an overview of the different methodological aspects in the 
definition and measurement of readmission rates that need to be consid-
ered when interpreting readmission rates as a reflection of quality of hospital 
care for external purposes.
58
metHoDS
A systematic computerized literature search was applied in the bibliograph-
ic databases Embase, Medline OvidSP, Web-of- Science, Cochrane central 
and PubMed for the period of 1st January 2001 to 27th May 2013.
With the search terms we aimed to cover quality indicators, quality mea-
surement and readmission. This resulted in the following search strategy, 
which was adapted for the different bibliographic databases: (‘clinical in-
dicator’/de OR ‘performance measurement system’/exp OR ‘quality control 
procedures’/de OR ‘quality control’/de OR ‘medical audit’/de OR (((qualit* 
OR perform* OR safet* OR governance) NEAR/3 (indicat* OR measure* OR 
assessment* OR control* OR marker* OR metric*)) OR ((clinical OR medical) 
NEAR/3 (indicator* OR audit*))):ab,ti) AND (‘hospital readmission’/de OR (re-
admiss* OR rehospital* OR ((re OR return) NEAR/3 (hospital* OR admiss*))):
ab,ti).
Studies were included when they were written in English, focused on meth-
odological aspects of readmission rates as a quality indicator for hospital 
care and full texts were available. We included only studies in major disease 
fields. Hence, studies focusing on rare diseases, just describing readmission 
rates over time or using readmissions as outcome measures of interventions 
were excluded.
Of the references identified in the literature search, titles and abstracts were 
screened and articles that did not meet the inclusion criteria were exclud-
ed. The full text of the remaining potentially eligible articles was reviewed to 
assess whether they should be included. In case of doubt, the article was 
discussed among the authors and if necessary, an independent researcher 
was consulted.
We discuss the methodological aspects that emerged from the literature 
review that are important for the validity of the readmission rates as an indi-
cator of quality of care.
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ReSUltS
Our search strategy resulted in 1609 unique references of which titles and 
abstracts were screened. Based on title and abstract 1189 studies were ex-
cluded. Of the remaining 420 articles another 319 were excluded based on 
full text review (Figure 1). We provide a detailed description of the included 
studies in the appendix, and below we discuss the most important findings. 
the context in which readmission rates are used
Prior to using the readmission rate as a measure of quality of care, the con-
text in which the indicator will be used needs to be clearly defined. The 
rationale for using readmission rates is one aspect of this context. The read-
mission rate can be used with the primary aim to improve quality of care or 
rather for reasons of cost control. Next, specification of the clinical processes 
of which quality of care is assessed is important. Currently, readmission rates 
are mostly intended to measure quality of care in hospitals. Which implies 
that the risk of being readmitted is determined by the quality of care deliv-
ered during the hospital stay. Yet, literature shows that the conditions after 
patients’ discharge, like the presence of a social network after discharge14 
as well as patients’ capacity for managing their own care, influence the 
likelihood of being readmitted.15,16 As a result, hospitals pay attention to im-
proving transitional care,17-24 for instance by patient education to prepare 
the patient for discharge and to coordinate outpatient follow up.23 Although 
such a transition phase may help, the actual post-discharge phase is not 
really in a hospital’s reach anymore. Another example are readmissions in 
chronic diseases, such as heart failure. These patients are readmitted often 
because of their comorbidities or because their condition becomes too se-
vere to be treated by the general practitioner, irrespective from the qual-
ity of delivered care during their hospital stay.1 Hence, the quality of care 
processes captured by readmission rates will often be broader than only 
in-hospital care.25
In summary, using readmission rates as a quality measure requires a clear 
definition of the context, including the rationale of measuring readmissions, 
the related care processes and the patient groups.
methodological aspects
Based on the literature we defined several methodological aspects that 
need to be considered when using the readmission rates as a quality indi-
cator (Table 1). These range from fundamental issues like the definition and 
the effect of competing outcomes, to more practical issues as the possibility 
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to adjust for case-mix and the data quality. These issues and their effects will 
be described in the next paragraphs. In the final paragraph we will focus 
on studies that have specifically tested the validity of readmission rates as a 
quality indicator.
Indicator definition
Type of readmission
The definition of readmissions determines the number of readmissions that 
will be counted (numerator). Planned procedures, such as staged opera-
tions, are readmissions that are not determined by quality of care and there-
fore should not be included in the numerator of the quality indicator.26,27 
However, this basic distinction is not always made.28 Hence, capture qual-
ity of care related readmissions requires a more specific definition (such as 
disease specific or emergency readmissions) rather than all-cause readmis-
sions.29
A frequently suggested alternative is to count unplanned readmission rates. 
However, not all unplanned readmissions are a result of poor quality of care 
as certain complications cannot be avoided. Research has shown that just 
about 25% of all readmissions are avoidable/preventable. Therefore, ide-
ally, the addition on whether a readmission was avoidable/preventable. 
Although high variation in overall readmission rate can be observed, this is 
not the case for the rate of preventable readmissions.2,29 Therefore, ideally 
it is defined, whether a readmission was avoidable/preventable (through 
proper care delivery)28,30 but the judgment on the preventability of a read-
mission remains subjective.2
1609
potentially relevant articles
420
full text articles reviewed
Figure 1. Flow chart of inclusion process
101
Articles included
1189
Excluded after title and abstract review
319
Excluded after full text review
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Time window 
The time window after the index admission in which admissions are regard-
ed as readmissions is not consistently defined in the literature. The indica-
tor is generally calculated on basis of readmissions within one month (28 
days UK, 31 days USA) regardless of the patient group and condition.28,31-33 
When choosing a time window, it needs to be considered that a too short 
time window might miss related readmissions while a large one increases 
the likelihood of included admissions unrelated to the index admission. For 
example, in cancer surgery a longer time frame would allow to provide a 
better overview of actual costs, but it would also include readmissions due 
to disease progression instead of poor quality of surgery.25 Clearly, the type 
of disease the patient was originally treated for is largely influencing the 
optimal timeframe.32 Therefore the timeframe for readmissions should be de-
fined per disease.
the effect of competing outcomes 
Association with (in-hospital) mortality
Mortality can be seen as a competing endpoint for readmissions: patients 
who die will not be readmitted.34,35 Therefore patients who died during their 
hospital stay need to be excluded from the denominator of the readmission 
rate. Further, hospitals with high 30-day in-hospital mortality rates are not 
necessarily outliers on the readmission rate as well.36 Research showed that 
the link between high readmission rates and mortality rates on hospital level 
is limited. A ‘modest’ inverse relationship was merely found for heart fail-
ure patients, and no relation could be observed for pneumonia and acute 
myocardial infarction, suggesting that the two indicators measure different 
aspects of quality of care, which are not strongly related.37 Therefore differ-
ent outcome measures, such as the readmission rate and the mortality rate 
should be brought in relation with each other to gain insight in total hospital 
performance.36,37
Association with length of in hospital stay 
Length of stay is generally decreasing, partly because of efficiency gaining 
interventions, such as a ‘just-in-time bed availability system’ to increase the 
bed turnover ratio.38,39 Research suggests a link between length of stay and 
the risk of being readmitted.39-45 For each day shorter in hospital, a 6% in-
crease in likelihood of readmission was found.40 Other studies fail to confirm 
this link,24,42,46-50 which might be due to inappropriate adjustment for disease 
severity.41,51
62
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Clinical 
setting
Type of 
readmission
Time window
Association 
with 
(in-hospital) 
mortality
Association 
with length 
of in-hospital 
mortality
methodological 
aspect
readmission rates are 
thought to reflect 
quality of hospital 
care17-24
missing distinction 
between planned/un-
planned procedures 
2,26-29
no consistent 
definition of the time 
window in which ad-
mission is considered 
as readmission28
generally 28-31 day 
time frame used 
regardless of patient 
group/condition31-33
a group of patients 
who receive poor 
quality of care are not 
readmitted, because 
they die or recover 
nevertheless31,34,35
a decreased length of 
hospital stay increases 
readmissions38,39
Problem
care after discharge 
also influences read-
mission14,25
inclusion of readmis-
sions unrelated to 
quality of care into the 
numerator26
leads to overestima-
tion of the rate of 
readmission 69
although 30 days 
seem generally suf-
ficient,31,33 for certain 
conditions it is a too 
short time window, 
while for others it in-
creases the likelihood 
of including admis-
sions unrelated to 
index admission25,32
not excluding patient 
who died from the 
denominator leads to 
a potential underesti-
mation of rate of qoc 
related readmission
the exact mechanism 
with readmission is 
inconclusive24,39,40,42-50
Potential solution
clear definition of the indicator, 
the patient group and the clinical 
setting(hospital care, integrated care) 
aimed to measure 
increase insight in influence of post 
discharge phase/social factors on 
readmissions14
relate readmission to other outcome 
measures such as mortality, emer-
gency department and observation 
service use14
evaluate home health care/nursing 
home information 15
specify definition of the indicator,27,28,31 
define disease-specific/emergency 
readmissions instead of overall read-
missions2
include indication on preventability/
avoidability of readmission in defini-
tion2,28-30
evaluate time frame based on condi-
tion under evaluation
exclude patients who died during 
hospital stay from denominator
link hospital data with death statistics, 
exclude patients from denominator 
who die outside hospital
relate the readmissions with mortal-
ity rate in order to understand total 
hospital performance36,37
further research to understand the 
mechanism between length of stay 
and readmission
Indicator definition
effect of competing outcomes
table 1. Overview of methodological aspects challenging the validity of re-
admission rates for benchmarking
qoc – quality of care
63
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Case-mix 
correction 
using admin-
istrative data 
vs. clinical 
data
Missing read-
missions to 
other institu-
tions
Coding
Complete-
ness and 
accuracy of 
data source
Validity of 
readmis-
sion rates 
as a quality 
measure
no consensus on 
which patient charac-
teristics affect read-
mission likelihood27,52
two high risk groups 
defined: the sickest 
and the poorest2,51,53,54
patients are readmit-
ted to institutions other 
than index hospital25,35
coding practice influ-
ences the validity re-
admission rates30,58,77-84
no conclusion on how 
to register readmis-
sions potentially 
related to qoc in reli-
able way2,59-61
reliable data col-
lection systems are 
lacking38
Readmissions are 
mainly calculated 
based on administra-
tive data16,63
administrative data 
suffer from inaccu-
racy, like non-exact/
incomplete registra-
tion of variables not 
relevant for financial 
concerns39,40,64-69
no gold standard on 
how to assess qoc in 
the literature
huge variation in con-
clusions in regard to 
the validity of the read-
mission indicator71-113
these factors are not 
standard variables in 
risk prediction models 
as often not avail-
able in administrative 
databases36 
current risk predic-
tion models perform 
moderately39,40,55-57
patients cannot 
always be followed 
between centers; 
only readmissions to 
same institutions are 
measured
assessing ‘same 
hospital’ readmissions, 
might be underes-
timation of the real 
number of readmis-
sions25
missing distinction 
between planned/un-
planned procedures 
leads to overestima-
tion of real readmis-
sion
variation in cod-
ing leads to biased 
comparison between 
hospitals
incomplete registra-
tion may lead to 
over/underestimation 
of real readmission
inaccurate indica-
tion of readmissions 
related to qoc may 
lead to overestimation 
of readmissions64,65
potentially invalid 
conclusions on qoc
apply proper case-mix correction 
for patient characteristics including 
socio-economic status and disease 
severity39,51 
further research on risk prediction 
models including linkage of primary 
care data and data information
further research on the proportion of 
patients readmitted to other hospitals 
than index hospital
unique patient information to follow 
patients between centers
increase investment in performance 
measurement systems16
research on data reliability28
 standardized data registry (electron-
ic data systems)16,62
engagement of the provider in mea-
surement, analysis and interpretation 
of the indicator16,64
aim for minimum data set with com-
plete registration
registration of unique patient identify-
ing information to enhance possibility 
for linking data(such as pharmacy 
data)70
enhancing linkage opportunities in-
creases possibility for better case-mix 
correction
above described methodological 
conditions need to be taken into 
account when further investigating 
readmissions as a quality indicator
additional data gathering for further 
investigation of outlier hospitals93
Data reliability
64
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Case-mix correction 
The likelihood that a patient is readmitted is not only affected by quality of 
care but also by characteristics of the patient. Between-hospital differences 
in readmission rates may be caused by differences in patient population 
and therefore readmission rates need to be adjusted for patient charac-
teristics. Although many case-mix correction models for readmissions have 
been developed, there is little consensus on which patient characteristics 
affect the likelihood of a readmission.27,52 Numerous studies, varying in their 
methodology, geographical characteristics, patient groups and consid-
ered variables, find different factors that increase the risk of re-admission. In 
general, two patient groups seem to be at a high risk of being readmitted: 
the sickest and poorest patients.2,20,51,53,54 However, these factors are often 
not included as standard variables in case-mix correction models, as these 
models are often based on administrative data and therefore miss detailed 
clinical information.
In a review that evaluated 30 validated readmission risk prediction mod-
els, the authors concluded that most models had poor predictive ability. 
Almost all studies had c-statistics less than 0.70,55 possibly due to missing 
demographic or clinical variables. In a more recent paper, the prediction 
model reached a higher predictive ability (c-statistic = 0.80).41 The authors 
concluded however that information on demographics, SES, prior utilization 
and diagnosis still had restricted predictive power.41 Thus, current research 
provides limited guidance on which variables should be included in models 
to adjust for case-mix.41,55-57 
Data reliability 
Missing readmissions to other institutions 
Not all patients are readmitted to the same center where they had their 
index admission. This is mainly due to the centralization of complex opera-
tions in tertiary centers, such as in oncology.25 When patients unexpectedly 
develop complications and are readmitted in their local center, they are 
not captured when only readmissions to the ‘‘same hospital’’ are counted.25 
Missing these patients leads to an underestimation of the true overall read-
mission rate.
Coding
The coding practice within a hospital has an essential impact on the valid-
ity of readmission rate as a quality indicator.58 The way a ‘‘planned’’ pro-
cedure is defined is crucial for the comparability between hospitals. Ide-
ally a planned readmission is coded in the registration system, for example, 
65
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with an additional coding element ‘‘staged’’ at the index admission, which 
would indicate that a follow-up procedure is planned.59
Urgent readmissions are sometimes considered as a potential proxy for the 
relatively subjective ‘avoidable readmissions’, as these are coded, for ex-
ample an admission through the ER. Although low urgent readmission rates 
showed to be related to low avoidable readmission rates60 it was shown that 
the ‘‘avoidability’’ of urgent readmissions also significantly varied by the 
time from discharge, with early readmissions being more likely to be avoid-
able.2,61
Other causes for biased comparisons between hospitals are the different 
and unspecific definitions of the type of readmissions assessed, and varia-
tion in coding between hospitals. It is essential who is in charge of the cod-
ing process. For example administrative staff at the department or hospi-
tal level, the treating clinician, or specialized data coders. The variation in 
coding practice may affect both the readmission rates and the case-mix 
variables.
Completeness and accuracy of data source
Electronic health records and health information exchange networks re-
sult in more accurate and complete clinical data.62 The major information 
source to calculate the readmission rate is administrative data. The advan-
tage of administrative data is that this data is standard available and pa-
tient journeys can be followed (within hospitals).63 Nevertheless, one major 
limitation of administrative data is the data inaccuracy,64 which includes the 
non-exact or incomplete registration of variables that are not relevant for 
financial concerns.38,40,41 Research showed that to a certain degree admin-
istrative data captures similar information compared to medical records, for 
example on all-cause readmissions.65-68 However more specific information, 
like the identification of unplanned readmissions or index procedure related 
readmissions, showed to be more difficult to extract.66,69 An accurate indica-
tion of whether a readmission is a part of treatment or due to a cancelled 
procedure and not a readmission related to a quality of care problem, 
would enhance the reliability of the data source.64,65
The case-mix correction variables that have been investigated so far are 
most often present in administrative databases. However, clinical informa-
tion such as disease severity is often lacking limiting case-mix correction 
possibilities. The addition of a unique patient identifier across different da-
tabases would enhance the possibility for linking data, such as pharmacy 
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data70 or clinical data. This would largely improve the possibilities for more 
precise definitions of readmissions and better case-mix correction.
Validity of readmission rates as a quality measure
No gold standard exists on how to assess quality of care. Usually different 
hospital structures and processes and their relation with patient outcomes 
are measured. The different definitions and proxies used in studies to quan-
tify quality of hospital care influence whether an association between the 
readmission rate and ‘quality’ is found. For example, we found studies that 
relate readmissions to hospital volume, but neither can be regarded as a 
‘gold standard’ of hospital quality.
Furthermore, the methodological aspects we discussed have a potential 
influence on the validity of the readmission rates as a quality indicator. These 
may contribute to the huge variation in conclusions with regard to the valid-
ity of readmission rates found in the literature. Different studies in different 
patient groups and conditions come to the conclusion that lower quality 
of hospital care is linked to a higher number of readmissions.71-94 Especially 
safety-related events (such as postoperative complications) show a relation 
with readmissions.71,95 Rosen and colleagues, who evaluated the correlation 
between patient safety indicators and readmissions, showed that patients 
who experienced a patient safety event had an increased risk of readmis-
sion.71 Nevertheless, there are also studies that are inconclusive,96-101 show an 
inverse relationship102,103 or no relationship at all between readmission rate 
and in-hospital quality of care.98,104-113 Analysis of additionally collected data 
could help to gain insight into outlier hospitals in order to understand driving 
mechanisms behind high readmission rates.93
67
3
DISCUSSIoN
This review aimed to summarize the methodological aspects that need to 
be considered when using the readmission rate as a measure for quality of 
hospital care for external purposes. We found that the validity of readmis-
sion rates as a quality indicator is influenced by the clinical process that is as-
sessed, the indicator definition, the extend of case-mix correction, the effect 
of competing outcomes and the data reliability. Ignoring or poorly handling 
these aspects may lead to a biased estimation of the overall readmission 
rate and a biased comparison of readmission rates between hospitals. As a 
result of variance in handling these methodological threats, studies on the 
validity of readmission rates as a quality indicator reach conflicting conclu-
sions. We conclude that given the limitations of readmission rates, they need 
to be used with caution as a measure of in-hospital quality, even more when 
used as a tool for a pay for performance scheme.
Some of the discussed factors concerning the readmission rate could in 
principal be improved by investing resources in accurate data registry and 
refinements of indicator description. For instance, by using unique patient 
identifiers to follow patients across centers. That would help to avoid missing 
readmissions to other institutions. Another option would be to flag planned 
admissions, which are a part of the treatment plan or due to cancelled pro-
cedures, to measure just the quality of care related readmissions.
Other problems, such as the competing endpoint ‘mortality’ are more com-
plex. Patients who died in hospital need to be excluded from the patient 
group forming the denominator to calculate the readmission rate, as they 
are not at risk any more to be readmitted. These deaths are captured in the 
mortality rate. Therefore it is essential to combine outcome in order to pro-
vide a more complete picture of the quality of hospital care.
Nevertheless there are theoretical considerations whether a readmission is 
an indication of bad quality of care. First, a readmission is obviously a more 
positive outcome than dying. Secondly, if there is for example a chance of six 
percent that a complication occurs after discharge, it would mean that 100 
patients need to be admitted longer, to avoid a complication in six patients.114 
It can be questioned whether by a longer length of hospital stay a complica-
tion really can be avoided or only detected at an earlier stage. It is also possi-
ble to inform the patient on the risk of developing a complication and decide 
together how to continue. Furthermore, it needs to be taken into account that 
readmissions are not always solely determined by quality of hospital care. For 
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certain diseases, like heart failure, the patient’s condition is the major driver 
behind repeated admissions. Patients with low socio-economic status, elderly 
and patients with co-morbidities are at high risk of getting readmitted. There-
fore case-mix correction is essential. Furthermore, the role of facilities outside 
the hospital and after the 30-day time window, like community services, need 
to be involved in the conceptual framework of readmissions. When aiming to 
improve quality of care (in and outpatient) increased integration and coop-
eration between primary and secondary care is needed.
The literature study revealed inconclusive results for some methodological 
aspects, such as the relation with length of stay, or patient characteristics. 
The studies we assessed investigated different patient populations and of-
ten were based on hospital administrative data. A recent high quality study 
which was not included in our review investigated surgical readmissions of 
479 471 patients from 3004 hospitals. The authors found that higher surgi-
cal volume was significantly related with lower composite readmission rates 
(upper volume quartile 12.7% vs. lower volume quartile 16.8% P,0.0001), and 
hospitals with the lowest surgical mortality rates had significantly lower re-
admission rates (lower mortality quartile 13.3% vs. upper mortality quartile 
14.2% P,0.0001). But high adherence to surgical process measures was only 
marginally linked with lower readmission rates (highest quartile vs. lowest 
quartile, 13.1% vs. 13.6%; P = 0.02), showing that it is still unclear whether low 
readmission rates are the result of good quality.115
Furthermore, the risk of getting readmitted is also varying between patient 
groups and conditions. This supports the idea that outcome measures, like 
the readmission rate, are not a one size fits all measure. Even if quality of 
hospital care and the transition phase can potentially be improved, read-
missions might be a more applicable measure for certain diseases than for 
others. For chronic diseases, where planned admissions are part of treat-
ment strategies, readmissions are a less suitable performance measure. At 
least not until generally used data systems can identify planned admissions 
with high certainty. It requires clinical knowledge to determine whether 
(avoidable) readmissions may theoretically represent poor quality of care 
for specific diseases. Consequently more research is needed to build reli-
able algorithms to identify avoidable readmissions.
In sum, avoidable readmissions are of high relevance, as they are an adverse 
event to patients and family and are a high financial burden for healthcare 
systems. The assessment of the indicator shows difficulties, as the indicator 
definition is often not explicit enough to identify readmissions related to qual-
69
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ity of care (avoidable readmissions). The data used to calculate the indicator 
is mainly administrative data, which generally includes incomplete and inac-
curate data elements and lacks clinical information. Furthermore, in many 
countries readmissions to other institutions cannot be followed. Readmission 
rates are influenced also by other factors than quality of hospital care, which 
include length of stay, (in-hospital) mortality and patient characteristics. The 
magnitude of influence is partly not know as data is missing to investigate 
the association (e.g. no post discharge mortality, no clinical characteristics). 
Further, the scientific evidence of the indicator is limited, as existing research 
shows conflicting results with regard to the influence of quality of hospital 
care on the readmission rate (see Appendix 1). This, however, could be re-
lated to the prior mentioned methodological aspects that are variously.
Using outcome measures externally to measure and compare hospital perfor-
mance has consequences. When financial consequences are linked to the 
outcome, unintended effects could occur. For example, hospitals may try to 
reduce their readmission to escape the penalty of exceeding the readmission 
rate by lowering admissions, moving readmissions after the 30-day window, 
or risk-avoidance in regards to high risk groups. These gaming efforts might 
reduce the focus on the actual intention: improving quality of hospital care.
A measure used for external purposes should be underpinned with solid evi-
dence for its validity. However, the link between readmissions and the qual-
ity of hospital care seems not to be fully explained yet. Still, this does not 
imply that there is no room for improvement for hospitals in their readmission 
rate and the indicator could not be useful for internal use. Research should 
continue to gain insight in the driving mechanisms behind readmissions for 
the different conditions to improve our understanding how the readmission 
rate is a part of the quality of hospital care picture. In addition, the readmis-
sion rate needs to be brought into relation with other outcome indicators, 
and hence considered as part of a bundle, to understand all aspects of 
hospital performance.36
The methodological aspects we identified need to be considered when us-
ing readmission rates as quality indicator. The use of readmission rates for 
external quality purposes, such as for pay for performance requires strict 
methodological criteria to avoid confounding. At its current state the rate 
of readmission does not fulfill the methodological requirements of a reliable 
and valid indicator. Therefore the indicator should not be used for exter-
nal purposes. As this is nevertheless currently happening, readmission rates 
should be interpreted with great caution.
70
C
ha
pt
er
 3
   
A
 s
ys
te
m
a
tic
 re
vi
ew
 o
n 
th
e 
re
lia
b
ili
ty
 a
nd
 v
a
lid
ity
 o
f t
he
 q
ua
lit
y 
in
d
ic
a
to
r r
ea
d
m
iss
io
n 
ra
te
ReFeReNCeS
1. Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the Medicare fee-for-
 service program. N Engl J Med.360(14): 1418-28.
2. Van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ (2011) Proportion of hospital readmissions 
deemed avoidable: A systematic review. CMAJ. 183(7):E391-E402.
3. Krumholz HM, Merrill AR, Schone EM, Schreiner GC, Chen J, et al. (2009) Patterns of Hospital Perfor-
mance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission. Circula-
tion-Cardiovascular Quality and Outcomes. 2(5):407-13.
4. Jensen PH, Webster E, Witt J (2009) Hospital type and patient outcomes: an empirical examination using 
AMI readmission and mortality records. Health Econ. 18(12):1440-60.
5. Bernheim SM, Grady JN, Lin ZQ, Wang Y, Wang YF, et al. (2010) National Patterns of Risk-Standardized 
Mortality and Readmission for Acute Myocardial Infarction and Heart Failure Update on Publicly Re-
ported Outcomes Measures Based on the 2010 Release. Circulation-Cardiovascular Quality and Out-
comes. 3(5):459-67.
6. Schiotz M, Price M, Frolich A, Sogaard J, Kristensen JK, et al. (2011) Something is amiss in Denmark: 
a comparison of preventable hospitalisations and readmissions for chronic medical conditions in the 
Danish Healthcare system and Kaiser Permanente. BMC Health Serv Res. 11:347.
7. Axon RN, Williams MV (2011) Hospital readmission as an accountability measure. JAMA. 2;305(5):504-5.
8. Desai AS, Stevenson LW (2012) Rehospitalization for heart failure: predict or prevent? Circulation. 
24;126(4):501-6.
9. Department of Health. Emergency readmission rates (2008) London: Department of Health.
10. Department of Health. The operating framework. 2010. Available: https://www.gov.uk/government/up-
loads/system/uploads/attachment_data/file/151906/dh_122736.pdf.pdf. Accessed (2013 Jul 8..
11. Australian Government. Australian Institute of Health and Welfare. National Healthcare Agreement: 
PI 23-Unplanned hospital readmission rates, 2013 QS. Available: http://meteor.aihw.gov.au/content/in-
dex.phtml/itemId/507456. Accessed 2013 Jul 11.
12. Gu Q, Koenig L, Faerberg J, Steinberg CR, Vaz C, et al. (2014) The medicare hospital readmissions reduc-
tion program: potential unintended consequences for hospitals serving vulnerable populations. Health 
Serv Res.49(3):818-37.
13. Mattke S, Kelley E, Scherer P, et al. (2006) “Health Care Quality Indicators Project Initial Indicators Re-
port”, OECD Health Working Papers. Paris.
14. Kangovi S, Grande D (2011) Hospital readmissions - Not just a measure of quality. J Am Med Assoc. 
306(16):1796-7.
15. Spector WD, Mutter R, Owens P, Limcangco R (2012) Thirty-day, all-cause readmissions for elderly pa-
tients who have an injury-related inpatient stay. Med Care. 50(10):863-9.
16. Forster AJ, van Walraven C (2012) The use of quality indicators to promote accountability in health care: 
the good, the bad, and the ugly. Open Med. 6(2):e75-9.
17. Shepperd S, Lannin NA, Clemson LM, McCluskey A, Cameron ID (2013) Discharge planning from hospital 
to home. Cochrane Database Syst Rev. 1:CD000313.
18. Lambrinou E, Kalogirou F, Lamnisos D, Sourtzi P (2012) Effectiveness of heart failure management pro-
grammes with nurse-led discharge planning in reducing re-admissions: A systematic review and meta-
analysis. Int J Nurs Stud. 49(5):610-24.
19. Wong FKY, Ho MM, Yeung S, Tam SK, Chow SK (2011) Effects of a health-social partnership transitional 
program on hospital readmission: A randomized controlled trial. Soc Sci Med. 73(7):960-9.
20. Demir E, Chaussalet T, Adeyemi S, Toffa S (2012) Profiling hospitals based on emergency readmission: A 
multilevel transition modelling approach. Comput Methods Programs Biomed. 108(2):487-99.
21. Jha AK, Orav EJ, Epstein AM (2009) Public reporting of discharge planning and rates of readmissions. 
New Engl J Med. 361(27):2637-45.
22. Benbassat J, Taragin MI (2013) The effect of clinical interventions on hospital readmissions: a meta-re-
view of published meta-analyses. Isr J Health Policy Res. 2(1):1.
23. Burke RE, Kripalani S, Vasilevskis EE, Schnipper JL (2013) Moving beyond readmission penalties: Creating 
an ideal process to improve transitional care. J Hosp Med. 8(2):102-9.
71
3
24. Chan FW, Wong FY, Yam CH, Cheung WL, Wong EL, et al. (2011) Risk factors of hospitalization and re-
 admission of patients with COPD in Hong Kong population: analysis of hospital admission records. BMC 
Health Serv Res. 11:186.
25. Rochefort MM, Tomlinson JS (2012) Unexpected Readmissions After Major Cancer Surgery. An Evalua-
tion of Readmissions as a Quality-of-Care Indicator. Surg Oncol Clin North Am. 21(3):397-405.
26. McCormack R, Michels R, Ramos N, Hutzler L, Slover JD, et al. (2013) Thirty-day readmission rates as a 
measure of quality: causes of readmission after orthopedic surgeries and accuracy of administrative 
data. J Healthc Manag. 58(1):64-76; discussion -7.
27. Brooke BS, De Martino RR, Girotti M, Dimick JB, Goodney PP (2012) Developing strategies for predicting 
and preventing readmissions in vascular surgery. J Vasc Surg. 56(2):556-62.
28. Fischer C, Anema HA, Klazinga NS (2012) The validity of indicators for assessing quality of care: a review 
of the European literature on hospital readmission rate. Eur J Public Health. 22(4):484-91.
29. Van Walraven C, Jennings A, Forster AJ (2012) A meta-analysis of hospital 30-day avoidable readmis-
sion rates. J Eval Clin Pract. 18(6):1211-8.
30. Courtney EDJ, Ankrett S, McCollum PT (2003) 28-Day emergency surgical re-admission rates as a clinical 
indicator of performance. Ann R Coll Surg Engl. 85(2):75-8.
31. Rumball-Smith J, Hider P (2009) The validity of readmission rate as a marker of the quality of hospital 
care, and a recommendation for its definition. New Zealand Med J. 122(1289).
32. Demir E, Chaussalet TJ, Xie H, Millard PH (2008) Emergency readmission criterion: a technique for deter-
mining the emergency readmission time window. IEEE Trans Inf Technol Biomed. 12(5):644-9.
33. Maurer PP, Ballmer PE (2004) Hospital readmissions - are they predictable and avoidable? Swiss Medical 
Weekly. 134(41-42):606-11.
34. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO (2013) Rehospitalization for heart failure: 
Problems and perspectives. J Am Coll Cardiol. 61(4):391-403.
35. Grocott MPW (2010) Monitoring surgical outcomes: How and why? Curr Anaesth Crit Care. 21(3):129-36.
36. Almoudaris AM, Burns EM, Bottle A, Aylin P, Darzi A, et al. (2013) Single measures of performance do not 
reflect overall institutional quality in colorectal cancer surgery. Gut. 62(3):423-9.
37. Krumholz HM, Lin Z, Keenan PS, Chen J, Ross JS, et al. (2013) Relationship between hospital readmission 
and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumo-
nia. JAMA. 309(6):587-93.
38. Basu A, Howell R, Gopinath D (2010) Clinical performance indicators: Intolerance for variety? Int J Health 
Care Qual Assur. 23(4):436-49.
39. Heggestad T (2002) Do hospital length of stay and staffing ratio affect elderly patients’ risk of readmis-
sion? - A nation-wide study of Norwegian hospitals. Health Services Research. 37(3):647-65.
40. Kaboli PJ, Go OT, Hockenberry J, Glasgow JM, Johnson SR, et al. (2012) Associations between reduced 
hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 veterans 
affairs hospitals. Ann Intern Med. 157(12):837-45.
41. Shulan M, Gao K, Moore CD (2013) Predicting 30-day all-cause hospital readmissions. Health Care Man-
ag Sci. 16(2):167-75.
42. Kramer AA, Higgins TL, Zimmerman JE (2013) The association between ICU readmission rate and patient 
outcomes. Crit Care Med. 41(1):24-33.
43. Ahmed J, Khan S, Lim M, Chandrasekaran TV, MacFie J (2012) Enhanced recovery after surgery pro-
tocols - compliance and variations in practice during routine colorectal surgery. Colorectal Disease. 
14(9):1045-51.
44. Dobrzanska L, Newell R (2006) Readmissions: A primary care examination of reasons for readmission of 
older people and possible readmission risk factors. J Clin Nurs. 15(5):599-606.
45. Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, et al. (2012) Patient readmission and mortality 
after colorectal surgery for colon cancer: Impact of length of stay relative to other clinical factors. J Am 
Coll Surg. 214(4):390-8.
46. Dunlay SM, Weston SA, Killian JM, Bell MR, Jaffe AS, et al. (2012)Thirty-day rehospitalizations after acute 
myocardial infarction: A cohort study. Ann Intern Med. 157(1):11-8.
47. Dallal RM, Trang A (2012) Analysis of perioperative outcomes, length of hospital stay, and readmission 
rate after gastric bypass. Surg Endosc Interv Tech. 26(3):754-8.
72
C
ha
pt
er
 3
   
A
 s
ys
te
m
a
tic
 re
vi
ew
 o
n 
th
e 
re
lia
b
ili
ty
 a
nd
 v
a
lid
ity
 o
f t
he
 q
ua
lit
y 
in
d
ic
a
to
r r
ea
d
m
iss
io
n 
ra
te
48. Lau ACW, Yam LYC, Poon E (2001) Hospital re-admission in patients with acute exacerbation of chronic 
 obstructive pulmonary disease. Respiratory Medicine. 95(11):876-84.
49. Kiran RP, Delaney CP, Senagore AJ, Steel M, Garafalo T, et al. (2004) Outcomes and prediction of hospi-
tal readmission after intestinal surgery. J Am Coll Surg. 198(6):877-83.
50. Kociol RD, Liang L, Hernandez AF, Curtis LH, Heidenreich PA, et al. (2013) Are we targeting the right 
metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care 
inpatient days. Am Heart J. 
51. Johnson T, Bardhan J, Odwazny R, Harting B, Skarupski K, et al. (2012) Hospital care may not affect the 
risk of readmission. Qual Manag Health Care. 21(2):68-73.
52. Van Walraven C, Wong J, Hawken S, Forster AJ (2012) Comparing methods to calculate hospital-spe-
cific rates of early death or urgent readmission. CMAJ. 184(15):E810-E7.
53. Khawaja FJ, Shah ND, Lennon RJ, Slusser JP, Alkatib AA, et al. (2012) Factors associated with 30-day 
readmission rates after percutaneous coronary intervention. Arch Intern Med. 172(2):112-7.
54. Goldfield NI, McCullough EC, Hughes JS, Tang AM, Eastman B, et al. (2008) Identifying potentially pre-
ventable readmissions. Health Care Financ Rev. 30(1):75-91.
55. Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Kripalani S (2011) Readmission risk model-
ing: A systematic review. J Gen Intern Med. 26:S125.
56. Correll PK, Xuan W, Williamson M, Sundararajan V, Ringland C, et al. (2007) Reattendance at hospital for 
asthma in two Australian states, 2000-2003. Respirology. 12(2):220-6.
57. Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith AL, et al. (2011) Hospitalization epi-
demic in patients with heart failure: Risk factors, risk prediction, knowledge gaps, and future directions. 
J Card Fail. 17(1):54-75.
58. Cram P, Ibrahim SA, Lu X, Wolf BR (2012) Impact of alternative coding schemes on incidence rates of key 
complications after total hip arthroplasty: a risk-adjusted analysis of a national data set. Geriatr orthop 
surg rehabil. 3(1):17-26.
59. Hannan EL, Zhong Y, Lahey SJ, Culliford AT, Gold JP, et al. (2011) 30-Day readmissions after coronary 
artery bypass graft surgery in New York State. JACC Cardiovasc Interventions. 4(5):569-76.
60. van Walraven C, Austin PC, Forster AJ (2012) Urgent readmission rates can be used to infer differences in 
avoidable readmission rates between hospitals. Journal of Clinical Epidemiology. 65(10):1124-30.
61. Bianco A, Mole A, Nobile CGA, Di Giuseppe G, Pileggi C, et al. (2012) Hospital Readmission Prevalence 
and Analysis of Those Potentially Avoidable in Southern Italy. Plos One. 7(11).
62. Ben-Assuli O, Shabtai I, Leshno M (2013) The impact of EHR and HIE on reducing avoidable admissions: 
controlling main differential diagnoses. BMC Med Inf Decis Mak. 13:49.
63. Holt PJE, Poloniecki JD, Hofman D, Hinchliffe RJ, Loftus IM, et al. (2010) Re-interventions, Readmissions 
and Discharge Destination: Modern Metrics for the Assessment of the Quality of Care. Eur J Vasc Endo-
vasc Surg. 39(1):49-54.
64. Amin BY, Schairer W, Tu TH, Ames CP, Berven S, et al. (2012) Improving benchmarking in spine surgery: 
Suggested modifications of the UHC algorithm for calculating readmission rates following spine surgery. 
Neurosurgery. 71(2):E575-E6.
65. Lindenauer PK, Normand SLT, Drye EE, Lin Z, Goodrich K, et al. (2011) Development, validation, and results 
of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med. 6(3):142-50.
66. Sellers MM, Merkow RP, Halverson A, Hinami K, Kelz RR, et al. (2013) Validation of New Readmission Data 
in the American College of Surgeons National Surgical Quality Improvement Program. Journal of the 
American College of Surgeons. 216(3):420-7.
67. Krumholz HM, Wang Y, Mattera JA, Wang YF, Han LF, et al. (2006) An administrative claims model suit-
able for profiling hospital performance based on 30-day mortality rates among patients with heart 
failure. Circulation. 113(13):1693-701.
68. Wallmann R, Llorca J, Gomez-Acebo I, Ortega AC, Roldan FR, et al. (2013) Prediction of 30-day cardiac-
related-emergency-readmissions using simple administrative hospital data. Int J Cardiol. 164(2):193-200.
69. Adeyemo D, Radley S (2007) Unplanned general surgical re-admissions - How many, which patients and 
why? Ann R Coll Surg Engl. 89(4):363-7.
70. Parker JP, McCombs JS, Graddy EA (2003) Can pharmacy data improve prediction of hospital out-
comes? Comparisons with a diagnosis-based comorbidity measure. Med Care. 41(3):407-19.
73
3
71. Rosen AK, Loveland S, Shin M, Shwartz M, Hanchate A, et al. (2013) Examining the Impact of the AHRQ 
 Patient Safety Indicators (PSIs) on the Veterans Health Administration: The Case of Readmissions. Med 
Care. 51(1):37-44.
72. Mokhtar SA, El.Mahalli AA, Al-Mulla S, Al-Hussaini R (2012) Study of the relation between quality of in-
patient care and early readmission for diabetic patients at a hospital in the eastern province of Saudi 
Arabia. East Mediterr Health J. 18(5):474-9.
73. Kergoat MJ, Latour J, Lebel P, Leclerc BS, Leduc N, et al. (2012) Quality-of-care processes in geriatric 
assessment units: principles, practice, and outcomes. J Am Med Dir Assoc. 13(5):459-63.
74. Auerbach AD, Hilton JF, Maselli J, Pekow PS, Rothberg MB (2009) Shop for quality or volume? Volume, 
quality, and outcomes of coronary artery bypass surgery. Ann Intern Med. 150(10):696-704+W-123.
75. Stukel TA, Alter DA, Schull MJ, Ko DT, Li P (2010) Association between hospital cardiac management and 
outcomes for acute myocardial infarction patients. Med Care. 48(2):157-65.
76. Chen JY, Ma Q, Chen H, Yermilov I (2012) New bundled world: quality of care and readmission in diabe-
tes patients. J Diabetes Sci Technol. 6(3):563-71.
77. Weber RS, Lewis CM, Eastman SD, Hanna EY, Akiwumi O, et al. (2010) Quality and performance indi-
cators in an Academic Department of Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 
136(12):1212-8.
78. Kent TS, Sachs TE, Callery MP, Vollmer Jr CM (2011) Readmission after major pancreatic resection: A 
necessary evil? J Am Coll Surg. 213(4):515-23.
79. Barbieri CE, Lee B, Cookson MS, Bingham J, Clark PE, et al. (2007) Association of procedure volume with 
radical cystectomy outcomes in a nationwide database. Journal of Urology. 178(4):1418-21.
80. Chung ES, Guo L, Casey Jr DE, Bartone C, Menon S, et al. (2008) Relationship of a quality measure com-
posite to clinical outcomes for patients with heart failure. Am J Med Qual. 23(3):168-75.
81. Judge A, Chard J, Learmonth I, Dieppe P (2006) The effects of surgical volumes and training centre sta-
tus on outcomes following total joint replacement: analysis of the Hospital Episode Statistics for England. 
J Public Health (Oxf). 28(2):116-24.
82. Boulding W, Glickman SW, Manary MP, Schulman KA, Staelin R (2011) Relationship between patient sat-
isfaction with inpatient care and hospital readmission within 30 days. Am J Managed Care. 17(1):41-8.
83. Youn YJ, Yoo BS, Lee JW, Kim JY, Han SW, et al. (2012) Treatment performance measures affect clinical 
outcomes in patients with acute systolic heart failure: Report from the Korean Heart Failure Registry. Circ 
J. 76(5):1151-8.
84. VanSuch M, Naessens JM, Stroebel RJ, Huddleston JM, Williams AR (2006) Effect of discharge instructions 
on readmission of hospitalised patients with heart failure: Do all of the Joint Commission on Accredita-
tion of Healthcare Organizations heart failure core measures reflect better care? Qual Saf Health Care. 
15(6):414-7.
85. Showalter JW, Rafferty CM, Swallow NA, DaSilva KO, Chuang CH (2011) Effect of Standardized Electron-
ic Discharge Instructions on Post-Discharge Hospital Utilization. Journal of General Internal Medicine. 
26(7):718-23.
86. Polanczyk CA, Newton C, Dec GW, Di Salvo TG (2001) Quality of care and hospital readmission in con-
gestive heart failure: An explicit review process. J Card Fail. 4:289-98.
87. Luthi JC, Lund MJ, Sampietro-Colom L, Kleinbaum DG, Ballard DJ, et al. (2003) Readmissions and the 
quality of care in patients hospitalized with heart failure. International Journal for Quality in Health Care. 
15(5):413-21.
88. Joynt KE, Orav EJ, Jha AK (2011) The association between hospital volume and processes, outcomes, 
and costs of care for congestive heart failure. Ann Intern Med. 154(2):94-102.
89. Horwitz LI, Wang YF, Desai MM, Curry LA, Bradley EH, et al. (2012) Correlations among risk-standard-
ized mortality rates and among risk-standardized readmission rates within hospitals. Journal of Hospital 
Medicine. 7(9):690-6.
90. Hernandez AF, Hammill BG, Peterson ED, Yancy CW, Schulman KA, et al. (2010) Relationships between 
emerging measures of heart failure processes of care and clinical outcomes. Am Heart J. 159(3):406-13.
91. Bottle A, Aylin P (2009) Application of AHRQ patient safety indicators to English hospital data. Qual Saf 
Health Care. 18(4):303-8.
92. Halfon P, Eggli Y, van Melle G, Chevalier J, Wasserfallen JB, et al. (2002) Measuring potentially avoidable 
hospital readmissions. Journal of Clinical Epidemiology. 55(6):573-87.
74
C
ha
pt
er
 3
   
A
 s
ys
te
m
a
tic
 re
vi
ew
 o
n 
th
e 
re
lia
b
ili
ty
 a
nd
 v
a
lid
ity
 o
f t
he
 q
ua
lit
y 
in
d
ic
a
to
r r
ea
d
m
iss
io
n 
ra
te
93. Halfon P, Eggli Y, Pretre-Rohrbach I, Meylan D, Marazzi A, et al. (2006) Validation of the potentially 
 avoidable hospital readmission rate as a routine indicator of the quality of hospital care. Med Care. 
44(11):972-81.
94. Maeda JLK (2010) Evidence-Based Heart Failure Performance Measures and Clinical Outcomes: A Sys-
tematic Review. Journal of Cardiac Failure. 16(5):411-8.
95. Encinosa WE, Hellinger FJ (2008) The impact of medical errors on ninety-day costs and outcomes: An 
examination of surgical patients. Health Serv Res. 43(6):2067-85.
96. Shahian DM, Meyer GS, Mort E, Atamian S, Liu X, et al. (2012) Association of National Hospital Quality 
Measure adherence with long-term mortality and readmissions. BMJ Qual Saf. 21(4):325-36.
97. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, et al. (2007) Association between 
performance measures and clinical outcomes for patients hospitalized with heart failure. J Am Med 
Assoc. 297(1):61-70.
98. Stefan MS, Pekow PS, Nsa W, Priya A, Miller LE, et al. (2012) Hospital Performance Measures and 30-day 
Readmission Rates. J Gen Intern Med. 1-9.
99. Nathwani D, Williams F, Winter J, Winter J, Ogston S, et al. (2002) Use of indicators to evaluate the quality 
of community-acquired pneumonia management. Clin Infect Dis. 34(3):318-23.
100. Morse RB, Hall M, Fieldston ES, McGwire G, Anspacher M, et al. (2011) Hospital-level compliance with 
asthma care quality measures at children’s hospitals and subsequent asthma-related outcomes. J Am 
Med Assoc. 306(13):1454-60.
101. Schopfer DW, Whooley MA, Stamos TD (2012) Hospital compliance with performance measures and 30-
day outcomes in patients with heart failure. Am Heart J. 164(1):80-6.
102. Mansi IA, Shi R, Khan M, Huang J, Carden D (2010) Effect of compliance with quality performance mea-
sures for heart failure on clinical outcomes in high-risk patients. J Natl Med Assoc. 102(10):898-905.
103. Marcin JP, Romano PS (2004) Impact of between-hospital volume and within-hospital volume on mor-
tality and readmission rates for trauma patients in California. Crit Care Med. 32(7):1477-83.
104. Patterson ME, Hernandez AF, Hammill BG, Fonarow GC, Peterson ED, et al. (2010) Process of care per-
formance measures and long-term outcomes in patients hospitalized with heart failure. Med Care. 
48(3):210-6.
105. Roccaforte R, Demers C, Baldassarre F, K.Teo K, Yusuf S (2005) Effectiveness of comprehensive disease 
management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur 
J Heart Fail. 7(7):1133-44.
106. Gawlas I, Sethi M, Winner M, Epelboym I, Lee JL, et al. (2012) Readmission After Pancreatic Resection is 
not an Appropriate Measure of Quality. Ann Surg Oncol. 1-7.
107. Jimenez-Puente A, Garcia-Alegria J, Gomez-Aracena J, Hidalgo-Rojas L, Lorenzo-Nogueiras L, et al. 
(2004) Readmission rate as an indicator of hospital performance: The case of Spain. Int J Technol Assess 
Health Care. 20(3):385-91.
108. Ricciardi MJ, Selzer F, Marroquin OC, Holper EM, Venkitachalam L, et al. (2012) Incidence and predictors 
of 30-day hospital readmission rate following percutaneous coronary intervention (from the national 
heart, lung, and blood institute dynamic registry). Am J Cardiol. 110(10):1389-96.
109. Auerbach AD, Maselli J, Carter J, Pekow PS, Lindenauer PK (2010) The relationship between case vol-
ume, care quality, and outcomes of complex cancer surgery. J Am Coll Surg. 211(5):601-8.
110. Rumball-Smith J, Blakely T, Sarfati D, Hider P (2013) The mismeasurement of quality by readmission rate: 
How blunt is too blunt an instrument?: A quantitative bias analysis. Med Care. 51(5):418-24.
111. Luthi JC, Burnand B, McClellan WM, Pitts SR, Flanders WD (2004) Is readmission to hospital an indicator 
of poor process of care for patients with heart failure? Qual Saf Health Care. 13(1):46-51.
112. Mayer EK, Bottle A, Aylin P, Darzi AW, Athanasiou T, et al. (2011) The volume-outcome relationship for 
radical cystectomy in England: An analysis of outcomes other than mortality. BJU Int. 108(8 B):E258-
E65.
113. McConnell KJ, Lindrooth RC, Wholey DR, Maddox TM, Bloom N (2013)Management practices and the 
quality of care in cardiac units. JAMA Intern Med. 173(8):684-92.
114. Marang-van de Mheen PJ, Dijs-Elsinga J, Otten W, Versluijs M, Smeets HJ, et al. (2010) The importance 
 of experienced adverse outcomes on patients’ future choice of a hospital for surgery. Qual Saf Health 
Care. 19(6):e16.
75
3
115. Tsai TC, Joynt KE, Orav EJ, Gawande AA, Jha AK (2013) Variation in surgical-readmission rates and 
 quality of hospital care. N Engl J Med. 369(12):1134-42.
76
C
ha
pt
er
 3
   
A
 s
ys
te
m
a
tic
 re
vi
ew
 o
n 
th
e 
re
lia
b
ili
ty
 a
nd
 v
a
lid
ity
 o
f t
he
 q
ua
lit
y 
in
d
ic
a
to
r r
ea
d
m
iss
io
n 
ra
te
aPPeNDIX
appendix 1. Descriptive information of included studies
Author Year Study type Condition/ Main data Definition Risk Nr. of patients
et al.   population source incl. adj. incl.
   group and year time frame  (denominator)
The context in which readmission rates are use
Kangovi14 2011 discussion  / / / / /
  paper
Spector15 2012 retrosp.  elderly/ Healthcare 30-day, all- yes 224193
  cohort injury  Cost and cause
  study  Utilization inpatient
    Project State  readmission
    Inpatient 
    Databases 
    2006
Shep- 2013 s.rev / / / / /
perd17
Lambri- 2012 s.rev hf / all-cause / /
nou (18)     readmissions
Wong19 2011 RCT / / 28 days rr  555
Demir20 2012 multilevel / 1997/2004 test different yes More than
  transition   national time windows  5 million
  model  hospital   patient /
    episodes    1000 random
    statistics    samples
    dataset
Jha21 2009 retrosp. chf CMS Hospital all-cause yes 2222 hospitals
  cohort  Quality 30-day
  study  Alliance data readmission
    2008
Ben- 2013 meta- hf, coronary / / / /
bassat22  review of heart disease
  published and bronchial
  s.rev asthma, 
   stroke, 
   chronicm 
   disorders
Burke23 2012 discussion / / / / /
  paper
77
3
Conclusion on the validity of the indicator and on the management/governance 
purpose of the indicator
Social factors need to be considered when determining readmission risk. Policy makers should monitor 
the consequences of readmission penalties. Next to 30-day rrs, 90- and 180-day rates, ED and observa-
tion service use, and mortality should be monitored. The readmission penalty incentivizes hospitals to ex-
pand their scope beyond traditional health services. Although hospitals cannot assume responsibility for 
all patients social needs, they can serve as a vehicle for connecting high-risk patients to resources like 
addiction counseling and community centers. Readmission policy could reward hospitals that address 
the root causes of readmission. The penalties also have the potential to create new access barriers.
Hospital experiences and injury characteristics influence rrs. a strategy to reduce rrs should not only 
focus on hospitals but also nursing homes and home health care.
Discharge plan tailored to the individual patient probably brings about reductions in rrs for older people 
admitted to hospital with a medical condition;
Hf management programs have potential to reduce readmissions; more research is needed
Using volunteers as substitutes for some of the professional care, may be effective for general medical 
patients
4 out of 5 worst performing hospitals are hospitals treating cancer patients. These hospitals are known 
to be the leading NHS Trusts in England, providing diverse range of services to complex patients and 
therefore it is inevitable to expect higher numbers of emergency readmissions.
Current effort to collect and publicly report data on discharge planning are unlikely to yield large 
reductions in unnecessary readmission.
Efficiency of in hospital interventions aimed at reducing rr need further study; for patients with heart 
diseases and bronchial asthma, rr may be considered as a publicly reported qi of community care, 
provided that future research confirms that efforts to reduce rr do not adversely affect other patients 
outcomes, such as mortality.
Controversy exists over the penalties fairness and likelihood of driving appropriate behavior. We call for 
development and use of multifaceted, collaborative transitions interventions that span settings, risk-ad-
justment models that allow for fairer comparisons.
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Indicator definition
Wal- 2011 s.rev* / / avoidable
raven2     readmissions
Roche- 2012 lit. rev/ major cancer / / / /
fort25  discussion surgery
  paper
McCor- 2013 retrosp. orthopedic hospital planned/un- / /
mack26  database surgeries admin. planned
  analyses  data 2007/9 30-day
     readmissions
Brooke27 2012  discussion vascular / / / /
  paper surgeries
Fischer28 2011 s.rev. / / / / /
Van Wal- 2012 meta- / / 30-day / /
raven29  analysis   urgent
     readmissions
Court- 2003 retrosp. general case notes 28-day / 1914 
ney30  case-note surgical 2000 emergency
  review division  readmissions
Rumball- 2009 lit. review / / unintended, / /
Smith3     acute
     readmission
     within 30-days
Demir32 2008 modeling copd, hf, National HES / /
  approach stroke, data
  to define congestive hf (England)
  time   1997/2004
  window
Maurer33 2004 pilot study internal 1998  / 884
   medicine
The effect of competing outcomes
Gheorg- 2013  hf OPTIMIZE-HF 30-day yes 41267
hiade34    registry readmissions
    1993/2006
Almouda- 2012  colorectal NHS data unplanned yes 144542
ris36   cancer England readmission
   resection 2000/1, 2007/8 within 28-days
Krum- 2013  hf, AMI, pn Medicare 30-day yes 586027
holz37    data 2005/8 readmissions
Grocott35 2010 lit. review elective / / / /
   surgery
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True proportion of potentially avoidable readmissions is unknown.
Given the large variation in the proportion of avoidable readmissions between studies using primary 
data, ‘avoidability’ cannot accurately be inferred based on diagnostic codes for the index admission 
and the readmission.
The proposed congressional plan to use rrs to assess hospital performance and determine reimburse-
ment should be pursued with extreme caution, pending further investigation
Careful data collection and abstraction when calculating early rr are important. Preventing surgical site 
infection and better coordinating care between orthopedic surgeons and primary care and medical 
subspecialty physicians may significantly reduce rr.
Risk factors associated with readmission remain poorly defined, and further research is needed to pro-
pose a conceptual model to explain the driving forces behind readmissions in vascular surgery.
The rr as an indicator should be used with care. Users should address issues related to definition, time-
frame and case-mix correction as part of the process to enhance validity in the European setting
Health system planners need to use caution in interpreting all cause readmission statistics as they are 
only partially influenced by qoc
Accurate emergency 28-day readmission rates can potentially highlight where care has been sub-
optimal, and readmissions and even deaths prevented. However, just comparing rates between trusts 
does not allow for inaccuracies in coding and makes no attempt to quantify the number of avoidable 
readmissions which, with better qoc, could be avoided.
Rr as a marker of the quality of hospital care has been used internationally and nationally, although its 
validity has only been partially substantiated. While prone to confounding, it remains a valuable indica-
tor due to its ease of collection and its ability to be able to be combined with other variables.
Given that the NHS performance rating framework regards rr as one of its key indicators, the research 
suggests that some hospitals may be disadvantaged by the use of one single number to define a time 
window.
Most readmissions occur within 30 day timeframe, 90 days consideration did not change the overall 
conclusion
A reduction in rrs, but this will require integration of these efforts on clinician/hospital/system level to 
improve overall outcomes.
Appraising institutional service quality in colorectal surgery is complex. High mortality outlier status does 
not necessarily predict poor performance across other domains. A clear understanding of the scope of 
each outcome metric used to reflect performance is required if these are to be openly reported.
Our findings indicate that many institutions do well on mortality and readmission and that performance 
on one does not dictate performance on the other. From a policy perspective, the independence of the 
measures is important. A strong inverse relationship might have implied that institutions would need to 
choose which measure to address.
Use PROMS, post-discharge follow up, simple questions about admission to other institutions, track mor-
tality to identify cases when patient die at home/attend a different medical institution other than the 
index institution for complications.
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Basu38 2010 retrosp. / clinical 28-day / /
  analysis  performance readmissions
    data 2006/7
Hegge- 2002 cross- elderly patient national 30-day yes 113055
stad39  sectional  patient unplanned
  study  database of readmission
    admissions to
    all acute care
    Norwegian
    hospitals 1996
Kaboli40 2012 observa- hf, COPD, AMI, observational 30-day yes 4124907
  tional study pn, gastro data readmissions
   intestinal 1997/2010
   hemorrhage
Shulan39 2013 retrosp. / Veterans 30-day yes 8718
  database  Healthcare readmissions
  analysis  Network
    Upstate
    New York data
    2011/12
Kramer42 2013 retrosp. patients admin. data ICU yes 369129
  cohort discharged (APACHE) readmissions
  study from ICU system
    2002/10
Ahmed43 2011 s.rev / / / / /
Dobrza- 2006 desc. data elderly patient 28-day yes 4222
na44  analysis patients records emergency
    2002/3 readmissions
Schnei- 2012 retrosp. colorectal SEER 30-day yes 149622
der45  data cancer Medicare readmissions
  analysis surgery database
   patients 1986/2005
Dunlay46 2012 retrosp. AMI population 30-day yes 3010
  cohort  based readmissions
  study  registry
    1987/2010
Dallal47 2012 retrosp. gastric bypass medical 30-day yes 1065
  multi- patients record review readmissions
  variable   2006/10
  analysis
Lau48 2001 retrosp. COPD patient chart / yes 551
  study  extraction
    1997
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This study highlights the difficulty in comparing the performance of hospitals due to the inherent lack 
of consistency. Therefore it is apparent that any ‘reward-rebuke’ system linked to performance should 
interpret the data with caution. It is therefore suggested that easy to control single value activities and 
standardized routine activities could be used to measure hospital performance. The hospital could com-
pare with its statistics from previous years.
With optimal hospital care and planning of aftercare, it is possible to prevent some new admissions or 
prolong the time period from discharge to a readmission. The consequences or costs of readmissions 
may be experienced differently by individual patients and their families compared with what is the 
case at the hospital or system level. So when monitoring system performance, readmission measures are 
relevant, particularly when considering vulnerable groups such as the elderly.
Payors of health care and quality organizations should carefully examine (un)intended consequences of 
financial incentives for episodes of care in our often fragmented health care system.
Demographics, socio-economic variables, prior utilization and Diagnosis-related Group (DRG) all have 
limited predictive power; more sophisticated patient stratification algorithm or risk adjuster is desired for 
more accurate readmission predictions. Even though our model can be used in both hospital compari-
sons and patient identification for readmission reduction, caution needs to be exercised. High predictive 
power is a necessary but not a sufficient condition for valid comparisons; unlike predictions, hospital 
comparisons demand more delicate use of confounders (e.g. health literacy) and more complete data. 
For predictions, the model should not and cannot replace clinical judgment.
We found no association between unit readmission rate and quality of care as reflected by aggregate 
mortality and lengths of stay when adjusted for patient case-mix. the use of readmis¬sion as a quality 
measure should only be implemented if patient case-mix is taken into account.
Higher compliance with after surgery protocols was associated with a reduced length of hospital stay. 
However, reduced length of hospital stay was associated with a high rate of readmission.
Institutionalized patients were readmitted sooner than those who lived at home: those discharged home 
vs. other sources and agreeing to increased social service provision had longer stays
on readmission. Shorter los on index admission (up to 72 hours) was associated with increased likelihood 
of earlier readmission.
Rrs after colectomies have increased during the past 2 decades and mean LOS after this operation has 
declined. More research is needed to understand the balance and possible tradeoff between these 
hospital performance measures for all surgical procedures.
Despite advances in medical care following MI, readmission risk has not declined. Angiography, reperfu-
sion and revascularization are mainstays of therapy in acute MI, and complications are associated with 
a large risk of readmission. Comorbidities appear to play a central and increasing role in readmissions. 
Comprehensive strategies of care in patients with MI need to be deployed that incorporate the treat-
ment of both cardiovascular and non-cardiovascular disease in order to prevent future hospitalizations.
Early discharge on postoperative day 1 is possible but no modifiable, random patient factors challenge 
predictable discharge planning. Reliable discharge on postoperative day 1 is not likely with current 
technologies.
Following factors were associated with shorter time to readmission: hospital admission within 1 year be-
fore index admission, los in index admission 45 days, nursing home residency, dependency in self-care 
activities, right heart strain pattern on electrocardiogram, on high dose inhaled corticosteroidandac-
tualbicarbonatelevel425mmoll. They may be relevant in the future planning of healthcare utilization for 
COPD patients.
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Chan24 2011 retrosp. COPD analysis of unplanned yes 65497
  study  admission 30-day
    episode data readmissions
    of acute
    medical
    wards 2006/7
Kiran49 2004 retrosp. intestinal data from 30-day yes 553
  data surgery hospital readmissions
  analysis patients Computer
    records 2002
Kociol50 2013 retrosp. hf clinical data 30-day yes 17387
  data  from GWTG-HF readmissions
  analysis  quality
    improvement
    registry linked
    to Medicare
    claims 2005/6
Johnson51 2012 retrosp. / single hospital 30/120 same- yes 4151
  data  data analysis center all-
  analysis  2004/6 cause
     readmissions 
     to general 
     medicine units
Case-mix correction using administrative data vs. clinical data
Van Wal- 2012 retrosp. / discharge urgent yes 3148648
raven52  data  abstract readmissions
  analysis  database of within 30-days
    162 hospitals
    2005/10
Kha- 2012 analysis of PCI prospective 30-day yes 15498
waja53  prosp. data  registered readmissions
  registry  database
    1998/2008
Gold- 2008 retrosp. / hospital potentially  yes 5.02 million
field54  data  admin. preventable
  analysis  database readmissions
    analysis
    2004/5
Kansa- 2011 s.rev. / / / / /
gara55
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A systematic approach in program provision in the community and a good discharge planning process 
targeting on COPD patients who are at high risk of unplanned readmission are essential.
Early readmission is an unpredictable sequel of major bowel operations; it does not correlate with 
shorter los. Identification of unpredictable complications does not adversely affect clinical outcomes. 
30 days readmissions of patients who have attained standardized discharge criteria may not be a valid 
indicator of qoc.
Although hospital 30-day rr was poorly correlated with LOS, quality measures, and 30-day mortality, 
better performance on the EOC metric was associated with better 30-day survival. Total inpatient days 
during a 30-day EOC may more accurately reflect overall resource use and better serve as a target for 
quality improvement efforts.
The findings suggest that more hospital care may not affect the likelihood of readmission and thus deny-
ing payment for readmission may be unwarranted.
The study found notable variation in rates of urgent readmission within 30 days based on the extent of 
adjustment for confounders and the unit of analysis. Slight changes in the methods used to calculate 
hospital-specific rrs influence their values and the consequent rankings of hospitals. Our results highlight 
the caution required when comparing hospital performance using rates of death or urgent readmission 
within 30 days.
About 1 in 10 PCI procedures resulted in a readmission within 30 days, most readmissions were due to 
a cardiovascular cause. Patients readmitted within 30 days of discharge were at an increased risk of 
1-year mortality.
MedPAC has proposed that Medicare should reduce payments to hospitals with high rrs. From a policy 
perspective the key challenge is to establish the extent of the payment reduction for a readmission. For 
true medical errors that are clearly related to mistakes in the delivery of care, not paying for the read-
mission may be justified. However, most readmissions are not so clearly linked to medical errors, and, 
although they may possibly relate to errors in judgment or lapses in execution that reflect poor quality 
care, they cannot be considered always preventable. A balance between the relative preventability of 
a readmission and the extent of the payment reduction associated needs to be achieved. The financial 
consequences of a readmission need to be significant enough to motivate hospitals to reduce rrs, with-
out penalizing hospitals for events over which they have limited control. MedPAC is essentially proposing 
that the extent of the payment reduction for a readmission be set separately for each hospital based 
on its risk adjusted rr. Hospitals with lowest risk adjusted rrs would have a small reduction in payment for 
readmissions, while hospitals with high rrs would have a larger payment reduction. The advantage to this 
approach is that an estimate of the relative preventability of readmissions does not have to be made. 
The amount of the payment reduction is based on the relative overall performance of hospitals in terms 
of their risk adjusted rr.
Most current readmission risk prediction models, whether designed for comparative or clinical purposes, 
perform poorly. Though in certain settings such models may prove useful, efforts to improve their perfor-
mance are needed as use becomes more widespread.
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Correll56 2007 retrosp. asthma linked hospital readmissions yes 139043
  data  and ED data to hospital or
  analysis  2000/3 emergency
     department
     within 28-day
     for asthma
Gia- 2011 lit. review hf / / / /
mouzis57
Data reliability
Cram58 2012 admin. THA Medicare 30-day yes 202773
  data  Provider readmissions
  analysis  Analysis/
    Review
    (MedPAR)
    2007/8
Hannan59 2011 retrosp. CABG surgery Cardiac 30-day yes 33936
  data  Surgery readmissions
  analysis  Reporting
    System 2005/7
Wal- 2012 retrosp. / hospital urgent / 1666
raven60  data  admin. data 30-days
  analysis   readmissions
Bianco61 2012 cross / medical 30-day yes 2252
  sectional  records review readmissions
  data  2005/7
  analysis
Ben- 2013 Track log- / electronic 7-day yes 281750
Assuli62  file analysis  health records readmissions
    information
    system data
    2004/7
Holt63 2010 retrosp. AAA repair HES data all-cause yes 143237
  data  2003/8 emergency
  analysis   readmissions
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There is evidence that programs to improve asthma care in the hospital setting result in reduced hospital 
readmissions. However, the likelihood of readmission for asthma is not only related to the qoc in hospital, 
but also to the qoc in the community, in particular, from the patient’s general practitioner or specialist.
30-day post discharge HF rrs are currently used as quality measures. This consideration raises several 
concerns. The published risk-adjusted hf readmission predictions models are not optimal for accurate 
risk prediction for reasons stated above. Performance of other models that are currently unpublished in 
peer-reviewed journals cannot be judged. There are no gold standard rules for when a person should 
be admitted with hf, and patients may be hospitalized for borderline clinical/nonclinical social reasons. 
Finally, qis such as hf rr might precipitate provider behaviors regarding resisting admissions; this may be a 
safety concern.
The study found important differences in the rates of THA complications depending upon the coding 
algorithms and time frame employed. Our results suggest that admin. data can be used to evaluate THA 
complications but that methodology should be carefully considered.
The authors speculate that readmissions have not decreased over time despite decreasing mortality 
rates, because efforts to coordinate in/outpatient care have been insufficient. Since the announcement 
by the Centers for Medicare/Medicaid Services that reimbursement for readmissions would be curtailed 
or eliminated, numerous organizations have sponsored symposia for coordinating inpatient and out-
patient care, it is hypothesized that hospitals that follow these suggestions will experience considerably 
reduced rrs.
Urgent rrs can be used to estimate the probability that avoidable rrs differ significantly between two 
hospitals. Hospitals with significantly lower urgent rrs frequently have negligibly lower avoidable rrs 
than comparator hospitals. These results highlight that urgent rrs should be used cautiously to compare 
hospital qoc
Avoidable readmissions are influenced by factors at the patient, organizational, and environmental lev-
els. Not all of these factors are actually in the hospitals’ control, although the cost of avoidable readmis-
sions will be borne principally by hospitals that can modify their structure and processes. More qualita-
tive information may improve the patient’s ability to manage aspects of his care after discharge, and 
for the elderly through interviews with the patients, family members, and caregivers about their needs. 
Management is one of the reasons that justifies vertical integrated, moreover, active post-discharge 
delivery systems that are poised to facilitate transitions between inpatient and outpatient care.
Viewing medical history via an EHR IS and using HIE network led to a reduction in the number of 7 day 
readmissions and single-day admissions for all patients. Using external medical history may imply a more 
thorough patient examination that can help eliminate unnecessary admissions. In most instances physi-
cians did not view medical history at all.
Readmissions at either 30-days or 1-year were associated with high mortality rates. This suggests that re-
admission is a useful outcome measure both for the burden on emergency services and because there 
is the underlying cause of the readmission, which has a direct impact on survival.
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Forster16 2012 discussion / / all-cause / /
  paper   urgent rr
     within 30-days
Amin64 2012 chart spine surgery admin.  30-days all- yes 5780
  review  hospital data cause
    2007/11 readmission
Lin- 2011 retrosp. elderly Medicare hospital- yes 453251
denauer65  cohort patients/pn claims 2005/6 specific
  study   30-day
     readmissions
Sellers66 2013 retrosp. surgical The American 30-day / 1748
  cohort patients College of postoperative
  study  Surgeons  all-cause
    National  readmissions
    Surgical 
    Quality 
    Improvement
    Program 
    data 2011
Krum- 2013 retrosp. AMI Medicare 30-day yes 279152
holz67  data  claims 2006 all-cause
  analysis   readmissions
Wall- 2013 cohort cardiovascular hospital 30-day yes 37381
mann68  study disease admin. data cardiac-
    2003 /9  related
     readmissions
Ade- 2007 retrosp. general case not adjusted yes 2652
yemo69  audit case surgery review 2003 unplanned
  note records   re-admission
     within 28 days
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Current approaches to measure qoc cannot fully meet the public’s expectation, that providers should, 
with fair methods, be held accountable. For this reason, we suggest several actions. First, we need a 
better understanding of the limitations of current indicators. To achieve this goal, the health sector will 
need to make modest investments in research on qis; this would cost significantly less than many other 
interventions in the health care system. To avoid perceived conflicts of interest, this investment should be 
directed toward experts who are able to critically assess qis but are not themselves responsible for hold-
ing people accountable. Second, providers need to be fully engaged in the measurement, analysis, 
and interpretation of indicator data. To achieve this goal, we recommend a gradual transition in funding 
methodology such that providers would be more accountable for their actual performance. Third, the 
entire health care system needs to increase investment in performance measurement systems. The cur-
rent approach—measuring what we can instead of what we should—is inadequate, especially in light 
of the large investments in health care services.
Findings identify the potential pitfalls in the calculation of rrs from admin. data sets. Benchmarking algo-
rithms for defining hospitals’ rrs must take into account planned staged surgery and eliminate unrelated 
reasons for readmission. When this is implemented in the calculation method, the rr will be more accu-
rate. Current tools overestimate the clinically relevant rr and cost.
Rehospitalization within 30 days of treatment for pneumonia is common, and rates vary across hospi-
tals. A risk standardized measure of hospital rrs derived from admin. claims has similar performance 
characteristics to one based on medical record review. The development of a valid measure of hospital 
performance and public reporting are important first steps towards focusing attention on this problem. 
A necessary prerequisite for public reporting of readmission is a validated, risk-adjusted measure that 
can be used to track performance over time and can facilitate comparisons across institutions.
Admin. data accurately captured all-cause readmissions, but could not identify unplanned readmis-
sions and less consistently agreed with chart review on cause. The granularity of clinically collected 
data offers tremendous advantages for directing future quality efforts targeting surgical readmission. If 
surgical rr is to be used as a quality metric, clinical data are likely a better source to use in order to more 
closely target preventable readmissions.
Rrs are influenced by the quality of inpatient and outpatient care, the availability and use of effective 
disease management programs, and the bed capacity of the local healthcare system. Some of the 
variation in readmissions may be attributable to delivery system characteristics. Additionally, interven-
tions during and after a hospitalization can be effective in reducing rrs in geriatric populations generally 
18-20 and for patients with AMI specifically.
The study provides a prediction model for 30-day cardiac-related diseases based on available admin. 
data ready to be integrated as a screening tool. It has reasonable validity and can be used to increase 
the efficiency of case management. There were series of factors that might be important for predicting 
readmission but could not be considered because of the design of the study. The admin. data did not 
contain several clinical variables that could only be obtained by chart review, quality of life measure-
ments, psychosocial and behavioral factors and use of primary care services or outpatient manage-
ment. It is likely that a more powerful prediction model may be derived from a combination of all these 
dimensions, but availability of this data is very difficult, costly and time consuming. A more comprehen-
sive hospital information system would allow exploring more variables and fit the prediction model in the 
future.
Unplanned general surgical re-admission rates collated from hospital PAS systems may be inaccurate. 
Nearly half of ‘genuine’, unplanned re-admissions involved patients with chronic and/or recurrent 
symptoms, which are predictable and may be preventable. Significant postoperative complications ac-
counted for few re-admissions in this study. While it is likely that these errors in the information database 
are wide-spread in the NHS, the magnitude may vary between hospital trusts (perhaps even with time) 
and may lead to breach(es) of set targets and (any consequent) penalties.
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Parker70 2011 retrosp. / automated 14-day yes 6721
  data  hospital and readmissions
  analysis  pharmacy 30-day
    data 1993/5 unplanned
     readmissions;
     unplanned
     readmissions
Validity of readmission rates as a quality measure
Rosen71 2013 retrosp. / VA Patient 30-day yes 2332794
  admin. data  Treatment readmissions
  analysis  File-admin.
    database
    2003/7
Mokhtar72 2012 retrosp.  diabetic medical 28-day / 1125
  cohort  patients records readmissions
  and case-  2000/8
  control 
  study
Kergoat73 2012 retrosp. geriatric medical hospital yes 934
  data patients records review readmissions
  analysis  2002/3
Auer- 2009 obser- CABG hospital 30-day yes 81289
bach74  vational  discharge readmissions
  cohort  data 2003/8
Stukel75 2010 population- AMI patients 30-day and yes 89115
  based   records review 1-year
  longitudenal   2000/6 readmissions
  cohort study
Chen76 2012 retrosp. diabetic admin. claims 2-30 day yes 30139
  data patients data 2009/10 readmissions
  analysis
Weber77 2010 retrosp. head and institutional 30-day yes 2618
  data neck surgery enterprise readmissions
  analysis  information
    warehouse
    2004/8
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A pharmacy-based measure of comorbid illness provided predictive performance similar to that of 
an ICD-9-based measure of comorbidity for hospital readmission and LOS. This is noteworthy because 
data contained in secondary diagnoses are recorded by hospital medical personnel for the purpose of 
documenting prognostic illness in patients and pharmacy claims were never intended for that purpose. 
Researchers concerned about the overall reliability of hospital coding of patients’ multiple conditions 
may be able to use equally predictive pharmacy data. Deficiencies in a diagnosis-based measure of 
risk may be somewhat ameliorated by including outpatient pharmacy data. This combined admin. 
data strategy is certainly cost-effective and may prove increasingly practical as more medical data 
become automated. Groups that have access to both pharmacy and other automated medical data 
are already using both sources of information to better understand and predict utilization within their 
patient populations.
Interventions that focus on minimizing preventable inpatient safety events as well as improving coor-
dination of care between and across settings may decrease the likelihood of readmission. Although 
previous studies have linked readmissions with the quality of inpatient care during the index hospitaliza-
tion, our study suggests that focusing on AEs provides another important way of viewing readmission as 
an indicator of qoc.
Adherence to American Diabetes Association guidelines for admission work-up and readiness for dis-
charge criteria were significantly more likely to decrease the risk of readmission within 28 days. Quality 
of inpatient care exerts a substantial influence on the risk of readmission. Hospital should improve the 
qoc delivered to diabetic patients, special emphasis should be placed on attendance at outpatient 
clinics for follow up after discharge.
A large gap between geriatric care principles and practice in GAUs has been observed. Improvement 
in care processes may be translated to decreased short-term health services use and mortality. This un-
derlines the importance to examine structural and patient-related factors that promote qoc processes.
Overall qoc was not associated with readmission risk - a particularly striking finding when juxtaposed 
with the association between quality and 30-day mortality rates. Although our data do not allow us to 
directly test these hypotheses, readmission risk may be more influenced by care delivered at discharge, 
such as care planning or the presence of support during the post discharge period, whereas in-hospital 
death is dependent more on decisions and care provided earlier in the hospital stay, such as medica-
tions.
Hospitals with higher levels of both medical and interventional management and higher quality initial 
ED assessment had better outcomes. Readmissions were particularly sensitive to care processes. In the 
face of the unwarranted variations in outcomes across hospitals, strategies that promote better ED and 
inpatient management of AMI patients are needed.
Receipt of LDL testing and adherence to statin medications were effective in decreasing the likelihood 
of 30-day hospital readmission and may be considered as elements of a quality focused incentive-
based health care delivery package for diabetes patients. Findings of this study also suggest that incen-
tive-based quality programs to increase the use of and adherence to statins among all patients with 
diabetes regardless of LDL level may be worthy of consideration.
Other factors that affect outcomes must be included in performance comparison. Two important fac-
tors are procedure acuity and the patient’s comorbid conditions. Although both factors have significant 
effects, the acuity of the procedure is the strongest determinant of the incidence of negative quality 
and pis and should be heavily weighted in physician comparisons. These data may serve as a tool to 
evaluate performance, to positively impact outcomes through identifying best practices and providing 
data to individual surgeons who may positively affect their patients’ outcomes.
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Kent78 2011 prosp. pancreas  prospectively 30-day yes 578
  collected resection entered data readmissions
  data  2001/9
  analysis
Barbieri79 2007 retrosp. cystectomy university / yes 6728
  database  Health
  analysis  System 
    Consortium 
    Clinical 
    Database 
    2002/5
Chung80 2008 retrosp. hf medical
  database  records review all-cause yes 400
  analysis  2004/6 readmissions
Judge81 2006 retrosp.  hip/knee joint HES data 1-year yes 492459
  database  replacements  1997/2002 readmissions
  analysis
Boul- 2011 obser- AMI, hf, pn Hospital 30-day risk- yes 2373082
ding82  vational  Compare standardized
  analysis  data 2005/8 readmissions
Youn83 2012 retrosp. hf Heart Failure cause- yes 1527
  database  Registry specific
  analysis  2004/9 readmissions
Van- 2013 retrosp. hf admin. and hf yes 1121
Such84  database  medical readmissions;
  analysis  record data all-cause
    2002/3 readmissions
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Readmissions after pancreatic resection were frequent, early, costly, and largely related to procedure-
specific complications. As initial hospital stay continues to decline in high-acuity surgery, readmissions 
might be required for optimal management of complications, which often manifest later in the recovery 
course. Clinical pathway deviations predict potential readmissions, and might prompt adjustments in 
management and disposition of patients at risk for returning to the hospital. Use of readmission data as 
a quality measure for surgical patients must follow a decision on how to interpret such readmissions: are 
they failed discharges or are they rescues? The rrs reported here and by others must be considered in 
the context of the complexity of pancreatic disease and surgery, and do not necessarily reflect poorly 
on the qoc. As the focal caregivers for our patients, we as surgeons should promote caution when using 
rrs as qis for our performance. At the very least, we should have a stake in the discourse, as public policy 
is developed in this domain.
Even among academic medical centers hospitals with a higher volume of cystectomies were associ-
ated amongst others lower rehospitalization rates. These data may provide a framework for self-assess-
ment and help establish criteria for performance evaluation.
Adherence to a composite of HFPM appears to be related to a reduction in all-cause readmissions for 
patients with hf but not short-term mortality. Given the resources required for data collection and report-
ing, it is important to further evaluate whether or not these measures are associated with near-term 
clinical benefit before they can be used as an appropriate and meaningful surrogate measure for qoc 
that is subsequently linked to reimbursement.
In England, there are fewer adverse events following TJR in high volume centers and in orthopedic train-
ing centers. Standardization of procedures may account for this finding. The data have implications for 
private practice in the UK and for the current move to undertake TJRs in Independent Sector Treatment 
Centers.
Higher overall patient satisfaction with discharge planning are associated with lower 30-day risk-stan-
dardized hospital rrs after adjusting for clinical quality. This suggests that patient centered information 
can have an important role in the evaluation and management of hospital performance. Despite 
dramatic improvements in clinical process performance for hf, there has been virtually no reduction 
in these rrs or costs. Our findings confirm the lack of association between hf clinical measures and rrs. 
Conversely, we found that patient-reported measures were highly associated with 30-day rrs. Therefore, 
patient perceptions about hospital care in general and discharge planning specifically may provide an 
important new tool for measuring the quality of transitions of care.
For patients with LVSD in Korea, adherence to treatment performance measures is associated with 
improved clinical outcomes. Although it is expected that application of these measures would result in 
substantial improvement in outcomes for hf patients, guideline recommendations for these measures 
are based on expert opinion.
There are likely many other factors which influence readmission that are not dealt with by the hf core 
measures. Further studies are needed to examine the additional aspects of both hospital care and 
care after discharge for patients with hf, to determine the best practices that should be endorsed to 
assure the highest qoc. This study presents stronger evidence for the use of discharge instructions as an 
evidence-based measure than has been produced previously. Documentation of discharge informa-
tion and patient education does appear, in fact, to be associated with reductions in both mortality and 
readmissions.
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Showal- 2011 retrosp. pre-  / data from readmissions yes 34088
ter85  and post-  electronic or ED visit
  implemen-  discharge within 30-days
  tation com-  document
  parison  2005/6
  cohort study  2007/8
Polan- 2001 prosp. chf prosp. 3-months yes 205
czyk86  collected  collected readmissions
  data   data 1997
  analysis
Luthi87 2003 retrosp. hf medical Readmissions yes 2943
  data  records up to 21
  analysis  1995/6 months
Joynt88 2011 retrosp. chf Medicare 30-day risk- yes 1029497
  data  claims 2006/7 adjusted
  analysis   readmissions
Horwitz89 2012 cross- AMI, hf, pn Medicare 30-day risk- yes 3013616
  sectional  claims adjusted
  study  2007/9 readmissions
Hernan- 2010 retrosp. hf OPTIMIZE-HF 1-year yes 20441
dez90  data  data 2003/4 cardiovascular
  analysis   readmissions
Bottle91 2009 retrosp. / HES data unplanned yes 13974949
  data  2005/6 readmissions
  analysis   within 28-days
Halfon92 2002 retrosp. / hospital  foreseen/ yes 3474
  data  system data unforeseen
  analysis  1997 1-year
     readmissions
Halfon93 2006 retrosp. elective medical 30-day yes 131809
  data surgery records 2000 adjusted rates
  analysis   of potentially
     avoidable 
     readmissions
Maeda94 2010 s. rev. hf / / / /
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Having a standardized discharge instructions process will not sufficiently address the complex issues 
around post-discharge hospital utilization. Multi-faceted interventions that comprehensively address nu-
merous aspects of the discharge process will be more likely to have a meaningful impact on post-hospi-
tal utilization, such as discharge conversations between health care providers and patients/caregivers, 
patient health literacy, appropriate post-hospital follow-up, and communication with outpatient provid-
ers. Although health IT initiatives are likely a necessary building block for achieving national health care 
quality goals, whether they result in intended outcomes needs to be evaluated closely. Additional work 
is needed to further understand the reasons for preventable hospital readmissions and post-discharge 
ED visits.
Hospital qoc for patients with chf is independently associated with 3-month rrs, and cardiologist involve-
ment during hospitalization is associated with overall qoc.
Results show that ACEI use at discharge in patients with LVSD is associated with decreased rrs. This sug-
gest that compliance with the ACEI prescribing recommendations listed in clinical practice guidelines 
for patients with hf due to LVSD confers benefit.
Experience with managing chf, as measured by an institution’s volume, is associated with higher qoc 
and better patient outcomes, but at a higher cost. Understanding which practices employed by high-
volume institutions account for these advantages can help improve qoc and clinical outcomes for all 
chf patients. Admin. data cannot fully account for variations in severity of illness across hospitals. How-
ever, although admin. data are imperfect, they are standardized, validated, increasingly used, even for 
public reporting.
Risk-standardized rrs are moderately correlated within hospitals, as are risk-standardized mortality rates. 
This suggests that there may be common hospital-wide factors affecting hospital outcomes.
Several evidence-based processes of care are associated with improved outcomes, can discriminate 
hospital-level qoc, and could be considered as clinical performance measures. Given the moderate 
associations between individual process measures and clinical outcomes, it may be appropriate to 
include multiple new measures in hospital profiling.
The move towards ‘‘payment for performance’’- led systems such as the UK’s Payment by Results initia-
tive should improve recording because of the financial incentive to accurately capture comorbidity 
and other clinical details—as is already the case in the US with DRGs. The Institute for Healthcare Im-
provement believes that data on safety are best used internally by the hospitals rather than being used 
to make judgments on them by external bodies.
It is likely that other factors (which are not routinely collected) could bias the detection pf potentially 
avoidable readmissions. E.g. abnormal laboratory values, failure to ambulate, mental status, marital sta-
tus, living situation, or income. Nevertheless, most readmissions are caused by the relapse of the original 
condition and by complications linked to inappropriate inpatient care
Adjusted rates of potentially avoidable readmissions are scientifically sound enough to warrant their 
inclusion in hospital quality surveillance. Indicator variability should not result from practices unrelated 
to qoc. E.g. hospitals may decrease their potentially avoidable rrs by failing to readmit (or postponing) 
patients requiring inpatient care, or by upcoding unsupported risk factors. There is not much evidence 
that this may occur when the indicators are not subjected to public reporting. A strong perverse incen-
tive would be for insurers not to reimburse early readmissions, as sometimes suggested. An explicit and 
automated algorithm to compute the indicator protects against falsification. However, the issue revolves 
mainly around the quality of the diagnoses and procedures coding.
The findings from this systematic review suggest that an increase in compliance with the hf performance 
measures leads to a consistent positive impact on patient outcomes although the strength, magnitude, 
and significance of this effect is variable across the individual pi.
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En- 2008 matched surgical MarketScan  readmission yes 161004
cinosa95  case- patients Commerical 90-days after
  control  Claims and surgery
  study  Encounter
    data 2001/2
Shahian96 2012 retrosp. AMI, hf, pn hospitals data all-cause yes Between 374
  cohort  2004/7 90-day  to 3020
  study   readmissions
Fonarow97 2007 retrosp. hf The Organized 60- to 90-day yes 5791
  data  Program to mortality and
  analysis  Initiate  combined
    Lifesaving  mortality/
    Treatment in  rehospitaliza-
    Hospitalized  tion rates.
    Patients with 
    HF registry 
    2003/4
Stefan98 2012  cross- AMI, hf, pn Hospital adjusted 30- yes 972-2940
  sectional   Inpatient day all-cause
  study  Quality readmissions
    Reporting 
    Program 2007
Nath- 2002 audit study pn audit data readmissions yes 205
wani99    1999/2000 within 2 weeks
Morse100 2011 cross- asthma admin. data asthma- yes 37267
  sectional  2008/10 related
  study   readmissions
     at 7,30,90 days
Schop- 2012 retrosp. hf Hospital 3-0-day yes 3655
fer101  database  compare readmissions  hospitals
  analysis  database
Mansi102 2010 retrosp. hf data 90-day yes 357
  cohort  collected for readmissions
  study  quality-
    management
    administration
    2003/4
Marcin103 2004 population- trauma computerized non- yes 102008
  based patients hospital scheduled/
  non-  discharge unknown
  concurrent   abstracts 30-day
  cohort study  1995/99 readmissions
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Medicare will stop reimbursing hospitals for the extra costs of eight patient safety events beginning 
in 2008. At that time, hospitals will have to revisit and re-evaluate their business case for increasing 
investments in patient safety improvements. One vital component of the business case is an accurate 
estimate of the potential returns to patient safety interventions.
Adherence with recommended AMI and pn care processes is associated with improved long-term out-
comes, whereas the results for hf measures are inconsistent. The evidence base for all process measures 
must be critically evaluated, including the strength of association between these care processes and 
outcomes in real-world populations. Some currently recommended processes may not be suitable as 
accountability measures.
Current hf performance measures, aside from prescription of an ACEI or ARB at discharge, have little 
relationship to patient mortality and combined mortality/ rehospitalization in the first 60 to 90 days after 
discharge. Additional measures and better methods for identifying and validating hf performance mea-
sures may be needed to accurately assess and improve care of patients with hf.
Hospitals with greater adherence to recommended care processes did not achieve meaningfully better 
30-day hospital rrs compared to those with lower levels of performance.
Regular evaluation of clinical performance through audit and feedback of information to stakeholders 
as a means of promoting change is now encouraged as part of the quality improving agenda of Clini-
cal Governance within the UK. The emphasis is on implementation and evaluation of clinical care. The 
study has confirmed the value of qis in evaluating cap management and has stimulated the develop-
ment and implementation of a local hospital–based integrated care pathway.
No association between CAC-3 compliance and subsequent ED visits and asthma-related readmis-
sions was found. The CAC-3 measure in its current form may not meet the criteria outlined by the Joint 
Commission for accountability measures. Until CAC-3 compliance can be linked to improved outcomes, 
the Joint Commission should reconsider whether the CAC-3 component of the measure set is appro-
priately classified as an ‘accountability measure’ suitable for public reporting, accreditation, or pay 
for performance. The Joint Commission embraces accountability measures as appropriate for use for 
public reporting and pay for performance. While the health of children hospitalized with asthma clearly 
improves when they receive relievers (CAC-1) and systemic corticosteroids (CAC-2), the CAC-3 measure, 
in its current form, may not meet the criteria set out for accountability measures.
After adjusting for socio-economic factors and hospital volume, only two (out of four) hf process indica-
tors were associated with lower readmissions.
Compliance with the Joint Commission on Accreditation of Healthcare Organizations’ TJC quality mea-
sures for hf was associated with higher rrs for hf. Several factors may explain this trend, including patient 
characteristics and focus on national reporting benchmarks rather than patient centered health care.
Relationships between trauma volume and outcomes exist but depend on which patient populations 
are studied and how the data are analyzed. Furthermore, trauma centers may be subject to the detri-
mental effects of high temporal volume overextending existing services and capacity. Since this study 
found that both between-hospital volume and within-hospital volume measures are associated with 
outcomes, we recommend that both measures be included in future volume outcome investigations.
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Patter- 2010 retrosp. hf national 1-year yes 22750
son104  data  clinical registry readmissions
  analysis  data 2003/4
Rocca- 2005 s.rev. hf / / / /
forte105
Gawlas106 2012 prosp.  pr case review 30-day yes 787
  populated   2006/10 readmissions
  database 
  analysis
Jimenez- 2004 cross- / clinical avoidable yes 784
Puente107  sectional   records readmissions
  obser-  review 1997 within
  vational    6-months
  study
Ric- 2012 retrosp. percutaneous Dynamic 30-day yes 10965
ciardi108  database coronary Registry readmissions
  analysis intervention 1997/2006
Auer- 2010 obser- complex Perspective adjusted yes 14170
bach109  vational  cancer database 30-day
  cohort  surgery 2003/5 readmissions
  study
Rumball- 2013 retrosp. surgical hospital acute public yes 89090
Smith119  data patients admin. data hospital
  analysis  2002/8 admissions 
     within 30days
Luthi111 2004 retrosp. hf hospital readmissions yes 1055
  cohort   admin. data within 30-days
  study  1999
Mayer112 2011 retrosp. radical hospital emergency yes /
  data cystectomy admin. data readmissions
  analysis  2000/1 within 30-days
    2006/7
Mc- 2013 survey; AMI survey data 30-day yes 597
Connell113  retrosp.  and admin. readmissions
  data  data 2010 for AMI
  analysis
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Hospital process performance for hf as judged by current CMS measures is not associated with patient 
outcomes within 1 year of discharge, calling into question whether existing CMS metrics can accurately 
discriminate hospital qoc for hf.
Disease management programs reduce mortality and hospitalizations in hf patients.
The study found the vast majority of readmissions after pr were to manage complications related to the 
operation and were not due to poor coordination of care/ discharge planning. Because evidence-
based measures to prevent these surgical complications do not exist, we cannot support the use of rrs as 
a qi after pr.
Hospitals and health administrations of both continents include the rr among the indicators regularly 
monitored. Most of the hospital readmissions are not avoidable with the modification of medical care 
during the index episode. Thus, rrs cannot be considered valid qoc indicators for the set of specialties in 
a general hospital. It is proposed to continue evaluating whether they can be valid qoc indicators within 
specific diagnoses.
Although in-hospital mortality and los after PCI have decreased over time, the observed 30-day cardiac 
rr was highly variable and risk of readmission was more closely associated with underlying patient char-
acteristics than procedural characteristics.
Although hospital and surgeon volume were not associated with outcomes, lower overall adherence to 
quality measures is associated with higher costs, but not improved outcomes. This finding might provide 
a rationale for improving care systems by maximizing care consistency, even if outcomes are not af-
fected.
The study found substantial error when using readmission as a marker of quality, and suggests that differ-
ences in readmission between populations are more likely to be due to factors other than qoc.
Readmission did not predict and was not a valid indicator of the qoc for hf patients. Early readmission 
is sometimes interpreted as a problem following discharge due to inadequate care during the hospital 
stay, but post discharge factors may contribute to readmission. The current limitations of routinely avail-
able outcome measures such as readmissions and the lack of valid risk adj. methods, the AHA/ACC Sci-
entific Forum on Quality of Care and Outcome Research in Cardiovascular Disease and Stroke does not 
recommend the use of readmission for comparing hospitals for patients with hf. However, this outcome 
measure might be documented and recorded over time and included as part of quality improvement 
projects within institutions. Adjustment for severity, comorbidity, other patient risk factors is crude and 
limited.
The study found no statistically significant relationship between volume and complication or rrs. it may 
be that readmission as a performance measure is more suitable when assessing a relatively homog-
enous patient population and when the severity of the condition shows little variance, such as in day 
surgery setting.
Management practices were not associated with lower rrs, a finding that may be consistent with evi-
dence suggesting that 30-day rr are driven primarily not by hospital practice but by a hospital’s patient 
population and the resources of the community in which it is located
* AAA repair- abdominal aortic aneurysm repair; ACEI- angiotensin-converting enzyme inhibitor; admin 
data- administrative data; aes-adverse events; arb-angiotensin receptor blocker; AMI-acute myocardial in-
farction; CABG-coronary artery bypass graft surgery; cap- Community-Acquired Pneumonia; CHF-conges-
tive heart failure; COPD-chronic obstructive pulmonary disease; ed-emergency department; eoc-episode 
of care; GAUs-Geriatric Assessment Units; HES-Hospital Episode Statistics; hf-heart failure; HFPM-heart failure 
performance measures; ICU- intensive care unit; lit. review-literature review; los-length of stay; pci-percuta-
neous coronary intervention; pi-performance indicator; pn-pneumonia; prosp - prospective; pr-pancreatic 
resection; rct-randomized controlled trial; retrosp.-retrospective; risk adj.-risk adjustment; rr-readmission rate; 
rrs-readmission rates; s.rev- systematic review; tha- total hip arthroplasty; qi-quality indicator;

Chapter 4.
a systematic review 
on the validity of 
readmission rates as 
a quality indicator for 
heart failure
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This article was published as: 
A systematic review and meta-analysis on the association between quality of 
hospital care and readmission rates in patients with heart failure.
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aBStRaCt
Introduction: In recent years, readmission rates have been increasingly used 
as a measure of quality of hospital care for patients with heart failure. The 
aim of this systematic review is to assess the scientific evidence regarding 
the relation between hospital readmission rates and quality of hospital care 
for patients with heart failure.
methods: We defined quality of hospital care for patients with heart fail-
ure by adhering to the performance measures developed by the American 
College of Cardiology (ACC)/American Heart Association (AHA). Relevant 
articles published in English and indexed in the bibliographic databases 
Embase, Medline OvidSP, Web of Science, Cochrane Central, and PubMed 
were reviewed.
Results: Of the 2,638 studies identified, 18 were included. They varied widely 
in their methodology, data sources used, and study populations. We found 
mixed but rather limited evidence that there is a relationship between the 
ACC/AHA process measures and the rate of readmission. Four of 10 stud-
ies showed a significant correlation of readmission rate with “angiotensin-
converting enzyme inhibitor/angiotensin receptor blocker use.” Three of 
9 studies showed a significant correlation between readmission rates and 
“evaluation of left ventricular systolic function.” One of 7 studies showed 
a significant correlation with “smoking cessation counseling,” and 2 of 8 
showed a significant correlation with “providing discharge instructions.” No 
evidence was found for a relationship between readmission rates and the 
performance measure “warfarin for atrial fibrillation.”
Conclusions: Readmission rates after heart failure are mostly not related to 
the evidence-based ACC/AHA in-hospital process indicators for heart fail-
ure. It is unclear whether in-hospital quality of care is the key determinate 
of the readmission rate or whether readmissions are likely influenced more 
by postdischarge care. Further research is needed to clarify whether the 
readmission rate is a reflection of hospital care or quality of care on a larger 
level, especially when it is used for a pay-forperformance scheme to mea-
sure quality of hospital care.
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BaCKGRoUND
In recent years, progressively sophisticated efforts have been undertaken 
to increase the transparency and accountability of the quality of hospital 
care. Hospital readmission rates are increasingly receiving attention, as they 
result in high health care costs1 and as they are thought to represent quality 
of hospital care.2
For some years, hospital risk-adjusted readmission rates have also been used 
for policy purposes.3 The Hospital Readmissions Reduction Program was set 
up by the Centers for Medicare and Medicaid Services (CMS) as a pay-for-
performance scheme in which hospitals with an excessive readmission rate, 
compared with the national mean, are financially penalized by being paid 
less.4,5
Heart failure, for which readmissions are common, is one condition included 
in this CMS pay-for-performance scheme.6 Furthermore, heart failure forms 
a growing public health problem in the United States, due to its high prev-
alence,7 high mortality risk,8 and high costs.1 It is estimated that $39.2 bil-
lion was spent on care for patients with heart failure in the United States in 
2010.9
The use of risk-standardized readmission rates in pay-for-performance 
schemes is based on the theory that hospitals that deliver low-quality hos-
pital care have higher readmission rates. In the scientific literature, the de-
bate regarding whether or not the rate of readmission is ready to be used 
for pay-for-performance schemes is still ongoing because there are several 
concerns about the validity of risk-standardized readmission rates as a mea-
sure of hospital care quality.10,11
If hospitals’ readmission rates are a valid indicator of the quality of delivered 
hospital care, based on Donabedian’s classic structure-process-outcome 
framework,12 they are expected to correlate with other hospital quality in-
dicators.
The American College of Cardiology/American Heart Association (ACC/
AHA) has developed a core set of evidence-based in-hospital heart failure 
process measures (Table I).13,14 For example, the beneficial effect of the ad-
ministration of angiotensin-converting enzyme inhibitor (ACEI), on outcome 
was shown in randomized controlled trials.15,16
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The aim of this study is to evaluate whether the evidence-based ACC/AHA 
process indicators are related to the readmission rate. Therefore,we per-
formed a systematic review to assess the scientific evidence on the rela-
tion between readmission rates and quality of hospital care for patients with 
heart failure,which was defined as adherence to the ACC/AHA process in-
dicators for heart failure.
table I. ACC/AHA process indicators based on the guidelines for the diag-
nosis and management of HF
Performance measure name Description
ACEI or ARB for LVSD HF patients with LVSD and without both ACEI andARB 
 contraindicationswho are prescribed an ACEI or ARB at hospital 
 discharge
Evaluation of LVS function HF patients with documentation in the hospital record that LVS function 
 was assessed before arrival, and during hospitalization, or is planned 
 after discharge
Adult smoking cessation HF patients with a history of smoking cigarettes, who are given smoking
advice/counseling cessation advice or counseling during hospital stay
Discharge instructions HF patients discharged home with written instructions or educational 
 material given to patient or caregiver at discharge or during the 
 hospital stay addressing all of the following: activity level, diet, 
 discharge medications, follow-up appointment, weight monitoring, 
 and what to do if symptoms worsen
Anticoagulant at discharge HF patients with chronic/recurrent AF and without warfarin
for HF patients with AF contraindications who are prescribed warfarin at discharge
Abbreviations: HF, Heart failure; LVSD, left ventricular systolic dysfunction; LVS, left ventricular systolic; AF, 
atrial fibrillation.
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metHoDS
We carried out a systematic literature review on the relation between the 
ACC/AHA in-hospital process indicators for heart failure and readmission 
rates. This article was drafted following the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analysis checklist17 (Appendix A).
Data sources and search strategy
With the help of a medical information specialist, 2 researchers (C.F. and 
H.L.) developed and carried out a broad systematic computerized litera-
ture search in the bibliographic databases Embase, Medline OvidSP, Web of 
Science, Cochrane Central, and PubMed. No time restrictions were set. All 
articles must be published in English, and they were included until 14th April 
2014. MeSH search terms were related to hospital quality indicators, quality 
control procedures, medical audit, measurement, and readmission/hospi-
talization. The fullsearch strategy, which was adapted for the several data-
bases searched, can be found in Appendix B. Furthermore, the reference 
lists of relevant articles were screened for additional articles. In addition, a 
free literature search was conducted.
Selection process
First, the titles and abstracts of all identified articles were screened by one 
reviewer (C.F.). Of the articles possibly eligible for inclusion, full texts were ob-
tained. The full text was screened by 2 reviewers independently (H.L., C.F.), 
using a screening form. The interrater reliability was measured by calculat-
ing the reviewers’ agreement percentage on the inclusion of the eligible 
full-text articles. In case of disagreement, studies were discussed among the 
2 researchers. If no agreement could be reached, a third researcher was 
consulted (E.S.).
eligibility criteria
The selected articles had to meet specific criteria. They had to be peer re-
viewed. The patient population under investigation had to be patients with 
heart failure. Studies had to investigate the relation between the readmis-
sion rate and at least one of the heart failure hospital process indicators 
described by the ACC/AHA core set 2005 (Table I).14 Studies with various out-
come definitions, disease-specific or all-cause readmission, and time inter-
vals between leaving the hospital and readmission from 28 days, 30 days, 
or up to 1 year were considered. Randomized controlled trials that evalu-
ated the process measures were not included because we aimed to test 
the indicators in the context where performance measurement takes place, 
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namely, in the real-world setting, without randomization, perfect data qual-
ity, blinded outcome assessment, and others.
Data abstraction
From each included study, we collected descriptive information, including 
authors’ names, publication year, study design, and data source used in 
the study. Furthermore, the information on the patient population, like the 
number of centers and patients and specific diagnoses included was as-
sessed. To be able to compare the studies, judge their quality, and interpret 
results, we abstracted information on the methodology used in the stud-
ies. The definition of the outcome measure was assessed, including type of 
readmission (disease-specific, all-cause readmission, planned/unplanned) 
and time interval between leaving the hospital and readmission. We as-
sessed how the authors handled the competing outcome of mortality. Re-
garding data reliability and methodology, we assessed whether the studies 
applied case-mix correction and whether the studies provided information 
on the data they used (eg, regarding the completeness and accuracy and 
by whom and in which way coding was done). We also checked whether 
readmissions to hospitals other than the one where the index admission took 
placewere captured in the data. In case of doubt during the data abstrac-
tion, cases were discussed among the 2 researchers (C.F., H.L.). If doubt per-
sisted or if information was missing, we contacted the authors of the original 
studies.
Data analysis
Of the studies providing effect estimates, we pooled the results using ran-
dom-effect meta-analysis. Results for each of the process measures were 
pooled separately, and also studies analyzing readmissions as a dichoto-
mous outcome (resulting in odds ratios [ORs]) were pooled separately from 
those analyzing time to readmission (resulting in hazard ratios [HRs]). Studies 
providing other numbers, such as correlation coefficients or percentages 
of adherence across quartiles of outcome,were not included in themeta-
analysis but described in a qualitative way. Moreover, studies that used a 
combined outcome (eg, death or readmission) from which readmissions 
could not be deducted and studies that used a composite quality measure 
instead of the separate process measures were excluded from the meta-
analysis. Some studies analyzed nonadherence vs adherence to the pro-
cess indicators. In that case, we transformed the OR or HR presented into 
the OR or HR for adherence vs nonadherence using the formula: 1/OR or 
1/HR. Cochran Q test was used to assess the homogeneity across the stud-
ies, and it was quantified by the I2 statistic, which reflects the amount of 
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heterogeneity that is attributable to the variation across studies, rather than 
chance.18 Meta-analyses are presented as forest plots createdwith the met-
aphor package in R statistics version 3.0.1 (The R Foundation for Statistical 
Computing, Vienna, Austria).
Funding
No extramural funding was sought or used to support this work. Wichor Bram-
er, Medical Information Specialist at the Library of the Erasmus MC University 
Medical Center, helped to develop the search strategy.
107
4
ReSUltS
Search result
Figure 1 shows that our search strategy yielded 2,638 articles, 2,622 through 
the initial search and 16 by reference review. Of those, 2,591 articles were ex-
cluded after title and abstract review. The full text of the resulting 47 articles 
was screened, which resulted in exclusion of another 31 articles. Twelve stud-
ies were excluded because they measured other process indicators than 
those recommended by the ACC/AHA. Five studies were excluded because 
they considered other outcome indicators than the rate of readmission. Ten 
studies focused on the ACC/AHA process and outcome indicators, but did 
not investigate the link between them. Another 4 studies were excluded 
because they used the indicators in an randomized controlled trial or in-
tervention study setting. This resulted in 16 articles eligible for inclusion. The 
free search resulted in 2 additionally included articles. Thus, 18 studies were 
included in our final analysis. The interrater agreement for the selection pro-
cess was 89%.
Figure 1. Flowchart of article inclusion process
Studies identified through electronic 
search:
total 2638
Primary search 2622
Reference search 16
Included for full text screening:
total 47
Primary search 31
Reference search 16
Excluded based on title and abstract 
screening:
total 2591
Did not meet the study aim
Excluded based on fulltext screening:
total 31
Other process measures 12
Other outcome measures 5
Did not study process outcome link 10
RCT 2
Intervention study 2
Included in analysis:
total 18
Primary search 15
Reference search 1
Plus via free search 2
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Description of the studies included
Of the 18 included studies, 15 were conducted in the United States.19–33 Five 
studies were single center,19,24,28,31,32 and the maximum number of centers 
was 3,655.27 The number of analyzed patients ranged from 23931 to 328,83029 
across the studies. Most studies (n = 14) were based on retrospective data 
(Table II). Seven studies defined adherence to the process indicators on the 
hospital level (as percentage adherence), whereas the other 11 studies de-
fined adherence on the individual patient level (adherence to ACC/AHA 
process indicators per patient: yes/no).
Half of the included studies (n = 9) considered a time interval of leaving the 
hospital and readmission of around 30 days.
Most of the studies included readmissions for all causes, whereas only 6 stud-
ies defined cause-specific readmissions as an outcome.20,24,26,32,34,35 Case-mix 
correction was executed in all but one study.25 A number of studies stated 
that they excluded in-hospital deaths, transferred patients, or patients who 
left the hospital against medical advice from the denominator. However, 
most of the studies did not provide information on such selections (Table 
II). In total, 8 studies could not be included in the meta-analysis and were 
only described qualitatively because they used combined outcomes and/
or combined process measures.
associations between process indicators and readmissions
Angiotensin-converting enzymeinhibitor/angiotensin receptor blocker use
The strongest evidence was found for an association between the use of 
ACE/angiotensin receptor blocker (ARB) blocker in eligible patients and the
rate of readmission. Ten studies tested the association, of which 8 could be 
included in the pooled analysis. The pooled OR for the effect of adminis-
trating ACEI or ARB blocker on readmissions was 0.7 (95% CI 0.4-1.23). The 
pooled HR indicated the same trend (HR 0.8, 95% CI 0.71-1.06), despite large 
heterogeneity across the studies. In general, administrating ACEI or ARB 
blocker seems to be associated with lower readmission rates.
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Evaluation of left ventricular systolic function
The evidence for a relation between “evaluation of left ventricular systolic 
function” and the rate of readmission wasmixed. Of 9 studies that tested the 
association, 6 studies were pooled in the meta-analysis.25–28,31,36 The pooled 
OR for the effect of evaluating the left ventricular systolic function on read-
missions was 0.98 (95% CI 0.72-1.34) (Figure 2). The meta-analysis of time to 
readmission even indicated an adverse effect of adhering to the process 
indicator (HR 1.04, 95% CI 1.01-1.07) (Figure 3). However, for both meta-analy-
ses, the I2 indicated a high level of heterogeneity across the studies. Two of 
the 3 studies that could not be included in the meta-analysis indicated a sig-
nificant association between the adherence to this indicator and the rate of 
readmission.30 Nevertheless, the overall evidence for this indicatorwas very 
heterogeneous, as supported by the fact that 2 studies reported a signifi-
cant negative effect of adhering to the indicator on readmission.21,26
Smoking cessation counseling
Limited evidence was found for a relation between smoking cessation coun-
seling and readmissions. Six studies tested the association between provid-
ing smoking cessation counseling and the rate of readmission. Of those, 4 
studies could be included in the meta-analysis. The pooled effects estimates 
showed no effect of providing smoking cessation counseling on (time to) re-
admission (OR 0.99 [95% CI 0.98-0.99], HR 0.99 [95% CI 0.99-1.00]). This effect 
was very consistent over the studies, as shown by the low I2. Also, the 2 stud-
ies not included showed no significant association between the smoking 
cessation counseling and readmission.21,33
Discharge instructions
Limited evidence was found for an association between the indicator “pro-
viding discharge instructions” and readmissions. A total of 9 studies tested 
the association, of which 6 could be included in the meta-analysis. The poo-
ledOR showed no effect of providing discharge instructions on readmission 
rates (OR 1.0, 95% CI 0.98-1.01) (Figure 2). The pooled HR showed a positive 
but nonsignificant effect of providing discharge instructions on time to re-
admission (HR 0.93, 95% CI 0.78-1.01) (Figure 2). The I2 indicated a low level of 
heterogeneity across the studies. The 3 studies not included in the pooled 
estimate of the OR had similar findings.
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table II. Descriptive information and methodological aspects of included 
studies
Descriptive
information
Methodological
aspects
Study type
Data source
Centers
Patients
Level of definition of 
process measures
Included patient 
population
Indicator definition
Effect of competing
outcomes
Data reliability
Reported data
Type of readmission
Time frame
Association with mortality
Case-mix adjustment
Readmissions to other 
hospitals
Coding
Completeness and
accuracy of data source
Chung et al, 2008
USA,19
Case-control study
Inpatient medical records
1
400
Patient
Primary diagnosis of HF
Time to all-cause readmission
Within 6 mo
Patients were right-censored for
readmission/death
+
+
Medical records were assessed 
by the quality assurance 
department in accordance 
with CMS standards
HR
Author, year, country
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Fonarow et al, 2007,
USA33
Prospective cohort study
Web-based registry optimize HF
91
5791
Patient
Primary diagnosis of HF, 
hypertensive heart disease with 
HF, or hypertensive heart and 
renal disease with HF; 
Age, >18 y discharged home
All-cause rehospitalization 
combined
60-90 d
Death included in outcome
+
+
Admission staff, medical staff, or 
both recorded race/ethnicity, 
usually as the patient was 
registered
Participating hospitals supplied 
data on eligible admissions 
according to established 
JCAHO methods;
The protocol was approved by 
each participating center’s 
institutional review board 
or through use of a central 
institutional review board;
Excluded patients discharged 
to skilled nursing facilities or 
other acute-care hospitals
OR
Hernandez et al, 2010,
USA20
Retrospective cohort study
OPTIMIZE-HF linked to Medicare 
claims data
141
20,441
Hospital
Discharge diagnosis of HF
Time to cardiovascular 
readmission
60-d and 1 y
In-hospital deaths excluded
+
+
Web-based case report 
form; system used automatic 
electronic data checks to 
prevent out-ofrange and 
duplicate entries, an audit 
of the database used pre 
specified criteria to verify the 
data against source documents 
for a 5% random sample of the 
first 10000 patients
The institutional review board 
approved the protocol; 
Patients transferred to another 
acute care hospital, discharged 
to hospice or a federal hospital, 
or left the hospital against 
medical advice excluded
HR
Author, year, country
Hernandez et al, 2011,
USA,21
Retrospective cohort study
GWTG-HF registry linked to 
in-patient claims data from CMS
176
19,952
Hospital
Admission for episode of 
worsening HF or developed 
significant HF symptoms during 
hospitalization with HF as primary 
discharge diagnosis; ICD-9-cm 
428.x, 402.x1, 404.x1, 404.x3
/
30 d 
In-hospital deaths excluded
+
+
Data were collected via a Web-
based registry
Hospitals with b15 cases were 
excluded; 
contraindications or other medi-
cal exceptions for that therapy, 
as well as those documented to 
be comfort care only excluded;
Discharge from the hospital 
with palliative care or hospice 
care also excludes a patient 
from each discharge process 
measure;
For outcome measures, transfer-
outs were also excluded
Correlation coefficient
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Descriptive
information
Methodological
aspects
Study type
Data source
Centers
Patients
Level of definition of 
process measures
Included patient 
population
Indicator definition
Effect of competing
outcomes
Data reliability
Reported data
Type of readmission
Time frame
Association with mortality
Case-mix adjustment
Readmissions to other 
hospitals
Coding
Completeness and
accuracy of data source
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Author, year, country
Jha et al, 2009,
USA,22
Retrospective cohort study
HQA data linked to AHA annual 
survey
4031
/
Hospital
Patients with CHF
Time to all-cause readmissions 
for CHF
30 d
In-hospital deaths excluded
+
+
Excluded hospitalreferral 
regions with fewer than 
100 patients admitted for 
pneumonia or congestive HF in 
the year under evaluation;
Included all patients 
discharged from hospitals in 
each hospital-referral region 
during the first 11 mo of the 
year under evaluation and 
calculated the proportion of 
patients who were readmitted 
within 30 d
Variation across percentiles of 
readmission/adherence
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Luthi et al, 2004,
Switzerland36
Retrospective cohort study
Medical records electronic 
medical records hospital 
administrative data
3
1055
Patient
Primary or secondary diagnosis 
of ICD-10 codes: 150.0, 150.1, 
150.9, 111.0, 113.0, 113.2
All-cause
30 d
In-hospital deaths excluded
+
-
The data were abstracted from 
copies of hospital medical 
records by trained nurses and/or 
medical record specialists
Interrater reliability was 
assessed in one hospital by a 
random replicate sample of 100 
medical records which were 
reabstracted;
Data were abstracted from the 
medical records of the index 
hospitalization†
OR
Author, year, country
Mansi et al, 2010,
USA,24
Retrospective cohort study
Recorded data for quality-
management administration
1
357
Patient
Primary diagnosis of HF*
Time to readmissions (only 
admissions for HF exacerbation)
90 d
In-hospital deaths excluded
+
-
Data abstraction was conducted 
by trained doctors/medical 
record specialists. In 2 hospitals 
the medical records were 
available for data abstraction. 
In the third, only the electronic 
medical records were available
Excluded patients: who were 
not expected to have follow-
up visits within the system, such 
as residents of other states, or 
patients who belonged to a 
different health care system 
and were in the institution on an 
emergency or temporary basis
OR
Kociol et al, 
2013, USA,23
Retrospective 
cohort study
AHA’s 
GetWith The 
Guidelines-HF 
Registry linked 
to Medicare 
claims data
149
173,871
Hospital
Primary 
diagnosis of 
HF;
Age, >65 y
Time to re-
hospitalization 
30 d
In-hospital 
deaths 
excluded
+
/
Hospitals 
submit clinical 
information 
using an online, 
interactive 
case-report 
form
Excluded 
transfers and 
excluded 
extremely 
low-volume 
hospitals with 
b15 cases
Variation across 
percentiles of 
readmission/
adherence
Mazimba et al, 
2013, USA,25
Retrospective 
cohort study
Medical 
records
4
6063
Patient
Primary diag-
nosis of HF by 
ICD-9 codes 
designated for 
CHF; Age, >18 y
/
30 d
/
-
-
A trained 
nurse 
abstractor 
prospectively 
collected 
data with an 
integrated 
electronic 
medical 
record system
OR
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Descriptive
information
Methodological
aspects
Study type
Data source
Centers
Patients
Level of definition of 
process measures
Included patient 
population
Indicator definition
Effect of competing
outcomes
Data reliability
Reported data
Type of readmission
Time frame
Association with mortality
Case-mix adjustment
Readmissions to other 
hospitals
Coding
Completeness and
accuracy of data source
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Author, year, country
Patterson et al, 2010,
USA,26
Retrospective cohort study
OPTIMIZE HF registry
150
22,750
Hospital
Primary diagnosis of HF: DRG 
codes§
Time to cardiovascular
readmission
At 1 y
In-hospital deaths excluded
+
/
Automatic electronic data 
checks prevented out-of-range 
entries and duplicates
In addition, an audit of 
the database based on 
predetermined criteria verified 
data against source documents 
for a 5% random sample of the 
first 10000 patients;
Excluded transfers or 
subsequent admissions for 
rehabilitations
HR
115
4
Author, year, country
Schopfer et al, 2012,
USA27
Retrospective cohort study
Hospital Compare database
3655
/
Hospital‡
Primary diagnosis of HF
/
30 d
+
/
Hospitals with fewer than 25 
patients with HF or incomplete 
data were excluded
OR
Shahian et a., 2012,
USA28
Observational retrospective 
cohort study
Hospital data linked to 
administrative data with unique 
patient identifier
1
2773
Patient
Discharge diagnosis of HF; 
Eligible for at least one National 
Hospital Quality Measure
Time to all-cause readmission
90 d and 1 y
In-hospital deaths excluded
+
+
For the HF discharge instruction 
measure, we limited the study 
cohort to patients who were 
discharged to home with or 
without services, thus mitigating 
any potential confounding by 
the care rendered at extended 
care facilities;
Excluded patients who left 
hospital against medical advice
OR
Stefan et al, 2012,
USA29
Cross-sectional analyses
Quality Improvement 
Organization Clinical Data 
Warehouse
Varied between 374 and 3020?
328,830
Hospital
Discharge diagnosis of HF;
Enrolled in fee-for-service 
Medicare;
Age, ≥66 y;
Discharged from an acute care;
Hospital that reported data to 
the Hospital IQR Program
Time to any admission
Within 30 d
In-hospital deaths excluded
+
-
Used discharge and quality of 
care assessment records that 
were submitted by hospitals 
that participated in the Hospital 
Inpatient Quality Reporting 
Program 
Transfers to/from another acute 
care hospital were assigned to 
the hospital that discharged the 
patient;
Extreme low volume hospitals 
further excluded
Correlation coefficient
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Descriptive
information
Methodological
aspects
Study type
Data source
Centers
Patients
Level of definition of 
process measures
Included patient 
population
Indicator definition
Effect of competing
outcomes
Data reliability
Reported data
Type of readmission
Time frame
Association with mortality
Case-mix adjustment
Readmissions to other 
hospitals
Coding
Completeness and
accuracy of data source
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Author, year, country
Sueta et al, 2000,
USA30
Retrospective cohort study
Patient medical record, North 
Carolina Medicare Beneficiary 
File/North Carolina Medicare 
Claims History File
48
1195
Patient
Discharge diagnosis ICD-9 
codes: 402, 404, 425, 428;
Age, ≥65 y
Readmission or mortality
30 d
In-hospital deaths excluded
+
+
Hospitals with fewer than 50 
patients with HF or incomplete 
data were excluded. 
Limitation: most patients did 
not have documentation of left 
ventricular function, although 
most had radiographic 
evidence of cardiomegaly or 
CHF
Patients admitted with an acute 
or recent myocardial infarction 
were excluded
HR
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Author, year, country
VanSuch et al, 2006,
USA32
Retrospective cohort study
Administrative/clinical data
1
782
Patient
Primary diagnosis of HF: 428, 
402, 404;
Age, ≥18 y
Time to readmissions, due to HF
related and unrelated causes
(2 analysis)
Up to 90 d
In-hospital deaths censored
+
-
Registered nurses reviewed the
medical records to determine 
the extent of compliance with 
the documentation of written 
discharge instructions
Patients included when they 
were discharged to home, 
home care or home care with 
intravenous treatment;
Patients discharged to skilled 
nursing facilities or other acute 
care hospitals were excluded;
Could not distinguish between 
planned and unplanned 
readmissions
HR
Whittaker et al, 2013,
USA31
Retrospective cohort study 
Electronic medical record 
review, data acquired from the 
hospital billing system
1
239
Patient
Primary diagnosis of HF (based 
on 24 ICD-9 codes);
Age >18 y
All-cause
30 d
In-hospital deaths excluded
+
-
Patients were excluded if they 
had a diagnosis of HF and 
received a LV assist device or 
a heart transplant and/or had 
a length of stay greater than 
120 d;
Furthermore, patients were 
excluded if they were 
transferred to another hospital, 
or left against medical advice
OR
Yoo et al, 2014,
Korea35
Retrospective observational
study
Survey data
23
1297
Patient
Admission to hospital with 
systolic HF or dyspnea and 
verification of HF by clinical 
findings;
Age, ≥20 y
Time to admission by 
aggravated HF
Within 1 y
In-hospital deaths excluded
+
/
Data were collected and 
managed by the Control of 
Data Committee of the study
Excluded patients with 
inadequate echocardiographic 
and clinical data
HR
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Descriptive
information
Methodological
aspects
Study type
Data source
Centers
Patients
Level of definition of 
process measures
Included patient 
population
Indicator definition
Effect of competing
outcomes
Data reliability
Reported data
Type of readmission
Time frame
Association with mortality
Case-mix adjustment
Readmissions to other 
hospitals
Coding
Completeness and
accuracy of data sourceC
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Author, year, country
Youn et al, 2012,
Korea34
Nationwide, prospective 
observational, multicenter study
KorHF registry
24
1527
Patient
HF symptoms as the
primary reason for
admission and signs of
congestion such as
pulmonary congestion or
systematic edema
Diagnose-specific
60 d, 1 y
Deaths within 1 y
excluded
+
-
Data were collected and 
managed by the Control of 
Data Committee of the Korean 
Heart Failure (KorHF) Registry
Excluded 17 patients with
no follow up data;
No distinction between
planned/unplanned
readmissions
OR
Abbreviations: GWTG-HF, GetWith the Guidelines–Heart Failure; CMS, Centres for Medicare and Medicaid 
Service; HQA, Hospital Quality Alliance; HF, heart failure, CHF, congestive heart failure
*Codes 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.20 to 428.33, 428.40 
to 428.43, and 428.9.
†Three centers included in the studymention that in the third hospital, the quality of the administrative da-
tawas not so good and therefore just a minor number of patients could be included; excluded patients,
if they had left the hospital againstmedical advice, were transferred to another acute care facility, were 
discharged in 1998, or had secondary HF due to valvular heart disease, acute myocardial infarction,
cor pulmonale, chronic renal failure, hyperthyroidosis, thiamine deficiency, amyloidosis, or chronic ob-
structive lung disease treated with oxygen.
‡Readmission rate defined on hospital level as well .§Codes 104, 112, 115-118, 121-125, 127-145, 476, 514-518, 
525-527, 535-536, 547-558.
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Figure 2. Meta-analysis of studies investigating the relationship between 
heart failure process indicators and rate of readmission (ORs).
Figure 3. Meta-analysis of studies investigating the relationship between 
heart failure process indicators and time to readmission (HRs).
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table III. Association between adherence to hospital process indicators and 
the rate of readmission
 HF process indicators
 ACEI, or ARB, Evaluation of Smoking  Discharge AC at Composite
 for LVSD LVS function cessation instructions discharge for
   counseling  HF patients 
     with AF
oRs
Luthi et al36  0.93 (0.48-1.79)  1.43 (0.93-2.22)   1.61 (0.59-4.35)
Mazimba et al25  0.77 (0.51-1.02)  0.69 (0.38-0.98) 0.97 (0.62-1.54)  0.98 (0.83-1.14)
Schopfer et al27  0.99 (0.99-1.00)  0.99 (0.98-1.00)  0.99 (0.99-1.00)  1.00 (0.98-1.01)
Youn et al34  0.18 (0.06-0.52)
Whittaker et al31  0.24 (0.01-3.94)  0.76 (0.30-1.92)
HRs
Hernandez 2010      1.02 (0.9-1.06)
Patterson 2010  0.97 (0.92-1.01)  1.04 (1.01-1.08)  0.99 (0.94-1.04)  1.0 (0.99-1.02)
Shahian 2012  0.65 (0.46-0.92) 1.16 (0.6-2.27)  1.08 (0.64-1.82)  0.83 (0.7-0.99)
VanSuch 2006  0.89 (0.71-1.18)    0.76 (0.65-0.9)
Yoo 2014  0.80 (0.55-1.16)
oRs combined outcomes*
Fonarow et al33  0.51 (0.34-0.78) 1.06 (0.81-1.38)  0.74 (0.50-1.09)  1.07 (0.89-1.28)  0.83 (0.64-1.09)
Sueta et al30   0.70 (0.53-0.93)
other outcome measures
Hernandez et al21  0.03 (0.68)  0.25 (0.002)†  0.06 (0.45)  0.04 (0.63)  −0.16 (0.05)
Jha et al22     Highest 
    compliance
    hospitals had 
    nearly same 
    rrs‡ as ones 
    with lowest 
    (23.7% vs 
    23.5%; P = .54)
Composite score
Stefan et al29       −0.02 (0.22)†,§
Chung et al19       HR 0.74 (0.57-0.97)§
Mansi et al24       OR 2.82 (1.46-5.44)§
Kociol et al23       Hospitals in highest 
      rr quartile had best
      compliance: 75% in
      longest rr quartile 
      vs 70% in shortest rr
      quartile (P b .0001)§
 4/10  3/9  0/6  2/9  0/4  1/4
* Combined readmission and mortality.
† Correlation coefficient (P value).
‡ Readmission rates.
§ Including indicators 1, 2, 4, and 5,
121
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Warfarin for atrial fibrillation
No evidence was found for an association between administrating warfa-
rin for atrial fibrillation and readmission. Of 4 studies testing the association, 
none could be included in the meta-analysis as they used different outcome 
measures. None of the studies found a significant association between ad-
ministrating warfarin and readmissions.20,21,33,36
Composite measures
Four studies did not test single indicators, but instead included several of the 
process measures in a composite score. Of these 4, Chung et al19 was the 
only study that found a significantly lower hazard of readmission when ad-
hering to the process indicators (HR 0.74, 95% CI 0.57-0.97). In contrast, Kociol 
et al23 and Mansi et al24 both found a significant increase in readmission with 
greater adherence to composites of process indicators (Table III).
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DISCUSSIoN
In this systematic review, we assessed the scientific evidence regarding the 
relation between readmission rates and quality of hospital care for patients 
with heart failure as measured by the ACC/AHA in-hospital process indica-
tors. We found that readmission rates are mostly not related to these evi-
dence-based process indicators.
There are several possible explanations for the fact that the studies included 
in our review did not find an association between adherence to process 
indicators and readmission rates:
Indicator definition
In most studies, no distinction between planned and unplanned readmis-
sions was made, whereas only unplanned admissions are possibly related 
to quality of care.37 In addition, the process measures themselves may not 
adequately capture the quality of care that was actually received by the 
patient. For example, “providing smoking cessation counseling” and “pro-
viding discharge instructions” do not assess the quality of the process but 
merely whether it has been executed. Furthermore, even when the smok-
ing cessation counseling was executed perfectly and the patient stopped 
smoking, it is doubtful this could decrease the risk of readmissionwithin 30 
days. Some process indicators require patient compliance in order to be 
effective. For example, the process indicator “ACEI/ARB blocker prescrip-
tion” does not measure whether the patient actually takes the medication 
in the prescribed dosages. Furthermore, some process indicators are only 
applicable to part of the population, such as warfarin for patients with atrial 
fibrillation.
Insufficient case-mix correction
Case-mix correction is of major importance when investigating any out-
come indicator as patients are not randomly distributed over hospitals, and 
process measures are not randomly assigned to patients within hospitals. 
Two patient aspects seem to increase the risk of being readmitted: being 
very sick and being very poor.37–40 Nevertheless, disease severity and socio-
economic status are seldom taken into account because information re-
garding these aspects is not available in the administrative data that were 
used in most studies. 
Some studies defined the process measures on the patient level and some 
on the hospital level, as percentage adherence. Measuring on the patient 
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level may result in confounding by indication because the sicker patients 
get the treatment, and without sufficient case-mix adjustment, we see a 
negative treatment effect.
Disregard competing outcomes
There is a relation between readmission rates and mortality rates per hospi-
tal,41 as patients who died during their index admission cannot be readmit-
ted anymore. Therefore, patients who have died should be excluded from 
the denominator for the readmission rate. This was done in most, but not all, 
of the included studies. 
In summary, we found that readmission rates are mostly not related to the 
evidence-based ACC/AHA in-hospital process indicators. This may be partly 
due to shortcomings of the studies included in our review, but there are also 
suggestions that the quality of the in-hospital processes is just not—or weak-
ly—reflected in the readmission rate.
Implications
Because heart failure readmissions are a heavy burden on the health care 
system, it is important to evaluate the quality of the care related to such 
readmissions. Readmission rates are used in many countries as a quality in-
dicator for hospital care, which assumes that they are determined by quality 
of hospital care, that is, hospital processes and structures. Currently, it is, how-
ever, not known which hospital processes and structures exactly determine 
readmissions. Furthermore, although readmissions may, to some extent, be 
influenced by the quality of care received in the hospital, this is certainly not 
the only (nor perhaps the most significant) contributing factor. Patient char-
acteristics, patients’ life circumstances, and the nature of posthospital care 
have also been shown to affect readmissions.42–44,1,45 Because the influence 
of these factors may vary between hospitals, they may be the underlying 
reason for outlier readmissions in hospitals.
External reporting and including readmissions in pay for performance 
schemes without knowing their cause have unintended consequences. 
When hospitals, which seem to perform badly in regard to their readmission 
rate, are punished without knowing where the high rates stem from, they 
may face unjustified punished, for example, for treating high-risk patients. 
Furthermore, when hospitals do not know which processes they have to im-
prove in order to reduce their high readmission rates but at the same time 
fear the financial consequences of having high readmission rates, gaming 
may be stimulated. Therefore, as long as readmissions related to quality of 
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hospital care cannot be identified and robust scientific evidence underpin-
ning the association between quality of hospital care and readmissions is 
lacking, readmission rates should be used for pay for performance purposes 
only with great caution.
A limitation of our study is that for some of the meta-analyses, only few stud-
ies could be included. This caused findings for some indicators to be de-
termined by one large study. However, the limited number of studies itself 
represents the limited evidence base for the use of readmission rates as an 
indicator of quality of hospital care. Although we have only studied ACC/
AHA process indicators, it is possible that other processes, such as β-block-
ers, spironolactone or adequate diuresis, and scheduling and executing 
postdischarge follow-ups, are more strongly related to readmissions.
In conclusion, readmission rates after heart failure are mostly not related 
to the evidence-based ACC/AHA in-hospital process indicators for heart 
failure. It is unclear whether in-hospital quality of care is the key determi-
nate of the readmission rate or whether readmissions are influenced more 
by postdischarge care. Further research is needed to clarify whether the 
readmission rate is a reflection of quality of hospital care or quality of care 
in general. Such research is especially important because this rate is used in 
pay-for-performance schemes to measure quality of hospital care.
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aPPeNDIX
appendix a. PRISMA checklist
Section/Topic
TITLE
Title
ABSTRACT
Structured summary
INTRODUCTION
Rationale
Objectives
METHODS
Protocol and registration
Eligibility criteria
Information sources
Search
Study selection
Data collection process
Data items
Risk of bias in individual
studies
No.
1
2
3
4
5
6
7
8
9
10
11
12
Reported 
on page no.
99
101
102
103
/
105, 110-118
104, 105
129
104, 105
104
104-106
/
Checklist item
Identify the report as a systematic review, meta-analysis, 
or both.
Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility crite-
ria, participants, and interventions; study appraisal and syn-
thesis methods; results; limitations; conclusions and implica-
tions of key findings; systematic review registration number.
Describe the rationale for the review in the context of 
what is already known.
Provide an explicit statement of questions being ad-
dressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).
Indicate if a review protocol exists, if and where it can be 
accessed (eg, Web address), and, if available, provide 
registration information including registration number.
Specify study characteristics (eg, PICOS, length of follow-
up) and report characteristics (eg, years considered, lan-
guage, publication status) used as criteria for eligibility, 
giving rationale.
Describe all information sources (eg, databases with 
dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.
Present full electronic search strategy for at least one da-
tabase, including any limits used, such that it could be 
repeated.
State the process for selecting studies (ie, screening, eli-
gibility, included in systematic review, and, if applicable, 
included in the meta-analysis).
Describe method of data extraction from reports (eg, pi-
loted forms, independently, in duplicate) and any process-
es for obtaining and confirming data from investigators.
List and define all variables for which data were sought 
(eg, PICOS, funding sources) and any assumptions and 
simplifications made.
Describe methods used for assessing risk of bias of indi-
vidual studies (including specification of whether this was 
done at the study or outcome level), and how this infor-
mation is to be used in any data synthesis.
128
C
ha
pt
er
 4
   
A
 s
ys
te
m
a
tic
 re
vi
ew
 o
n 
th
e 
va
lid
ity
 o
f r
ea
d
m
iss
io
n 
ra
te
s a
s a
 q
ua
lit
y 
in
d
ic
a
to
r f
o
r h
ea
rt
 fa
ilu
re
Summary measures
Synthesis of results
Risk of bias across studies
Additional analyses
RESULTS
Study selection
Study characteristics
Risk of bias within studies
Results of individual studies
Synthesis of results
Risk of bias across studies
Additional analysis
DISCUSSION
Summary of evidence
Limitations
Conclusions
FUNDING
Funding
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
State the principal summary measures (eg, risk ratio, dif-
ference in means).
Describe the methods of handling data and combining 
results of studies, if done, including measures of consis-
tency (eg, I2) for each meta-analysis.
Specify any assessment of risk of bias that may affect the 
cumulative evidence (eg, publication bias, selective re-
porting within studies).
Describe methods of additional analyses (eg, sensitivity or 
subgroup analyses, meta-regression), if done, indicating 
which were prespecified.
Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.
For each study, present characteristics for which data 
were extracted (eg, study size, PICOS, follow-up period) 
and provide the citations.
Present data on risk of bias of each study and, if available, 
any outcome level assessment (see item12).
For all outcomes considered (benefits or harms), present, 
for each study: (a) simple summary data for each inter-
vention group and (b) effect estimates and confidence 
intervals, ideally with a forest plot.
Present results of each meta-analysis done, including con-
fidence intervals and measures of consistency.
Present results of any assessment of risk of bias across stud-
ies (see item 15).
Give results of additional analyses, if done (eg, sensitivity 
or subgroup analyses, meta-regression
(see item 16).
Summarize the main findings including the strength of evi-
dence for each main outcome; consider
their relevance to key groups (eg, healthcare providers, 
users, and policy makers).
Summarize the main findings including the strength of evi-
dence for each main outcome; consider their relevance 
to key groups (eg, healthcare providers, users, and policy 
makers).
Provide a general interpretation of the results in the con-
text of other evidence, and implications for future re-
search.
Describe sources of funding for the systematic review and 
other support (eg, supply of data); role of funders for the 
systematic review.
105, 106
105, 106
/
/
Figure 1
Tables II and III
/
Table III or plots
Plots
NA
/
119
124
123, 124
NA
129
4
appendix B. Search strategy
(“clinical indicator”/de OR “performance measurement system”/exp OR 
“quality control procedures”/de OR “quality control”/de OR “medical audit”/
de OR (((qualit* OR perform* OR safet* OR governance) NEAR/3 (indicat* OR 
measure* OR assessment* OR control* OR marker* OR metric*)) OR ((clinical 
OR medical) NEAR/3 (indicator* OR audit*))):ab,ti) AND (“hospital readmis-
sion”/de OR (readmiss* OR rehospital* OR ((re OR return) NEAR/3 (hospital* OR 
admiss*))):ab,ti).

Part III
empirical studies on the 
reliability and validity 
of quality indicators for 
hospital care 

Chapter 5.
the influence of data 
quality on the reliability 
of quality indicators for 
hospital care
Helen a anema, Job Kievit, Claudia Fischer, 
ewout W Steyerberg, Niek S Klazinga
This article was published as: 
Influences of hospital information systems, indicator data collection and 
computation on reported Dutch hospital performance indicator scores. 
BMC Health Services Research. 2013; 13:212.
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aBStRaCt
Background: For health care performance indicators (PIs) to be reliable, 
data underlying the PIs are required to be complete, accurate, consistent 
and reproducible. Given the lack of regulation of the data-systems used 
in the Netherlands, and the self-report based indicator scores, one would 
expect heterogeneity with respect to the data collection and the ways indi-
cators are computed. This might affect the reliability and plausibility of the 
nationally reported scores.
methods: We aimed to investigate the extent to which local hospital data 
collection and indicator computation strategies differ and how this affects 
the plausibility of self-reported indicator scores, using survey results of 42 
hospitals and data of the Dutch national quality database.
Results: The data collection and indicator computation strategies of the 
hospitals were substantially heterogenic. Moreover, the Hip and Knee 
replacement PI scores can be regarded as largely implausible, which was, to 
a great extent, related to a limited (computerized) data registry. In contrast, 
Breast Cancer PI scores were more plausible, despite the incomplete 
data registry and limited data access. This might be explained by the role 
of the regional cancer centers that collect most of the indicator data for 
the national cancer registry, in a standardized manner. Hospitals can use 
cancer registry indicator scores to report to the government, instead of their 
own locally collected indicator scores.
Conclusions: Indicator developers, users and the scientific field need to 
focus more on the underlying (heterogenic) ways of data collection and 
conditional data infrastructures. Countries that have a liberal software market 
and are aiming to implement a self-report based performance indicator 
system to obtain health care transparency, should secure the accuracy 
and precision of the heath care data from which the PIs are calculated. 
Moreover, ongoing research and development of PIs and profound insight 
in the clinical practice of data registration is warranted.
5
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INtRoDUCtIoN
Monitoring the quality of health care by means of performance indicator 
scores is part and parcel of national health care systems. Performance 
indicators (PIs) are used to monitor and improve quality and patient safety 
and to stimulate accountability and market processes in countries worldwide 
(e.g. USA (www.ahrq.com), UK (www.hqip.org.uk), and Denmark (www.ikas.
dk). To play this role effectively, performance indicators need to be reliable 
and valid measures of health care quality1-3 particularly when hospitals’ 
performances are ranked and published in the lay press4 and/or used to link 
reimbursement to indicator results.4,5
National hospital performance indicator programs commonly use PIs that 
are selected on basis of expert judgment (e.g. medical doctors, patient 
organizations) and existing scientific evidence6 about valid relations 
between health care processes and outcome indicator (e.g.7). These 
PIs have often been successfully implemented in other countries. Due to 
differences in national healthcare and local hospital organization, copying 
a performance indicator into another health system does not automatically 
imply a valid reflection of the underlying health care process that it is intended 
to measure. Although small pilot studies to assess data collection, indicator 
computation, data sending and data analyses are commonly executed 
prior to national PI implementation 6, thorough evaluations of reliability and 
validity of the PIs after implementation, are scarce.8,9 Therefore it remains 
unclear whether such selected PIs can be validly used in the national health 
care system.
For a PI to be valid, it needs to be composed with the least possible measure-
ment error. Most indicators consist of a numerator (e.g. number of patients 
that timely received antibiotics prophylaxis) and a denominator specifying 
the population at risk10,11 (e.g. the number of patients that should receive the 
prophylaxis). To compose the numerator and denominator, patients that fit 
the inclusion criteria need to be identified in the data systems. This selection 
process is explained in instruction manuals that describe the specific steps 
that need to be taken. Each step yields a data element, for instance the 
date of surgery, or a secondary diagnosis (comorbidity). For some steps it is 
required to select several data elements and as such consist of a set of rules 
that combine several data elements, the latter increasing the complexity of 
the process.12
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In many quality indicator programs, (e.g. in the USA: AHRQ, Kaiser Perman-
ente, Veteran Affairs Quality program; Denmark: IKAS; Germany: BQS) the 
coordinating organizations are responsible for PI data collection and com-
putation, as opposed to programs that rely on self-report of the participat-
ing hospitals. They abstract the indicator data from digital administrative 
(hospital information system) or financial databases using computerized 
data abstraction algorithms. This approach however, is effective only when 
the data-systems are identical for all participating hospitals. When hospi-
tals do not have an integral electronic patient record, patient information 
is stored in several information systems. Moreover, when a country has a 
liberal software market (US, The Netherlands) and the PIs are based on self-
report, coupling of these independent information systems in an attempt to 
automatically collect the data might be difficult and prone to error due to 
the various software environments. Although manually selecting the data 
from all the systems and paper records seems less error-prone, it is very time 
consuming. It could be assumed, therefore, that hospitals obtain their own, 
unique, strategy to compute the PI score, which makes comparison of the 
PI scores difficult. Therefore, we question whether the construction of Dutch 
hospital information systems that are used to compute PI scores and the 
extent to which data elements are available and accessible affect the 
accuracy and precision of the PI scores in a negative way.
To investigate this, we study the Dutch local hospital data-infrastructure, 
here defined as the availability and accessibility of PI data elements. In 
2008, the Dutch government implemented hospital PIs for various disease 
specific groups (Dutch Health Care Transparency Program; DHTPa). All 
Dutch hospitals are required to report these PIs to the government on 
a yearly basis, to pursue public disclosure of health care performance, 
data benchmarking, selective contracting by insurance companies, and 
decision making processes of patients looking for a healthcare provider. The 
selection of the indicators was performed by disease specific expert groups 
of medical doctors, patient organizations, and health care insurers, on the 
basis of published guidelines and expert opinion. Attempts were made to 
standardize the structure, process and intermediate outcome indicator 
definitions, as well as the data collection and indicator computation 
instructions. These instructions are principally code based, that is, based 
upon diagnose and procedure codes such as the ICD-9 classification or DRG 
codes (Diagnosis Related Group codes). Dutch hospitals are independent 
organizations and free to choose information technology systems for clinical 
and administrative data. Therefore, developing instructions that are specified 
for the information system that is used to handle the data is not feasible.
5
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Since Dutch hospitals are solely responsible for reporting the required in-
dicator scores, reliability (precision and accuracy) of the self-reported PIs 
might be particularly at risk. Thus, given the lack of regulation of the data-
infrastructure (information systems that are used) in the Netherlands, and 
the self-report based indicator scores, one would expect heterogeneity 
with respect to the data collection and the ways indicators are computed. 
Moreover, it can be expected that hospitals that have a low level of 
automation and difficulties to connect all the individual information systems, 
make use of data that are registered in external databases such as the 
National Cancer Registry of the Comprehensive Cancer Centers (in Dutch: 
IKNL; further referred to as CCC).
Together, we aimed to obtain insight in the precision and accuracy of 
publically available PI scores and the impact that the local hospital data-
infrastructure has on these aspect using Dutch indicator scores of two sets of 
surgical PIs (Table 1 and Appendix 1): Hip and Knee Replacements (further 
referred to as HR or KR) and Breast Cancer (further referred to as BC). First, 
to obtain a general idea of the accuracy and precision and second, to 
investigate the long term pattern of a hospital’s performance, we evaluated 
the plausibility of the available PI scores of health care delivered between 
2008 and 2010. With plausibility we mean the extent to which the indicator 
score is in line with what we can expect from the health care procedure, on 
basis of the literature, guideline compliance and audit studies. For example, 
a process indicator score of 100% that measures the number of patients that 
timely received surgically related antibiotic prophylaxis might be implausible, 
as relevant literature on guideline compliance reveals average scores as low 
as 50%.13-15 Second, using data obtained through a questionnaire among a 
sample of Dutch hospitals in 2010, we checked whether the data elements 
that are required to compute the indicator scores were registered at all.
Further, if available, we wanted to know whether these data elements were 
easy to access or only after time consuming actions, whether hospitals 
calculated the indicator on basis of the entire population at risk, or whether 
the PI score was merely estimated. And finally, we investigated the relation 
between the data-infrastructure (data availability and accessibility), the 
way hospitals calculated the indicator scores and the plausibility of the 
submitted indicator score.
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5
metHoDS
Study design
A cross-sectional mixed methods design, using both qualitative and quanti-
tative data from three different sources was used to explore the effect of the 
data-infrastructure on the accuracy and the precision of the PI scores.
Study population
The study population consisted of national hospitals (in 2010) of which 24 
were small hospitals (< 320 beds), 48 were intermediate (320–627 beds), 
and 28 were large hospitals (> 627 beds), 27 were teaching hospitals and 
table 1. Overview of process and outcome indicators hip and knee replace-
ments and breast cancer
 National Performance Indicators
 Total Hip and Knee replacements * S P O
 2b % of patients that was administered thrombosis prophylaxis for 6 weeks to 3 months  X
 post-surgery, in case of total hip or knee surgery
 4b % of patients that did not (2008 & 2009)/ did (2010) receive a homologue blood  X
 transfusion, in case of total hip or knee surgery
 5b % of patients that was administered antibiotics perioperatively  X
 5c % of patients that was administered antibiotics 15 to 60 min. prior to surgery or to  X
 blood emptiness
 5d % of patients with a deep wound infection after a total hip or knee replacement   X
 Breast Cancer ** S P O
 1 % of patients who were seen by a breast cancer nurse specialist preoperatively  X
 2 % of patients that was reviewed preoperatively in a multi-disciplinary team meeting  X
 3 % of patients with a non-radical primary tumor resection   X
 4 % of surgeons in the surgery department that perform surgical treatments of breast  X
 tumors
 5 % of patients that are operated within 4 weeks after the final lab results are known  X
 6a % of patients with local recurrences within 5 years after breast-conserving surgery   X
 6b % of patients that have local recurrences within 5 years after ablative breast surgery   X
 7 % of patients with a breast tumor that was postoperatively reviewed in a  X
 documented multi-disciplinary team meeting
* Note: 5 yes/no ‘Hip/Knee structure indicators’ are omitted from the table as they were not included in 
the current study; ** Indicators 1, 2 and 7 were removed from the indicator set in 2009, 4 in 2011; S structure, 
P process, O intermediate outcome; The PIs consist of numerators and denominators that each are com-
posed of several variables according to combinatory logic that is described in instruction manuals. See for 
details of numerators and denominators Appendix 1.
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seven were university hospitals. A teaching hospital is a large hospital 
that is approved of training medical doctors, without being affiliated to a 
university.
In total 42 national hospitals (42%) gave informed consent to participate 
in the study and returned the questionnaire. This representative sample 
included five small (< 320 beds), 25 intermediate (320–627 beds) and nine 
large hospitals (> 627), 13 were teaching hospitals and two were university 
hospitals.
Data sources
DHTP performance indicator database (A)
In 2009, 2010 and 2011, approximately 100 Dutch hospitals submitted perfor-
mance indicator scores (web-based entry tool), indicative of care delivered 
the year before (2008, 2009 and 2010 respectively) at the DHTP.
Additional reliability data DHTP (B)
Besides the indicator scores, the DHTP requires hospitals to upload informa-
tion (self-report) regarding the reliability of the submitted indicator scores. 
One dichotomous item specifically targets how the hospital computed the 
indicator score, i.e. by means of an integral calculation of the total population 
at risk (further referred to as ‘calculation’), or by merely estimating it (further 
referred to as ‘estimation’). ‘Estimating’ implies either an extrapolation of 
scores based on a small sample or based on locally implemented protocols. 
This item was used for our question about the strategy that hospitals used to 
compose the indicator and was only available for the hospitals that were 
enrolled in the qualitative part of our study in 2010.
Web-based questionnaire (C)
The short web-based questionnaire targeted the hospital’s local data 
infrastructure (collection of computer programs and databases) and was 
setup to answer our questions about the data infrastructure (what is the data 
availability and data accessibility?). Data availability was dichotomously 
assessed; a hospital confirmed whether the required information was 
registered somewhere in the hospital or not. Data accessibility was divided 
into three categories:
1)Automatically (Aut) accessible, 2) partly automatically accessible (Partly 
Aut), 3) or manually accessible (Man). Automatically accessible refers to 
data elements that are stored within a computer information system, can 
be easily reviewed (‘only a few mouse clicks away’) and can be abstracted 
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5
by means of computerized search algorithms (Queries). Partly automatically 
accessible refers to data elements that are available in electronic systems, 
can be reviewed easily, but cannot be abstracted by means of a comput-
erized search algorithm as some manual actions are required. Manually 
accessible refers to data elements that are available but only through labor 
intense data handlings such as medical chart reviews.
The BC questionnaire differed from that of the hip and knee questionnaire on 
the accessibility items. In the Netherlands, the accessibility of performance 
indicators can be dependent upon external organizations. For example, 
the data of BC care is simultaneously collected by the Dutch CCC. Data-
managers of these centers retrospectively visit a hospital and collect and 
register cancer specific information (tumor type, health status etc.) in the 
national cancer database (NKR). When uploading the DHTP indicators, 
hospitals can decide whether to use their own calculated indicator scores or 
those calculated by the CCC. As part of our interest in indicator composition 
strategies, we additionally added an item in the BC questionnaire about 
whether hospitals collected and calculated their own BC indicator scores, 
or whether indicator scores from the CCCs was used.
analyses
In the current study we used the following variables of interest:
The plausibility of the PI score: plausible score (PS): a score larger than 0% 
and smaller than 100%; implausible score (IS): a score of 0% or 100%.
Data-availability scores: all required data elements available (A); not 
available (NA).
Data-accessibility scores: data elements automatically available, partly 
automatically available, manual available; and easy accessible (EA), 
difficult to access (DA).
Indicator computation scores: PI score based on integral calculation of 
population (Cal); estimation of PI score (Est); CCC calculation: indicator 
score calculated by the CCC (BC only).
To get an overall idea of the plausibility of the submitted national PI scores 
we first provide an overview of the characteristics (means and SDs) of the PI 
scores that are available in the DHTP database (Data source A) and judge 
the plausibility (that is, perfect performance of 100% or 0%) and compare 
the indicator scores with what could be expected on basis of the literature 
(qualitative approach). Secondly, to answer our question regarding the 
data infrastructure we analyses the web-questionnaire items (Data Source 
1.
2.
3.
4.
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C) and present frequency results of data-availability and data accessibility 
scores. Finally, to obtain information about the relation between the 
data infrastructure, the procedures that hospitals use to compose the PIs 
(obtained from Data Source B) and the resulting PI scores, we calculated 2 
× 2 and 2 × 3 Chi-square tests. Results are presented separately for the Hip 
replacements indicator set and the Breast Cancer indicator set. As Hip and 
Knee replacements yield fairly similar scores (see Table 2 and Figure 1B), we 
present the data of HR only.
  2008   2009   2010
 PI N M SD Range N M SD Range N M SD Range IS
 2b 64 99.92 0.602 95 –100 95 99.8 0.949 93 – 100 94 99.9 0.30 98 – 100 53
 4b 52 91.27 22.79 0 – 100 91 90.6 15.24 0 - 100 93 16.13 26.58 0 – 100 6
 HR  5b 65 100 0.000 100 - 100 96 99.7 1.402 93 - 100 94 101.0 15.65 70 – 100 53
 5c 59 97.38 14.00 0 – 100 94 98.0 5.827 66 - 100 93 98.9 16.98 64 – 100 37
 5d 60 0.816 0.740 0 – 2.7 93 0.719 0.674 0 – 2.75 93 0.754 0.804 0 – 4 5
 GM  60 78 8 / 94 78 5 / 93 63 12 / 37
 2b 63 99.92 0.663 95 - 100 94 99.8 0.834 93 - 100 93 100 0.246 98 – 100 52
 4b 54 91.17 25.72 0 - 100 89 95.6 10.99 0 - 100 92 11.65 27.15 0 – 100 7
 KR 5b 64 100 0.00 100 - 100 95 99.8 1.101 92 - 100 93 99.6 2.342 78 – 100 52
 5c 59 96.84 15.71 0 - 100 93 97.8 6.52 60 - 100 92 96.8 8.979 49 – 100 39
 5d 59 0.50 0.649 0 – 3 92 0.554 0.631 0 – 3.2 92 0.544 0.616 0 – 3.3 6
 GM  60 78 9 / 93 79 4 / 92 62 8 / 37
 1 68 100 5.055 75 – 100 / / / / / / / / /
 2 68 100 3.200 85 – 100 / / / / / / / / /
 3 66 9.675 5.464 0 – 24 95 9.215 4.733 0 – 29 94 7.279 4.026 0.95 - 23 0
 4 68 41.4 12.68 10 - 75 95 38.5 11.53 10 - 60 / / / / /
 BC
 5 63 90.48 14.92 17 - 100 95 89.2 10.30 51 - 100 94 88.9 11.85 34 – 100 0
 6a 57 2.130 2.247 0 -11 89 1.748 1.945 0 - 9 93 1.490 1.703 0 – 8 0
 6b 57 2.700 2.838 0 - 11 90 2.581 2.522 0 - 11 93 2.455 2.351 0 - 10 0
 7 65 100 5.568 74 - 100 / / / / / / / / /
 GM  64 56 6 / 93 28 6 / 94 25 5 / 0
Note: PI Performance Indicator, N number of hospitals, M mean, SD standard deviation, GM grand mean, 
IS Implausible Score (100% or 0% score three consecutive years), HR Hip replacements, KR Knee replace-
ments, BC Breast Cancer; Number of hospitals vary slightly throughout the text due to differences in how 
hospitals are enrolled in the study (concerns vs separate hospitals). Note 2: No perfect score defined for 
Performance indicator BC 4.
table 2. Results of the descriptive statistics of hip and knee replacements 
and Mammacare
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ReSUltS
Hip replacement indicators
Data source A: Plausibility of the reported scores
All PIs have high averages (ceiling effect; see Table 2) and PIs 4b (2008, 2009, 
2010) and 5c (2008) have large ranges, from 0% to 100%. A 0% compliance 
to blood transfusion guidelines can be regarded as implausible, being most 
likely an error. This might be explained by a change in the indicator definition 
of 4b in 2010; from ‘no homologue blood transfusions’ to ‘homologue blood 
transfusions’. Homologue blood transfusions increase the risk of blood borne 
infections and thus need to be reduced (Dutch Institute for Health Care 
improvement CBO guideline hip and knee arthrosis 2007).16 As described in 
the introduction, high averages of the PIs can be regarded as unrealistic, 
particularly when performance is consistently high for several consecutive 
years. We determined the number of 100% scores (and 0% scores for outcome 
indicator 5d; further referred to as ‘implausible score’) for each year and 
calculated the number of hospitals that maintained a perfect score for 
three consecutive years. Implausible scores were rather consistent for the 
indicators 2b, 5b and 5c (53, 53 and 37 times; see Table 2). Also, five hospitals 
scored an implausible 0% of post-operative deep wound infections in three 
consecutive years (outcome indicator 5d).
Data source C: Heterogeneity of reported local data infrastructure
The questionnaire revealed that, averaged over all indicators, 26 hospitals 
(62%) reported to have all the required data elements that are necessary 
for the calculation of the PI available at the time of study (Figure 1A). When 
at least one data element was missing (data element unavailable; n = 16), 
eight hospitals indicated to miss one or two data elements, four hospitals 
missed three or four data elements and four hospitals missed five or six data 
elements. Most of the HR data elements were on average automatically 
accessible (43%) or partly automatically accessible (30%), whereas 17% was 
only manually accessible (10% of the information was not available). The 
data elements that were most frequently indicated to be fully automatic 
accessible were necessary for computing the denominator (category ALL: 
elements: 0 patient identification number, 1 financial code hip replacement, 
2 procedure code hip replacement, 3 date of hip replacement surgery), 
whereas the data elements that are less easily accessible are necessary for 
the numerators of the various indicators.
5
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Figure 1. Reported data infrastructure of the orthopedic and oncology sets’ 
as short and concise descriptive title of Figure 1ABC
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Data source ABC: Relation between computation methods, data collection 
and PI score
To investigate the relation between the data availability and computation 
methods we first divided the hospitals in two separate categories; those who 
indicated to have at least one required data element for a certain indicator 
unavailable (NA = not available; in total 15 hospitals) and those who had 
all required data elements for an indicator available (A = available; in total 
27 hospitals). Chi square tests revealed that the computation method that 
hospitals choose is significantly associated with the data availability. That is, 
when data were unavailable, indicator scores were on average more often 
estimated as compared to calculated (Est = 91%; Cal = 9%). When data were 
available this pattern was reversed (Est = 42%; Cal = 58%; χ2 (1) = 51.71, p < 
0.01. However, nearly half of the indicator scores were estimated even when 
all the required data elements were available.
ABC: Reported data infrastructure of the orthopedic and oncology sets. 
AUT = fully automatic accessible, Partly = partly automatic, partly manually 
accessible, Man = manually accessible, NOT = not available; HR = Hip 
replacement, KR = Knee replacement, BC = Mammacarcinoma; Numbers 
1, 2, 3 etc. = numbers that indicate the indicator variable which is part of the 
indicator set; 2b 4b 5b etc. = the unique number of the indicator.
A similar association might be found between data accessibility and the 
composition method. To test this association we divided the data set of our 
sub sample with all data elements Available (N = 27) in an ‘Easy Access’ 
(EA) and ‘Difficult Access’ (DA) category for each indicator separately. 
We assigned 1, 2 or 3 points to the accessibility scores Automatic, Partly 
Automatic and Manual and averaged the scores per indicator. An EA score 
for a certain indicator was obtained when the average accessibility score 
was below 1.5, or else it was given a DA score. 
Table 3 revealed that the 27 hospitals reported to have all data available of in 
total 186 indicators (76 + 73 + 32 + 5). Most indicators were classified as ‘Difficult 
to access’ (76 + 73 = 149) as compared with the ‘Easy access’ category (32 + 5 
= 37). Again Chi square tests revealed a significant relation between composi-
tion strategy and data accessibility as reported for the data availability χ2 (1) = 
42.35, p < 0.01), but this relation was different as compared to the NA category. 
That is, when data was difficult to access an almost equal number of indicators 
were based upon integral calculations and estimations (Cal = 51%; Est = 49%). 
When data was easy to access, the percentage of scores that were based 
upon an estimation decreased considerably (Cal = 86%; Est = 5%). 
5
146
table 3. Number of Hip Replacement indicators with plausible, implausible 
and missing values for the separate indicator computation and data collec-
tion strategies
      2b 4b 5b 5c 5d total
 Na   Cal  2 0 0 0 1 3
    eSt  12 2 7 9 0 30
 A  DA  CAL Total 12 22 12 10 20 76
     IS 11 4 11 7 7 40
     PS 1 18 1 3 12 35
     mV 0 0 0 0 0 0
    eSt total 24 5 21 22 1 73
     IS 23 3 20 21 1 68
     PS 1 2 1 1 0 5
     mV 0 0 0 0 0 0
  ea  Cal total 1 11 4 3 13 32
     IS 1 1 4 2 4 12
     PS 0 10 1 1 11 23
     mV 0 0 0 0 0 0
    eSt total 1 0 1 2 1 5
     IS 1 0 0 1 0 2
     PS 0 0 0 1 1 2
     mV 0 0 0 0 0 0
Note: IS Implausible (100% or 0%) Score, PS Plausible Score (<100%), MV missing value, NA Not available, EA 
easy access category, DA Difficult Access category, Cal calculation, EST Estimation; All data in frequen-
cies. Scores are frequencies at the level of indicators, and not at hospital level, to avoid excluding hospitals 
with missing values from the analysis.
Next, we tested the association between the data infrastructure of avail-
able data and the plausibility of the indicator scores. Overall more implau-
sible (IV) than plausible scores (PV) were observed (A: IS = 65%, PS = 35%). 
However, easy accessible data yielded more plausible indicator scores (PS 
= 64%; IS = 38%) as compared to the difficult access indicators (PS = 27%; DA, 
IS = 73%; χ2 (1) = 24.64, p < 0.01).
Finally, to see whether the plausibility of the indicator scores was more 
associated to the composition strategy as compared to the data 
infrastructure we summated across all data-infrastructure categories (NA + 
DA + EA) all the indicators that were calculated and checked whether they 
were implausible or plausible scores and did the same for the estimated 
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5
indicators. The Chi square test revealed a strong significant association (χ2 
(1) = 59.05, p < 0.01). Implausible indicator scores were more often estimated 
(91%) as compared to calculated (38%) whereas plausible scores (scores 
< 100%) were more often calculated (62%) as compared to estimated (9%).
Breast cancer indicators
Data source A: Plausibility of the reported scores
In contrast to the orthopedic data, implausible perfect scores in three 
consecutive years could not be identified. 
Data source C: Heterogeneity of reported local data infrastructure 
The questionnaire revealed that, averaged over all indicators, one third of 
the hospitals (13 out of 41) have all the required data elements available 
(Figure 1C). When having registered some of the required data elements (27 
hospitals), eight hospitals indicated to miss one or two data elements, one 
hospital missed three data elements and another hospital reported to miss 
ten of the required twelve data elements. Most of the information was on 
average partly automatically accessible (39%), whereas 24% was automati-
cally and 30% only manually accessible (7% was not available). The data 
   1 2 3 4a 4b total
 NA  total 1 3 3 8 8 23
  oWN 0 3 0 0 0 3
  CCC 1 0 3 7 7 18
  mV 0 0 0 1 1 2
 A DA total 28 32 28 29 28 145
  oWN 16 28 14 3 4 65
  CCC 12 4 13 25 23 77
  mV 0 0 1 1 1 3
 EA total 8 4 7 5 5 29
  oWN 4 2 3 1 1 11
  CCC 4 1 4 4 4 17
  mV 0 1 0 0 0 1
table 4. Number of breast cancer care indicators for the separate indicator 
computation and data collection strategies
Note: OWN Self-calculated, CCC calculated by Collective Cancer Center, MV missing value, NA Not avail-
able, EA easy access category, DA Difficult Access category, Cal calculation, Est Estimation; Scores are 
frequencies at the level of indicators, and not at hospital level, to avoid excluding hospital with missing 
values from the analysis.
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element that was indicated as automatically accessible the most frequent 
(element 0: patient identification number) was necessary for computing the 
denominator. 
Data source ABC: Relation between computation methods, data collection 
and PI score
In contrast to the results of the orthopedic indicator sets, only one hospital 
indicated to have estimated the indicator score. Therefore we focused on 
the hospitals choice to use the CCC to compose the indicator score, or to 
use own scores. As can be observed in Table 4 (total column) most indicator 
scores were, on average, based upon CCC data when data was not available 
(NA; CCC = 18 indicators, OWN= 3 indicators). To test whether the choice to 
use the CCC data was associated with the accessibility of available data 
we determined for each indicator and access category separately how 
often a hospital used the CCC score and tested the association with a 2 × 2 
(DA/EA vs. OWN, CCC) chi square test. The chi square test revealed that the 
accessibility did not seem to influence the choice for the CCC (DA: OWN= 
46%, CCC = 54%; EA: OWN= 39%, CCC =61%; χ2 (1) = 0.74, p = 0.39). As was 
described above, implausible perfect scores on the breast cancer indicators 
are scarce. Therefore we did not further investigate the effect of the data 
infrastructure and composition strategy on the indicator score.Ch
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DISCUSSIoN
Summary
The current study revealed that the Dutch PI hospital data infrastructure is 
heterogeneous, and the reported performance data under investigation 
can be regarded as largely implausible, particularly those of the Hip and 
Knee replacement indicators. Moreover, in both cases, only few data 
elements were ‘one mouse click away’ (poorly accessible), indicating a large 
amount of labor to extract all the required data from stand-alone computers 
and (paper) medical records. In case of automatic availability, manual 
collection was still necessary to complete the computation. Together with 
the overall under reporting of the required data elements, this leads to more 
implausible, estimated scores in the HKR case. That is, when HKR data was 
unavailable or difficult to access, hospitals did not withdraw from submitting 
indicator scores but estimated their indicator score to be 100%. In contrast, 
the CCC employees, who have access to items that are unavailable for the 
hospitals, (for instance for the data elements of ‘percentage of patients with 
recurrences within 5 years after surgery’) covered most of this labor intensive 
work for the BC PIs, and therefore, that data is less implausible. It has to be 
noted here, that many hospitals preferred to use their own indicator scores, 
when available, instead of that of the CCC even if the data was poorly 
accessible. As hospitals are free to choose which scores to be uploaded, 
we conclude that for both indicator sets the heterogeneous data collection 
and indicator computation largely affects the comparability of hospital 
performance.
Policy implications
A governance model that increasingly relies on performance information 
as the basis for policy decisions (e.g. directly through selective contracting 
and indirectly through transparency of performance of care providers in the 
media), assumes the existence of high quality, reliable and valid perfor-
mance information. Interestingly, this study has shown that the accuracy 
and precision of the PIs is questionable and further improvement of the 
current local hospital data-infrastructure in the Netherlands is necessary. 
There are several bottlenecks that need to be dealt with, ranging from the 
patchwork of hospital information systems, to the lack of a data-quality 
feedback loop back to the government. 
Our results suggest that a nationally organized registry (in the case of 
breast cancer) led to more plausible indicator scores. Having one entity 
responsible for the data collection and indicator computation increases the 
5
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comparability of the hospitals performance scores. Within the hip and knee 
replacement care, a fully operational and nationally coordinated medical 
registry does not yet exist. Therefore, hospitals are entirely dependent on their 
own local data infrastructure. As a result, many hospitals choose to upload 
indicator scores that are estimated on basis of locally implemented treatment 
protocols and not on basis of empirical observations, neither of the entire 
population, nor of a representative sample. In the latter case, one would 
expect lower indicator scores (score < 100%), as the timely administration of 
antibiotic prophylaxis does not often exceed 70%.13-15 Estimating the indicator 
score instead of withdrawing from reporting altogether might be explained 
by the experienced external pressure caused by for example ranking lists 
that are published by the lay press. Hospitals end up at the bottom of the 
ranking when no indicator score is available, hence reporting 100% might be 
considered a favorable strategy to prevent reputation damage. Nevertheless, 
other factors such as a lack of priority or understaffing might additionally be 
at work as hospitals estimated their indicator score even though the data 
was available and reasonably accessible. The reporting of estimated data 
needs to be prevented as it results in an unrepresentative reflection for the 
quality of care delivered. Clinicians could for example set up a systematic 
peer review and consensus conference to discuss the PI scores before 
submitting them to the public database.
Despite the positive effect of the National Cancer Registry (NCR) on the 
Breast Cancer indicator plausibility, more profound standardization of 
these processes remains warranted. Particularly as governmental (DHTP) 
regulation regarding the data sources and the software systems that should 
be used for data collection and indicator computation is still lacking. 
This allows hospitals to choose their own strategies, which decreases the 
comparability of performance between hospitals. An alternative solution 
might be provided by disease specific registries that appear to be effective 
in improving health care quality and reducing costs, through publically 
available outcomes of health care.17
Recently, several diagnoses specific medical registries have been set up 
in the Netherlands (e.g. Dutch Surgical Colorectal Audit).18 Such a system 
avoids problems which arise when combining different data sources such 
as administrative data that can be easily calculated, with those based on 
other specific internal sources that can be easily manipulated. A drawback, 
however, is that a registry is set up from a unilateral, health care professional 
approach. The Netherlands has chosen to develop performance indicators 
according to a consensus driven perspective, implying that e.g. patient orga-
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nizations and health care insurers are involved in the indicator selection and 
development process. Nevertheless this perspective might have led to a situ-
ation that methodological arguments for indicator selection and refinement 
lost too easily from political arguments to reach consensus on indicators that 
are supported by a broad selection of stakeholders. A consensus approach 
might benefit from more regulation with respect to the data quality, for 
instance by developing a data quality control framework that encompasses 
the most crucial steps of prevention, detection and actions to be taken with 
respect to insufficient data quality,19 particularly when using administrative 
data systems. It has been suggested that administrative data alone is not 
always appropriate for the valid computation of performance measures.10,20 
Moreover, a language formalization process of all the relevant items during 
the indicator development phase seems vital as in the Netherlands every 
hospital collects its own data, has its own local data infrastructure, and DHTP 
has no insight in the underlying data that hospitals submit.21,22 After such a 
formalization process it could additionally be suggested to improve already 
existing national databases such as the Dutch Hospital Discharge registry or 
financial databases that are hosted by health care insurance companies.
Finally, the consensus approach entails that the indicators are used for 
several goals such as benchmarking performance, pay for performance 
schemes, selective contracting by insurance companies, and decision-
making processes of patients looking for a healthcare provider. Particularly 
in the case of self-reported data, it should be made clear which indicators 
can be used for which specific goal.
Conclusion
Our study provided insight in how performance indicator scores can be 
affected by heterogeneity of hospital information systems, data collection 
and data computation methods; factors that influence the reliability. 
Therefore, indicator developers, users and the scientific field need to focus 
more on the complexity of health care measurement instruments and 
conditional data infrastructures. Countries that have a liberal software mar-
ket and are aiming to implement a self-report based performance indicator 
system to obtain health care transparency, should secure the accuracy and 
precision of the heath care data from which the PIs are calculated from. 
Moreover, ongoing research and development of PIs and profound insight 
in the clinical practice of data registration is warranted.
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endnotes
a.In Dutch: Zichtbare Zorg.
b.According to the CCMO (Central Committee on Research involving 
Human Subjects), no medical-ethical approval of the study was necessary.
abbreviations
PI: Performance indicator; HKR: Hip and knee replacements; HR: Hip replace- 
ments; KR: Knee replacements; DHTP: Dutch health care transparency 
program; CCC: Comprehensive cancer centers; CCMO: Central committee 
on research involving human subjects.
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aPPeNDIX
appendix 1. National Performance Indicators: numerators and denominators
  total Hip and Knee replacements * S P o
 2b % of patients that was administered thrombosis prophylaxis for 6 weeks to 3 months   X
  post-surgery, in case of total hip or knee surgery
 Num Number of patients that received thrombosis prophylaxis for 6 weeks to 3 months 
  post-total hip or knee surgery
 Den Number of patients that underwent total knee or total hip replacement in a certain 
  calendar year
 4b % of patients that did not (2008 & 2009)/ did (2010) receive a homologue blood   X
  transfusion, in case of total hip or knee surgery
 Num Number of patients that received (2008 & 2009)/ did not receive (2010) a homologue 
  blood transfusion
 Den Number of patients that underwent total knee or total hip replacement in a certain 
  calendar year
 5b % of patients that was administered antibiotics perioperatively  X
 Num Number of patients that was administered antibiotic prophylaxis, peri-operatively.
 Den Number of patients that underwent total knee or total hip replacement in a certain 
  calendar year
 5c % of patients that was administered antibiotics 15 to 60 min. prior to surgery or to   X
  blood emptiness
 Num Number of patients that was administered antibiotics 15 to 60 min. prior to total hip 
  or knee surgery or to blood emptiness
 Den Number of patients that underwent total knee or total hip replacement in a certain 
  calendar year
 5d % of patients with a deep wound infection after a total hip or knee replacement   X
 Num Number of patients with a deep wound infection after a total hip or knee 
  replacement
 Den Number of patients that underwent a total knee or total hip replacement in a 
  certain calendar year
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  Breast Cancer ** S P o
 1 % patients who were seen by a breast cancer nurse specialist preoperatively  X
 Num Number of patients with a breast tumor that had at least one preoperative meeting 
  with a breast cancer nurse specialist
 Den Total number of patients with primary surgery of a breast tumor
 2 % patients that was reviewed preoperatively in a multi-disciplinary team meeting  X
 Num Number of patients with a breast tumor that was reviewed in a documented, 
  multi-disciplinary team meeting, prior to any treatment
 Den Total number of patients that was diagnosed with a breast tumor
 3 % patients with a non-radical primary tumor resection   X
 Num Number of patients with a non-radical, primary tumor resection (breast saving 
  surgery)
 Den Total number of patients with a primary tumor resection (breast saving surgery)
 4 % surgeons in the surgery department that perform surgical treatments of breast  X
  tumors
 Num Number of surgeons in department that perform surgical treatments of breast tumors
 Den Total number of surgeons in department
 5 % patients that are operated within 4 weeks after the final lab results are known  X
 Num Number of patients that are operated within 4 weeks after the final lab results are 
  known
 Den Total number of patients with a primary tumor resection
 6a % patients with local recurrences within 5 years after breast-conserving surgery   X
 Num Number of patients with local recurrences within 5 years after breast-conserving 
  surgery, primarily treated in own center (no referral)
 Den Total number of patients with breast conserving therapy, primarily treated in own 
  center (no referral)
 6b % patients that have local recurrences within 5 years after ablative breast surgery   X
 Num Number of patients with local recurrences within 5 years after ablative breast 
  surgery, primarily treated in own center (no referral)
 Den Total number of patients with ablative breast surgery, primarily treated in own center 
  (no referral)
 7 % of patients with a breast tumor that was postoperatively reviewed in a  X
  documented multi-disciplinary team meeting
 Num Number of patients that was postoperatively reviewed in a documented 
  multi-disciplinary team meeting
 Den Total number of patients with breast surgery
* Note: 5 yes/no ‘Hip/Knee structure indicators’ are omitted from the table as they were not included in the 
current study; ** Indicators 1,2 and 7 were removed from the indicator set in 2009, 4 in 2011; S = structure, P 
= process, O = intermediate outcome; The PIs consist of numerators and denominators that each are com-
posed of several variables according to combinatory logic that is described in instruction manuals.
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Testing the construct validity of hospital care quality indicators: A case-study on 
hip replacement.
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aBStRaCt
Background: Quality indicators are increasingly used to measure quality of 
care and compare quality across hospitals. In the Netherlands over the past 
few years numerous hospital quality indicators have been developed and 
reported. Dutch indicators are mainly based on expert consensus and face 
validity and little is known about their construct validity. Therefore, we aim 
to study the construct validity of a set of national hospital quality indicators 
for hip replacements.
methods: We used the scores of 100 Dutch hospitals on national hospital 
quality indicators looking at care delivered over a two year period. We as-
sessed construct validity by correlating structure, process and outcome indi-
cators using chi-square statistics, bootstrapped Spearman correlations, and 
independent sample t-tests. We studied indicators that are expected to cor-
relate as they measure the same clinical construct.
Results: Among the 28 hypothesized correlations, three correlations were sig-
nificant in the direction hypothesized. Hospitals with low scores on wound in-
fections had high scores on scheduling postoperative appointments (meet-
ing scheduled = 0.01; no meeting scheduled = 0.02; p-value = 0.001) and 
high scores on not transfusing homologous blood (correlation coefficient = 
-0.28; p-value = 0.05). Hospitals with high scores on scheduling complication 
meetings also had high scores on providing thrombosis prophylaxis (correla-
tion coefficient = 0.21; p-value = 0.04).
Conclusions: Despite the face validity of hospital quality indicators for hip 
replacement, construct validity seems to be limited. Although the individ-
ual indicators might be valid and actionable, drawing overall conclusions 
based on the whole indicator set should be done carefully, as construct 
validity could not be established. Factors that may explain the lack of con-
struct validity are poor data quality, no adjustment for case-mix and statisti-
cal uncertainty.
Key words: hip replacement, database, health care quality, quality indica-
tors, validity
6
160
C
ha
pt
er
 6
   
Th
e
 in
flu
e
n
c
e
 o
f d
a
ta
 q
u
a
lit
y 
o
n 
th
e
 c
o
rr
e
la
tio
n
s 
b
e
tw
e
e
n 
q
u
a
lit
y 
in
d
ic
a
to
rs
 fo
r h
o
sp
ita
l c
a
re
BaCKGRoUND
As quality improvement becomes a central tenet of health care, quality 
indicators (QIs) are becoming increasingly important. Quality is monitored 
and publicly reported in order to provide patients and health insurers with 
information regarding choices and to improve the quality of the underlying 
complex and resource-intensive care procedures 1.
For such purposes QIs need to be based on reliable data 2,3, and they must 
cover quality aspects on a structural, process, and outcome level 4. The un-
derlying assumption is that good structures of care increase the likelihood 
of good processes and good processes increase the likelihood of good out-
comes (the Donabedian framework) 4. Another important prerequisite for 
the external usefulness of the indicators and fair comparison of hospitals is 
that QIs are valid 5 and actionable. QIs need to provide insight into which 
factors determine the occurrence of an outcome, so that hospitals are able 
to act on the process to improve the outcome. 
Total hip replacements are very interesting for quality of care research be-
cause hip replacements are common, elective procedures that are being 
performed more and more frequently 6. Although the clinical and econom-
ic effectiveness of hip replacements is proven 7, it is still possible to observe 
variation in performance between providers 8,9. As a result, these orthopae-
dic procedures have for instance been included in pay-for-performance 
schemes by social insurance programs such as Medicare and Medicaid 10. 
In such a program hospitals are rewarded for meeting pre-defined perfor-
mance targets related to the health care that is delivered 11. In the pay-for-
performance scheme of Medicare and Medicaid, the so-called ‘Premier 
Quality Initiative Demonstration’, a composite score was created from three 
measures of surgical process quality and three measures of surgical out-
come. A performance bonus consisting of two percent of diagnosis-related 
group payments for total hip and knee arthroplasty was given to hospitals 
that scored in the top 10 percent on the composite measure 10. For such ex-
ternal use (as well as for internal use such as in local hospital quality improve-
ment), it is critical that indicators present a valid picture of the quality of the 
health care that is provided by a hospital 5. However, empirical evaluations 
of the relation between outcome indicators and process and structure indi-
cators that measure the same construct are scarce in Europe12. Even if qual-
ity indicators are tested in different health care systems, an evaluation in the 
health care system in which the indicator is used is essential. Differences in 
national health care and local hospital organization may influence the indi-
161
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cator’s validity 1. Insight into the validity of QIs is particularly important when 
data reliability is at stake, for instance when there are no national standards 
that hospitals or database software providers should follow when setting 
up their in-hospital quality registries in which the quality data is entered 1,2. 
This is the case in the Netherlands, where QIs were developed by the Dutch 
Health Care Transparency Program (DHTP) through a combination of expert 
consensus and available scientific literature. They were tested in only a few 
hospitals. Employees of the hospitals are required to calculate and report 
these QIs annually to the DHTP; public reporting and publication of these 
QIs has occurred for several subsequent years 13. 
Therefore we aimed to evaluate several publicly available indicators of 
quality of hospital care in the Netherlands related to hip replacements (15 
indicators) with regard to their construct validity, or the “degree to which an 
indicator measures what it claims to be measuring” 14. In this study construct 
validity is operationalized by a significant correlation, in the expected di-
rection, between two quality indicators that measure the same underlying 
construct.
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metHoDS
We conducted a cross-sectional data analysis, using quantitative data from 
two registration years (2008 and 2009) as reported by the hospitals. 
QIs under investigation
The QIs we evaluated are all related to pre-operative and post-operative 
health care for hip replacements. We used data from two consecutive 
years. Table1 shows an overview of the definitions, numerators (i.e. number 
of patients who underwent a certain care process) and denominators (i.e. 
total number of patients) of the structure, process and outcome (S-P-O) QIs 
evaluated in this study. Moreover, it can be seen that the structure QIs in the 
hip replacement set are dichotomous (yes/no), whereas the majority of the 
process and outcome indicators are continuous measures (a proportion of 
patients with particular treatment or outcome).
Data source
Dutch Health Care Transparency Program Data (DHTP)
The QI data originate from a national database hosted by the DHTP 15. Each 
year, Dutch hospital staff collect and submit to DHTP hospital-specific per-
formance scores (numerators and denominators) for various diseases and 
interventions based on health care delivered in the preceding calendar 
year. In 2009 and 2010 hospitals were not obliged to report performance 
information about health care delivered in 2008 and 2009; as a result, not 
all hospitals participated. From 2010 onwards hospitals were obliged to sub-
mit the indicator scores. The hip replacement dataset included a total of 
ten structure indicators, four process indicators and one outcome indicator 
(Table 1). For our study we selected the available numerators and denomi-
nators for each hospital and indicator. All QI scores were aggregated on the 
hospital level.
table 1. Included DHTP total hip replacement quality indicators
total hip replacement 
Qi Qi name Indicator  QI definition
num-  type**
ber
qi1 Preoperative patient  S* Definition: hospitals provide written or audio-visual 
 information  preoperative patient information (yes/no)
163
Qi Qi name Indicator  QI definition
num-  type**
ber
qi2a Guideline thrombosis  S Definition: hospitals have a guideline or protocol on 
 prophylaxis  thrombosis prophylaxis for cases of hip replacement 
   (yes/no)
qi2b Thrombosis prophylaxis P Definition and Numerator: in hip replacement cases, the 
   number of operations in which patients received medical 
   thrombosis prophylaxis within 6 weeks and no more than 
   3 months after the operation
qi3a Complication register S Definition: an automated information system is available 
   to provide insight into the occurrence of complications 
   (e.g. wound infection, lung emboli) within 6 weeks of HR 
   (yes/no)
qi3b Appointment within 6 weeks S Definition: to detect complications, a postoperative 
   appointment is held within 6 weeks of a hip replacement 
   (yes/no)
qi3c Orthopaedic registration form S Definition: in hip replacement cases, an orthopaedic 
   registration form is used to register complications (yes/no)
qi3d Complications meeting S Definition: minuted meetings are held to discuss hip-
   replacement complications (number of meetings per 
   year)
qi3e Improvement plan S Definition: minuted meetings are held to discuss hip-
   replacement complications, if necessary an improvement 
   plan with the person in charge is assigned (yes/no)
qi4a Blood management guideline S Definition: a blood-management guideline or protocol to 
   reduce perioperative administered in case of hip-
   replacement is present (yes/no)
qi4b Transfusion of homologue  P Definition and Numerator: in hip replacement cases, the 
 blood  number of operations in which patients did not receive 
   transfusion of homologue blood
qi5a Guideline for antibiotic  S Definition: a guideline/protocol is available for antibiotic 
 prophylaxis  prophylaxis in the event of hip replacement (yes/no)
qi5b Perioperative antibiotics P Definition and Numerator: in hip replacement cases, the 
   number of operations in which perioperative antibiotics 
   were administered
qi5c Antibiotics 60 - 15 minutes P Definition and Numerator: in hip replacement cases, the 
   number of operations in which patients received 
   antibiotics 60 to 15 minutes before incision
qi5d Wound infection O Definition and Numerator: in hip replacement cases, the 
   number of patients with deep wound infections within 
   6 weeks of the operation
qi6 National prosthetic register S Definition: the hospital participates in the national 
   arthroplasty register (yes/no)
6
* According to number in DHTP hip and knee replacement indicator set
** S = structure, P = process, O = outcome;
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table 2. Hypothesized indicator correlation and direction of association
 hypothesized indicator correlations Evidence expected p-value
  for  correlation indicator
  expected  direction correlation
  indicator   strength
  correlation   2008 2009
hc* 1 having a thrombosis prophylaxis management guideline  (25) positive  / /
 (qi2a**) and the percentage of patients who accurately 
 receive a thrombosis prophylaxis (qi2b)
hc 2 having a blood management guideline (qi4a) and the  (26) (25) positive  / /
 percentage of patients who do not receive a blood 
 transfusion (qi4b)
hc 3 having a guideline for antibiotic prophylaxis (qi5a) and  (25) positive  / /
 the percentage of patients who receive antibiotic 
 prophylaxis perioperative (qi5b)25
hc 4 having a guideline for antibiotic prophylaxis (qi5a) and  (25) positive  / /
 the percentage of patients who receive antibiotic 
 prophylaxis 60-15 minutes before incision (qi5c)25
hc 5 the percentage of patients who receive their  (26-28) negative  / 0.74
 perioperative antibiotic prophylaxis in a timely manner 
 (qi5b) and the percentage of patients with deep wound 
 infection (qi5d)26-28
hc 6 the percentage of patients that receive antibiotic  (26-28) negative  0.14 0.74
 prophylaxis 60-15 minutes before incision (qi5c)and the 
 percentage of patients with deep wound infection 
 (qi5d)26-28
hc 7 the percentage of patients who receive no blood  (29, 30) negative  0.05 0.07
 transfusion (qi4b) and the percentage of patients with 
 deep wound infection (qi5d) 29,30
hc 8 having a timely postoperative appointment (q3b) and   negative  / 0.001
 the percentage of patients with deep wound infections 
 (qi5d)
hc 9 having a complication register (qi3a) and providing a   positive  0.73 0.19
 thrombosis prophylaxis (qi2b)
hc 10 having a complication register (qi3a) and the percentage   positive  0.09 0.57
 of patients receiving no blood transfusion (qi4b)
hc 11 having a complication register (qi3a) and the   positive  / 0.60
 percentage of patients receiving perioperative antibiotic 
 prophylaxis (qi5b)
hc 12 having a complication register (qi3a) and the percentage   positive  0.29 0.57
 of patients receiving antibiotic prophylaxis 60-15 minutes 
 before incision (qi5c)
hc 13 having a complication register (qi3a) and the percentage   negative  0.74 0.43
 of patients with deep wound infection (qi5d)
hc 14 having an orthopaedic registration form (qi3c) and the  (31) positive  0.80 0.89
 percentage of patients receiving thrombosis prophylaxis 
 (qi2b)
165
* hypothesized correlation (hc), ** quality indicator (qi)
hc 15 having an orthopaedic registration form (qi3c) and the  (31) positive  0.98 0.26
 percentage of patients receiving no blood transfusion 
 (qi4b)
hc 16 having an orthopaedic registration form (qi3c) and the  (31) positive  / 0.06
 percentage of patients receiving perioperative antibiotic 
 prophylaxis (qi5b)
hc 17 having an orthopaedic registration form (qi3c) and the  (31) positive  / 0.28
 percentage of patients receiving antibiotic prophylaxis 
 60-15 minutes before incision (qi5c) 31
hc 18 having an orthopaedic registration form (qi3c) and the  (31) positive  0.60 0.42
 percentage of patients with deep wound infections (qi5d) 31
hc 19 having complication meetings (qi3d) and the percentage   positive  0.50 0.04
 of patients receiving thrombosis prophylaxis (qi2b)
hc 20 having complication meetings (qi3d) and the percentage   positive  0.26 0.91
 of patients receiving no blood transfusion (qi4b)
hc 21 having complication meetings (qi3d) and the percentage   positive  / 0.16
 of patients receiving perioperative antibiotic prophylaxis 
 (qi5b)
hc 22 having complication meetings (qi3d) and the percentage   positive  0.26 0.32
 of patients receiving antibiotic prophylaxis 60-15 minutes 
 before incision (qi5c)
hc 23 having complication meetings (qi3d) and the percentage   negative  0.39 0.91
 of patients with deep wound infections (qi5d)
hc 24 having an improvement plan to avoid complications   positive  0.86 0.52
 (qi3e) and the percentage of patients receiving thrombosis 
 prophylaxis (qi2b)
hc 25 having an improvement plan to avoid complications   positive  0.09 0.17
 (qi3e) and the percentage of patients receiving no blood 
 transfusion (qi4b)
hc 26 having an improvement plan to avoid complications   positive  / 0.39
 (qi3e) and the percentage of patients receiving 
 perioperative antibiotic prophylaxis (qi5b)
hc 27 having an improvement plan to avoid complications   positive  0.51 0.05
 (qi3e) and the percentage of patients receiving antibiotic 
 prophylaxis 60-15 minutes before incision (qi5c)
hc 28 having an improvement plan to avoid complications   negative  0.26 0.72
 (qi3e) and the percentage of patients with deep wound 
 infections (qi5d)
analysis
To describe the range in scores across hospitals we calculated the mean 
and interquartile range (IQR) of all indicator scores and denominators on 
the hospital level.
6
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Based on the description in the indicator manual, the literature and medical 
expert opinion, we hypothesized 28 correlations between hip replacement 
indicators that measure the same underlying construct. Table 2 shows an 
overview of the hypothesized indicator correlations and their direction of 
association.
First, to investigate the relationship between continuous structure, process 
and outcome indicators we used non-parametric Spearman correlations. 
To assess the uncertainty in the estimated correlation coefficient we cal-
culated 95% confidence intervals. To give a more robust estimation, these 
intervals were additionally estimated (bootstrapped) using 1000 random 
replicas (fictitious hospitals) that were constructed from the original dataset. 
The relationships between the dichotomous structure indicators were ana-
lysed by means of chi-square tests. Finally, to examine the relationship be-
tween dichotomous structure and continuous process/outcome indicators 
independent sample t-tests were applied. Here we also bootstrapped using 
1000 random replicas. Analyses were conducted in the statistical programs 
SPSS version 21. Significance was set at α < 0.05. P-values below 0.1 were re-
garded as marginally significant.
167
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ReSUltS
Of the total number of 100 hospitals in the Netherlands, on average, 64 hos-
pitals provided data to calculate indicator scores in year 2008. The partici-
pation increased in subsequent year, in which on average 95% of the hospi-
tals provided data. Many indicator scores improved from 2008 to 2009. For 
example, the percentage of wound infections ranged from 0 to 3% across 
hospitals in 2008, while in 2009 the range was from 0 to 0.03%. (Table 3).
Based on their face validity and on the literature, we hypothesized 28 cor-
relations (hypothesized correlations, hc) to be significant. We found three of 
these correlations to be significant in the direction hypothesized, of which 
one was found in the data from 2008 and two were found in the data from 
2009 (hc 7, hc 8, hc 19).
As expected, hospitals that reported planning appointments within six weeks 
after surgery scored lower on the number of deep wound infections than 
hospitals that did not report scheduling postoperative meetings (hc 8: yes 
appointment = 0.01% infections, no appointment = 0.02% infections, p-value 
= 0.001). Further, our analysis showed that hospitals with a higher percent-
age of patients who did not receive a homologue blood transfusion had a 
lower percentage of wound infections, although this correlation was only 
marginally significant (hc 7: r = -0.28, p-value = 0.05). Hospitals that reported 
to have more complication meetings were also more likely to report to pro-
vide thrombosis prophylaxis (hc 19: r = 0.21, p-value = 0.04).
We found several indicator correlations, which were not a priori expected.
We found two significant structure-structure correlations. We observed that 
hospitals that maintained a complication registration were more likely to 
score high on planning a postoperative appointment with the patient within 
six weeks after surgery (χ2: 19.97, p-value < 0.01). Further, hospitals that re-
ported holding complication meetings also reported using an improvement 
plan (yes improvement plan = 11%; no improvement plan 0%, p-value = 0.01). 
We also observed several process-process correlations. First of all, hospitals 
that reported to administer thrombosis prophylaxis were more likely to report 
to administer perioperative and preoperative antibiotic prophylaxis to their 
patients (Spearman R = 0.27, p-value < 0.05) (Spearman R = 0.28, p-value < 
0.05). We additionally observed a significant correlation between the ad-
ministration of antibiotic prophylaxis and the timely administration of antibi-
otic prophylaxis (Spearman R = 0.46, p-value < 0.01). The timely administra-
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table 3. Hospital-level variation in total hip replacement scores in year 2008 
and 2009
       2008         2009
    Indicator scores on  Denominators   Indicator scores on   Denominators
    hospital level   on hospital     hospital level  on hospital
            level        level
   N**  mean IQR min-max median IQR  N**  mean IQR min-max  mean IQR
qi*1 preoperative   68  1 1-1 1-1  / /  97  1 1-1 0-1  / /
 patient 
 information
qi2a guideline   68  1 1-1 1-1  / /  68  1 1-1 1-1  / /
 thrombosis 
 prophylaxis
qi2b thrombosis   64  100 100-100 95 -100  245 49-745  95  100 100-100 93-100  226 56-647
 prophylaxis
qi3a complication   68  1 1-1 0-1  / /  97  1 1-1 0-1  / /
 register
qi3b appointment   68  1 1-1 1-1  / /  97  1 1-1 0-1  / /
 within 
 6 weeks
qi3c orthopaedic   68  1 1-1 0-1  / /  97  1 1-1 0-1  / /
 register form
qi3d complication   63  11 4-12 0-52  / /  96  11 4-12 0-260  / /
 meeting
qi3e improvement   65  1 1-1 0-1  / /  96  1 1-1 0-1  / /
 plan
qi4a blood   68  1 1-1 1-1  / /  68  1 1-1 1-1  / /
 management 
 guideline
qi4b transfusion of   52  91 94-100 0-100  241 49-745  90  91 88-100 11-100  222 56-647
 homologous 
 blood
5a guideline for   68  1 1-1 1-1  / /  68  1 1-1 1-1  / /
 antibiotic 
 prophylaxis
5b perioperative   65  100 100-100 100-100  245 49-745  65  100 100-100 100-100  226 56-647
 antibiotics
qi5c antibiotics   59  97 100-100 0-100  237 49-745  94  98 100-100 66-100  226 56-647
 60-15 minutes
qi5d wound   60  1 0-1 0-3  245 49-745  93  0 0-0 0-0  213 52-647
 infections
qi6 countrywide   68  1 1-1 0-1  / /  97  1 1-1 0-1  / /
 implemen-
 tation
 average  64  X X X     95  X X X
*Quality indicator (qi)  **Number of hospitals that delivered the indicator score
169
6
tion of antibiotics was negatively associated with having an improvement 
plan (having an improvement plan = 98; having no improvement plan = 100, 
p-value = 0.03), taking part in the countrywide implementation registration 
(taking part = 97.9; not taking part = 100, p-value = 0.03) and having postop-
erative appointments with patients (having postoperative appointments = 
98; having no postoperative appointments = 100, p-value = 0.04).
Having an improvement plan was related to the percentage of patients 
who received their antibiotic prophylaxis in a timely manner; however, they 
were related differently than what was expected (hc 27: yes improvement 
plan = 98%; no improvement plan = 100%, p-value = 0.03) (Table 4).
table 4. Associations among total hip replacement indicators within the 
years 2008 and 2009
 quality indicator number
   qi3aa qi3b qi3c qi3e qi6 qi3d qi2b qi4b qi5b qi5c qi
             5d
CHI-SQUARE TEST
Quality Quality Year
indicator Indicator
number  Name
 (indicator
 type)
qi3a Complication  2008
 register (Sb) 2009
qi3b Appointment  2008 \
 within 6 weeks  2009 19.97
 (S)  (0.00)c
qi3c Orthopaedic 2008 0.57 \
 register form  (0.45)
 (S) 2009 0.43 0.09
   (0.51) (0.77)
qi3e Improvement 2008 0.29 \ 0.13
 plan (S)  (0.59)  (0.71)
  2009 0.28 4.38 0.13
   (0.60) (1.00) (0.71)
qi6 Countrywide 2008 1.41 \ 0.20 0.10
 implementation  (0.24)  (0.66) (0.75)
 (S) 2009 0.43 0.09 0.18 0.13
   (0.51) (0.77) (0.67) (0.71)
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INDEPENDENT T-TEST       SPEARMAN CORRELATION 
        COEFFICIENT
qi3d Complication 2008 yes 11 \ yes 10.5 yes 11 yes 10.8
 meeting  no 8.2  no 13 no 0 no 8.0
 (S)  (0.41) d  (0.81) (0.01) (0.73)
  2009 yes 11.3 yes 11.4 yes 11.7 yes 11.7 yes 11.6
   no 13.1 no 12 no 4.5 no 4.7 no 7
   (0.86) (0.98) (0.19) (0.19) (0.74)
qi2b Thrombosis 2008 yes 99.9 \ yes 60 yes 99.9 yes 99.9 0.09
 prophylaxis  no 100  no 100 no 100 no 100 (0.50)e
 (P)  (0.73)  (0.80) (0.86) (0.83)
  2009 yes 99.9 yes 99.8 yes 99.8 yes 99.8 yes 99.8 0.21
   no 98.9 no 98.9 no 99.8 no 99.4 no 100 (0.04)
   (0.19) (0.18) (0.89) (0.52) (0.65)
qi4b Transfusion of 2008 yes 90.7 \ yes 91 yes 99.1 yes 90.9 -0.16 0.08
 homologous  no 98.4  no 90.7 no 100 no 97.4 (0.26) (0.58)
 blood  (0.09)  (0.98) (0.09) (0.12)
 (P) 2009 yes 91.8 yes 91.5 yes 92 yes 91.8 yes 91.5 0.01 0.17
   no 89.3 no 94.1 no 82.9 no 75.8 no 93.6 (0.91) (0.12)
   (0.57) (0.70) (0.26) (0.17) (0.55)
qi5b Perioperative 2008 \ \ \ \ \ \ \ \
 antibiotics 2009 yes 99.7 yes 99.6 yes 99.6 yes 99.7 yes 99.6 0.15 0.27 0.15
   no 99.2 no 100 no 100 no 97.8 no 100 (0.16) (0.01) (0.17)
   (0.60) (0.07) (0.06) (0.39) (0.06)
qi5c Antibiotics 2008 yes 97.1 \ \ yes 99 yes 97.2 0.15 -0.04 -0.11 \
 60-15 minutes  no 100   no 50 no 100 (0.26) (0.79) (0.45)
 (P)  ( 0.29)   (0.51) (0.74)
  2009 yes 98 yes 98 yes 98.4 yes 98 yes 97.9 0.10 0.28 0.12 0.46
   no 99 no 100 no 88.5 no 100 no 100 (0.32) (0.01) (0.25) (0.00)
   (0.57) (0.04) (0.28) (0.03) (0.03)
qi5d Wound 2008 yes 0.8 \ yes 0.8 yes 0.84 yes 0.8 0.12 -0.03 -0.28 \ 0.20
 infections  no 1.0  no 1.0 no 0.44 no 0.3 (0.39) (0.84) (0.05)  (0.14)
 (O)  (0.74)  (0.60) (0.26) (0.17)
  2009 yes 0.01 yes 0.01 yes 0.01 yes 0.01 yes 0.01 0.01 -0.04 -0.19 -0.03 0.04
   no 0.01 no 0.02 no 0.0 no 0.01 no 0.01 (0.91) (0.71) (0.07) (0.74) (0.74)
   (0.43) (0.001) (0.42) (0.72) (0.89)
a numbers indicate indicator numbers according to vertical indicator numbering 
b S= structure, P= process, O=outcome 
c x2 test (p-value)
d t-test: mean group 1, 2 (p-value)
e Spearman correlation coefficient (p-value)
bold numbers indicate significance
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DISCUSSIoN
By correlating structure, process, and outcome indicators we measured the 
construct validity of national quality indicators for hip replacement. Of the 
28 a priori expected correlations (per year) only three were observed to 
be significant in the direction hypothesized. Additionally eight correlations 
that were not a priori expected were also found to be significant. None of 
the correlations were consistent over the two-year time period, despite the 
scientific foundation of the quality indicators and overall expert consensus 
regarding their validity. Therefore, the construct validity of the quality indi-
cator set under evaluation seems limited. We only found three of the a priori 
expected correlations to be significant. For example, we observed that in 
hospitals that scheduled an appointment with a patient within six weeks af-
ter the patient’s hip replacement, the number of relevant wound infections 
after hip replacement was lower compared to hospitals that did not plan 
such an appointment. This is consistent with the international literature and 
with the widely held opinion that an appointment within this period helps 
to detect postoperative complications at an early stage, and thereby to 
prevent advanced, severe wound infections 16. We additionally observed 
several process-process correlations, which, in retrospect, might indicate an 
overall quality awareness culture on the hospital level. For example, hospi-
tals that had high scores on the administration of perioperative antibiotics 
also had high scores on the administration of antibiotics prior the incision.
An important factor that can explain the lack of construct validity that was 
observed in our study is the low data reliability. Although the data registra-
tion showed signs of improvement in 2009 compared to 2008, data reliability 
remained an issue. In previous studies it was found that differences in data 
collection and reporting methods used by hospital employees, such as the 
use of different indicator definitions, most likely influenced the comparability 
of the DHTP data 2. Moreover, many of the indicators are not very specific. 
For instance, 9 of the 15 hip replacement indicators are dichotomous indica-
tors (yes/no). But for example, although guidelines are available (e.g. qi4a, 
qi5b), this does not ensure the quality of the guideline or the adherence to 
the guideline. 
The lack of correlation we found among the indicators may be explained 
by the limited variation and the small numbers observed among many of 
the included quality indicators. For example, in 2008 the average event 
rate for patients developing wound infections was merely 1%. When there 
are few observations and event rates are that low, indicator scores will ran-
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domly fluctuate over time, even if the underlying quality of care remains 
constant 17.
Furthermore, an important factor influencing construct validity is the lack of 
case-mix correction, as case-mix factors make up a large part of observed 
outcome variation 18. Lack of adjustment for patient characteristics, which 
are not related to quality of hospital care but influence the patients’ risk for 
an outcome, may lead to a biased reflection of quality of care and an unfair 
comparison between hospitals. As aggregated hospital-level data currently 
does not include information on the underlying patient characteristics, a 
valid and fair analysis between the hospitals cannot be guaranteed. 
As quality improvement has become a central tenet of health care, QIs are 
becoming increasingly important. Many countries have already started their 
own QI program and many more are preparing to start QI programs soon. 
Despite the increasing number of countries implementing QI programs, the 
number of studies testing the validity of indicators is limited. While a num-
ber of studies have tested the construct validity of indicators in the U.S. 19, 
20, 21-24, a limited number of such studies have been conducted in the Eu-
ropean health care setting 12. However, given the differences in national 
health care and local hospital organization, indicators should be evaluated 
before they are adopted from another health system. The validity of quality 
of care indicators cannot be assumed for a health care setting outside of 
the one where the indicator was developed and tested 1. Therefore, further 
research on the validity of the currently used indicators in the health care 
setting in which they are used is warranted. Several methodological lessons 
can be learned from our observations. In order for a QI to be valid, it must 
be reliable 2. An indicator’s reliability is determined by the accuracy of the 
underlying data and the unambiguousness of the definition of the indica-
tor 2. Moreover, when hospital employees are responsible for collecting the 
data and computing the QIs, there needs to be some central control over 
these processes. Moreover, to increase data reliability the software market 
should be regulated and standards should be set for the development of 
automatic data extraction software. In order to find relations between indi-
cators, it is crucial to take into account the influence of low event rates and 
case-mix differences. Failing to adjust for these factors may confound the 
relationship between quality indicators.
In our study we could not adjust for patient characteristics and low event 
rates, as we only had hospital-level data, which is a limitation of our study. 
There are other limitations of our study that need to be noted. First, we op-
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erationalized construct validity by the correlation between two test scores. 
Usually, in psychometric research, a person’s score on for example a new 
psychological test is correlated with a score on a more established test 
measuring the same underlying construct 14. In our study both test scores 
were derived from the same database and were both the subject of study. 
Merely the presence of a significant correlation that was expected based 
on the literature was considered to be an indication of the construct validity 
of both indicators. One could argue therefore that the method of validity 
assessment in our study is not very strong. A better way to assess the con-
struct validity is to correlate the indicator scores of interest with measures 
derived from other clinical databases. However, for countries in which reli-
able health care databases are scarce ours is the only approach possible. 
In our study we used a significant correlation in the expected direction as 
a sign for construct validity; however, most of the significant correlations 
were weak. Third, when assessing multiple correlations one typically cor-
rects for multiple testing, for instance with a Bonferoni correction. As we a 
priori planned our correlations based on the available scientific evidence, 
we did not correct for multiple testing. However, we do realize that we have 
to treat the observed significant correlations with caution. Further research 
and trend data is needed to test construct validity over a longer time period 
in order to be able to identify systematic indicator associations.
Conclusion
In all it can be concluded that despite the face validity of hospital qual-
ity indicators for hip replacement, construct validity seems to be limited. 
Although the individual indicators might be valid and actionable, drawing 
overall conclusions based on the whole indicator set should be done care-
fully, as construct validity could not be established. Factors that may explain 
the lack of construct validity are poor data quality, no adjustment for case-
mix and statistical uncertainty. Before any action can be taken based on 
the indicator scores, these limitations must be addressed.
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aBStRaCt
Background: When comparing performance across hospitals it is essential 
to consider the noise caused by low hospital case volume and to perform 
adequate case-mix correction. We aimed to quantify the role of noise and 
case-mix correction on standardized postoperative mortality and anasto-
motic leakage (AL) rates.
methods: We studied 13 120 patients who underwent colon cancer resec-
tion in 85 Dutch hospitals. We addressed differences between hospitals in 
postoperative mortality and AL, using fixed (ignoring noise) and random ef-
fects (incorporating noise) logistic regression models with general and ad-
ditional, disease specific, case-mix correction.
Results: Adding disease specific variables improved the performance of 
the case-mix correction models for postoperative mortality (c-statistic in-
creased from 0.77 to 0.81). The overall variation in standardized mortality 
ratios was similar, but some individual hospitals changed considerably. For 
the standardized AL rates the performance of the adjustment models was 
poor (c-statistic 0.59 and 0.60) and overall variation was small. Most of the 
observed variation between hospitals was actually noise.
Conclusions: Noise had a larger effect on hospital performance than ex-
tended case-mix correction, although estimates for some individual hospi-
tals were affected by more detailed case-mix correction. To compare out-
comes between hospitals it is crucial to consider noise due to low hospital 
case volume with a random effects model.
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INtRoDUCtIoN
Accountability to the public has become a major topic in health care in 
the past decade; consequently outcome measures increasingly receive at-
tention.1,2 Colorectal cancer is the third most common cancer,3 in 2012 an 
incidence of 13 408 new cases is registered in the Netherlands.4 Surgeries for 
colorectal cancer cause considerable morbidity and mortality.5 In cancer 
surgery mainly short-term outcome measures are used to measures quality 
of care, as they are little influenced by non-modifiable disease-related fac-
tors.6 Short-term outcome measures for colorectal cancer surgery include 
postoperative mortality and anastomotic leakage (AL). AL is one of the most 
serious complications in colon cancer surgery, as it is associated with in-
creased morbidity and mortality.7 Moreover, variations between providers 
can be observed.8-10
However, variation in outcome across centres is not made up exclusively by 
quality of care differences, which it is intended to display.11,12 Case-mix fac-
tors are thought to explain a large part of the observed outcome variation,13 
but case-mix models are usually fairly generic.14 Especially when they are 
based on administrative data, not intended for quality assessment.15-17 For 
colon cancer, research has shown that surgical high risk profile patients are 
not equally distributed across centres.18,19
Next, partial variation across centres can be attributed to ‘noise’ in the 
comparison (variation by chance). The noise in the comparison is especially 
influenced when the hospital case volume, so the number of patients with 
an event per hospital, is low. For example, an average number of 10 deaths 
per year in a hospital will fluctuate over the years because of chance, also 
if no changes in quality occur. With larger numbers of outcomes per hos-
pital (e.g. >50) the effect of chance variation decreases. Random effects 
regression models are able to take the variation by chance into account, in 
contrast to the mainly used fixed effects models.20,21
In this study we aimed to quantify the role of noise and case-mix correction 
on standardized postoperative mortality and AL rates.
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metHoDS
Study population
For this study data was derived from the Dutch Surgical Colorectal Audit 
(DSCA), a national, web-based and interactive database.22 The database, 
in which all Dutch hospitals participate, includes detailed information on 
patient-and tumour characteristics, diagnostics, procedures and outcomes 
of patients undergoing a resection of a primary colorectal carcinoma. In 
each hospital a surgeon is appointed for the data-entry. For participating 
hospitals it is possible to review their uploaded data as well as benchmark-
ing information on a protected web page. Further, data quality reports are 
sent to the hospitals.18 Approximately 97 percent of all patients with a pri-
mary colorectal carcinoma resection in the Netherlands are captured in 
this database.23 The dataset is based on evidence-based guidelines and 
annually verified with the Netherlands Cancer Registry (NCR) data. Further 
information on the data collection and methodology of the DSCA can be 
found elsewhere18,22 [www.dsca.clinicalaudit.nl].
We used data of all patients who underwent a primary colon carcinoma 
resection in the Netherlands between 1st of January 2011 and 31st of Decem-
ber 2012 (92 hospitals, 13 672 patients). Seven hospitals (with 552 patients) 
were excluded because they had zero outcome events (no deaths or no 
anastomotic leakage (AL)), resulting in 85 hospitals and 13120 patients in-
cluded in the analyses.
Predictors and outcome measures
Demographic variables included age and gender. Clinical variables in-
cluded American Society of Anesthesiologists (ASA) score, Charlson comor-
bidity index, International Union Against Cancer tumour node metastasis 
(TNM) classification of malignant tumours (6th edition), histological tumour 
type and tumour number and distance, in case of double tumour (distant 
tumours are located in a segment not adjacent to other (hemi left, hemi 
right and rectum)) and preoperative complications (perforation with fecal 
peritonitis, abscess, bowel obstruction, blood loss/anemia). The postopera-
tive short-term outcomes assessed were postoperative mortality and 
anastomotic leakage. Postoperative mortality was defined as dead during 
the index admission in which the surgery took place or within 30 days after 
surgery. AL was defined as ‘a clinically relevant anastomotic leak requiring 
a reintervention’. Both radiological and surgical reinterventions were consid-
ered.
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Statistical analysis
To describe between-hospital differences in operated patients we calcu-
lated medians and interquartile ranges for the baseline demographic and 
clinical characteristics on hospital level. We constructed six different models 
for each of the two outcomes (postoperative mortality and AL):
A crude fixed effects logistic model with taking no patient characteris-
tics or chance into account.
A fixed effects logistic multivariable model including generic case-mix 
factors: age, gender, urgency of surgery, Charlson comorbidity index 
and year of operation.
The extended case-mix adjusted fixed effects logistic model, which con-
sists of model 2 plus additional disease specific factors. The variables 
considered were age, gender, urgency of surgery, Charlson comorbid-
ity index, year of operation, ASA-score, TNM stage, preoperative tumour 
complications, histological tumour type, number and distance of tu-
mours.
These three models were also fitted as logistic random effects models with 
hospital as a random intercept. Such a random effects model takes out the 
noise in the comparison. To evaluate the effect of additional case-mix cor-
rection, the c-statistic (equivalent to the area under the ROC curve) was 
used. The c-statistic quantifies discrimination, i.e. the models ability to sepa-
rate patients with different outcomes.24 A c-statistic of 0.5 indicates no dis-
criminative power at all, whereas a model with c-statistic of 1.0 indicates 
perfect discrimination.
Standardized postoperative mortality and AL rates were used to quantify 
the effect of case-mix correction and noise on the overall between-hospital 
variation and the estimated outcomes for individual hospitals. The Standard-
ized Mortality (or AL) Rate (SMR) is a ratio between the observed number of 
deaths in a hospital and the number of expected deaths in a hospital. The 
expected number of deaths per hospital was estimated with the case-mix 
correction models. Being either the overall mortality rate (crude model) or 
the sum of the predicted probabilities per hospital (general and extended 
model). The observed number of deaths in the fixed effects model is the 
counted number of deaths. In the random effects models the observed 
number of deaths is the overall intercept plus the hospital specific random 
intercept from the crude random effects model, transformed into a prob-
ability. Multiplying this probability by the total number of patients in that 
hospital gives the ‘observed’ number, adjusted for variation by chance. An 
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SMR above 100 indicates “excess deaths” whereas a number below 100 in-
dicates that a hospital performed better as one would have predicted on 
basis of the hospitals expected deaths. 
The effect of the different models on the overall between-hospital variation 
was quantified by calculating interquartile ranges of the SMRs. The effect on 
individual hospital SMRs was assessed with bi-plots. 
Missing data in the predictors were imputed with multiple imputation using 
all relevant prognostic factors and outcome. 
Statistical analysis were carried out with the statistical software packages 
SPSS version 18.0 (SPSS, Chicago, IL, USA) and R statistical software 3.0.1 (R 
Foundation for Statistical Computing, Vienna, Austria).
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ReSUltS
Between 1st January 2011 and 31st December 2012 13 120 patients underwent 
colon cancer surgery and were registered in the DSCA data set. For the out-
come postoperative mortality we analyzed 13 120 patients. Information on 
the outcome anastomotic leakage (AL) was missing in 1756 patients and we 
thus analyzed 11 364 patients. Three baseline variables had missing values: 
ASA-score (3%), urgency (<1%) and histological tumour type (2%). Across the 
85 participating hospitals considerable variation in patient characteristics 
was observed. For example, the mean age varied by two years across hos-
pitals (interquartile range 70-72), but larger variation was observed in the 
patients with preoperative complications (26%-56%) and the number of ur-
gent operations (16%-24%) (Table 1).
Case-mix correction models
In the univariate analysis it appeared that the odds of postoperative mor-
tality was higher in patients who were older (OR, 2.3; 95% CI, 2.0-2.5), had a 
higher Charlson score (OR, 1.3; 95% CI, 1.3-1.4), higher ASA-score (e.g. ASA-
score 2 vs. ASA-score 1: OR, 2.3; 95% CI, 1.4-3.6), an urgent operation (OR, 2.7; 
95% CI, 2.2-3.3), higher TNM stage (e.g. TNM stage 2 vs. TNM stage1: OR, 2.3; 
95% CI, 1.4-3.6) and preoperative complications (OR, 2.2; 95% CI, 1.4-3.6). 
Predictors that significantly increased the odds of developing an AL were: 
male gender (OR, 1.5; 95% CI, 1.3-1.7), higher Charlson score (OR. 1.0; 95% CI, 
1.0-1.1), an urgent operation (OR, 1.5; 95% CI, 1.3-1.7), higher ASA-score (e.g. 
ASA-score 2 vs.1: OR, 1.2; 95% CI, 1-1.4), a distant tumour (OR, 1.6; 95% CI, 1.0-
2.6) and preoperative complications (OR, 1.4; 95% CI, 1.2-1.6) (Table 2).
In the multivariable case-mix models significant predictors for postoperative 
mortality were an urgent operation (mortality: OR, 2.8; 95% CI, 2.3-3.4; AL: OR, 
1.5; 95% CI, 1.3-1.9) and a higher Charlson score (mortality: OR, 1.3; 95% CI, 1.2-
1.3; AL: OR, 1.1; 95% CI, 1.0-1.1). The presence of preoperative complications and 
ASA-score were important predictors for both outcomes. For instance, a higher 
ASA-score increased the likelihood of both events significantly, with a patient 
with ASA-score four or five had an almost 12-fold risk of dying compared to a 
patient with an ASA-score of 1 (OR, 11.6; 95%CI, 6.6-20.4) and a nearly twofold 
risk for the occurrence of an AL (OR, 1.7; 95%CI, 0.93-3.2). Older age was only a 
statistically significant predictor for postoperative mortality (OR 2.1, 95% CI 1.9-
2.4), a 10 years older age implied a twofold risk of postoperative mortality (Table 
2). Gender, the number and location of the tumour were significant predictors 
for the outcome AL. Patients with a distant tumour had a 62% higher chance of 
an AL compared to a patient with a single tumour (OR, 1.6; 95% CI, 1.0-2.6).
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 Number of  Between hospital comparison
 patients  Median IQRc
Patients 13 120  137 101-194
Age (in years)a 13 120  71 70-72
Gender a 13 120 Female 52% 49%-55%
Year of operationa 13 120 2012 51% 47%-55%
Charlson scorea 13 120  1 0.8-1.1
ASA-scoreb 13 081 Normal healthy patient (1) 17% 12%-22%
  Mild systemic disease (2) 55% 51%-60%
  Severe systemic disease (3) 24% 18%-30%
  Life-threatening disease/ 1% 1%-3%
  Moribund patient (4/5)
Urgencyb 13 090 Elective 81% 76%-84%
  Urgent/Acute 19% 16%-24%
TNM stageb 13 120 0 1% 0%-2%
  I 17% 14%-19%
  II 36% 31%-40%
  III 32% 29%-35%
  IV 13% 10%-16%
  X 0 % 0 %-1%
Histological  12 930 Adenocarcinoma 92% 90%-96%
tumour typeb
  Mucinous adenocarcinoma 5 % 1%-8%
  Signet ring cell carcinoma 0% 0%-1%
  Others 0% 0%-1%
Number of tumour  13 120 Single tumour 96% 94%-97%
and locationb
  Close double tumour 2% 1%-3%
  Synchronous colorectal tumour 2% 1%-3%
Preoperative  13 120 Yes 37% 26%-56%
tumour 
complicationb
Anastomotic  11 364 Yes 6.7% (9)d 4.7%-8.8% (5-12)
leakage
Postoperative  13 120 Yes 3.2% (5)d 2.3%-4.3% (3-7)
mortality
7
table 1. Between hospital variation of patients undergoing colon cancer 
resection in Dutch hospitals
a generic case-mix factor
b extended case-mix factor
c interquartile range
d percentage ( total numbers)
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table 2. Multivariable models with outcomes postoperative mortality and 
anastomotic leakage with different case-mix correction
 Postoperative mortality   Anastomotic leakage
 Univariate Generic Extended Univariate Generic Extended
 analysis case-mix case-mix analysis case-mix case-mix
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
age per decadea 2.3 2.0-2.5 2.1 1.9-2.4 1.9 1.7-2.2 0.9 0.8-1 0.9 0.8-0.9 0.8 0.8-0.9
year of operationa
2012 1  1  1  1  1  1
2011 1.1 0.9-1.3 1.1 0.9-1.3 1.1 0.9-1.3 1.0 0.9-1.2 1.0 0.8-1.1 1.0 0.9-1.2
Charlson scorea 1.3 1.3-1.4 1.3 1.2-1.3 1.1 1.1-1.2 1.0 1.0-1.1 1.1 1.0-1.1 1.0 1.0-1.1
Urgencya
Elective 1  1  1  1  1  1
Urgent/acute 2.7 2.2-3.3 2.8 2.3-3.4 1.8 1.4-2.2 1.5 1.3-1.8 1.5 1.3-1.9 1.3 1.0-1.6
Gendera
Female 1  1  1  1  1  1
Male 1.1 0.9-1.3 1.2 1.0 -1.4 1.1 0.9-1.4 1.5 1.3-1.7 1.5 1.3-1.7 1.4 1.2-1.7
Histological typeb
Adenocarcinoma 1    1  1    1
mucinous  0.8 0.5-1.3   0.7 0.4-1.2 1.0 0.7-1.4   1.0 0.7-1.4
adenocarcinoma
Signet ring cell  1.1 0.4-3.1   0.7 0.3-2.2 1.5 0.8-3.1   1.3 0.7-2.7
carcinoma
Others 1.0 0.5-2.1   0.9 0.4-2.1 0.5 0.2-1.1   0.5 0.2-1.2
aSa-scoreb
Normal healthy  1    1  1    1
patient (1)
Mild systemic  2.3 1.4-3.6   1.3 0.8-2.1 1.2 1-1.4   1.3 1.0-1.6
disease (2)
Severe systemic  9.5 6.0-15.0   3.5 2.2-5.8 1.5 1.2-1.9   1.6 1.3-2.1
disease (3)
Life-threatening  37.5 22.1-63.7   11.6 6.6-20.4 1.7 0.9-3.1   1.7 0.9-3.2
disease/ Moribund 
patient (4/5)
tNm Stageb
0 1    1  1    1
I 1.8 0.5-5.7   1.3 0.4-4.3 1.1 0.5-2.2   0.9 0.4-1.8
II 2.0 0.6-6.2   1.2 0.3-3.9 1.4 0.7-2.7   1.1 0.6-2.3
III 1.8 0.6-5.6   1.2 0.3-4.0 1.4 0.7-2.7   1.1 0.5-2.2
IV 3.6 1.1-11.4   2.3 0.7-7.9 1.6 0.8-3.2   1.1 0.6-2.4
X 4.0 1.0-15.7   2.8 0.7-11.5 1.5 0.5-4.2   1.3 0.4-3.5
Preoperative 
complicationb
No 1    1  1    1
Yes 2.2 1.8-2.6   1.3 1.1-1.7 1.4 1.2-1.6   1.2 1.1-1.5
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With regard to the overall model performance, the c-statistic increased 
from 0.765 (95%CI 0.744-0.787) for the generic mortality case-mix correction 
model to 0.816 (95%CI 0.796-0.836) for the extended case-mix correction 
mortality model. For AL the c-statistic with generic case-mix and extended 
case-mix were 0.585 (95% CI: 0.565-0.606) and 0.605 (95% CI: 0.585-0.625) 
respectively.
effect of case-mix and noise adjustment
Without any adjustment (crude fixed effects model) the between-hospital 
differences in standardized postoperative mortality appeared substantial 
(interquartile range 70-129). When taking into account generic patient char-
acteristics, the differences even increased (interquartile range 67-141). Using 
Number & location 
tumourb
Single tumour 1    1  1    1
Close synchronous  0.7 0.3-1.4   0.7 0.3-1.4 1.1 0.7-1.7   1.1 0.7-1.7
colorectal tumour
Distant synchronous  1.6 0.9-2.9   1.5 0.8-2.7 1.6 1.0-2.6   1.6 1.0 -2.6 
colorectal tumour
ageneric case-mix factor 
bextended case-mix factor
table 3. Standardized mortality/anastomotic leakage ratios and model per-
formance of fixed and random effects models
 Standardized postoperative Standardized anastomotic
 mortality ratio  leakage ratio
 IQRa  IQRa
Fixed effects model
Crude  70 129 69 127
Generic case-mix correction 67 141 69 133
Extended case-mix correction 67 133 68 133
Random effects model
Crude 100 100 86 109
Generic case-mix correction 100 100 83 110
Extended case-mix correction 100 100 84 110
a Interquartile range
188
Figure 1. Between–hospital variation for standardized postoperative mortal-
ity ratio (SMR) based on generic and extended case-mix correction in fixed 
and random effects models
SM
R 
ra
nd
o
m
 e
ffe
ct
 c
ru
d
e
SM
R 
ra
nd
o
m
 e
ffe
ct
 g
en
e
ric
SM
R 
ra
nd
o
m
 e
ffe
ct
 e
xt
en
d
ed
SM
R 
ra
nd
o
m
 e
ffe
ct
 c
ru
d
e
SM
R 
ra
nd
o
m
 e
ffe
ct
 g
en
e
ric
SM
R 
ra
nd
o
m
 e
ffe
ct
 e
xt
en
d
ed
SM
R 
ra
nd
o
m
 e
ffe
ct
 c
ru
d
e
SM
R 
ra
nd
o
m
 e
ffe
ct
 g
en
e
ric
SM
R 
ra
nd
o
m
 e
ffe
ct
 e
xt
en
d
ed
SMR random effect crude SMR random effect crude SMR random effect crude
SMR random effect generic SMR random effect generic SMR random effect generic
SMR random effect extended SMR random effect extended SMR random effect extended
200150100500
15
0
50
0
200150100500
15
0
50
0
200150100500
15
0
50
0
200150100500
15
0
50
0
200150100500
15
0
50
0
200150100500
15
0
50
0
200150100500
15
0
50
0
200150100500
15
0
50
0
200150100500
15
0
50
0
the extended case-mix model revealed, however, that a part of the differ-
ences could be explained by the extra disease specific variables; the SMRs 
converged again to an interquartile range of 67-133. Additionally, for some 
individual hospitals, the SMR changed substantially with additional case-mix 
correction.
Taking into account the noise in the comparison with a random effects mod-
el diminished remaining differences in standardized mortality rates between 
the hospitals totally (Table 3) (Figure 1). 
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Figure 2. Between-hospital variation for standardized anastomotic leakage 
ratio (SMR) based on generic and extended case-mix correction in fixed 
and random effects models
For the outcome AL the crude fixed effects model indicated similarly large 
outcome differences (interquartile range 69-127). The generic case-mix cor-
rection and the extended case-mix correction had very limited effect on 
the overall variation and on the standardized AL rates of individual hospitals 
(Figure 2). The random effects models revealed that also for AL most of the 
between-hospital variation was attributable to noise in the comparison (in-
ter-quartile range, crude random effects model: 86-109). This can be also 
seen from Figure 2: the spread in AL ratios becomes much smaller when tak-
ing into account noise.
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DISCUSSIoN
In this study we quantified the role of noise and case-mix correction on stan-
dardized postoperative mortality and anastomotic leakage (AL) rates. We 
found that additional disease specific case-mix correction had some effect 
on standardized postoperative mortality rates compared to generic case-mix 
correction. However, all variation between hospitals in standardized postop-
erative mortality rates was explained by noise in the comparison. AL rates were 
not affected by case-mix correction, but a large part of the between hospital 
variation was again explained by noise.
Case-mix correction
It is generally recognized that between-hospital comparisons in outcome 
should be adjusted for potential differences in case-mix. Yet, many current 
case-mix correction models include only a limited number of generic case-
mix factors and lack disease specific information.
We found that several of the additional disease specific case-mix correction 
variables were significant predictors of postoperative mortality. Adding those 
predictors to the models resulted in an improvement of the discriminative abil-
ity of the model to a c-statistic of 0.81. In contrast, the models for the outcome 
AL performed rather poor with a c-statistic of around 0.6. These findings are in 
line with results of earlier research showing that while postoperative mortality 
is highly sensitive to (disease specific) case-mix factors,25-27 postoperative com-
plications are especially influenced by intraoperative risk factors.28 A recent 
study concluded that disease specific case-mix variables did result in notice-
able model improvement in terms of c-statistic.29 These authors started how-
ever with an extensive prediction model and added only two cancer-specific 
variables.
When comparing outcomes across centres, it is not only relevant whether 
a case-mix variable is predictive of the outcome, but also whether it shows 
variation across hospitals.30 For instance, a strong predictor of mortality that is 
equally distributed across all hospitals would not affect the SMRs when added 
to the case-mix correction model. In our data the distribution of generic case-
mix correction factors, such as age, varied little between hospital, compared 
to disease specific factors, such as preoperative complications and ASA score. 
This explains that although the generic case-mix correction model had a high 
c-statistic, the model had a limited effect on the SMRs. While the extended 
adjustment model, with only a somewhat higher c-statistic affected the SMRs 
C
ha
pt
er
 7
  T
he
 im
p
a
ct
 o
f s
ta
tis
tic
a
l u
nc
e
rt
a
in
ty
 a
nd
 c
a
se
-m
ix
 c
o
rre
ct
io
n 
on
 th
e 
re
lia
b
ili
ty
 a
nd
 v
a
lid
ity
 o
f q
ua
lit
y 
in
d
ic
a
to
rs
 fo
r c
o
lo
n 
ca
nc
e
r s
ur
g
e
ry
191
7
much more. Consequently, our findings confirm that the c-statistic has limited 
usefulness for quantifying the credibility and accuracy of comparisons across 
hospitals.31 The discriminative ability only reflects between-patient outcome 
variation and not differences in the distribution of patient characteristics across 
hospitals. Therefore, the c-statistic will remain unchanged if the added risk fac-
tor is equally distributed across hospitals. For AL the case-mix factors varied 
similarly across hospitals but had only a limited predictive strength. Hence, the 
standardized AL rates were minor affected by case-mix correction. Clinical 
expertise needs to be used to develop risk adjustment models specifically for 
the clinical condition or procedure of interest.31
Noise
In the cases in which the effect of additional case-mix correction was limited, 
the consideration of noise was essential for the outcome comparison between 
hospitals. Taking the noise into account with the random effects models di-
luted all observed variation in postoperative mortality across the hospitals, as 
well as a vast amount of variation in anastomotic leakage. Our findings are in 
line with previous work showing that the number of patients, and specifically 
the number of patients who got the event per hospital (hospital case volume), 
have a much greater impact on the accuracy of the hospital comparison 
than the c-statistic of the risk-adjustment model.31 Even when applying exten-
sive case-mix correction, a number of hospitals will be misclassified when the 
effect of noise caused by a low hospital case volume is not taken into ac-
count.32,33 The amount of noise directly depends on the number of observed 
outcomes. If the total patient number is large, a rare outcome will still lead to 
a low hospital case volume and thus a lot of random variability. The AL rates 
were less affected by noise than the postoperative mortality rates. This is, as 
the number of events per hospital was almost twice as high (median 9) as the 
number of deaths (median 5), which is crucial from a statistical point of view. 
In contrast to the fixed effects models, random effects models allow to draw 
inferences on the overall patient population, which enables the estimation of 
expected outcome in future patients.
Choice for an outcome indicator
Death is the most undesirable outcome for a patient. Therefore postoperative 
mortality forms a highly relevant outcome indicator and needs to be moni-
tored. Methodologically, however, mortality as a measure for quality of care 
has several disadvantages: even when the absolute patient numbers are high, 
with the steady improvement of medical care and centralization, the number 
of deaths per hospital is decreasing, leading to a higher impact of noise when 
comparing mortality rates between hospitals.34 This is especially the case when 
192
comparing disease specific outcomes,35 as in our study, where on average 
just 5 patients per hospital died in the two years study period. To increase the 
number of patient volume and event rates disease specific outcomes can be 
rather monitored over a longer time period or alternatively aggregated on 
hospital level. Doing so, however, complicates the interpretation and improve-
ment of the outcome, as the direct link to care processes cannot be made,36 
feedback loops get longer and therefore results become less relevant and 
actionable for care givers.
Another problem, also shown in this research, is the sensitivity of mortality to 
case-mix factors.36 Given the limitations of mortality rates as an indicator of 
surgical quality, other indicators are worthwhile to monitor in addition. Anas-
tomotic leaks are severe post-operative complications causing significant 
burden to patients37 and closely related to the surgical process and therefore 
likely be attributable to quality of care. As our study confirmed, their incidence 
rate is higher than the ones of postoperative mortality, which is crucial from a 
methodological point of view. A further advantage of this indicator is its ro-
bustness towards patient characteristics.38 We could show that general patient 
and disease specific characteristics had a minor predictive ability for ALs, sug-
gesting that observed outcome differences might be due to treatment and 
hospital factors. Nevertheless, to date no standard definition of AL exists in the 
literature.39 When aiming for a valid benchmark of this outcome indicator, a 
standardized definition forms a pre-requisite.
Strengths and limitations
A major strength of this study is its large, national cohort. The use of audit data 
enabled the analysis of reliable, clinical case-mix correction information. Al-
though we tested for a range of important clinical variables, patients’ behav-
ioural factors could not be taken into account in this study.
Implications
When outcome indicators are used to compare hospital performance, high-
quality prospectively set up data registries are a basic pre-requisite. As our 
study shows, it is important that clinical data are available to perform ade-
quate case-mix correction. High quality data demands active monitoring and 
data validation.40 In addition to postoperative mortality, AL seems to be suit-
able as an indicator of surgical performance, as they occur frequent and are 
less sensitive to case-mix. However, a single indicator never can reflect a whole 
quality spectrum. Hospitals performing poor on one indicator do not necessar-
ily perform poor on other related indicators.41 This implies that multiple (related) 
indicators, such as postoperative mortality and surgical complications, should 
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be measured and compared. Novel statistical methods might reduce noise 
by jointly analyzing multiple surgical indicators, for example, by summarizing 
them as complicated course or textbook outcome.42
In conclusion, noise, due to low hospital case volume, had a larger effect on 
hospital performance than extended case-mix correction. Although some 
individual hospital outcome rates were affected by more detailed case-mix 
correction. To compare outcome rates between hospitals it is crucial to take 
into account the noise due to low hospital case volume with a random effects 
model.
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aBStRaCt
Background: Outcomes for oesophago-gastric cancer surgery are com-
pared with the aim to benchmark quality of care. Adjusting for patient char-
acteristics is crucial to avoid biased comparisons between providers. The 
study objective was to develop a case-mix adjustment model for compar-
ing 30-, 90-day mortality and anastomotic leakage rates after oesophago-
gastric (O-G) cancer resections.
methods: The study reviewed existing models, considered expert opinion 
and examined audit data in order to select predictors that were conse-
quently used to develop a case-mix adjustment model for the National Oe-
sophago-Gastric Cancer Audit, covering England and Wales. Models were 
developed on patients undergoing surgical resection between April 2011 
and March 2013 using logistic regression. Model calibration and discrimina-
tion was quantified using a bootstrap procedure.
Results: Most existing risk models for O-G resections were methodologically 
weak, out-dated or based on detailed laboratory data not generally avail-
able. In 4882 O-G cancer patients used for model development, 30-day 
mortality was 2.3%, 90-day mortality was 4.4% and 6.2% of patients devel-
oped an anastomotic leakage. The internally validated models, based on 
predictors selected from the literature, showed moderate discrimination 
(AUC 0.65 for 30-day mortality, 0.66 for 90-day mortality and 0.59 for anasto-
motic leakage) and good calibration.
Conclusions: Based on available data, three case mix adjustment models 
for postoperative outcomes in patients undergoing curative surgery for O-G 
cancer were developed. These models should be used for risk adjustment 
when assessing hospital performance in the NHS, and should be tested in 
other large health systems. 
Keywords: oesophago-gastric cancer resection, case mix adjustment, 30-
day mortality, 90-day mortality, anastomotic leakage 
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INtRoDUCtIoN
As public interest in quality of hospital care is growing, outcome measures 
are increasingly used to benchmark hospital performance. When compar-
ing outcomes between hospitals, risk adjustment for patient characteristics 
is crucial because when patient populations differ between hospitals, dif-
ferences in outcome may represent differences in baseline risk rather than 
quality of care. Insufficient case-mix adjustment then leads to unfair com-
parisons. This is of particular relevance where surgery bears substantial risks, 
as in the case of O-G cancer resections.
The National Oesophago-Gastric Audit (NOGCA) was set up to monitor the 
quality of care provided to patients with O-G cancer in England and Wales, 
to evaluate care processes and patient outcomes 1. A recent systematic 
review concluded, however, that current models for prediction of outcomes 
after oesophagectomy had numerous limitations in regarding methodology 
and clinical credibility 2. Centralization of surgery, decision-making in multi-
disciplinary teams and improved care pathways have already been shown 
to contribute to a decrease in short-term mortality 3, 4, so that earlier predic-
tion models might no longer be valid. The aim of the present study was to 
develop a case-mix adjustment model for comparisons of 30- and 90-day 
mortality, and anastomotic leak rates after resections for O-G cancer be-
tween NHS trusts, based on a review of existing prediction models, expert 
opinion and audit data.
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metHoDS
Data collection
The study used data submitted to the National Oesophago-Gastric (O-G) 
Cancer Auditfrom all 154 English NHS trusts that provide O-G cancer care 
and from all 13 Welsh NHS organisations contributing to the Welsh Cancer In-
formation System (CANISC). The Audit included adults diagnosed with inva-
sive, epithelial cancer of the oesophagus or stomach between 1 April 2011 
and 31 March 2013, and captured information using a prospectively devel-
oped database on the patient (age at diagnosis, gender, comorbidities, 
Eastern Co-operative Oncology Group (ECOG) functional performance), 
cancer details (cancer site oesophagus including Siewert types I-III junc-
tional tumours, or stomach), histology, TNM stage (Tumour, Node Metasta-
sis) version 7 5, , American Society of Anesthesiologists (ASA) score, comor-
bidities and procedure (performance of neoadjuvant treatment, operation 
mode), as described previously1. All patients undergoing curative resection 
were included in the present study; those undergoing curative oncological 
treatment for squamous cell carcinoma and all palliative patients were ex-
cluded, (Appendix Figure A1). 
Review of existing models
Potential prognostic factors for 30-day, 90-day mortality and anastomotic 
leak were selected on the basis of a review of the existing literature and 
clinical expert advice. Literature was searched for multivariable risk models 
of short-term mortality (30-, 90-days, or in-hospital mortality) or complica-
tions including anastomotic leaks following O-G cancer surgery. From stud-
ies meeting these inclusion criteria, risk factors included in the models that 
were available in routine clinical databases and not modifiable by the pro-
vider were selected (Appendix Table A1).
outcome measures
The short-term outcomes were 30-day and 90-day all-cause postoperative 
mortality and anastomotic leak rates6. Date of death was obtained from the 
Office for National Statistics death certificate register. Anastomotic leak was 
defined as a severe disruption to the anastomosis (whether detected clini-
cally or radiologically, and irrespective of whether it is managed conserva-
tively or by re-operation) 7. All leaks, including those from conduit staple lines 
away from the oesophago-gastric anastomosis, were included in the study 
based on self-reported data from the surgeon/surgical team. 
202
C
ha
pt
er
 8
   
Th
e 
d
ev
el
op
m
en
t o
f a
 c
a
se
-m
ix
 c
o
rre
ct
io
n 
m
od
el
 fo
r c
om
p
a
rin
g 
ou
tc
om
es
 o
f o
es
op
ha
g
o
-g
a
st
ric
 c
a
nc
e
r s
ur
g
e
ry
model development and statistical analysis
Potential predictors were tested initially in univariable logistic regression 
models. Variable categories containing small number were regrouped in 
advance (ASA score, co-morbidity count, predominant histology by cancer 
location, performance status, histology type). The linearity of the continu-
ous independent variable age at diagnosis with 30-, 90-day mortality and 
anastomotic leakage was tested by adding quadratic terms. As this did not 
significantly improve the models, no quadratic terms were included in the 
model. To prevent exclusion of predictors with borderline significance, a p-
value of 0.10 was used rather than 0.05 for inclusion of variables in the mod-
el. Decisions to include and exclude predictors were primarily based on the 
evidence gathered from the literature review and complemented with the 
information generated from the statistical analyses and expert clinical opin-
ion. Odds ratios (OR) with 95% confidence intervals were used to express the 
strength of the predictive effects. 
The model performance was assessed with respect to discrimination and 
calibration 8. Discriminative ability represents how well the model was able 
to discriminate between patients with and without the outcome of interest, 
expressed as the area under the receiver operating curve (AUC, c-statistic) 
ranging from 0.5 – 1.0, where 0.5 indicates no discriminative power and 1.0 
perfect discrimination. Calibration of the model was assessed by using scat-
ter plots of observed versus predicted outcomes in deciles of predicted risk 
on the imputed data set. 
The internal validity of the models was evaluated using a bootstrapping pro-
cedure 9. With bootstrapping, multiple patient samples were drawn, consid-
ered as cases included under the same conditions as in the original data 
set. 800 bootstrap samples were used to re-estimate the multivariable logis-
tic regression coefficients and consequently applied to the original dataset, 
resulting in 800 AUC statistics. The mean of these AUCs represented the opti-
mism-corrected or internally validated AUC. 
All analyses were performed in Stata and R. Missing data was assumed to 
be Missing at Random and was handled with the MICE (multiple imputation 
by chained equations) approach by White and Royston using Stata software 
(version 12 (StataCorp LP, College Station, Texas, USA)) 10. Chained equations 
with 10 imputation sets were used. The outcome measures and the indepen-
dent variables deprivation, age at diagnosis, ECOG performance status, 
ASA score, gender, tumour location, number of comorbidities, size and/or 
extent of the primary tumour (T stage from the TNM classification) and re-
203
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gional lymph nodes (N stage of the TNM classification) were included in the 
imputation model. A sensitivity analysis comparing complete-case analysis 
with the one derived from the imputation model demonstrated no signifi-
cant differences (Appendix Table A2, Table A3). The bootstrap procedure 
was performed with the validate function in the rms package in R statistical 
software, and the imputation with the MICE (multiple imputation by chained 
equations) approach by White and Royston using Stata software (version 12 
(StataCorp LP, College Station, Texas, USA)) 10.
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ReSUltS
Published prognostic models
The literature search resulted in the identification of 41 prediction models 
for short-term outcomes after O-G cancer surgery. Some of the studies that 
we identified had a dual aim, i.e. providing insight in predictor effects and 
providing predictions based on the combination of predictors in a multivari-
able model. 34 models addressed postoperative mortality (12 studies used 
30-day mortality, three used 90-day mortality, 16 used in-hospital mortality, 
2 used major morbidity inclusive death, one postoperative mortality not fur-
ther defined) and seven were predicting anastomotic leakages (AL) (Table 
1). The majority of the studies considered outcomes after oesophagectomy 
and were designed as clinical prediction models as opposed to risk-adjust-
ment models for provider comparisons. Numerous models were based on 
the POSSUM, O-POSSUM, P-POSSUM scores, a prediction score requiring de-
tailed laboratory test values. These POSSUM scores are based on data not 
commonly available in audit data, such as white blood cell count or urea 
level 12, 17, 21, 26, 27, 31, 35-37. In addition, the majority of the studies were based on 
single centre data that either pooled data over long periods of time 11, 13-17, 
19-21, 23, 26, 31, 33, 34, 36, 37 or had a small sample size (e.g. N = 70, 121, 143, 204, 232) 11, 
16, 20, 21, 37 and were performed in other countries than the UK. Event rates were 
typically far higher than those currently observed in the NOGCA, especially 
in the models developed in earlier years 19-22. The predictive ability of most 
models was limited, at maximum, moderate 21, 22, 24, 30. 
A detailed description of the predictors identified in the literature search 
and reasons for in-or exclusion is available in the appendix (Appendix 
Table A1). 
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table 1. Descriptive information of currently available prediction models of 
O-G cancer short-term outcomes
Law  HKG 1982-92 Oesophageal 1 1105 In-hospital 15.5% /
(1994) 33      mortality
Bartels  GER 1982-5 Oesophageal 1 432 30-day 10% /
(1998)18      mortality 
  (1996)     (1%)
Liu  AUT 1994-7 Oesophageal 1 70 In-hospital 13% /
(2000) 19      mortality &
      complication
Karl  USA 1989-99 Ivor Lewis  1 143 30-day 2.1% /
(2000) 10   Gastro-   mortality
   Oesophageal   
      AL 3.5%
Zafirellis  UK 1990-9 Oesophageal 1 204 30-day 12.7% AUC=0.62
(2002) 20      mortality  POSSUM
Bailey  USA 1991-2000 Oesophageal 109 1777 30-day 9.8% c-index
(2003) 21      mortality  0.69
McCulloch  UK 1999-2002 Gastro- 26 955 In-hospital 12% AUC=0.68
(2003) 11   oesophageal   mortality  POSSUM
      Surgical   AUC=0.71
      complications  POSSUM
Mariette  FR 1982-93 Oesophageal 1 742 In-hospital 5.4% /
(2004) 12  (1994-2002)    mortality (2.9%)
      AL 9.8%
       (2.2%)
Law  HKG 1990-5 Oesophageal 1 421 In hospital 1.1% /
(2004) 13      mortality
Atkins  USA 1996-2002 Oesophageal 1 379 Operative 5.8% /
(2004) 22      mortality
Tekkis  UK 1994-2000 Gastro- 36 1042 In-hospital 12% AUC=79.7
(2004) 34   oesophageal   mortality  O-POSSUM
        AUC=74.6
        P-POSSUM
Junemann- UK 1992-9 Ivor Lewis 1 276 AL 5.1% /
Ramirez    gastro-
(2004) 14   oesophageal 
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Steyerberg  USA/ 1991-1996 Oesophageal Population 3592 30-day 11% AUC=0.66
(2006) 23 NL   database /  mortality
    clinical
    centre  (in 4cohorts) (10%,
       7%,4%)
Viklund  SWE 2001-3 Oesophageal Nationwide 275 30-day 3% /
(2006) 24    study  mortality &
      AL 8%
Naga-bhushan  UK 1990-2002 Gastro- 1 313 30-day 10.2% AUC=0.61
(2007) 35   oesophageal   mortality  O-POSSUM
        AUC=0.68
        P-POSSUM
Lagarde NL 1993-2005 Oesophageal 1 663 In-hospital 3.6% AUC=0.60
(2007) 25      mortality  O-POSSUM
Lai  HKG 2001-5 Oesophageal 14 545 In-hospital 5.5% AUC=0.776
(2007) 26      mortality  POSSUM
        AUC=0.776
        P-POSSUM
        AUC=0.676
        O-POSSUM
Ra  USA 1997-2003 Oesophageal Population 1172 In-hospital 14%  /
(2008) 27    database  mortality
Wright  USA 2002-7 Oesophageal 73 STS 2315 Major  /
(2009) 28    General  morbidityc
    Thoracic  (incl. death
    Data-base  and AL)
Park  UK 1995-2007 Oesophageal ICNARC 7227 In-hospital 11% AUC=0.60
(2009) 29    Case-mix  mortality  APACHE II d
    Programme
    Database     AUC=0.63
    181    SAPSS IIe
        AUC=0.65
        ICNARC f
Dutta  UK 2005-9 Gastro- 1 121 30-day 4% AUC=0.759
(2011) 36   oesophageal   mortality  POSSUM
        AUC=0.715
        O-POSSUM
Bosch  NL 1991-2007 Oesophageal 1 278 90-day 5.4% AUC=0.766
(2011) 31      mortality  P-POSSUM
        AUC=0.756
        O-POSSUM
Morita  JPN 1964-79 Oesophageal 1 1106 In-hospital 16.1% /
(2011) 32      mortality
207
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b Anastomotic leakage; c Including reoperation for bleeding, AL, pneumonia, re-intubation, ventilation be-
yond 48 hours, or death; d Acute Physiology and Chronic Health Evaluation; e Simplified Acute Physiology 
Score; fICNARC physiology score; g Nun score calculated using the log-likelihood ratio of blood-borne vari-
ables of the systematic inflammatory response (albumin, WCC and CRP from POD4)
Sunpaweravong  THA 1998-2007 Oesophageal 1  232 30-day 3.8% /
(2012) 15      mortality
      AL 15.9%
Noble  UK 2005-10 Oesophageal 1 258 AL 10% AUC=0.801
(2012) 16        Nun scoreg
  2011    AL  AUC=0.879
        Nun score
      major  AUC=0.856
      complication/   Nun score
      death
Koppert NL 2005-9 Gastro- Eindhoven 6223 30-day 7.7% /
(2012) 44   oesophageal Cancer  mortality
    Registry
Rutegard  SW 2001-5 Oesophageal Nationwide 559 90-day 7.1% /
(2012) 31      mortality
Kassis  USA 2001-11 Oesophageal STS General 7595 AL 10.6% /
(2013) 17    Thoracic
    Database
Patient characteristics
Of 22 766 patients identified the study included 4882 patients who had un-
dergone O-G cancer resection in the period between April 2011 and March 
2013 (Table 2). The patients had a mean age of 66 years (interquartile 
range=14 years) and the majority were male (74%). In 2135 (43.7%) patients, 
at least one comorbidity was present. Most patients had an adenocarcino-
ma histology (89%), while the most common location was the lower third of 
the oesophagus and Siewert type 1 tumour (39%). 30-day mortality was 2.3% 
(N=112) and 90-day mortality was 4.4% (N=216). 6.2% (N=305) of the patients 
developed an AL. Further descriptive information is shown in Table 2. 
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table 2. Descriptive information on study population
 No. of
Patient and prognostic information patients %
year of operation, 2013
2012 2417 49.5
2013 2465 50.5
age, years  4873 66.3*
Missing values 9 0.2
Comorbidity count  
No comorbidities 2747 56.3
One comorbidity 1311 26.8
Two comorbidities 566 11.6
Three or more comorbidities 258 5.3
Gender  
Male 3618 74.1
eCoG (WHo) performance status  
Carries out all normal activity 2519 51.6
Restricted but walks/does light work 1557 31.9
Walks, full self-care but no work 527 10.8
Limited self-care – fully disabled 120 2.5
Missing values 159 3.3
Size and/or extent of the primary tumour (t)  
No evidence of primary tumour (T0) 202 4.2
Tumour invades lamina propria or submucosa (T1) 929 19.0
Tumour invades muscularis propria (T2) 792 16.2
Tumour invades adventitia (T3) 2323 47.6
Tumour invades adjacent structures (T4) 490 10.0
Missing values 146 3.0
Regional lymph nodes (N)  
No regional lymph node metastasis (N0) 2143 43.9
Metastasis in 1 to 2 regional lymph nodes (N1) 1498 30.7
Metastasis in 3 to 6 (N2) 615 12.6
Metastasis in 7 or more (N3) 508 10.4
Missing values 118 2.4
aSa Scale  
Normal healthy patient 816 16.7
Mild systemic disease 2502 51.2
Severe systemic disease 1248 25.6
Life-threatening disease/ Moribund patient 60 1.2
Missing values 256 5.2
209
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HIStoloGy  
Adenocarcinoma 4336 88.8
Squamous cell carcinoma 420 8.6
Other carcinoma types 126 2.6
Predominant histology by cancer location  
Squamous cell carcinomas of the oesophagus  492 10.1
Adenocarcinomas of the upper and middle oesophagus 184 3.8
Adenocarcinomas of the lower third of the oesophagus and Siewert type 1 tumours  1906 39.0
Siewert type II and type III tumours  844 17.3
Tumours of the stomach  1456 29.8
level of socio-economic deprivation (ImD quintile)  
1 Least deprived 840 17.2
2 860 17.6
3 846 17.3
4 800 16.4
5 Most deprived 746 15.3
Missing values 790 16.2
Patient outcomes  
Anastomotic leak 305 6.2
30-day postoperative mortality 112 2.3
90-day postoperative mortality 216 4.4
*Mean
model performance and validation
The models AUC was of our primary interest as they present the models 
predictive ability. The discriminative ability was moderate for the mortal-
ity models (AUC 0.70 for the 30-day mortality and AUC 0.69 for the 90-day 
mortality outcome) and somewhat lower for the AL model (AUC=0.63). In-
ternally validated AUCs were 0.65 for the 30-day mortality model, 0.66 for 
the 90-day mortality model and 0.59 for the anastomotic leakage model, 
indicating some over fitting. 
model calibration
The scatter plots of predicted and observed probabilities showed that pa-
tients had an overall low risk for developing one of the three tested out-
comes. For example, patients in the highest risk decile for developing an 
AL had a risk below 0.2 on average in the overall cohort. The difference 
between observed and predicted risk for developing an AL was smaller 
than 0.1.
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Figure 1a,1b,1c. 30-day, 90-day mortality and anastomotic leakage model 
calibration by deciles of risk
30-day model callibration by risk deciles
90-day model callibration by risk deciles
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anastomic leakage model callibration by risk deciles
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Univariable analyses
In the following paragraphs odds ratio are presented to give an impression 
of the strength of the different predictors. However, our main aim is to give 
valid prediction and not valid estimates of the individual predictor effects.
 
The risk factor with the strongest association with all outcomes was the ASA 
grade (ASA grade 3 vs 1: 30-day mortality: OR=4.7 (95%CI=2.2-10); 90-day 
mortality: OR=5.0 (95%CI=2.8-8.8); AL: OR=1.4 (95%CI=1.0-2.0)). A greater 
number of comorbidities also increased the risk for all three outcomes (3 or 
more comorbidities vs.no comorbidities: 30-day mortality: OR 2.9 (95%CI: 
1.5-5.6); 90-day mortality: OR 3.0 (95%CI: 1.8-4.8); AL: OR 1.7 (95%CI; 1.0-2.7)). 
Further, patients with an ECOG performance status of 3 or higher had a 
threefold risk of dying within 30- or 90-days compared to patients with an 
ECOG performance status of 0. In contrast, female gender and cancer lo-
cated in the stomach compared to the oesophagus was associated with 
decreased risk of developing an AL (Table 3).
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table 3. Univariable logistic regression analyses for 30-day and 90-day mor-
tality and anastomotic leakage
Predictor 30-day 90-day anastomotic 
 mortality mortality leakage
 n=4882 n=4882 n=4882
 oR 95% CI oR 95% CI oR 95% CI
Age per decade, years 1.3* 1.1-1.6 1.3 1.1-1.5 1.0 0.9-1.1
Gender 
Male 1  1  1
Female 0.8 0.5-1.2 0.7 0.5-1.0 0.7 0.5-0.9
Comorbidity count
No comorbidities 1  1  1
One comorbidity 1.5 1.0-2.4 1.5 1.1-2.1 1.5 1.2-2.0
Two comorbidities 2.4 1.4-4.1 2.5 1.7-3.7 1.7 1.2-2.5
Three or more comorbidities 2.9 1.5-5.6 3.0 1.8-4.8 1.7 1.0-2.7
ECOG (WHO) performance status
Carries out all normal activity 1  1  1
Restricted but walks/does light work 1.2 0.7-1.8 1.3 1.0-1.9 0.9 0.7-1.2
Walks, full self-care but no work 1.7 1.0-3.0 2.1 1.4-3.1 0.8 0.5-1.2
Limited self-care – fully disabled 3.4 1.6-7.4 3.8 2.1-6.7 1.1 0.5-2.2
ASA Scale
Normal healthy patient 1  1  1
Mild systemic disease 1.8 0.9-3.9 2.3 1.3-4.0 1.0 0.7-1.4
Severe systemic disease 4.7 2.2-10.0 5.0 2.8-8.8 1.4 1.0-2.0
Life-threatening disease/ Moribund patient 7.1 2.1-24.4 8.7 3.5-21.6 0.8 0.2-2.7
Predominant histology by cancer location
Squamous cell carcinomas of the oesophagus 1  1  1
Adenocarcinomas of the upper and middle oesophagus 0.9 0.3-2.7 0.7 0.3-1.7 0.5 0.3-1.1
Adenocarcinomas of the lower third of the oesophagus and  0.9 0.5-1.6 1.0 0.6-1.6 0.7 0.5-0.9
Siewert type 1 tumours
Siewert type II and type III tumours 0.6 0.3-1.3 1.0 0.6-1.6 0.7 0.5-1.1
Tumours of the stomach 0.7 0.4-1.4 0.9 0.5-1.4 0.4 0.3-0.6
Histology
Adenocarcinoma 1  1  1
Squamous cell carcinoma 1.3 0.7-2.4 0.9 0.5-1.5 1.5 1.0-2.2
Other type 1.1 0.3-3.4 1.3 0.6-2.7 1.1 0.5-2.2 
Size and extent of primary tumour (T)
No evidence of primary tumour (T0) 1  1  1
Tumour invades lamina propria or submucosa (T1) 0.6 0.2-1.4 0.7 0.3-1.5 1.0 0.5-1.8
Tumour invades muscularis propria (T2) 0.8 0.3-1.9 1.2 0.6-2.6 0.9 0.5-1.7
Tumour invades adventitia (T3) 0.6 0.3-1.4 0.9 0.5-1.9 0.9 0.5-1.6
Tumour invades adjacent structures (T4) 0.7 0.3-1.7 1.5 0.7-3.2 0.7 0.4-1.4
Regional lymph nodes (N)
No regional lymph node metastasis (N0) 1  1  1
Metastasis in 1 to 2 regional lymph nodes (N1) 1.2 0.8-1.8 1.3 1.0-1.9 1.0 0.8-1.3
Metastasis in 3 to 6 (N2) 0.8 0.4-1.5 1.4 0.9-2.2 0.8 0.6-1.2
Metastasis in 7 or more (N3) 1.0 0.5-2.0 1.8 1.1-2.7 0.9 0.6-1.3
213
8
* Numbers in bold indicate significance
multivariable analyses
Predictors with a p-value of <0.1 in the univariable data analysis for 30-day 
mortality were patient age at diagnosis, the number of comorbidities, ECOG 
performance status and ASA score. Furthermore, for 90-day mortality, out-
come gender and regional lymph nodes (N) were identified as important 
predictors. For the anastomotic leakage model, the following predictors 
were chosen on basis of the univariable data analysis: gender, number of 
comorbidities, ASA score, histologic tumour type and tumour location. In 
consistency with previous studies and clinical expert opinion, the predictors 
gender, age, TNM stage, and ECOG performance status and predominant 
histology by cancer location and deprivation were entered into the multi-
variable models. 
Table 4 presents the results for the multivariable case-mix adjustment mod-
els. For 30-day mortality, comorbidity count and ASA grade were the stron-
gest predictors. A patient with an ASA grade of 4 or higher had an increase 
odds of 4.7 (95%CI 1.3-16.5) to die within 30-days compared to a patient 
with ASA grade 1. ASA grade was also the strongest predictor for the 90-day 
mortality outcome (ASA grade 4 or higher vs ASA grade 1 OR 5.1; 95% CI 2.0-
13.3). Other predictors significantly associated with the mortality outcomes 
were: age at diagnosis, and the number of comorbidities. 
The multivariable analysis for anastomotic leakage revealed that the num-
ber of comorbidities was strongly associated with the development of anas-
tomotic leaks (3 or more comorbidities vs. no comorbidities OR=1.7; 95% CI 
1.0-2.8). Further, patients with a tumour located in the stomach had a de-
creased of developing an AL (OR 0.4; 95% CI: 0.1-0.6). 
The model equations are presented in table 5.
 
Level of socio-economic deprivation (IMD quintile)
1 least deprived 1  1  1
2 0.8 0.5-1.4 0.7 0.4-1.1 0.9 0.6-1.3
3 0.6 0.3-1.1 0.8 0.5-1.2 0.8 0.6-1.2
4 0.8 0.4-1.4 0.8 0.5-1.3 0.6 0.4-0.9
5 most deprived 0.8 0.5-1.5 1.0 0.7-1.5 0.9 0.7-1.3
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table 4. Multivariable logistic regression for 30-day and 90-day mortality 
and anastomotic leakage
 30-day 90-day anastomotic
 mortality mortality leakage
 n=4882 n=4882 n=4882
 RoC 0.698 RoC 0.694 RoC 0.631
 Optimism  Optimism Optimism
 corrected* corrected corrected
Predictor ROC 0.646 ROC 0.664 ROC 0.587
 oR 95% CI oR 95% CI oR 95% CI
Age per decade, years  1.2 1.0-1.5 1.2 1.0-1.4 0.9 0.8-1.1
Gender
Male   1  1
Female   0.7 0.5-1.1 0.7 0.5-0.9
Comorbidity count 
No comorbidities 1  1  1
One comorbidity 1.3 0.8-2.1 1.3 0.9-1.9 1.5 1.1-2.0
Two comorbidities 1.8** 1.1-3.2 1.9 1.3-2.8 1.7 1.2-2.5
Three or more comorbidities 2.1 1.0-4.1 2.0 1.2-3.3 1.7 1.0-2.7
ASA Grade
I Normal healthy patient 1  1  1
II Mild systemic disease 1.6 0.7-3.5 1.9 1.1-3.4 1.0 0.7-1.4
III Severe systemic disease 3.5 1.6-7.8 3.5 1.9-6.3 1.4 1.0-2.1
IV Life-threatening disease/Moribund patient 4.7 1.3-16.5 5.1 2.0-13.3 0.8 0.2-2.8
ECOG (WHO) performance status
Carries out all normal activity 1  1  1
Restricted but walks/does light work 0.9 0.6-1.4 1.1 0.8-1.5 0.9 0.7-1.2
Walks, full self-care but no work 1.3 0.7-2.2 1.6 1.1-2.5 0.8 0.5-1.2
Limited self-care – fully disabled 1.8 0.8-4.1 2.3 1.3-4.3 1.0 0.5-2.0
Size and/or extent of the primary tumour (T)
No evidence of primary tumour (T0) 1  1  1
Tumour invades lamina propria or submucosa (T1) 0.5 0.2-1.3 0.7 0.3-1.4 1.1 0.6-2.0
Tumour invades muscularis propria (T2) 0.7 0.3-1.8 1.1 0.5-2.3 1.0 0.6-2.0
Tumour invades adventitia (T3) 0.5 0.2-1.2 0.7 0.3-1.4 1.0 0.5-1.8
Tumour invades adjacent structures (T4) 0.6 0.2-1.9 1.1 0.5-2.6 1.0 0.5-2.1
Predominant histology by cancer location
Squamous cell carcinomas of the oesophagus 1  1  1
Adenocarcinomas of the upper and middle oesophagus 1.0 0.3-2.8 0.6 0.2-1.6 0.5 0.2-1.0
Adenocarcinomas of the lower third of the oesophagus and  0.8 0.4-1.5 0.8 0.5-1.3 0.6 0.4-0.8
Siewert type 1 tumours
Siewert type II and type III tumours 0.5 0.2-1.1 0.7 0.4-1.2 0.6 0.4-0.9
Tumours of the stomach 0.5 0.3-1.0 0.5 0.3-0.8 0.4 0.1-0.6
Regional lymph nodes (N)
No regional lymph node metastasis N(0) 1  1  1
Metastasis in 1 to 2 regional lymph nodes N(1)  1.3 0.8-2.1 1.4 1.0-2.0 1.0 0.8-1.3
Metastasis in 3 to 6 N(3) 0.8 0.4-1.7 1.4 0.9-2.2 0.9 0.6-1.3
Metastasis in 7 or more N(4) 1.2 0.6-2.5 1.8 1.1-2.9 1.0 0.6-1.5
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Deprivation
1 Least deprived     1
2     0.9 0.6-1.3
3     0.8 0.6-1.1
4     0.6 0.4-0.9
5 most deprived     0.9 0.6-1.3
* ROC derived from bootstrapped sample (internal validation)
** Numbers in bold indicate significance
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table 5. Model equations for 30-day mortality, 90-day mortality and anas-
tomotic leakage
equation
Log(odds)= - 5.3205 + 0.0200 x (age) + 0.2984 x (one comorbidity) + 0.6168 x (two comorbidi-
ties) + 0.7318 x (three or more comorbidities) + 0.4760 x (ASA grade, mild systemic disease) + 
1.2677 x (ASA grade, severe systemic disease) + 1.5399 x (ASA grade, life threatening disease/
moribund patient) – 0.0971 x (ECOG performance status, restricted but walks/does light work) 
+ 0.2315 x (ECOG performance status, walks, full self-care but no work) + 0.6159 x (ECOG per-
formance status, limited self-care/fully disabled) - 0.6664 x (t, tumour invades lamina propria 
or submucosa) - 0.3077 x (t, tumour invades muscularis propria) - 0.6496 x (t, tumour invades 
adventitia) – 0.4202 x (t, tumour invades adjacent structures) + 0.2779 x (n, metastasis in 1 to 2 
regional lymph nodes) – 0.1897 x (n, metastasis in 3 to 6) + 0.1920 x (n, metastasis in 7 or more) 
- 0.0238 x (tumour location, adenocarcinomas of the upper and middle oesophagus) - 0.1957 
x (tumour location, adenocarcinomas of the lower third of the oesophagus and Siewert type 
I tumours) - 0.6097 x (tumour location, Siewert type II and type III tumours) - 0.6246 x (tumour 
location, tumours of the stomach)
Log(odds)= - 4.8534 - 0.0152 x (age) - 0.2884 x (female gender) + 0.0963x (one comorbidity) + 
0.6472 x (two comorbidities) + 0.7033 x (three or more comorbidities) + 0.6452 x (ASA grade, 
mild systemic disease) + 1.2431 x (ASA grade, severe systemic disease) + 1.6439 x (ASA grade, 
life-threatening disease/moribund patient) + 0.0963 x (ECOG performance status, restricted 
but walks/does light work) + 0.5003 x (ECOG performance status, walks, full self-care but no 
work) + 0.8491 x (ECOG performance status, limited self-care/fully disabled) – 0.4057 x (t, tu-
mour invades lamina propria or submucosa) + 0.0802 x (t, tumour invades muscularis propria) 
– 0.3967 x (t, tumour invades adventitia) + 0.1470 x (t, tumour invades adjacent structures) 
+ 0.3290 x (n, metastasis in 1 to 2 regional lymph nodes) + 0.3344 x (n, metastasis in 3 to 6) 
+ 0.5829 x (n, metastasis in 7 or more) - 0.4601 x (tumour location, adenocarcinomas of the 
upper and middle oesophagus) – 0.1990 x (tumour location, adenocarcinomas of the lower 
third of the oesophagus and Siewert type 1 tumours) – 0.3851 x (tumour location, Siewert type 
II and type III tumours) - 0.6925 x (tumour location, tumours of the stomach)
Log(odds)= - 1.8702 – 0.0041 x (age) – 0.3540 x (female gender) + 0.4164 x (one comorbidity) 
+ 0.5220 x (two comorbidities) + 0.5169 x (three or more comorbidities) - 0.0297 x (ASA grade, 
mild systemic disease) + 0.3451 x (ASA grade, severe systemic disease) – 0.1911 x (ASA grade, 
life-threatening disease/moribund patient) – 0.1031 x (ECOG performance status, restricted 
but walks/does light work) – 0.2274 x (ECOG performance status, walks, full self-care but no 
work) + 0.0049 x (ECOG performance status, limited self-care/fully disabled) + 0.0941 x (t, tu-
mour invades lamina propria or submucosa) + 0.0571 x (t, tumour invades muscularis propria) 
- 0.0119 x (t, tumour invades adventitia) + 0.0411 x (t, tumour invades adjacent structures) + 
0.0132 x (n, metastasis in 1 to 2 regional lymph nodes) – 0.1418 x (n, metastasis in 3 to 6) - 0.0188 
x (n, metastasis in 7 or more) - 0.7059 x (tumour location, adenocarcinomas of the upper and 
middle oesophagus) – 0.5504 x (tumour location, adenocarcinomas of the lower third of the 
oesophagus and Siewert type 1 tumours) - 0.4800 x (tumour location, Siewert type II and type 
III tumours) - 0.9781 x (tumour location, tumours of the stomach) - 0.1101 x (deprivation 2) -
0.2117 x (deprivation 3) – 0.5143 x (deprivation 4) -0.0692 x (deprivation 5 most deprived)
model
30-day 
mortality
90-day
mortality
anastomotic
leakage
(al)
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DISCUSSIoN
This study developed models for case-mix adjustment of postoperative out-
comes in oesophago-gastric (O-G) cancer patients undergoing curative 
resection. Our models are based on the largest contemporary patient co-
hort and exclusively based on data routinely available from the National 
Oesophago-Gastric Cancer Audit (NOCGA). Registries in other countries 
collect similar data items and may adopt the new risk models when pursu-
ing obligatory outcome reporting and comparison between providers, as it 
is the case in the NHS. 
ASA grade and the number of comorbidities were found to be the stron-
gest predictors for both short-term mortality and anastomotic leakage (AL). 
This is in line with previous literature that identified severely ill patients being 
more likely to have an increased morbidity risk 22, 23, 29, 38. Our three case-
mix adjustment models, based on routinely available data in the NHS, had 
similar predictive ability to the ones found in the literature. While model per-
formance might be improved by adding further clinical/laboratory based 
data items, we recommend against this for national comparisons. First, our 
review showed that the performance of models including complex clini-
cal/laboratory data (such as the POSSUM score) differed substantially, and 
second, these clinical data elements are not routinely available in Cancer 
Registries or through the NOGCA database. 
Other predictors identified in the literature include provider related variables 
such as choice of treatment and volume. But, as we aimed to develop a 
case-mix adjustment model to monitor outcomes between providers, fac-
tors that can be influenced by the provider, are not corrected for. For this 
reason, only those pre-operative factors were considered, which are found 
readily available in hospital databases and are not possible to be modified 
by the provider. The choice of variables might differ in a prognostic model 
which aims to predict risk in ‘new’ patients as opposed to a case-mix ad-
justment models which is usually used in retrospect on the data available. 
Taking into account patient characteristics that influence the postopera-
tive outcome when comparing performance across providers is necessary 
to ensure that true differences in performance rather than differences in 
patient characteristics are being assessed 39. Nevertheless, outcome differ-
ences must be interpreted with caution even after sufficient case-mix ad-
justment there might be remaining unmeasured confounders which influ-
ence the outcome. 
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Further, the question remains which indicator best reflects quality of surgi-
cal care. 30-days mortality rates are decreasing over time. While studies 
using data from the UK from 1990 and 2002 report an average postopera-
tive 30-day mortality rate of 11.4% 21, 36, a study using data from the period 
2005-2009 report a 4% 30-day mortality rate 37. In our study, using data from 
April 2011 to March 2013, the 30-day mortality rate was 2.3%. While his is a 
positive development for clinical practice, 30-day mortality rates become 
less useful as quality indicators because the estimated mortality rates per 
hospital are based on smaller numbers of cases and hence more uncer-
tain 39. Rates of 90-day mortality are higher and research showed that the 
causes of death at 90-days after surgery are still strongly associated with 
surgical performance 40-42. Deciding between measuring 30- or 90-day mor-
tality can be regarded as a trade-off: with shorter follow-up, the included 
deaths will be mostly related to the surgery, but later deaths will be missed. 
While with a longer follow up period later deaths are included, potentially at 
the expense of including deaths unrelated to the surgery. Anastomotic leak-
ages occur more frequently as well, which makes them attractive as quality 
indicator from a statistical point of view. The models for anastomotic leak-
age performed relatively poor. This is consistent with prior research which 
showed that postoperative complications are more difficult to predict on 
basis of patient characteristics than postoperative mortality 43. This raises 
the hypothesis that their occurrence is determined by the quality of surgical 
care and to a lesser extent by patient characteristics. Thus, for several rea-
sons anastomotic leakage rates seem a valuable quality indicator. Howev-
er, judging hospital quality based on one indicator is a simplistic approach 
that should not be advocated. Monitoring several outcome and process 
indicators together will probably provide the most global picture on hospital 
performance. This is particularly true where the indicator is based on self-
reported data (as in the case of anastomotic leak rates in this study, which 
should be interpreted in conjunction with return-to-theatre rates and inten-
sive care utilization). Nevertheless, , when comparing outcomes, case-mix 
adjustment is of crucial importance to make valid comparisons and avoid 
risk adverse behavior. We therefore aimed to develop the best possible risk 
adjustment model, although we recognize that some residual confounding 
will always remain and that also adjusted mortality rates should still be inter-
preted with caution.
A major strength of this study is its large, national representative, population-
based cohort. The use of audit data enabled the analysis of reliable, clini-
cal case mix adjustment information and robust outcome ascertainment 
by linking to the Office of National Statistics mortality data. Future studies 
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should address other routinely available information possibly influencing pa-
tient outcomes. A potential limitation of this study is that missing data were 
observed for some key variables and that the coding of complications is 
subject to coding differences, and potentially under-reporting, between 
NHS trusts.
In conclusion, we developed well performing case mix adjustment models 
based on routinely available data for predicting postoperative short-term 
mortality following O-G cancer surgery. These can be used for the risk ad-
justment in the assessment of hospital performance in the NHS or other large 
health systems. 
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Patients with primary diagnosis of O-G cancer 
between 1.4.2011 and 31.3.2013
n=22 766
aPPeNDIX
appendix 1. Flow chart patient inclusion process
Excluded patients without surgical treatment 
plan (either oncology or endoscopic treat-
ment only or best supportive care)
n= 17 199
Patients undergoing oesophagectomy or 
gastrectomy 
n= 5567
Excluded patients with palliative surgical 
intent (n=377) and non-curative procedure 
(open-and-shut or bypass procedure, n=217)
Patients with curative O-G resection 
n=4973
Excluded records with missing or incorrect 
consultant GMC codes
n=91
Patients with curative O-G resection included 
in the analysis
n=4882
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appendix 2. Summary of in-/excluded predictors for postoperative mortality 
(30-day, 90-day and in-hospital mortality) identified by literature review
 Risk predictors for 30 and 90 day mortality
Considered Patient Comorbidities tumour treatment Serum levels other
for inclusion characteristics  charac- process 
in model?   teristics
Yes Age; Comorbidity TNM stage;
 Patient  count
 performance  Congestive
 score; heart failure/
 ASA rating; peripheral
  vascular 
  disease/
  cardiac 
  disease;
  Pulmonary 
  comorbidity;
  (Insulin 
  dependent)
  Diabetes; 
  Renal 
  comorbidity;
No: Can be   Urgency of Neoadjuvant  ALa
influenced    operation; therapy;  Surgeon’s
by    Amount of  assessment
provider    blood loss;  on patients
    Incomplete  fit for 
    resection;  surgery; 
    Type of  Worse 
    operation;  swallowing 
    Postoperative  score;
    pulmonary 
    complications;
    Pneumonia
    Need for 
    transfusion
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No: Not  Alcohol Charlson score;   Forced expiratory POSSUM;b
routinely  consumption; Peripheral   volume in P-POSSUM; c
available in  (History of vascular   1 second <60%; O-POSSUM;d
clinical  previous)  disease;   Alkaline
datasets Smoking; Coronary   phosphatase
 Race; heart disease~   level more
 Steroid use; Coronary   than 125 U/L;
 Mid-arm  artery disease;   FEV1/FVC;
 circumference; Hypertension;   Physiological
 Number of  Hepatic   measurements
 stairs climbed; disease;   on admission to
  Ascites;   critical care:
     Partial pressure of 
     arterial oxygen 
     (PaO2): fraction 
     of inspired 
     oxygen (FiO2) 
     ratio; 
     Lowest 
     arterial pH;
     Creatinine; 
     Serum albumin;
     Urea; 
     Mechanical 
     ventilation; 
     Incentive 
     spirometry;
     Poor cardiac, 
     respiratory, 
     hepatic function;
No:       Hospital
Not       volume;
applicable       Palliative
for this study      resection;
      Year of 
      operation;
a Anastomotic leakage
b POSSUM (Physiological and Operative Severity Score for the enumeration of mortality and morbidity) in-
cludes the following variables: age(y), cardiac history, respiratory history, blood pressure, pulse rate, Glasgow 
coma score, haemoglobin (g/%), white cell count (X1012/L), urea, plasma sodium (mmol/l), plasma potas-
sium (mmol/l), electrocardiogram, operative severity, multiple procedures, total blood loss (ml), peritoneal 
soiling, presence of malignancy, mode of surgery 45
c P-POSSUM (Portsmouth-modified Physiological and Operative Severity Score for the enumeration of Mortal-
ity and morbidity) includes the following variables: age (y), Glasgow Coma Score, cardiac signs, respiratory 
signs, electrocardiography, systolic pressure (mm Hg), pulse rate(beats/min), haemoglobin level (g/dL), 
white blood cell count (X1012/L), urea level (mmol/L), sodium level(mmol/L), potassium level(mmol/L), surgical 
severity, multiple procedures, total blood loss, peritoneal soiling, presence of malignancy, mode of surgery 45
d O-POSSUM (Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity 
Oesophagogastric surgery) includes the following variables: age (y), Glasgow Coma Score, cardiac signs, 
respiratory signs, electrocardiography, systolic pressure (mm Hg), pulse rate(beats/min), haemoglobin level 
(g/dL), white blood cell count (X1012/L), urea level (mmol/L), sodium level(mmol/L), potassium level(mmol/L), 
surgical severity, multiple procedures, mode of surgery 45 
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appendix 3. Summary of in-/excluded predictors for postoperative complica-
tion/ anastomotic leakage identified by literature review
 Risk predictors for anastomotic leakage
Considered Patient Comorbidities tumour treatment process Serum levels other
for inclusion characteristics  charac-  
in model?   teristics
yes Age;  (Congestive) tumour
 ASA rating; Heart failure; stage;
 Decreased diabetes;
 functional Copd; a
 status; (Insulin
 Gender; dependent) 
  Diabetes;
  Coronary 
  (artery) 
  disease;
No: Can be    Surgical procedure type;
influenced     Additional organ
by provider    resection; 
    Procedure duration;
    Blood transfusion;
    Operation time;
No: Not  Race; Hypertension;  Forced expiratory  POSSUMc
routinely  Smoking status; (Peripheral)  volume in 1second   Increased
available  Steroid use; Vascular   <60% of predicted;  complexity
in clinical  Low BMI; b disease;  Alkaline phosphatase  score?
datasets Obesity; Dyspnoea;  level of more than
  Coronary   125 U/L;
  disease;   Lower serum albumin 
  Renal   concentration;
  insufficiency;  WCC (white cell count);  
    Post-operative CRP 
    (C reactive protein);
    FEV1/FVC;
No: Not       Year of
applicable       operation;
of this study
aChronic obstructive pulmonary disease
bBody mass index
c POSSUM (Physiological and Operative Severity Score for the enumeration of mortality and morbidity) in-
cludes the following variables: age(y), cardiac history, respiratory history, blood pressure, pulse rate, Glasgow 
coma score, haemoglobin (g/%), white cell count (X1012/L), urea, plasma sodium (mmol/l), plasma potassium 
(mmol/l), electrocardiogram, operative severity, multiple procedures, total blood loss (ml), peritoneal soiling, 
presence of malignancy, mode of surgery 45
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appendix 4. Descriptive statistics in the complete case analysis and in the im-
puted dataset
 Complete  Imputed
 dataset dataset
Year of operation
2012 2417 49.5 2417 49.5
2013 2465 50.5 2465 50.5
Age, years 4873 66.3* 4882 66.3*
Missing values 9 0.2  
Comorbidity count    
No comorbidities 2747 56.3 2747 56.3
One comorbidity 1311 26.8 1311 26.8
Two comorbidities 566 11.6 566 11.6
Three or more comorbidities 258 5.3 258 5.3
Gender    
Male 3 618 74.1 3 618 74.1
ECOG (WHO) performance status    
Carries out all normal activity 2519 51.6 2601 53.3
Restricted but walks/does light work 1557 31.9 1611 33.0
Walks, full self-care but no work 527 10.8 543 11.1
Limited self-care – fully disabled 120 2.5 127 2.6
Missing values 159 3.3  
Size and /or extent of the primary tumour (T)    
No evidence of primary tumour T(0) 202 4.2 205 4.2
Tumour invades lamina propria or submucosa T(1) 929 19.0 957 19.6
Tumour invades muscularis propria T(2) 792 16.2 820 16.8
Tumour invades adventitia T(3) 2323 47.6 2389 48.9
Tumour invades adjacent structures T(4) 490 10.0 511 10.5
Missing values 146 3.0  
Regional lymph nodes (N)    
No regional lymph node metastasis N(0) 2143 43.9 2182 44.7
Metastasis in 1 to 2 regional lymph nodes N(1) 1498 30.7 1544 31.6
Metastasis in 3 to 6 N(2) 615 12.6 634 13.0
Metastasis in 7 or more N(3) 508 10.4 522 10.7
Missing values 118 2.4  
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ASA Scale    
Normal healthy patient 816 16.7 866 17.7
Mild systemic disease 2502 51.2 2651 54.3
Severe systemic disease 1248 25.6 1301 26.6
Life-threatening disease/Moribund patient 60 1.2 64 1.3
Missing values 256 5.2  
Histology    
Adenocarcinoma 4336 88.8 4336 88.8
Squamous cell carcinoma 420 8.6 420 8.6
Other carcinoma types 126 2.6 126 2.6
Predominant histology by cancer location    
Squamous cell carcinomas of the oesophagus  492 10.1 492 10.1
Adenocarcinomas of the upper and middle oesophagus  184 3.8 184 3.8
Adenocarcinomas of the lower third of the oesophagus and  1906 39.0 1906 39.0
Siewert type 1 tumours
Siewert type II and type III tumours  844 17.3 844 17.3
Tumours of the stomach  1456 29.8 1456 29.8
Deprivation    
1 Least deprived 840 17.2 999 20.5
2 860 17.6 1047 21.4
3 846 17.3 999 20.5
4 800 16.4 942 19.3
5 Most deprived 746 15.3 895 18.3
Missing values 790 16.2  
Patient outcomes    
Anastomotic leak 305 6.2 305 6.2
30-day postoperative mortality 112 2.3 112 2.3
90-day postoperative mortality 216 4.4 216 4.4
*Mean
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appendix 5. Univariable analysis in the complete case analysis and in the im-
puted dataset
Predictor original dataset Imputed dataset
 30-day 90-day anastomotic 30-day 90-day anastomotic
 mortality mortality leakage mortality mortality leakage
 oR 95% CI oR 95% CI oR 95% CI oR 95% CI oR 95% CI oR 95% CI
Age per decade, years 1.3* 1.1-1.6 1.3 1.1-1.5 1.0 0.9-1.1 1.3** 1.1-1.6 1.3 1.1-1.5 1.0 0.9-1.1
Gender
Female 0.8 0.5-1.2 0.7 0.5-1.0 0.7 0.5-0.9 0.8 0.5-1.2 0.7 0.5-1.0 0.7 0.5-0.9
Comorbidity count
No comorbidities 1  1  1  1  1  1
One comorbidity 1.5 1.0-2.4 1.5 1.1-2.1 1.5 1.2-2.0 1.5 1.0-2.4 1.5 1.1-2.1 1.5 1.7-2.0
Two comorbidities 2.4 1.4-4.1 2.5 1.7-3.7 1.7 1.2-2.5 2.4 1.4-4.1 2.5 1.7-3.7 1.7 1.2-2.5
Three or more  2.9 1.5-5.6 3.0 1.8-4.8 1.7 1.0-2.7 2.9 1.5-5.6 3.0 1.8-4.8 1.7 1.0-2.7
comorbidities 
ECOG (WHO) 
performance status
Carries out all normal  1  1  1  1  1  1
activity
Restricted but walks/ 1.2 0.7-1.8 1.3 0.9-1.8 0.9 0.7-1.2 1.2 0.7-1.8 1.3 1.0-1.9 0.9 0.7-1.2
does light work
Walks, full self-care but  1.6 0.9-2.9 2.1 1.4-3.1 0.8 0.5-1.1 1.7 1.0-3.0 2.1 1.4-3.1 0.8 0.5-1.2
no work
Limited self-care –  3.7 1.7-8.1 3.7 2.0-6.8 1.1 0.6-2.3 3.4 1.6-7.4 3.8 2.1-6.7 1.1 0.5-2.2
fully disabled
ASA Scale
Normal healthy patient 1  1  1  1  1  1
Mild systemic disease 1.9 0.8-4.2 2.2 1.2-4.0 1.0 0.7-1.4 1.8 0.9-3.9 2.3 1.3-4.0 1.0 0.7-1.4
Severe systemic disease 5.0 2.3-11.1 5.0 2.8-9.0 1.4 1.0-2.0 4.7 2.2-10.0 5.0 2.8-8.8 1.4 1.0-2.0
Life-threatening disease/ 8.2 2.3-29.0 9.5 3.8-23.9 0.8 0.2-2.8 7.1 2.1-24.4 8.7 3.5-21.6 0.8 0.2-2.7
Moribund patient
Predominant histology by 
cancer location
Squamous cell carcinomas  1  1  1  1  1  1
of the oesophagus
Adenocarcinomas of the  0.9 0.3-2.7 0.7 0.3-1.7 0.5 0.3-1.1 0.9 0.3-2.7 0.7 0.3-1.7 0.5 0.3-1.1
upper and middle 
oesophagus
Adenocarcinomas of the  0.9 0.5-1.6 1.0 0.6-1.6 0.7 0.5-0.9 0.9 0.5-1.6 1.0 0.6-1.6 0.7 0.5-0.9
lower third of the 
oesophagus and Siewert 
type 1 tumours
Siewert type II and type III  0.6 0.3-1.3 1.0 0.6-1.6 0.7 0.5-1.1 0.6 0.3-1.3 1.0 0.6-1.6 0.7 0.5-1.1
tumours
Tumours of the stomach 0.7 0.4-1.4 0.9 0.5-1.4 0.4 0.3-0.6 0.7 0.4-1.4 0.9 0.5-1.4 0.4 0.3-0.6
Histology
Adenocarcinoma 1  1  1  1  1  1
Squamous cell 1.3 0.7-2.4 0.9 0.5-1.5 1.5 1.0-2.2 1.3 0.7-2.4 0.9 0.5-1.5 1.5 1.0-2.2
Other carcinoma type 1.1 0.3-3.4 1.3 0.6-2.7 1.1 0.5-2.2 1.1 0.3-3.4 1.3 0.6-2.7 1.1 0.5-2.2
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Size and/or extent of the 
primary tumour (T)
No evidence of primary  1  1  1  1  1  1
tumour T(0)
Tumour invades lamina  0.6 0.2-1.4 0.7 0.3-1.7 1.0 0.5-1.8 0.6 0.2-1.4 0.7 0.3-1.5 1.0 0.5-1.8
propria or submucosa T(1)
Tumour invades muscularis  0.8 0.3-1.9 1.2 0.6-1.6 0.9 0.5-1.6 0.8 0.3-1.9 1.2 0.6-2.6 0.9 0.5-1.7
propria T(2)
Tumour invades 0.6 0.3-1.4 0.9 0.6-1.6 0.9 0.5-1.6 0.6 0.3-1.4 0.9 0.5-1.9 0.9 0.5-1.6 
adventitia T(3)
Tumour invades adjacent  0.7 0.3-1.8 1.5 0.5-1.4 0.7 0.4-1.5 0.7 0.3-1.7 1.5 0.7-3.2 0.7 0.4-1.4
structures T(4)
Regional lymph nodes (N)
No regional lymph node  1  1  1  1  1  1
metastasis N(0)
Metastasis in 1 to 2 regional  1.2 0.8-1.9 1.3 1.0-1.9 1.0 0.8-1.3 1.2 0.8-1.8 1.3 1.0-1.9 1.0 0.8-1.3
lymph nodes N(1)
Metastasis in 3 to 6 N(2) 0.7 0.4-1.4 1.4 0.9-2.1 0.8 0.6-1.2 0.8 0.4-1.5 1.4 0.9-2.2 0.8 0.6-1.2
Metastasis in 7 or more N(3) 1.0 0.5-1.9 1.7 1.1-2.7 0.8 0.6-1.3 1.0 0.5-2.0 1.8 1.1-2.7 0.9 0.6-1.3
Deprivation           
1 Least deprived 1  1  1  1  1  1
2 1.1 0.6-1.9 0.8 0.5-1.2 0.9 0.6-1.4 0.8 0.5-1.4 0.7 0.4-1.1 0.9 0.6-1.3
3 0.6 0.3-1.3 0.8 0.5-1.2 0.8 0.5-1.2 0.6 0.3-1.1 0.8 0.5-1.2 0.8 0.6-1.2
4 0.8 0.4-1.5 0.7 0.4-1.2 0.7 0.4-1.0 0.8 0.4-1.4 0.8 0.5-1.3 0.6 0.4-0.9
5 Most deprived 1.1 0.6-2.0 1.2 0.8-1.8 0.9 0.6-1.4 0.8 0.5-1.5 1.0 0.7-1.5 0.9 0.7-1.3
* Numbers in bold indicate significance 


Chapter 9.
the validity of 
quality indicators for 
oesophago-gastric 
cancer surgery
Claudia Fischer, Hester F lingsma, Niek S Klazinga, Richard Hardwick, 
David Cromwell, ewout W Steyerberg, oliver Groene
This article is submitted. 
Volume-outcome revisited: the effect of hospital and surgeon volumes on 
multiple outcome measures in oesophago-gastric cancer surgery.
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aBStRaCt
Background: Most studies that found a volume outcome effect in resection 
surgery for oesophago-gastric cancer were conducted before the centrali-
sation of clinical services and reflect a higher baseline risk of surgery that ex-
ists today. This study evaluated the relation between hospital- and surgeon 
volume and different risk-adjusted outcomes after curative oesophago-
gastric (OG) cancer surgery in England between 2011 and 2013. 
methods: Multivariable random-effects logistic regression models were used 
to quantify the effect of surgeon and hospital volume on three outcomes: 
30-day and 90-day mortality and anastomotic leakage. The between-clus-
ter heterogeneity was estimated with the median odds ratio (MOR).
Results: The study included patients treated at 42 hospitals and 329 surgeons. 
Higher hospital volume was associated with lower 30-day mortality (OR: 0.94; 
95% CI: 0.91-0.98) and lower anastomotic leakage rates (OR: 0.96; 95% CI: 
0.93-0.98) but not 90-day mortality. Higher surgeon volume was only associ-
ated with lower anastomotic leakage rates. Hospital volume explained a 
part of the between-hospital variation in 30-day mortality whereas surgeon 
volume explained part of the between-hospital variation in anastomotic 
leakage.
Conclusions: In the setting of centralized O-G cancer surgery in England, we 
could still observe an effect of volume on short-term outcomes. However, 
the effect is inconsistent, depending on the type of outcome measure un-
der consideration, and much smaller than in previous studies. Efforts to cen-
tralise O-G cancer services further should carefully address the effects of 
both hospital and surgeon level on outcomes, and their effects on a range 
of outcome measures that are relevant to patients.
Keywords: oesophago-gastric cancer surgery, hospital volume, surgeon vol-
ume, postoperative mortality, complications
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INtRoDUCtIoN
For many surgical procedures, patient outcomes have been found to be 
related to surgical volume (the number of procedures that is performed in 
a specific unit), with studies typically showing that higher volumes are as-
sociated with lower postoperative mortality 1. As a result, the centralization 
of high-risk oncological services, including oesophago-gastric cancer (O-G 
cancer), is occurring in many countries 2-6. In the United States, the Leapfrog 
Group, a consortium of leading employers and private health care experts 
has set a minimum volume threshold of 13 O-G cancer resections per hospi-
tal per year 7, 8. In the Netherlands, a minimum of 20 O-G cancer resections 
per year has been recently introduced 9. In the UK, the Department of Health 
published a recommendation to centralize curative surgical services into 
specialised cancer centres in 2001 10 and it is recommended that surgeons 
perform a minimum of 15 – 20 annual resections 11. As a consequence, a pro-
cess of reorganization has taken place in the National Health Services (NHS) 
during the past decade, which has resulted in a smaller number of acute 
trusts (hospital organisations) doing this type of surgery.
In O-G cancer surgery, risk-adjusted postoperative mortality and compli-
cation rates are widely used as quality indicators 12. Case volume has also 
been proposed as a marker for quality in the past because of the substan-
tial evidence of a volume-outcome relationship 13. However, past studies 
were based on much higher baseline mortality rates than those observed in 
current practices. For example, a study from the UK based on patient data 
from 1990 to 2002 reported an average 30-day postoperative mortality rate 
of 11.4% 14. Another study, using more recent data, reported a 30-day mor-
tality rate of 4% 15. It is unclear whether under these circumstances a vol-
ume-outcome relationship is still detectable given that, in a centralized set-
ting, all trusts may exceed recommended thresholds. In addition, the exact 
mechanism behind the volume-outcome relation is still not fully understood 
16, 17. It is suggested that both the experience of the surgeon and the com-
plete hospital team contribute to surgical outcomes 13. An exploration of this 
mechanism is of importance because there is an increasing trend in report-
ing not only hospital-level, but also surgeon-level volume and outcomes. 
Finally, there are more outcomes of interest for O-G cancer surgery than the 
commonly used 30-day mortality. Recent publications suggest that anasto-
motic leakage rates and 90-day postoperative mortality are also important 
in assessing the quality of surgical care 18-22. 
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This study was undertaken to examine the relation between hospital- and 
surgeon volume and different risk-adjusted outcomes after O-G cancer sur-
gery in a setting of centralized care, and the between-hospital and surgeon 
differences in outcome.
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metHoDS
Data
We used data submitted to the National Oesophago-Gastric Cancer Audit 
(NOGCA), which evaluates the care delivered by all (n=154) English hospi-
tals that provide care to adults diagnosed with invasive, epithelial cancer of 
the oesophagus or stomach. Data are collected prospectively by hospital 
staff and have been submitted to the audit since 1 April 2011. Details on the 
audit method and dataset have previously been published 23. All patients 
undergoing curative surgery between 1 April 2011 and 31 March 2013 were 
included in the study. We excluded patient undergoing curative oncologi-
cal treatment for squamous cell carcinoma and all palliative patients. Fur-
ther, we excluded hospitals which operated on less than 10 patients (Ap-
pendix 1). 
Predictors and outcomes
We considered three outcomes: 30-day mortality, 90-day mortality and 
anastomotic leakage. Mortality was defined as all-cause postoperative 
mortality within 30 or 90 days after surgery. Date of death was obtained 
from the Office for National Statistics death certificate register. Anastomotic 
leakage was defined as severe disruption to the anastomosis, irrespective of 
whether detected clinically or radiologically, and irrespective of whether it 
is managed conservatively or by re-operation 24. 
Pre-operative patient and tumour characteristics to be used for case-mix 
adjustment were based on prior research. All regression models included: 
comorbidity count, age, ASA score, ECOG (WHO) performance status, T 
stage, N stage, cancer location. Patient gender was also included in the 
models for the outcomes 90-day mortality and AL, and deprivation was in-
cluded in the AL model. Distinct domains of deprivation, such as income 
deprivation, employment deprivation, health deprivation and disability are 
weighted and combined into a single overall deprivation score. This score 
is used to rank areas in England according to their inhabitants score on the 
combined deprivation score 12, 25. We analysed hospital and surgeon vol-
ume. Hospital was defined as NHS trust, which is a division within the English 
NHS that can consist of up of up to five hospitals. Usually O-G cancer surgery 
is only performed in one hospital in the trust. Surgeon was defined as the 
principal operating surgeon.
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Hospital volume was defined as the number of O-G cancer surgeries per-
formed at a NHS trust per year. Surgeon volume was defined as the annual 
number of operations conducted by an individual surgeon.
 
Statistical analysis
Patient characteristics were described as means or percentages. We de-
scribed surgeon and hospital volume in the study period with median vol-
ume per hospital/surgeon. To describe outcome differences, we divided 
the hospitals/surgeons in quartiles based on volume and presented the out-
come rates for each volume quartile. 
The effect of hospital and surgeon volume on the three patient outcomes 
was tested in multivariable case-mix adjusted logistic regression models, 
with volume added as a continuous variable. We tested whether the re-
lationship between volume and the outcomes was non-linear by adding 
squared terms and comparing these with linear terms based on the chi-
square statistic.
We assessed differences in mortality and anastomotic leakage rates be-
tween hospitals with random effects models, which are considered appro-
priate for analyses of outcome differences between centres because they 
can account for correlation between patients within hospitals 26. First, we 
analysed between hospitals and surgeons differences without any adjust-
ment. This random effects model includes two random intercepts: one for 
hospital and one for surgeon and no other covariates. The variance of the 
random intercepts represents the between hospital/surgeon variation with-
out any adjustment, but taking into account the random variation. In the 
second model the case-mix adjustment variables were added as covari-
ates, to adjust the between hospital/surgeon variation for differences in pa-
tient characteristics. In a next step, we added surgeon and hospital volume 
one by one as covariates. In a final step, we included both surgeon and 
hospital volume. 
In random effects models the between hospital/surgeon variation is reflect-
ed in the variance of the random intercepts (τ2). We used the median odds 
ratio (MOR) to quantify this variation. The MOR is a direct function of τ2 (MOR 
= exp ( √ 2 x τ2 x Φ–1 (0.75)) 27. The MOR can be equal or greater than 1, 
an MOR of 1 reflects no variation between the hospitals. The larger the be-
tween-hospital variation, the higher the MOR will be 27. 
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There were no missing values in patient outcomes. Missing data in predictors 
were imputed using a ‘multiple imputation by chained equations’ model in-
cluding the outcome measures and the independent variables deprivation, 
age at diagnose, ECOG performance status, ASA score, gender, tumour 
location, number of comorbidities, size and/or extent of the primary tumour 
(T), regional lymph nodes (N). Imputation and statistical analysis were per-
formed Stata software, version 11(StataCorp.2009.Stata Statistical Software: 
Release: 11) and in R statistical software 2.7.2 using the Hmisc, the lm4 and 
rms packages (R Foundation for Statistical Computation, Vienna) Syntax 
code for R is provided in Appendix 2.
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ReSUltS
Descriptives 
The study included 4868 patients treated at 42 hospitals and 329 surgeons. 
Patients had a mean age of 66 years and the majority were male (n=3610; 
74%). Fifty six percent of patients had no recorded co-morbidities (n=2735). 
Most patients scored an ECOG performance score of 0 (carries out all nor-
mal activity) (n=2515; 52%) or 1 (restricted but walks/does light work) (n=1550; 
32%). The majority of the patients had a T stage of 3 (Tumour invades adven-
titia) (n=2318; 48%) and an ASA score of 2 (mild systemic disease) (n=2498; 
51%). The majority of patients had an adenocarcinoma of the lower third 
of the oesophagus and a Siewert type 1 tumour (n=1904; 39%). Overall, 30-
day mortality was 2.3% (n=111), 90-day mortality was 4.4% (n=215), and 6.3% 
(n=305) of the patients developed an anastomotic leakage (AL).
Variation on surgeon and hospital level
Volume varied between both surgeons and hospitals. The median hospital 
volume was 55 patients per year, with an interquartile range of 41 and 68 
(Figure 1a). Many surgeons did not perform the recommended minimum of 
15-20 annual resections. The median surgeon operated 6 patients per year, 
and the interquartile range was 4 and 9 (Figure 1b).
table 1. Characteristics of the patients included in the study
Patient and prognostic information No. of patients %
age, years  4859 66*
Missing values 9 0.2
Comorbidity count  
No comorbidities 2735 56.2
One comorbidity 1309 26.9
Two comorbidities 566 11.6
Three or more comorbidities 258 5.3
Gender  
Male 3610 74.2
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eCoG (WHo) performance status  
Carries out all normal activity 2515 51.7
Restricted but walks/does light work 1550 31.8
Walks, full self-care but no work 526 10.8
Limited self-care - fully disabled 120 2.5
Missing values 157 3.2
Size and/or extent of the primary tumour (t)  
No evidence of primary tumour T(0) 202 4.1
Tumour invades lamina propria or submucosa T(1) 927 19.0
Tumour invades muscularis propria T(2) 790 16.2
Tumour invades adventitia T(3) 2318 47.6
Tumour invades adjacent structures T(4) 489 10.0
Missing values 142 2.9
Regional lymph nodes (N)  
No regional lymph node metastasis N(0) 2137 43.9
Metastasis in 1 to 2 regional lymph nodes N(1) 1496 30.7
Metastasis in 3 to 6 N(2) 614 12.6
Metastasis in 7 or more N(3) 507 10.4
Missing values 114 2.3
aSa Scale  
Normal healthy patient 811 16.7
Mild systemic disease 2498 51.3
Severe systemic disease 1246 25.6
Life-threatening disease/ Moribund patient 60 1.2
Missing values 253 5.2
Cancer location  
Squamous cell carcinomas of the oesophagus  491 10.1
Adenocarcinomas of the upper and middle oesophagus  183 3.8
Adenocarcinomas of the lower third of the oesophagus and Siewert type 1 tumours  1904 39.1
Siewert type II and type III tumours  840 17.3
Tumours of the stomach  1450 29.8
Deprivation  
1 Least deprived 838 17.2
2 859 17.6
3 844 17.3
4 799 16.4
5 Most deprived 745 15.3
Missing values 783 16.1
*Mean
243
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Figure 1ab. Hospital volume (1a), surgeon volume (1b)
Median hospital volume = 55
Interquartile range = 41 - 68
Median surgeon volume = 6
Interquartile range = 4 - 9
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The descriptive analysis of outcomes by quartiles of hospital volume and 
surgeon volume showed an overall lower risk for all outcomes in the high-
est volume quartiles compared to the lowest volume quartiles (Table 2). For 
example, 30-day mortality was 3.0% in the lowest hospital volume quartile 
compared 1.3% in the highest quartile. The anastomotic leakage risk was 
7.9% in the lowest average annual surgeon volume quartile compared to 
the highest quartile, in which the risk for anastomotic leakage was 1.3%.
table 2. 30-day, 90-day mortality and anastomotic leakage risk according 
to quartiles of hospital volume and surgeon volume
  average hospital volume  average surgeon volume
 Total Q 1 Q 2 Q 3 Q 4 Q 1 Q 2 Q 3 Q 4
  (0-49) (50-65) (66-91) (92-148) (0-5) (6-9) (10-13) (14-28)
N  1,253 1,148 1,360 1,107 1,144 1,156 1,292 1,169
30-day  2.3 3.0 3.1 1.7 1.3 2.4 2.3 2.6 0.7
mortality, %
90-day  4.4 5.0 5.0 3.8 3.9 4.5 5.4 4.0 1.4
mortality, %
anastomotic  6.3 7.1 8.9 6.3 2.5 7.9 7.1 4.6 1.3
leakage,%
table 3. Association between adjusted volume predictors and the outcomes 
30-day mortality, 90-day mortality and anastomotic leakage
 30-day  90-day  anastomotic  
 mortality mortality leakage
 oR 95%CI oR 95%CI oR 95%CI
Surgeon volume*
Adjusted for case-mix 1.03 0.84-1.25 1.01 0.87- 1.16 0.88 0.78-1.00
Adjusted for case-mix and hospital volume 0.92 0.76-1.12 0.97 0.85-1.11 0.81 0.72-0.92
Hospital volume*
Adjusted for case-mix 0.94 0.91-0.98 0.98 0.96-1.00 0.95 0.93-0.97
Adjusted for case-mix and surgeon volume 0.94 0.91-0.98 0.98 0.96-1.01 0.96 0.93-0.98
* ORs represent the effect of 5 extra patients per year
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Higher hospital volume was a significant predictor for lower 30-day mor-
tality, after adjustment for case-mix and surgeon volume (OR: 0.94 (95%CI: 
0.91-0.98) per increase of 5 patients per year) (table 3). Surgeon volume had 
no significant effect on 30-day mortality. Higher surgeon and higher hos-
pital volume were independent predictors of lower risk of an anastomotic 
leakage (hospital volume OR: 0.96 (95%CI: 0.93-0.98), surgeon volume: OR: 
0.88 (95% CI: 0.78-1.00). Neither hospital volume nor surgeon volume were 
significant predictors for 90-day mortality when controlling for each other 
(Table 3).
Hospital volume explained part of the variation in 30-day mortality between 
the hospitals. The median odds ratio (MOR) decreased from 1.38 without 
controlling for hospital volume in the model to 1.30 when hospital and sur-
geon volume were added to the models as covariates (Figure 2). The MOR 
represents the odds of dead within 30 days of a patient from a randomly 
selected hospital compared to the odds if he/she would go to another ran-
domly selected hospital. In this model the MOR represents outcome differ-
ences between centres, after taking into account the random variation, 
differences in patient characteristics and that patients were treated by sur-
geons and hospitals with varying procedure volumes. Differences between 
hospitals in this model thus may be due to quality of care related factors, 
other than volume. Surgeon volume did not explain between-hospital or 
between-surgeon variation in 30-day mortality (Figure 2, Figure 3). 
Hospital volume explained more of the between-surgeon variation in anas-
tomotic leakages (change in MOR from 1.67 to 1.56) (Figure 2). The other 
way around, surgeon volume explained a very small part of the variation 
between hospitals (change in MOR from 1.29 to MOR 1.27) (Figure 3) (Ap-
pendix 3).
While hospital volume explained a minimal amount of between-hospitals 
variation in 90-day mortality, surgeon volume did not explain any variation 
in 90-day mortality at all (Figure 2, Figure 3). 
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Figure 2. Between-hospital variation in outcomes
Figure legend: Change in median odds ratio (MOR) on hospital level considering different case mix and pre-
diction factors for 30-day, 90-day mortality and anastomotic leakage
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90-day
mortality
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1,2
1
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Figure 3. Between-surgeon variation in outcomes
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Figure legend: Change in median odds ratio (MOR) on surgeon level considering different case mix and pre-
diction factors for 30-day, 90-day mortality and anastomotic leakage
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DISCUSSIoN
Main findings
This study has shown that despite centralization, differences between hos-
pitals and surgeons in patient outcomes after O-G surgery still exist in Eng-
land. These between-hospital and between-surgeon differences are partly 
explained by surgeon and hospital volume but the volume outcome rela-
tion is different for the different outcomes (30-day and 90-day mortality and 
anastomotic leakage). Higher hospital volume was associated with lower 
30-day mortality, but high surgeon volume was not. Neither hospital volume 
nor surgeon volume affected 90-day mortality. Higher surgeon and hospi-
tal volume were both associated with fewer anastomotic leakages, but sur-
geon volume was the stronger predictor. 
Volume-outcome relation 
Higher volume hospitals have lower 30-day mortality rates; this in line with 
earlier research in both O-G cancer and other surgical oncological proce-
dures 3, 28. However, no clear definition of ‘high volume’ exists yet 29. A recent, 
study on patients undergoing oesophagectomy in the Netherlands showed 
that increasing annual hospital volume was associated with a nonlinear de-
crease in mortality up to 40-60 oesophagectomies, after that a plateau was 
reached 30. This finding was not replicated in our data: we found a linear 
relationship while the majority of hospitals treated more than 50 patients. 
Despite the centralization that took place in the UK, we still found an effect 
of volume. 
In contrast, we did not find surgeon volume to be a significant predictor 
of 30-day mortality. Surgeon volume and hospital volume possibly reflect 
different aspects of quality of care. It has been suggested that next to the 
surgeon skills there are other hospital factors in high volume hospitals that 
reduce mortality risk, such as post-operative care, care pathways and mul-
tidisciplinary team work 31-34. 
Surgical volume and hospital volume had only a minor effect on 90-day 
mortality. Although still a substantial amount of patients dies between 30- 
and 90-days after surgery, their death seems not to be influenced by the 
surgeon or hospital volume. Previous research showed that although part 
of the deaths occurring after 30 days is still related to surgery, and increas-
ing proportion related to cancer recurrence 19. Both, higher surgeon and 
hospital volume showed to be related to fewer anastomotic leakages, but 
surgeon volume had a stronger effect. It can be imagined that anastomotic 
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leakages are closely related to technical surgical skills that high volume sur-
geons have better developed. 
When calculating surgeon volume for highly complicated but rare proce-
dures, it has been suggested to count also related procedures 35. In our study 
we had no data to take into account other operations as O-G resections. 
We could however capture surgeries that were performed by one surgeon 
in different centres. This is especially important when some surgeons oper-
ate in multiple hospitals and others do not. 
Recommendations
In different countries different volume norms are used, which is the reflec-
tion of mixed scientific evidence. We found that even in the centralized UK 
setting there is a relation between volume and 30-day mortality and anas-
tomotic leakages. This finding suggests that further increasing hospital vol-
umes, and to a lesser extent surgeon volumes, might improve short-term out-
comes. However, on-going centralization might also have negative effects 
on for example access and equity, which we did not study. 
We studied different outcomes that are used as quality indicators. Anasto-
motic leakages (AL) rates were affected by hospital volume. This is in line with 
previous findings that surgical complications seem to be a good indicator 
for surgical quality as they are closely related to the surgical process and are 
not so much influenced by patient characteristics 12, 36, 37. This makes AL rates 
‘actionable’ hospital quality indicators. Apart from the clinical relevance, 
the relatively frequent occurrence makes them attractive as a quality indi-
cator from a statistical point of view, as rates per hospital can be estimated 
relatively certain. A large disadvantage of complications as an outcome 
indicator is their possibly unclear definition, especially compared to mortal-
ity. Different definitions of complications, or a different interpretation of the 
same definition, may lead to biased hospital comparisons 38.
Adjusted 30-day mortality differences between hospitals were partly ex-
plained by hospital volume. However, a large disadvantage of this measure 
is the low event rate. Even in our data pooled from two years, the absolute 
numbers of deaths within 30-days per hospital were small (median absolute 
number per hospital = 2), which makes the estimates per hospital uncertain 
and challenges the comparison between hospitals 39, 40. 
In that sense 90-day mortality rate is more attractive as more deaths oc-
cur. However, 90-day mortality differences between hospitals were not ex-
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plained by hospital volume. Possibly the 90-day mortality rates might reflect 
aspects of quality of care not related to volume. But we consider it is more 
likely that a longer time period introduces effects of confounding factors 
that dilute the relation between quality of care and outcome. Previous re-
search showed the ‘ideal’ timeframe to measure quality of O-G cancer 
surgery lies somewhere between 30 and 90 days 21. In all, always multiple 
indicators should be monitored as this gives a more comprehensive picture 
and hospitals often do not score good or bad on all indicators 41. 
Next to variation between hospitals, we did observe variation in outcome 
between surgeons. But these were not explained by any of the volume indi-
cators. In addition, the absolute numbers of deaths of ALs per surgeon are 
extremely low, which makes outcome rates per surgeon unsuitable as qual-
ity indicators: the difference between 0 or 1 death per year cannot tell us 
anything about quality, only about bad luck. 
In summary, in the setting of centralized O-G cancer surgery in England, we 
could still observe an effect of hospitals volume on 30-day mortality and AL 
rates, suggesting that further centralization might be considered based on 
our data. However, the effects are much weaker and less consistent than 
those observed in previous research. Surgeon volume only affected AL rates, 
so represents only part of the surgical process. AL rates and 30-day mortality 
rates per hospital could be useful as quality indicators, but both have their 
own large disadvantage: definition problems for AL and low frequency for 
mortality. 90-day mortality likely reflects other things than the quality of sur-
gery and thus is less suitable as a quality indicator. Surgeon level outcomes 
are very infrequent and volume did not explain the differences.
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Patients with primary diagnosis of OG cancer 
between 1.4.2011 and 31.3.2013
n=22,766
aPPeNDIX
appendix 1. Flow chart patient inclusion process inclusion process
Excluded patients without surgical treatment 
plan (either oncology or endoscopic treat-
ment only or best supportive care)
n= 17403
Patients undergoing oesophagectomy or 
gastrectomy = 5567
Excluded patients with palliative surgical 
intent (n=377) and non-curative procedure 
(open-and-shut or bypass procedure, n=217)
n= 594
Patients with curative oesphago-gastric 
resection 
n=4973
Excluded records with missing or incorrect 
consultant GMC codes
n=91
Patients with curative oesphago-gastric 
resection included in the analysis
n=4882
Excluded hospitals, which operated on less 
than 10 patients (n = 10)
n= 14
Patients with curative oesphago-gastric 
resection included in the analysis
n=4868
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appendix 2.
R code 
#load required packages
library(lm4) #fits random effect logistic regression models
library(foreign) #can import foreign data files
#Import STATA datafile
MyData <- read.dta(“S:/MyDocuments/……………..dta”, convert.dates=TRUE, 
convert.factors=TRUE, missing.type=TRUE, convert.underscore=TRUE)
#Random effects model with 30-day mortality as outcome, patient character-
istics, surgeon and #hospital volume as covariates, and two random effects: 
one for surgeon and one for hospital #(Figure 1, Figure 2, outcome 30-day 
mortality bar group, last bar)
MyModel <- glmer(30day.mortality ~ volume.surgeon + volume.hospital + 
age + as.factor(comorbidity) + as.factor(performancestatus) + as.factor(t)+ 
as.factor(n) + as.factor(asa)+ as.factor(tumour.location) + (1| surgeon) + 
(1|hospital), data=MyData, family=binomial)
#moR between surgeons 
exp(0.674*(sqrt(as.numeric(VarCorr(MyModel)[[1]])))) 
#moR between hospitals
exp(0.674*(sqrt(as.numeric(VarCorr(MyModel)[[2]])))) 
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appendix 3. table 1. Between surgeon and between-hospital variation in 30-
day, 90-day mortality and anastomotic leakage
 Unadjusted adjusted for  adjusted for adjusted for adjusted for
  patient  patient patient patient
  characteristics characteristics and characteristics and characteristics,
   hospital volume surgeon volume surgeon and
     hospital volume
 moR* moR moR moR moR
30-day mortality
Combined  1.48 1.42  1.46 1.43
between surgeons (1-2.93) (1-2.87)  (1-2.91) (1-2.88)
Combined  1.33 1.38 1.26  1.30
between hospitals (1-1.81) (1 – 1.86) (1 – 1.74)  (1 – 1.78)
90-day 
mortality
Combined  1.41 1.36  1.37 1.37
between surgeons (1-1.81) (1 – 1.76)  (1 – 1.77) (1 – 1.77)
Combined  1 1.14 1.08  1.11
between hospitals (1-1.55) (1 – 1.69) (1 – 1.63)  (1 – 1.66)
anastomotic 
leakage
Combined  1.29 1.29  1.27 1.27
between surgeons (1-1.71) (1 – 1.71)  (1 – 1.69) (1 – 1.69)
Combined  1.66 1.67 1.61
between hospitals (1.63-2.01) (1.64 – 2.02) (1.58 – 2.02)
*Median odds ratio (95% Confidence Interval)


Part IV
Discussion and summary

Chapter 10.
General discussion
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GeNeRal DISCUSSIoN
Hospital quality indicators are widely implemented for purposes such as in-
creasing accountability and transparency as well as achieving the overarch-
ing goal of quality improvement. However, it is not clear whether currently 
used hospital quality indicators actually reflect quality of care.1 The aim of 
this thesis was to expand our knowledge on how to measure quality of hospi-
tal care, particularly with regard to its use for external comparison. We spe-
cifically investigated reliability and validity, as these are key aspects of qual-
ity indicators.2 For reliability we focused on data quality, indicator definitions 
and statistical uncertainty. For validity we focused on case-mix correction. 
 
The specific research questions were:
Which aspects of data quality affect the reliability of quality indicators 
for hospital care? 
How clear are the definitions of currently used quality indicators for hos-
pital care?
To what extent does statistical uncertainty affect the reliability of out-
come indicators for surgical colon and oesophago-gastric cancer 
care? 
To what extent does case-mix correction affect the validity of outcome 
indicators for surgical colon and oesophago-gastric cancer care?
For research question 1 and 2 we studied the data underlying Dutch na-
tional indicators (DHTP (Dutch Health Transparency Program), in the time 
period 2008/09) and performed a literature study on readmission rates. We 
found that administrative data is usually suboptimal for calculating qual-
ity indicators for external purposes, such as pay for performance schemes. 
Data quality problems include heterogeneous data information systems, in-
accurately registered data (e.g. estimated instead of calculated indicator 
scores), and incomplete data (e.g. due to the inability to follow patients if 
they went to other hospitals, low number of secondary diagnoses). 
Our literature studies showed that indicator definitions are often ambiguous. 
Clear indicator definition is a crucial aspect of reliability as unspecific indi-
cator definitions lead to different interpretations of the indicator, which may 
result in a biased estimation of the indicator score. 
To answer research question 3 and 4 we analysed Dutch colon cancer au-
dit data (Dica, years 2011/12) and English oesophago-gastric (O-G) cancer 
audit data (years 2011/12). 
1.
2.
3.
4.
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We found that statistical uncertainty leads to uncertain estimates of the out-
come rate per hospital. Taking into account statistical uncertainty with ran-
dom effect models showed that differences between hospitals in outcome 
after colon cancer surgery were to a large extent attributable to chance. 
Especially when event rates are low, such as in the case of postoperative 
mortality, and when comparing outcomes per surgeon, it is crucial to take 
into account uncertainty.
We found that case-mix explains a certain extent of outcome variation be-
tween hospitals in 30-day mortality and to a lesser extent in anastomotic 
leakages in both colon and oesophago-gastric cancer and therefore case-
mix is important to take into account. 
We developed a case-mix correction model using the English O-G cancer 
audit data (years 2011/2012). This model can be used for correcting for case-
mix when comparing short-term outcomes following O-G surgery. 
This final chapter is divided into two parts. The first part discusses our main 
findings per research question. In the second part we interpret our findings 
and present implications for science and policy. 
Data quality
Our first research question addressed the impact of data quality on the reli-
ability of hospital quality indicators. High-quality data, namely data that are 
as complete and as error-free as possible, form an essential requirement for 
reliable hospital quality indicators.
In Chapter 3 we presented an overview of factors threatening the reliability 
of the outcome indicator readmission rate. Most quality indicators are cal-
culated using administrative data. Although this type of data has several 
advantages, such as being easy to obtain and including large patient pop-
ulations, we found that the low quality of administrative data hampers the 
calculation of reliable quality indicators due to the data’s inaccuracy and 
incompleteness (Chapter 3, Chapter 5, Chapter 6). While basic case-mix 
information, such as age, is mostly available in administrative databases, 
clinical information, such as disease severity, is often lacking. 
Our literature study showed that in currently used administrative databases 
patients often cannot be followed. This is problematic because outcomes 
of interest for quality of care measurement, such as death or readmission, 
occur after hospital discharge. Therefore, the ability to follow patients be-
yond hospital discharge is essential.3 Especially with increasingly centralized 
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care, patients may be readmitted in centres other than the one where the 
primary admission took place. Missing these readmissions creates an under-
estimation of the outcome in the index hospitals. Unique patient identifiers, 
which allow following patients across hospitals, are essential (Chapter 3). 
We found that coding plays an important role in determining the level of 
data quality. Variations in coding practices can have a significant effect on 
the validity of the registered data elements. This variation is usually caused 
by the fact that different hospitals put different types of staff in charge of 
the coding process (e.g. medical vs. administrative staff) and by the fact 
that the indicators are broadly defined, allowing subjective judgements to 
be made. 
Another factor threatening the reliability of indicators is the burden of the 
data collection. For the DHTP indicators it was shown that data collection 
and computation strategies vary widely between Dutch hospitals. For ex-
ample, when data elements are relatively inaccessible and require a large 
amount of labour to extract the necessary information, some hospitals de-
livered an estimation of the indicator score. As a result, many self-report-
ed quality indicators show implausible indicator scores. Indicators that are 
based on data elements collected in a standardized manner by the na-
tional cancer registry were much more plausible (Chapter 5).
Indicator definitions
Our research question 2 addressed the impact of indicator definitions on 
reliability. The definition of an indicator determines which patient group is 
included (denominator) and which events are counted (numerator). Both, 
the denominator and the numerator can be affected by vague definitions. 
In our literature studies we showed that the numerator of the readmission 
rate is seldom precisely defined (Chapter 2, Chapter 4). In the majority of 
the studies we looked at, the definitions in the studies only included the time-
frame in which the outcome was investigated. Usually events between 28 
and 31 days were captured.
Summary of data issues
In our reviews we found that poor data quality and unclear indicator defini-
tions are common problems encountered when using administrative data 
for the purpose of measuring quality of care. Data collection and compu-
tation strategies vary widely in practice. Our empirical study showed that 
the data elements that are difficult to abstract show low reliability because 
sometimes they are just estimated instead of calculated. We found that 
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imprecise indicator definitions are generally seen in the literature, the ba-
sic distinction between planned and unplanned events is seldom made. 
Current administrative databases often do not allow this distinction to be 
made. The usual time frame for investigating events is around 30-days, ir-
respective of the underlying disease. We showed that low data quality 
and imprecise indicator definitions lead to an over- or underestimation of 
an indicator score. Ignoring this aspect of low reliability leads to biased 
comparisons between hospitals.
Statistical uncertainty
Our third research question addressed the impact of statistical uncertainty 
on the reliability of hospital quality indicators. 
Our empirical studies have shown that the number of postoperative deaths 
and anastomotic leakages are low in colon cancer and oesophago-gastric 
cancer patients. For example, in the Dutch colon cancer cohort the median 
postoperative mortality rate per hospital was 3% (absolute number: 5 pa-
tients) (Chapter 7). As was shown in our analysis, when numbers are that low, 
the impact of statistical uncertainty is significant, which results in uncertain 
estimates of the outcome rate per hospital. The effect of statistical uncer-
tainty was smaller in our second outcome, anastomotic leakage following 
colon cancer surgery, which occurred more frequently than postoperative 
deaths (anastomotic leakage in median hospital: 7%, 9 patients). This is ex-
plained by the fact that not only the total number of treated patients per 
hospital, but the frequency of the outcome, determines the size of the im-
pact of statistical uncertainty.4
Advanced statistical models, specifically random effect models, can be 
effectively used to take statistical uncertainty into account. These models 
assume that the hospitals are all part of a larger population. As a result, ex-
treme but uncertain estimates in individual hospitals are shrunken towards 
the overall mean. When event rates are high the models based on the fixed 
and random effect will reveal similar results.5
In Chapter 7 it was shown that it is crucial which method is chosen when 
comparing outcomes between hospitals where outcome rates are usually 
low. For postoperative mortality following colon cancer surgery, we found 
that taking the random variation into account diluted all observed varia-
tion in postoperative mortality between hospitals. There was no variation in 
postoperative mortality beyond random variation. 
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The effect of statistical uncertainty will increase even further when the unit 
of comparison becomes smaller, for instance, when comparing outcomes 
between surgeons (Chapter 9). In those cases relevant outcome differences 
are unlikely to be detected and therefore they are not recommended for 
external reporting.
Besides the indicator scores for individual hospitals, there may also be inter-
est in the variation in outcome between hospitals. Quantifying such overall 
outcome differences can be done in several ways, for example, with the 
interquartile range or standard deviation of the outcome rates. Measures to 
quantify outcome differences from random effect models (taking into ac-
count statistical uncertainty) are not easily interpretable. Several measures 
have been proposed based on the tau2, which is the variance of the ran-
dom effects.6 In Chapter 9 we used the median odds ratio (MOR) to quantify 
the outcome variation between hospitals. The MOR is a direct function of 
tau2 and quantifies the variation between hospitals (or surgeons) by com-
paring two persons with the same covariates, chosen randomly from dif-
ferent hospitals. The MOR can be equal to or greater than 1; an MOR of 1 
reflects no variation between the hospitals. The larger the between-hospital 
variation, the higher the MOR will be.7 For example, an MOR of 2 means that 
if two ‘similar’ patients are treated in two randomly selected hospitals, one 
patient will have twice the odds of a poor outcome compared to the other. 
A further advantage of the MOR is that it can be directly compared with the 
odds ratios of other covariates in the model, for example the effect of a cer-
tain patient characteristic or treatment.7 An alternative measure is the intra-
class correlation coefficient (ICC). However, the ICC is a less straightforward 
measure for interpreting dichotomous outcomes compared to continuous 
outcomes, because in linear regression the individual and the hospital-level 
variance are measured on the same scale, while in logistic regression indi-
vidual and hospital level variance are not directly comparable.8 Overall, 
the MOR seems a more attractive measure for quantifying variation in out-
come. The MOR is directly comparable with fixed-effects odds ratios,7 is not 
statistically dependent on the number of events, and it quantifies the level 
variance on the commonly known odds ratio scale.8
Summary on statistical uncertainty
Disregarding statistical uncertainty can have a significant negative impact 
on the reliability of outcome indicators for quality of hospital care. 
We found that estimated outcome rates per hospital can be very uncertain. 
Ignoring this statistical uncertainty, by applying fixed-effect models, leads 
to an overestimation of outcome differences between hospitals. Therefore, 
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random effect models are preferable because they prevent over-interpre-
tation. The lower the patient numbers and event rates, the bigger the prob-
lem of statistical uncertainty. Consequently outcomes that occur more fre-
quently are more attractive as outcome indicators.
Case-mix correction
Not every patient carries the same risk of a specific outcome; for example, 
more severely ill patients carry a higher risk of having complications or dy-
ing compared to less severely ill patients. This risk difference would not be 
of significant importance if patients were randomly assigned to hospitals (or 
surgeons). As this is not the case,9-11 the difference in patient characteristics 
may explain a part of the observed outcome variation between hospitals. 
Research question 4 addressed the influence of case-mix correction on the 
validity of hospital quality indicators for colon and O-G cancer.
In Chapter 8 we demonstrated that postoperative mortality in O-G cancer 
was affected to some extent by patient characteristics. The effect of pa-
tient characteristics on postoperative mortality in colon cancer patients was 
more substantial (Chapter 7). Patients’ characteristics, which are generally 
present in administrative data, showed a relatively high predictability (c-
statistic: 0.76 (a measure of the discriminative ability of the model)). Cancer 
care is becoming increasingly centralized. This makes risk adjustment, espe-
cially for tumour- and disease-related factors, even more important since 
patient profiles will increasingly vary between specialized and non-special-
ized hospitals. Adding these factors increased the c-statistic to 0.82. 
We also tested the effect of adding these specific characteristics to the 
case-mix model on the variation in postoperative mortality following co-
lon cancer surgery between hospitals. It was found that, compared to the 
unadjusted mortality rates, the effect of general case-mix correction on 
the postoperative mortality estimates per hospital was limited. This may be 
explained by the fact that a case-mix variable is important when it is pre-
dictive of the outcome, and varies between hospitals.12 The c-statistic only 
reflects the between-patient outcome variation, but does not take into ac-
count the differences in the distribution of the patient characteristics across 
the hospitals and therefore could be misleading. In our study population 
the general patient characteristics, such as age, were equally distributed 
across the centres. Disease-specific variables, such as pre-operative tumour 
complications, varied more across the centres. Therefore, including disease-
specific correction variables in addition to the general case-mix variables 
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did affect the mortality estimates per hospital more. We therefore conclude 
that disease-specific case-mix correction is important and that the c-statis-
tic alone is not very useful for quantifying the credibility and accuracy of a 
case-mix correction model.13
Our findings for the outcome anastomotic leakage were different. Com-
pared to mortality, anastomotic leakages for both cancer conditions were 
to a much smaller extent determined by patient characteristics (e.g. co-
lon cancer: c-statistic: 0.58). Adding tumour-specific information did not in-
crease the predictive performance of the model (c-statistic: 0.60). A com-
parable AUC value was found in the O-G cancer patients (c-statistic: 0.59). 
The low predictability may be caused by anastomotic leakages being less 
attributable to patient characteristics. Another explanation may be that we 
missed important predictors for anastomotic leakage. However, this is rather 
unlikely, since we had two patient cohorts with rich patient and tumour in-
formation available, and similar findings for both cohorts. 
We also tested the effect of adding tumour-specific characteristics to the 
case-mix model for comparison of anastomotic leakage rates between hos-
pitals. For the overall hospital comparison, extended case-mix correction 
was shown to have a limited effect on the outcome anastomotic leakage.
In Chapter 3 we discussed why a case-mix correction model should con-
tain variables that are related to the outcome and show variation between 
hospitals. Our literature review showed that for the readmission rate these 
variables have not been clearly identified yet. Although numerous case-mix 
correction models with varying methodology, geographical characteristics, 
underlying patient groups and included variables have been developed, 
little consensus exists on which variables actually are better at predicting re-
admissions.14,15 Information with regard to the patient’s disease severity and 
socioeconomic status, factors which are thought to majorly contribute to 
the likelihood of this outcome, are frequently missing in prediction models. 
Administrative data, which are usually used to calculate the indicator, do 
not contain this kind of information.16,17
Summary on case-mix correction
When outcomes are (partly) determined by patient characteristics and 
these patient characteristics vary across hospitals, case-mix correction is 
crucial for the validity of indicators used to measure quality of hospital care. 
There is no ‘perfect’ case-mix model, but our studies showed that disease-
specific variables changed the results of the hospital comparisons. There-
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fore, disease-specific variables should be included in case-mix correction 
models for comparing outcomes between hospitals. 
Our empirical studies showed that patient characteristics do not have the 
same effect on all outcome measures. Some quality indicators are more 
robust and have less need for case-mix correction than others (e.g. anasto-
motic leakages vs. postoperative mortality).
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GeNeRalIzaBIlIty oF FINDINGS
Our case studies on data issues were based on national quality indicators 
based on hospital administrative data of the years 2011 and 2012. We inves-
tigated two indicator sets based on administrative data. Since every indica-
tor set can show different levels of reliability, depending on the amount of 
labour needed to calculate the indicators, we conclude that our findings 
on reliability aspects of hospital quality indicators based on administrative 
self-reported data can only be generalized with caution for the Netherlands 
and other health care systems. 
However, we may assume that our findings have implications for other ad-
ministrative databases which use a self-reporting system and commonly 
defined indicators. This assumption is confirmed by international studies 
that have found significant variation in the data accuracy of administrative 
data.18-21 However, some of the causes of low administrative data quality 
may have already been addressed in other countries. The Nordic countries, 
for example, have a long tradition of registry-based epidemiological re-
search, which uses unique patient identifiers to enable the linkage between 
registries. This results in rich disease and treatment information (e.g. drug de-
scription in ambulatory care) and allows researchers to follow patients be-
yond hospital discharge.22 Our finding that many indicators are inaccurately 
defined supports previous findings from other countries23 (Chapter 4). Even in 
the US, where readmission rates are used for pay-for-performance schemes, 
research highlights problems in data quality and indicator definition.24-26
In this thesis we studied the influence of statistical uncertainty and case-
mix correction using Dutch and English clinical audit data. Since the patient 
profiles of Dutch and English patients are not expected to significantly differ 
from those of oncological patients in other Western countries, our findings 
on the influence of case-mix correction when measuring quality of hospital 
care can be generalized to other health care settings where patient char-
acteristics are expected to vary across hospitals. Statistical uncertainty is 
always influential when patient numbers and especially event rates are low, 
irrespective of the health care system in which they are measured. 
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ImPlICatIoNS FoR ReSeaRCH
In this thesis we first addressed the reliability of indicators measuring quality 
of hospital care. We found that data quality is a very important determinant 
of the indicators’ reliability. Future research should investigate ways to opti-
mize data quality determining factors. Data quality is determined in part by 
the feasibility of abstracting and registering the necessary data elements in 
the data registration system. 
Our research showed that indicators that were hard to abstract from the 
data registration systems showed low reliability, because they were difficult 
to calculate (it is believed that) these indicators were estimated (by hospital 
staff) instead of calculated. Data elements that require extensive efforts to 
be delivered need to be identified, their reliability tested and, in case of 
reliability issues, their generation needs to be facilitated. Further research is 
needed to try to minimise the burden of data registration. This may be done 
by investigating possible ways to link databases and to automatically calcu-
late necessary data elements. In the Netherlands a promising initiative has 
been taken by the ‘Netherlands Federation of University Medical Centres’.27 
The federation’s aim is to create a uniform and one-off registration of medi-
cal information for multiple purposes, based on international standards for 
medical data. 
In our studies ambiguous indicator definitions were shown to affect the valid-
ity of indicators measuring quality of hospital care. The identification of events 
related to quality of care represents a substantial challenge. Future research 
needs to deepen our understanding of what we are actually measuring. 
Therefore we need to focus on the different elements of the definition of a 
quality indicator (e.g. timeframe, type of outcome). Specifically for the read-
mission rate indicator, this implies investigating the optimal time frame of de-
fining an admission as readmission for the different diseases. Further, the con-
sequences of shortening or extending this timeframe need to be researched. 
Our research showed that even the basic distinction between planned and 
unplanned events is rarely made. Even if data systems do allow the distinc-
tion between planned and unplanned events to be made, some uncertainty 
remains. The decision whether a readmission was planned or unplanned is 
not always clear and objective. Research is needed to investigate alternative 
approaches, such as defining diagnoses in a way that will indicate a planned 
readmission before the patient is discharged. When a patient gets admitted 
within a certain timeframe the system can define the admission as an admis-
sion or readmission based on the a priori defined diagnoses. 
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In contrast to choosing a common timeframe, we propose that the time-
frame should be investigated and chosen based on the index disease and 
the purpose of the quality indicator. A timeframe that is too short may miss 
related events, while a timeframe that is too large increases the likelihood of 
including unrelated events. On the other hand, a short timeframe may give 
more accurate insight into technical quality of hospital care, while a longer 
timeframe may be able to reflect overall system performance. 
Patients do not always get readmitted to the index hospital nor do they al-
ways die within the in-hospital period. More research is needed to identify 
the patterns of patient journeys and the consequences of missing these 
events. Further, algorithms need to be developed to abstract quality indica-
tors from administrative data.
Nevertheless, even when data registration is perfect, the person in charge 
of the data registration and coding may also influence the data quality. It 
will always be difficult to prevent the intentional manipulation of data.
Statistical uncertainty is largely caused by low patient and event rates. 
For statistical reasons, patient and event rates must not be too small. To in-
crease the number of patients and events, the time period of investigation 
can be extended. Our research suggests that for O-G and colon cancer 
a time period of about five calendar years would provide the necessary 
number of patients to have enough statistical power to detect significant 
outliers between surgeons for typical short-term outcomes, such as mor-
tality or anastomotic leakage. Using data over such a long time period, 
however, decreases the actionability and relevance of the data. Another 
way to increase the number of events and patients is to increase the unit 
of observation. For example, researchers could aggregate events over hos-
pitals instead of at the surgeon level. But even when data is aggregated 
on the hospital level and for a relevant time period, event rates may be 
still too low. An alternative approach would be to expand the number of 
events by combining different outcomes such as surgical complications, 
including bleedings, infections, or anastomotic leakages, or readmissions 
and length of stay. The events could also be weighted to create composite 
scores. However, such aggregated results may be (more) difficult to inter-
pret. Given these problems, research needs to focus on improving statistical 
methods in order to better deal with statistical uncertainty. Specifically, it 
should be determined whether there is a minimum number of patients and 
events that needs to be met in order to have an acceptable level of cer-
tainty, as was proposed by the Dutch Health Transparency Program (DHTP). 
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Further, researchers should determine what is the best way to present the 
results of between-hospital comparisons. 
In our studies we showed that patient characteristics have a substantial 
impact on the results of patient-outcome comparisons across providers. 
Numerous questions regarding case-mix correction still need to be an-
swered. Case-mix correction models for complications and readmissions 
were shown to have poor to average performance. It must be determined 
whether we can identify measurable, relevant variables that improve the 
case-mix correction models. In our research it was shown that disease se-
verity and socio-economic status are crucial considerations for case-mix 
correction. However, these two factors are also the hardest to capture using 
current data systems. The ability to study the effect of these variables needs 
to be enhanced, either by linking administrative data to detailed clinical 
databases or by collecting socioeconomic data of patients. The required 
extent of correction could be debated. For example, correcting for socio-
economic status does not provide hospitals an incentive to improve their 
quality of the care specifically for lower socio-economic groups. 
Further, there are case-mix factors that have not yet been well researched 
which might be especially important in a specialized/centralized care set-
ting. For example, if a patient is admitted for palliative care, death is not an 
undesirable outcome. However, current data systems do not allow research-
ers to distinguish curative from palliative deaths. Further, severely ill patients 
are transferred to specialized centres. Despite the fact that these patients 
carry a higher risk of undesired outcomes, whether a patient is transferred or 
not is usually not captured in the data. 
In the context of centralization, where severely ill patients are treated in spe-
cialized centres and their risk profile differs significantly from that of patients 
in small, not specialized centres, it is of interest to investigate whether the 
effect of case-mix variables varies between specialized and non-special-
ized centres. This can be done by testing the interaction between centres 
and the case-mix variable of interest or by including random slopes in the 
random effect models. 
In our studies it was also found that the discriminative ability was non-opti-
mal in judging the quality of a case-mix correction model. Research needs 
to focus on how to better quantify the performance of a model and to de-
termine whether a model can be regarded as ‘good enough’ to be ac-
cepted as a valid model. 
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A number of indicators are currently used to measure quality of hospital 
care. We investigated the suitability of some of them in this thesis. Future 
research needs to investigate complications as outcome measures for surgi-
cal care since the occurrence of complications may be a more reliable and 
valid indicator of quality of care than mortality. We mainly studied outcome 
indicators. Process indicators, however, are usually more actionable, since 
they are directly attributable to the care process. Therefore process indica-
tors should be further researched for their ability to quantify and compare 
quality of hospital care.
Indicators that capture the patient’s journey through primary and second-
ary care need to be further developed, as such indicators provide a more 
complete picture of the care delivered for chronic patients. 
In summary, future research should focus on the following topics:
- Increase feasibility of abstracting and registering relevant data elements 
in data registration systems.
- Minimize the burden of data registration (e.g. through data linkage).
- Investigate the elements of the definition of a quality indicator (e.g. type 
of outcome).
- Identify patterns of patient journeys. 
- Investigate the consequences of missing events that occur in hospitals 
other than the index hospital.
- Further develop ways to abstract quality indicators from administrative 
data.
- Improve statistical methods to deal with statistical uncertainty.
- Further improve case-mix correction models and define criteria to judge 
case-mix correction models.
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ImPlICatIoNS FoR PolICy
The availability of information on quality of care has become a cornerstone 
of healthcare, perhaps even more so in health care systems with a market 
mechanism. However, for the Netherlands it was recently stated that the 
absence of reliable and valid quality information is a major weakness of the 
health care system.32 In different countries, thousands of quality indicators 
are collected yearly; the data are made publicly available and are used 
for benchmarking and reimbursement strategies both on the hospital level 
as well as on the surgeon level. As this thesis shows, quality indicators have 
severe shortcomings that affect their reliability and validity. These shortcom-
ings are not sufficiently taken into account currently in the Netherlands. The 
indicators we evaluated have flaws in all studied aspects: data quality, in-
dicator definition, case-mix correction and statistical uncertainty. Ignoring 
these problems leads to a biased estimation of the indicator scores and 
leads to wrong conclusions on quality of care. Consequently, hospitals may 
be unjustifiably punished and reputations damaged. 
Ideally, measuring quality of care leads to quality improvement.33-35 It is ar-
gued, for example, that patients use hospital rankings to choose the ‘best’ 
provider. However, this is questionable. Research has shown that most pa-
tients actually do not use the information for decision making.32 With regard 
to care providers, the evidence on whether reporting health care perfor-
mance leads to quality improvement is mixed, especially when financial 
incentives are linked to performance.33-36
In order to be able to use quality information to improve quality of care, 
the quality measures must first be able to identify hospitals with real qual-
ity problems and second must provide insight into how to improve quality.. 
When there is a large amount of interest in quality information—for example, 
because of public reporting or when funding is linked to performance—
it needs to be realized that invalid and unreliable quality indicators may 
cause perverse effects such as avoiding admission of high-risk patients. 
Consequently, to create the right incentives for quality improvement, qual-
ity indicators for hospital care need to be reliable and valid. 
In this thesis the main outcome indicators investigated were readmissions, 
mortality and surgical complications. These indicators have good face va-
lidity and can potentially provide very useful insight into quality of hospital 
care. However, we identified many methodological issues with these out-
come indicators. 
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Mortality has strong face validity as a measure of hospital care, as death is 
the most undesirable outcome for patients. However, our research showed 
that mortality is more influenced by patient characteristics than quality of 
care. Other research has also shown that actually only a small percentage 
of deaths that occurred in hospitals are preventable. Of the 1000 cases re-
viewed, 5.2% were judged to have been preventable (i.e. having a greater 
than 50% probability that better care would have prevented death).37,38 Fur-
ther, it was shown that patients dying in hospital are often already near the 
end of their lives. It was estimated that only 0.5% (95%CI; 0.3% - 0.7%) of the 
patients whose deaths were possibly related to quality of care were expect-
ed in the absence of quality of care problems to live at least 3 more months 
in good cognitive health.37,39
Readmissions are an important indicator of quality of care as they are asso-
ciated with high costs. However, the indicator is often misunderstood. Read-
missions do not seem to solely measure quality of hospital care, but instead 
reflect the overall quality of the health system and social care. Depending 
on the underlying disease, they are also determined by what happens to 
the patients post discharge, their social network, and the patient’s compli-
ance. Only unplanned readmissions are expected to relate to quality. Read-
missions occurring soon after discharge (within seven days) are most likely 
related to hospital care and therefore might be the most preventable.40
The studied surgical quality indicator, anastomotic leakage, proved to be a 
possibly useful indicator for measuring surgical care. Anastomotic leakage 
occurs relatively frequently, is relatively robust for patient characteristics, 
and is closely related to the surgical intervention. Yet, research has shown 
that there is no universally accepted definition of anastomotic leakage; in 
a systematic review, 56 different definitions of anastomotic leakage were 
identified.41 Having no uniform definition of the indicator complicates the 
assessment and comparison across hospitals.
Although there is a tendency to prefer outcome indicators over process in-
dicators, the discussion on which type of indicator better reflects quality of 
hospital care is ongoing. Both indicator types have advantages and dis-
advantages. While outcome indicators are highly relevant for patients and 
payers and provide information on all aspects of delivered care, the events 
they quantify occur infrequently, they are confounded by factors unrelated 
to quality of care, and opportunities for improvement are hard to identify 
based on outcomes. Process indicators are generally evidence-based, are 
directly attributable to delivered care (actionable), usually do not require 
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case-mix correction, and have no time lags. However, process indicators 
also just represent what can be measured; they are less meaningful to pa-
tients. 
One indicator can never provide a full picture of all aspects of the delivered 
care. Therefore we recommend investigating sets of indicators that include 
structure, process and outcome indicators. This approach is also needed 
because some indicators may outweigh others. For example, a hospital with 
a long length of stay may score low on the readmission rate indicator, while 
a hospital with a high score on the readmission rate indicator may score 
low on the mortality rate indicator. The difficulty is that it is also known that 
patients prefer quality of care information to be presented in a simple form, 
such as a single number.35 Therefore different stakeholders may require dif-
ferent presentation of quality information.
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ReCommeNDatIoNS
Based on this thesis some specific recommendations can be made for the 
development and use of quality indicators that are used to assess the qual-
ity of hospital care in the Netherlands for external purposes. 
Indicator selection
Create indicator sets that contain structure, process and outcome indi-
cators for reasons of actionability.
For outcome indicators, choose indicators and data sources that allow 
case-mix correction, including disease-specific case-mix factors.
For outcome indicators, choose indicators for which a reasonable num-
ber of patients in the numerator can be expected.
Data registration and indicator definition
Strengthen data quality control.
Maximize the opportunity to use nationally unique patient identifiers 
(UPIs) to enable linkage of administrative databases and clinical data. 
Make indicator definitions as precise as possible to eliminate differences 
in interpretation. 
Reduce the total registration burden by reducing the number of indica-
tors, making more efficient use of existing data, and automating data 
collection.
Request hospitals to submit patient-level data in order to uniformly ab-
stract the numerator and denominator for the indicator.
Analysis
Use random effect models to take statistical uncertainty into account. 
Adjust for case-mix differences between hospitals. 
Use
Interpret currently publicly presented outcomes with caution as their va-
lidity and reliability is often poor.
Focus on outcome indicators that are relatively robust to case-mix dif-
ferences and occur relatively frequently, such as complications after sur-
gery. 
Do not use outcome indicators that are not sufficiently corrected for 
case-mix factors or occur infrequently for public reporting or financial 
purposes.
•
•
•
•
•
•
•
•
•
•
•
•
•
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Introduction
Information on quality of care plays a central role in healthcare nowadays. 
As a result of the growing demand for health care, increasing costs and 
evidence of variation in quality of care, the interest in the quantitative as-
sessment of health care quality has increased. Furthermore, today’s society 
demands ever more and more transparency, which requires the health care 
sector—as well as other public sectors—to provide insight into their perfor-
mance. 
Different stakeholders may use quality of care information for different pur-
poses. Health care professionals use it to evaluate their performance in or-
der to try to improve quality. Government agencies use quality of care infor-
mation to monitor and regulate quality of care, while insurance companies 
use it to select hospitals they want to contract, and patients may use it to 
compare hospitals in order to make informed treatment decisions. 
As quality of care information is used for such a variety of purposes, it is cru-
cial that quality measures are valid and reliable and actually do represent 
quality of care. However, despite a rapidly growing body of scientific litera-
ture on this topic, there is currently no consensus on how to measure quality 
of care.
Quality of care is commonly measured with quality indicators. Quality indi-
cators are measurement tools, screens, or flags that are used as guides to 
monitor, evaluate, and improve quality of care. They are often classified into 
three types: structure (e.g. nurse-to-bed ratio), process (e.g. proportion of 
patients who received discharge instructions) and outcome (e.g. proportion 
of patients who had to undergo reoperation) indicators. While in the scien-
tific literature no consensus exists on which type of quality indicator is best 
able to assess quality of care, in the last few years there has been a clear 
preference for outcome indicators.
Using outcome indicators as a measure of quality of hospital care requires 
that differences in outcomes between hospitals represent differences in un-
derlying quality of care. Therefore outcome indicators need to be evalu-
ated in terms of their psychometric criteria: how ‘good’ is the indicator? 
In this thesis we concentrate on the psychometric criteria reliability and 
validity. We study the following elements that determine the reliability and 
validity of an outcome indicator: data quality, definitions, statistical uncer-
tainty and case-mix (Table 1).
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table 1. Psychometric criteria to evaluate an outcome indicator studied in 
this thesis
Psychometric characteristic 
Reliability: Data quality: Uniformity in data (collection)
 Definitions: Accurate definition of numerator and denominator and other data 
  elements that are used to calculate the indicator 
 Statistical  Random variation caused by low numbers of patients/outcomes 
 uncertainty:
Validity: Case-mix: Differences in patient populations between hospitals
We investigate different outcome indicators for quality of hospital care in 
different disease fields with the main aim of expanding our knowledge on 
how to measure quality of hospital care for between-hospital comparisons. 
The specific research questions are the following:
Which aspects of data quality affect the reliability of quality indicators 
for hospital care? 
How clear are the definitions of currently used quality indicators for hos-
pital care?
To what extent does statistical uncertainty affect the reliability of outcome 
indicators for surgical colon and oesophago-gastric cancer care? 
To what extent does case-mix correction affect the validity of outcome 
indicators for surgical colon and oesophago-gastric cancer care?
These questions are answered in eight chapters. Table 2 presents an over-
view of these chapters. The table shows the indicators studied, the clinical 
fields, and the data sources, including year and country. 
Reliability and validity
In part II (literature studies) and part III (empirical studies) the impact of data 
issues, statistical uncertainty and case-mix correction on the reliability and 
validity of indicators measuring quality of hospital care is studied.
In the systematic literature review in Chapter 2, we demonstrate that the 
quality indicator rate of readmission is often used in the European context. 
However, it is seldom accurately defined. The 486 included studies showed 
limited consensus on the time frame that should be used to calculate the 
indicator and the types of readmission to consider. 
1.
2.
3.
4.
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table 2. Outcome indicators for the quality of hospital care studied in this 
thesis
Outcome  Clinical field Datasource Country Year  Chapter
indicator
Readmission General Literature International 1999-2010 2
 General Literature International 2001-2013 3
 Heart failure Literature International      /  -2014 4
Relapse Breast cancer Administrative NL 2009-2011  5
Complications Hip and knee replacement Administrative NL 2009-2011 5 and 6
 Colon cancer  Clinical NL 2011-2012  7
 Oesophago-gastric cancer Clinical UK 2011-2013  8 and 9
mortality* Colon cancer Clinical NL 2011-2012  7
 Oesophago-gastric cancer Clinical UK 2011-2013  8 and 9
*postoperative mortality, 30-day mortality, 90-day mortality.
The literature study in Chapter 3 summarizes methodological aspects of 
the definition and measurement of the readmission rates that need to be 
considered when interpreting readmission rates as a reflection of quality of 
hospital care. We found that administrative data is usually suboptimal for 
calculating quality indicators for external purposes, such as pay-for–perfor-
mance schemes. Data quality problems include heterogeneous data infor-
mation systems, inaccurate data registration, and incomplete data. Further, 
we found that defining the context in which readmissions are used is crucial. 
This context includes the patient group and which elements of quality of 
care the readmissions rate is expected to reflect. Finally, the multi-faceted 
nature of quality of care and the correlation between readmissions and 
other outcomes limit the indicator’s validity. 
In Chapter 4 the association between heart failure process indicators and 
the outcome indicator readmission rate was investigated. We found that 
readmission rates after heart failure hospitalization are mostly unrelated to 
the evidence-based ACC/AHA in-hospital process indicators for heart fail-
ure. The strongest evidence was found for the process indicator ‘ACE inhibi-
tor/ARB blocker use’; four out of ten studies showed a significant correlation 
between this indicator and readmission rates. It is unclear whether readmis-
sions are largely determined by processes of hospital care; they may be 
more strongly influenced by post-discharge care or patient characteristics. 
In Chapters 5 and 6 we present our studies on the data quality of the Dutch 
administrative database DHTP (Dutch Healthcare Transparency Program) in 
the years 2008 and 2009. In Chapter 5 we investigated the extent to which 
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local hospital data collection and indicator computation strategies differ 
in the Netherlands and how these differences affect the plausibility of self-
reported indicator scores on hip and knee replacement and breast cancer 
indicators. We used survey results from 42 Dutch hospitals. We found that 
the data collection and indicator computation strategies varied widely be-
tween the hospitals. The hip and knee replacement quality indicator scores 
were often implausible, which was mostly due to poor data registry. In con-
trast, breast cancer quality indicator scores were more plausible. 
In Chapter 6 we used the national data of the DHTP scores to assess the con-
struct validity of structure, process and outcome indicators for hip replace-
ment. Among the 28 hypothesized correlations between the hospitals’ scores 
on different indicators (e.g. high percentage of antibiotics provided is cor-
related with a low percentage of wound infections), just three correlations 
were in the direction hypothesized and statistically significant. Hospitals with 
a low percentage of wound infections scored high on scheduling postop-
erative appointments (p-value=0.001) and high on not transfusing homolo-
gous blood (p-value=0.05). Hospitals with higher scores on scheduling com-
plication meetings also scored higher on providing thrombosis prophylaxis 
(p-value= 0.04). Our results showed that although the individual indicators 
might be valid and actionable, drawing overall conclusions based on the 
whole indicator set should be done carefully, as construct validity could not 
be established. Factors that may explain the lack of construct validity are 
poor data quality, no adjustment for case-mix and statistical uncertainty. 
The literature study in Chapter 3 showed that hospital quality indicators are 
usually based on administrative data. However, administrative data con-
tain a limited set of (clinical) patient characteristics which makes sufficient 
case-mix correction difficult. Administrative data often do not contain dis-
ease-specific information or information on the patient’s socio-economic 
status, while both have been shown to be important case-mix correction 
variables. 
In Chapter 7 we investigated the impact of statistical uncertainty and case-
mix correction on postoperative mortality and anastomotic leakage rates 
amongcolon cancer patients. We studied 13,120 patients who underwent 
colon cancer resection in 85 Dutch hospitals. We addressed differences be-
tween hospitals in rates of postoperative mortality and anastomotic leakage 
using fixed (ignoring statistical uncertainty) and random effects (incorporat-
ing statistical uncertainty) logistic regression models with general and dis-
ease-specific case-mix correction. It was found that overall statistical uncer-
tainty had a larger effect on hospital performance than extended case-mix 
correction, although some individual hospital outcome rates were affected 
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by more detailed case-mix correction. This finding highlights the importance 
of considering statistical uncertainty caused by low hospital case volume 
when comparing outcomes between hospitals.
In Chapter 8 we developed a case-mix correction model to adjust for pa-
tient characteristics when comparing short-term outcomes in oesophago-
gastric cancer patients. We used data from the English national audit on 
oesophago-gastric cancer, which included 4882 patients. The models for 
30-day mortality, 90-day mortality and anastomotic leakage were internally 
validated with bootstrapping techniques, showing moderate discriminative 
ability (AUC 0.65 for 30-day mortality, 0.66 for 90-day mortality and 0.59 for 
anastomotic leakage). The models can be used for risk adjustment when as-
sessing hospital performance in the NHS or other large health systems.
In Chapter 9 we assessed differences in short-term outcomes following oe-
sophago-gastric cancer surgery between hospitals and surgeons and the 
influence of hospital and surgeon volume on these outcomes. We used 4868 
cases of the National Oesophago-Gastric Cancer Audit (NOGCA) from the 
year 2011 to 2013 to study the outcomes 30-day mortality, 90-day mortal-
ity and anastomotic leakage. Multivariate logistic regression models were 
used to quantify the effects of surgeon and hospital volume on outcome. 
Outcome differences between surgeons and hospitals were quantified by 
multivariable random effects logistic regression models, including a surgeon 
and hospital level, to take into account case-mix and statistical uncertainty. 
Our analysis showed that higher hospital volume was associated with lower 
30-day mortality. Higher surgeon volume was associated with lower anas-
tomotic leakage rates. Hospital volume explained a part of the between-
hospital variation in 30-day mortality, whereas surgeon volume explained 
part of the between-hospital variation in anastomotic leakage. The effect 
of centralization was inconsistent and depended on the type of outcome 
measure under consideration. Therefore, efforts to centralise O-G cancer 
services further should carefully address the effects this will have on out-
comes at both the hospital and surgeon level.
Discussion
The aim of this thesis was to expand our knowledge on how to measure qual-
ity of hospital care for between-hospital comparisons. We studied reliability 
and validity of quality indicators and specifically focused on data quality, 
indicator definitions, statistical uncertainty and case-mix correction.
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The specific research questions were: 
Which aspects of data quality affect the reliability of quality indicators 
for hospital care? 
How clear are the definitions of currently used quality indicators for hos-
pital care?
To what extent does statistical uncertainty affect the reliability of outcome 
indicators for surgical colon and oesophago-gastric cancer care? 
To what extent does case-mix correction affect the validity of outcome 
indicators for surgical colon and oesophago-gastric cancer care?
 
We found that poor data quality and unclear indicator definitions are com-
mon problems when using administrative data for the purpose of measuring 
quality of care. Important issues that affect data quality are heterogeneous 
data information systems, inaccurate data registration, and incomplete 
data. We further found that many indicators are not clearly defined. For 
example, the distinction between planned and unplanned readmission is 
seldom made. Ignoring these reliability factors may lead to biased compari-
sons between hospitals.
Our analyses showed that disregarding statistical uncertainty and case-mix 
correction can have a significant negative impact on the reliability and 
validity of outcome indicators for quality of hospital care. We found that 
estimated outcome rates per hospital can be very uncertain and ignoring 
this statistical uncertainty can lead to an overestimation of the differences 
between hospitals. We found that patient characteristics do not have the 
same effect on all outcome measures. Some quality indicators were shown 
to be more robust towards case-mix correction than others (e.g. anasto-
motic leakage vs. postoperative mortality). When outcomes are (partly) de-
termined by patient characteristics and these patient characteristics vary 
across hospitals, case-mix correction, including disease-specific variables, is 
crucial for the reliability and validity of outcome indicators. 
Our findings have several implications regarding future research. Future re-
search is needed to optimize data quality. As data quality is determined by 
the feasibility of abstracting and registering the necessary data, research 
should focus on minimizing the burden of data registration. This may be 
done by investigating possibilities to link databases and to automatically 
calculate necessary data elements. Further, more research is needed to 
identify the patterns of patient journeys and to gain insight into the conse-
quences of missing events that occur outside the hospital. 
1.
2.
3.
4.
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Further, research needs to focus on statistical methods on how to better deal 
with statistical uncertainty and how to present the results of between-hos-
pital comparisons. Specifically, it should be determined whether there is a 
specific minimum number of patients and events that needs to be met in or-
der to have an acceptable level of uncertainty. With regard to case-mix, we 
found that case-mix correction models for complications and readmissions 
had just poor to average performance. It needs to be determined wheth-
er the case-mix correction models perform poorly because the events are 
not predicted by patient factors or because relevant variables have been 
missed. Further, research needs to focus on how to quantify the perfor-
mance of a case-mix correction model and how to decide if a model can 
be regarded as ‘good’. 
From a policy perspective, in order to be able to use quality information to 
improve quality of care, the quality measures must first be able to identify 
hospitals with real quality problems and second must provide insight into 
how to improve quality. When there is a large amount interest in quality infor-
mation—for example, because of public reporting or when funding is linked 
to performance—it needs to be realized that invalid and unreliable quality 
indicators may cause perverse effects such as avoiding high-risk patients. 
Consequently, to create the right incentives for quality improvement, quality 
indicators for hospital care need to be reliable and valid. 
To improve the reliability and validity of quality indicators that are used to 
assess the quality of hospital care in the Netherlands for external purposes, 
some specific recommendations can be made based on this thesis:
Indicator selection
Create indicator sets that contain structure, process and outcome indi-
cators for reasons of actionability.
For outcome indicators, choose indicators and data sources that allow 
case-mix adjustment, including disease-specific case-mix factors.
For outcome indicators, choose indicators for which a reasonable num-
ber of patients in the numerator can be expected. 
•
•
•
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Data registration and indicator definition
Strengthen standard based data quality control.
Maximize the opportunity to use nationally unique patient identifiers 
(UPIs) to enable linkage of administrative databases and clinical data. 
Make indicator definitions as precise as possible to eliminate differences 
in interpretation. 
Reduce the total registration burden by reducing the number of indica-
tors, making more efficient use of existing data, and automating data 
collection.
Request that hospitals submit patient-level data in order to uniformly ab-
stract the numerator and denominator for the indicator. 
Analysis
Use random effect models to take statistical uncertainty into account. 
Adjust for case-mix differences between hospitals. 
Use
Interpret currently publicly presented outcomes with caution as their va-
lidity and reliability is often poor.
Focus on outcome indicators that are relatively robust to case-mix dif-
ferences and occur relatively frequently such as complications after sur-
gery. 
Do not use outcome indicators that are not sufficiently corrected for 
case-mix factors or occur infrequently for public reporting or financial 
purposes.
•
•
•
•
•
•
•
•
•
•
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SameNVattING
Introductie
Informatie over kwaliteit van zorg speelt tegenwoordig een centrale rol bin-
nen ons zorgstelsel. Als gevolg van een toenemende vraag naar gezond-
heidszorg, stijgende kosten en aanwijzingen voor variatie in kwaliteit van 
zorg, is er een groeiende interesse in kwantitatieve beoordeling van de 
kwaliteit van de gezondheidszorg. Daarnaast is er vanuit de maatschappij 
steeds meer behoefte aan transparantie omtrent de prestaties van de zorg-
sector en andere publieke sectoren. 
Informatie over kwaliteit van zorg wordt door verschillende belanghebben-
den voor uiteenlopende doelen gebruikt. Zorgverleners kunnen hun eigen 
kwaliteit evalueren en verbeteren. Overheidsinstanties monitoren en regu-
leren kwaliteit van zorg, verzekeringsmaatschappijen selecteren ziekenhui-
zen om zorg in te kopen en patiënten kunnen ziekenhuizen vergelijken om 
daarna een ziekenhuis te kiezen. 
Omdat de informatie over kwaliteit van zorg voor zoveel doeleinden wordt 
gebruikt, is het van groot belang dat de kwaliteitsmaten valide en betrouw-
baar zijn. Ondanks de toename in wetenschappelijke literatuur over dit on-
derwerp, is er tot noch toe geen consensus bereikt over hoe kwaliteit van 
zorg moet worden meten. 
Kwaliteit van zorg wordt over het algemeen gemeten aan de hand van kwa-
liteitsindicatoren. Kwaliteitsindicatoren zijn meetbare aspecten van kwaliteit 
van zorg die worden gebruikt om de kwaliteit van zorg te monitoren, eva-
lueren en verbeteren. Deze indicatoren worden vaak in drie groepen ver-
deeld: structuur- (bijv. aantal verpleegkundigen t.o.v. het aantal bedden), 
proces- (bijv. proportie van patiënten die instructies krijgen bij ontslag uit het 
ziekenhuis), en uitkomstindicatoren (bijv. het aantal patiënten dat een her-
operatie moet ondergaan). Terwijl in de wetenschappelijke literatuur geen 
consensus bestaat over welk type indicatoren zou moeten worden gebruikt 
om kwaliteit van zorg te beoordelen, is op dit moment een duidelijke trend 
te zien in de richting van uitkomstindicatoren. Zo worden bijvoorbeeld sterf-
tecijfers gebruikt als maat voor kwaliteit van ziekenhuiszorg. 
Om uitkomstindicatoren te kunnen interpreteren als maat voor kwaliteit van 
ziekenhuiszorg is het van belang dat verschillen in uitkomsten tussen ziekenhui-
zen daadwerkelijke de kwaliteit van de geleverde zorg representeren. Daarom 
dienen de indicatoren nauwkeurig te worden geëvalueerd aan de hand van 
psychometrische criteria; hoe ‘goed’ zijn eigenlijk de indicatoren zelf?
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Dit proefschrift richt zich op twee psychometrische criteria: betrouwbaar-
heid en validiteit. We onderzoeken verschillende elementen die de be-
trouwbaarheid en validiteit van een uitkomstindicator kunnen beïnvloeden, 
namelijk de kwaliteit van de data waaruit de indicator berekend wordt, de 
gebruikte definities, statistische onzekerheid en case-mix (tabel 1).
tabel 1. Psychometrische criteria ter evaluatie van uitkomstindicatoren die 
worden behandeld in dit proefschrift
Psychometrisch kenmerk
Betrouwbaarheid: Kwaliteit van Uniformiteit van de data (dataverzameling)
 data:
 Definities: Nauwkeurige definitie van teller en noemer en andere gegevens die 
  worden gebruikt om de indicator te berekenen
 Statistische Willekeurige variatie veroorzaakt door lage aantallen patiënten/
 onzekerheid: uitkomsten
Validiteit: Case-mix: Verschillen in patiëntenpopulatie tussen ziekenhuizen
In dit proefschrift wordt de betrouwbaarheid en validiteit van verschillen-
de uitkomstindicatoren voor verschillende ziektebeelden onderzocht. Doel 
hiervan is het vergroten van wetenschappelijke kennis over het meten van 
kwaliteit van ziekenhuiszorg om vergelijkingen tussen ziekenhuizen mogelijk 
te maken. 
De specifieke onderzoeksvragen zijn:
Welke aspecten van de kwaliteit van de data hebben invloed op de 
betrouwbaarheid van kwaliteitsindicatoren voor ziekenhuiszorg?
Hoe duidelijk zijn de definities van de kwaliteitsindicatoren die momen-
teel worden gebruikt voor de ziekenhuiszorg?
Hoe belangrijk is statistische onzekerheid voor de betrouwbaarheid van 
uitkomstindicatoren voor de kwaliteit van operatieve zorg bij slokdarm- 
en darmkanker?
Hoe belangrijk is case-mixcorrectie voor de validiteit van de uitkomst-
indicatoren voor de kwaliteit van operatieve zorg bij slokdarm- en darm-
kanker?
1.
2.
3.
4.
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Deze vragen zullen worden beantwoord in tien hoofdstukken. Tabel 2 geeft 
een overzicht van deze hoofdstukken. In de tabel zijn de onderzochte indi-
catoren, het ziektebeeld en de databron (met jaar en land van herkomst) 
weergegeven. 
tabel 2. Uitkomstindicatoren voor de kwaliteit van zorg die in dit proefschrift 
worden onderzocht
 Uitkomstindicatoren in deze studies ziektebeeld Databron land Jaar
 Heropname Sterfte* Naadlekkage Wondinfecties terugval
 Hoofdstuk     Algemeen Literatuur
 2 + 3
 Hoofdstuk      Hartfalen  Literatuur
 4
     Hoofd- Borstkanker Admini- NL 2009-
     stuk 5  stratief  2011
    Hoofdstuk   Heup/knie- Admini- NL 2009-
    5 +6  prothese stratief  2011
  Hoofdstuk Hoofdstuk    Dikkedarm- Klinisch NL 2011-
  7 7   kanker   2012
  Hoofdstuk  Hoofdstuk   Slokdarm- Klinisch UK 2011-
  8 +9 8 +9   kanker   2013
*postoperatieve sterfte, 30-dagen sterfte, 90-dagen sterfte;
Betrouwbaarheid en validiteit
In deel I (literatuurstudies) en deel II (empirische studies) wordt de impact 
van dataregistratie en indicatordefinities op de betrouwbaarheid van indi-
catoren die de kwaliteit van zorg meten onderzocht. Uit de literatuurstudie 
in hoofdstuk 2 blijkt dat de kwaliteitsindicator “heropname in het ziekenhuis” 
vaak wordt gebruikt binnen Europa. Heropnames worden echter zelden 
nauwkeurig gedefinieerd. In de 486 geïncludeerde studies was er weinig 
consensus te vinden wat betreft de tijdsperiode waarbinnen de heropname 
zou moeten vallen en welke types van heropname zouden moeten worden 
meegeteld. 
De literatuurstudie in hoofdstuk 3 vat de methodologische aspecten die 
zouden moeten worden overwogen bij het definiëren en meten van her-
opnames samen. We vonden dat administratieve data in veel gevallen 
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suboptimaal zijn voor het berekenen van kwaliteitsindicatoren voor externe 
doeleinden als het vergelijken van ziekenhuizen. Problemen met de data-
kwaliteit zijn onder andere: heterogene informatiesystemen, onnauwkeu-
rige of foutieve dataregistratie en incomplete data. Daarnaast bleek de 
context waarin de heropname plaatsvindt van groot belang, bijvoorbeeld 
welke aspecten van kwaliteit van zorg de heropname naar verwachting 
weerspiegelen. Tenslotte wordt de betrouwbaarheid van de indicatoren 
beperkt door de vele verschillende aspecten die deel uit maken van kwa-
liteit van zorg. 
In de literatuurstudie in hoofdstuk 4 hebben we het verband tussen proces-
indicatoren en de uitkomstindicator heropname onderzocht bij hartfalen. 
We vonden dat het aantal heropnames na een opname door hartfalen 
per ziekenhuis niet gerelateerd was aan de scores op de procesindicatoren 
voor hartfalen. Onduidelijk is daarom of heropnames worden bepaald door 
processen binnen het ziekenhuis. Heropnamen kunnen ook worden beïn-
vloed door de zorg die wordt geboden na ontslag uit het ziekenhuis.
In hoofdstuk 5 en 6 worden studies gepresenteerd over de betrouwbaarheid 
van de Nederlandse ‘Zichtbare Zorg’ indicatoren over het jaar 2008/09.
In hoofdstuk 5 onderzochten we de mate waarin de dataverzameling en 
de berekening van indicatoren verschilt tussen ziekenhuizen en welk effect 
dit heeft op de betrouwbaarheid van de indicatorscores op indicatoren 
voor heup- en knievervanging en borstkanker. Voor het onderzoek werden 
vragenlijsten naar de Nederlandse ziekenhuizen gestuurd. We vonden dat 
er grote verschillen zijn in dataverzameling en het berekenen van de indica-
toren tussen de ziekenhuizen. De kwaliteitsindicatorscores voor de heup- en 
knieprotheses waren vaak onwaarschijnlijk, meestal als gevolg van slechte 
dataregistratie. De scores op de indicatoren voor borstkanker waren aan-
nemelijker.
In hoofdstuk 6 werd gebruik gemaakt van de nationale database van 
‘Zichtbare Zorg’ indicatoren voor het vaststellen van de constructvaliditeit 
van structuur-, proces- en uitkomstindicatoren voor heupvervangingen. Van 
de 28 correlaties tussen ziekenhuisscores op verschillende indicatoren die 
te verwachten waren (bv. een hoog percentage antibiotica voorgeschre-
ven is gecorreleerd met een laag percentage aan wondinfecties), waren 
er slechts drie statistisch significant en in de veronderstelde richting gecor-
releerd. Deze resultaten laten zien dat, al hoewel de indicatoren op zichzelf 
valide en bruikbaar zijn, men voorzichtig moet zijn in het trekken van alge-
mene conclusies over meerdere indicatoren, aangezien samenhang tussen 
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indicatoren beperkt was. Factoren die invloed zouden kunnen hebben ge-
had op het gebrek aan correlatie zijn: slechte kwaliteit van de data, geen 
correctie voor case-mix en statistische onzekerheid.
In hoofdstuk 7 wordt de invloed van statistische onzekerheid en case-mix-
correctie op postoperatieve sterfte en naadlekkage bij dikke darmkanker 
patiënten onderzocht. We gebruikten gegevens van 13.120 patiënten die 
een darmkanker resectie ondergingen in één van de 85 Nederlandse zie-
kenhuizen. We vergeleken de ziekenhuizen op basis van postoperatieve 
sterfte en de anastomotische lekkage met gebruik van zogenaamde fixed 
effects modellen (waarbij geen rekening wordt gehouden met statistische 
onzekerheid) en random effects modellen (waarbij wel rekening wordt ge-
houden met statistische onzekerheid). We corrigeerden zowel voor gene-
rieke als ziekte specifieke case-mix factoren. We vonden dat de statistische 
onzekerheid een groter effect had op de geschatte verschillen tussen zie-
kenhuizen dan de uitgebreide case-mixcorrectie. Alhoewel de uitkomsten 
van enkele ziekenhuizen wel werden beïnvloed door een gedetailleerde 
case-mixcorrectie. Deze bevinding onderstreept hoe belangrijk het is om 
rekening te houden met statistische onzekerheid bij het vergelijken van uit-
komsten tussen ziekenhuizen, zeker als de uitkomst (per ziekenhuis) niet zo 
vaak voorkomt. 
De literatuurstudie in hoofdstuk 3 laat zien dat kwaliteitsindicatoren voor 
ziekenhuizen vaak gebaseerd zijn op administratieve data. Echter, admini-
stratieve databases bevatten maar beperkte informatie over de (klinische) 
patiëntkarakteristieken. Administratieve data bevatten bijvoorbeeld vaak 
geen ziektespecifieke-informatie of informatie over de sociaal-economi-
sche status van de patiënt, terwijl beiden belangrijke case-mixcorrectie 
factoren zijn gebleken. De mogelijkheden voor case-mixcorrectie zijn dus 
beperkt op basis van administratieve data. 
In hoofdstuk 8 is er een case-mixcorrectie model ontwikkeld om te corrige-
ren voor patiëntkarakteristieken, bij het vergelijken van korte termijn uitkom-
sten van slokdarmkankerpatiënten. Er werd gebruik gemaakt van Engelse 
nationale audit data met informatie over 4882 patiënten. De verschillende 
modellen voor 30-dagen mortaliteit, 90-dagen mortaliteit en naadlekkage 
hadden een beperkt onderscheidend vermogen. Desondanks kunnen de 
modellen worden gebruikt voor correctie voor patiëntkarakteristieken bij 
het vergelijken van uitkomsten van slokdarmkanker tussen Engelse zieken-
huizen. 
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In hoofdstuk 9 worden verschillen tussen ziekenhuizen en tussen chirurgen 
in kortetermijnuitkomsten (30-dagen mortaliteit, 90-dagen mortaliteit en 
naadlekkage) na een slokdarmkanker resectie bekeken. Daarnaast werd 
de invloed van ziekenhuis- en chirurgvolume op deze uitkomsten onder-
zocht. Voor de studie werd gebruik gemaakt van 4868 patiënten uit de 
Engelse nationale audit (2011 tot 2013). We gebruikten multivariabele logis-
tisch regressie modellen om het effect van chirurg- en ziekenhuisvolume op 
de uitkomst te schatten. De verschillen in uitkomsten tussen ziekenhuizen en 
tussen chirurgen werden geschat met een multivariabel random-effects lo-
gistisch regressiemodel, met een level voor chirurg en voor ziekenhuis, zodat 
er rekening kon worden gehouden met zowel case-mix verschillen als statis-
tische onzekerheid. We vonden dat een hoger ziekenhuisvolume geassoci-
eerd is met een lagere 30-dagen mortaliteit. Een hoger chirurg-volume is ge-
associeerd met minder naadlekkage. Het bleek dat ziekenhuisvolume een 
deel van de variatie tussen ziekenhuizen in 30-dagen mortaliteit verklaarde. 
Chirurgvolume verklaarde een deel van de variatie in naadlekkage tussen 
ziekenhuizen. Het effect van volume verschilde dus tussen uitkomstmaten. 
Daarom zou bij eventuele verdere centralisatie van de medische zorg voor 
slokdarmkanker, moeten worden gekeken naar zowel de effecten van zie-
kenhuisvolume als van chirurgvolume. 
Discussie 
Het doel van dit proefschrift was om de kennis over het meten van kwaliteit 
van ziekenhuiszorg om ziekenhuizen te kunnen vergelijken te vergroten, spe-
cifiek over de betrouwbaarheid en validiteit van de kwaliteitsindicatoren. 
De onderzoeksvragen waren: 
Welke aspecten van de kwaliteit van de data hebben invloed op de 
betrouwbaarheid van kwaliteitsindicatoren voor ziekenhuiszorg?
Hoe duidelijk zijn de definities van de kwaliteitsindicatoren die momen-
teel worden gebruikt voor de ziekenhuiszorg?
Hoe belangrijk is statistische onzekerheid voor de betrouwbaarheid van 
uitkomstindicatoren voor de kwaliteit van operatieve zorg bij slokdarm- 
en darmkanker?
Hoe belangrijk is case-mixcorrectie voor de validiteit van de uitkomst-
indicatoren voor de kwaliteit van operatieve zorg bij slokdarm- en darm-
kanker?
We vonden dat onvoldoende datakwaliteit en onduidelijke definities van 
indicatoren een negatieve invloed hebben op de betrouwbaarheid van 
kwaliteitsindicatoren, met name bij het gebruik van administratieve data 
1.
2.
3.
4.
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voor het meten van kwaliteit van zorg. Belangrijke aspecten die invloed 
hebben op de datakwaliteit zijn heterogeniteit in data informatiesystemen, 
inaccurate dataregistratie en incomplete data. Verder vonden we dat veel 
indicatoren niet duidelijk genoeg zijn gedefinieerd, bijv. het verschil tussen 
geplande en ongeplande heropname wordt maar zelden gemaakt. Het 
negeren van deze betrouwbaarheids-aspecten kan leiden tot vertekening 
in de vergelijking tussen ziekenhuizen.
We vonden dat als geen rekening wordt gehouden met statistische onze-
kerheid en case-mix, dit een grote negatieve invloed heeft op de validiteit 
van de uitkomstindicatoren voor kwaliteit van ziekenhuiszorg. De geschatte 
uitkomsten per ziekenhuis kunnen erg onzeker zijn en het negeren van deze 
statistische onzekerheid leidt tot het overschatten van verschillen tussen 
ziekhuizen. Case-mixcorrectie had een wisselend effect op de verschillende 
uitkomstmaten. Sommige kwaliteitsindicatoren bleken minder beïnvloed te 
worden door case-mixcorrectie(bijv. naadlekkage) dan anderen (bijv. mor-
taliteit). Als uitkomsten (deels) worden bepaald door patiëntkarakteristieken 
en als er een variatie is in deze karakteristieken tussen ziekhuizen, dan is een 
case-mixcorrectie essentieel voor de validiteit van de uitkomstindicatoren. 
Op basis van deze conclusies kunnen aanbevelingen geformuleerd wor-
den. Er is meer onderzoek nodig om de datakwaliteit voor de berekening 
van kwaliteitsindicatoren te optimaliseren. Omdat de datakwaliteit afhan-
kelijk is van de mogelijkheid om de benodigde data te verkrijgen en te re-
gistreren, zou onderzoek zich moeten richten op het minimaliseren van de 
registratielast. Dit zou bijvoorbeeld gedaan kunnen worden door naar mo-
gelijkheden te kijken om databases aan elkaar te koppelen en door het 
automatisch berekenen van bepaalde data-elementen. Verder is er ook 
meer onderzoek nodig om inzicht te krijgen in de consequenties van het 
niet meenemen van uitkomsten die buiten het ziekenhuis plaatsvinden. 
Met betrekking tot de statistische onzekerheid, zou onderzoek zich moeten 
richten op statistische methoden die beter kunnen omgaan met statistische 
onzekerheid en op hoe ziekenhuisverschillen zouden moeten worden ge-
presenteerd aan verschillende belanghebbenden. Een specifieke vraag is 
of er een minimum aantal patiënten en uitkomsten is dat een acceptabel 
niveau van statistische onzekerheid garandeert. Voor de case-mixcorrectie 
modellen werd gevonden dat de modellen voor complicaties en voor her-
opnames matig presteerden. Er moet worden bekeken of deze modellen 
matig presteerden omdat de uitkomsten moeilijk kunnen worden voorspeld 
door patiënten factoren of dat er nog relevante variabelen missen in het 
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model. Verder moet onderzoek zich richten op hoe de prestatie van case-
mixcorrectie modellen te kwantificeren en hoe te definiëren wanneer een 
model als ‘goed’ kan worden beschouwd. 
Vanuit beleidsperspectief is een vereiste voor het verbeteren van kwaliteit 
op basis van kwaliteitsinformatie dat de indicatoren de slecht presterende 
ziekenhuizen kunnen identificeren, maar vervolgens ook inzicht geven in 
hoe deze zorg verbeterd zou kunnen worden. Naarmate de consequenties 
die aan informatie over kwaliteit van zorg worden verbonden groter zijn, 
bijvoorbeeld bij openbaarmaking of bij financiële consequenties, neemt de 
kans op ongewilde resultaten toe. Bijvoorbeeld het vermeiden van patiën-
ten met hoge risico’s door ziekenhuizen. Hieruit volgt dat om het gewilde 
resultaat te bereiken – het verbeteren van de kwaliteit van zorg – de kwali-
teitsindicatoren voor ziekenhuiszorg betrouwbaar en valide moeten zijn.
Om de betrouwbaarheid en validiteit van de kwaliteitsindicatoren die in 
het Nederlandse zorgstelsel worden gebruikt voor vergelijkingen tussen zie-
kenhuizen te vergroten, doen wij enkele aanbevelingen op basis van dit 
proefschrift:
Selectie van indicatoren:
- Maak indicatorsets die zowel structuur-, proces- en uitkomstindicatoren 
bevatten omdat ziekenhuizen dan aanwijzingen hebben wat ze kunnen 
verbeteren. 
- Voor uitkomstindicatoren: kies indicatoren en databronnen die case-
mixcorrectie mogelijk maken, ook voor de ziektespecifieke case-mix-
factoren
- Voor uitkomstindicatoren: kies indicatoren met een verwacht aantal pa-
tiënten in de teller van ten minste 15 per eenheid. Bijv. minstens 15 ver-
wachte sterfgevallen per ziekenhuis per jaar.
Dataregistratie en indicator definities
- Strengere kwaliteitscontrole op de data
- Maak zoveel mogelijk gebruik van unieke nationale ‘patient identifiers’ 
om deze manier klinische en administratieve databases aan elkaar te 
kunnen koppelen
- Maak de indicatordefinities zo nauwkeurig mogelijk om verschillen in 
interpretatie te voorkomen
- Verlaag de registratielast door vermindering van het aantal indicatoren, 
een efficiënter gebruik van bestaande gegevens en geautomatiseerde 
dataverzameling
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- Vraag ziekenhuizen om data op patiëntenniveau in te voeren, zodat 
teller en noemers van de indicatoren uniform uit de database kunnen 
worden gehaald 
Analyse
- Gebruik random-effect modellen om rekening te houden met statis- 
tische onzekerheid
- Corrigeer voor case-mix verschillen tussen ziekenhuizen
Gebruik
- Wees voorzichtig bij het interpreteren van de uitkomstindicatoren die op 
dit moment worden gepubliceerd, de validiteit en betrouwbaarheid zijn 
vaak beperkt
- Gebruik uitkomstindicatoren die relatief weinig worden beïnvloed door 
case-mix verschillen en die relatief vaak voorkomen, zoals bijvoorbeeld 
complicaties na een chirurgische ingreep
- Maak uitkomstindicatoren waarbij niet voldoende is gecorrigeerd voor 
case-mix factoren, of die niet vaak genoeg voorkomen (minder dan 
15 uitkomsten per jaar/per eenheid) niet openbaar en verbind er geen 
financiële consequenties aan

303
aCKNoWleDGemeNtS
I definitely could have chosen a warmer country, but do I regret coming to 
the Netherlands? Definitely not! These past years here in the Netherlands 
have been such a great journey and doing my PhD was certainly a highlight 
of it.
Completing this PhD thesis would not have been possible without the gui-
dance, contributions and encouragement of certain people who I would 
like to thank. 
My gratitude goes first of all to Prof. Dr. ewout Steyerberg my promotor. Ewout, 
I want to thank you for your trust from the early stages of my PhD project. 
You gave me a great deal of freedom and responsibility in my work, which 
made the work very exciting and helped me to learn so much over the last 
few years. You are an extraordinary researcher. I always left meetings that I 
had with you feeling positive, newly motivated and with fresh ideas (and a 
lot of work to do). Thank you for all your input, time and support. 
I would like to thank Prof. Niek Klazinga, my promotor. Niek, I first met you 
when I sneaked into your course on Methods of Health Services Research 
at the Nihes Program in 2008. I am so grateful I did that because it was with 
you my work in the field of health services research started. Back then I had 
no idea that the following years we would work together but this happened 
and started with me working as an intern at the AMC. After this I worked with 
you in the European Health Services Research project and you were also 
involved during my PhD period in diverse projects. Throughout these years 
you have provided me with intellectual guidance, mentorship and support 
(and you accomplished all of this without usually being in the same coun-
try). I always enjoyed working with you and want to thank you for all that you 
have done for me. 
Dr. Hester lingsma, I couldn’t have wished for a better copromotor. Hester, I 
am grateful for all your input; for reading the many drafts and for teaching 
me so much about science. I would also like to thank you for being patient 
with me and always supporting my ideas. Your ability to make complicated 
things easy and your sense of humor made it again and again a pleasure 
to work with you.
304
I would like to acknowledge the time and effort of the members of my doc-
toral commission for reviewing my thesis and for their presence at the de-
fense ceremony. 
Over the past few years I had the opportunity to work with many people 
on different projects, such as the Netherlands Federation of University Me-
dical Centres (NFU) and the Dutch Healthcare Authority (NZA) project, the 
Integrated Cancer Centre South (IKZ), the Dutch Institute for Clinical Audi-
ting (DICA), and the National Oesopahgo-gastric Cancer Audit (NOGCA) 
groups. I want to thank all of my co-authors and project partners for their 
collaboration, time and input. 
A special thanks to Dr. oliver Groene who provided me the opportunity to 
work with the NOGCA data at the Royal College of Surgeons in London for 
several months. Oliver, you and your lovely colleagues at the department 
made me feel very welcome. I had a very nice time in London (although 
you would sometimes understand my English better than my Austrian Ger-
man). I am happy you are a part of my doctoral committee at my defense. 
My kind colleagues at the erasmusmC also did their part. Bouwine and San-
dra, I am glad to have shared my time at the ErasmusMC with you. Thanks 
for being such “gezellige” roommates and for all your support. Sandra, our 
conference trip to Rio is such a nice memory. Nikki, Iris, and Hester thanks a 
lot for saving me a lot of aggravation and time by translating the summary 
of my thesis into Dutch. I also want to thank Sanne and the rest of the secre-
taries and ICT team for their great support. Caspar, thanks for your help with 
my statistical questions. 
At the beginning of my PhD project I spent time working at the academic 
medical Center (amC). Many thanks to my former roommates and col-
leagues, I miss my time at the AMC!
The research master program of the Vrije Universiteit Amsterdam brought 
me to the Netherlands. maurits van tulder and marcel adriaanse, this mas-
ter program enabled me to obtain a PhD position - thanks for all you have 
taught me. My fellow eight lCD’ers, thanks for the many nice memories I 
have of our study time. Tsjitske, Mariska and Mine, I’ll never forget our trip to 
Turkey!
a
ck
no
w
le
dg
em
en
ts
305
My paranimfem tsjitske, I am so glad you are next to me at my defense. 
You have been a dear friend since the first day we met at the VU for our 
LCD master program. My paranimfem Sandra, we started our PhD projects 
together and we finished it together side by side at each other’s defenses. 
So nice! 
But doing a PhD requires more than just the direct, work-related help. Many 
dear people, from close by and from far away, indirectly helped me to fi-
nish this book by offering their love and support. I want to thank all of those 
friends, but especially my dear family. 
Ein Doktorat zu machen, im Ausland zu leben (und dabei noch eine gute 
Tochter zu sein), ist nicht immer einfach. Wie sehr freu ich mich doch immer 
aufs nach Hause Kommen und euch alle wieder zu sehen. Xandi, ich habe 
so ein Glück dich als Schwester zu haben. Papa, Mama und Andi, Xandi: 
Danke für eure unermüdliche und liebevolle Unterstützung. 
Dragi Ivane, srce moje, zahvalnost za toliko divnih stvari sto si ucinio za mene, 
kao i moje osjecaje prema tebi ne mogu opisati u par recenica. Zivot je pun 
iznenadenja i nikad ne znamo tocno sta nas ceka. Vjerujem da ono najbolje 
je jos pred nama. 

307
aBoUt tHe aUtHoR
Claudia Fischer was born in Sankt Andrae im Lavanttal in Austria on the 17th 
of June 1985. After obtaining her A-levels in 2004 she started studying health 
care management at the University of Applied Sciences in Feldkirchen, Aus-
tria. She finished her ‘magistra’ degree in 2008. Once finishing her magistra-
thesis, which focused on the implementation of trainee programs from the 
for-profit sector in the hospital setting, she started the research master pro-
gram ‘Lifestyle and Chronic Disorders’ at the Vrije Universiteit in Amsterdam 
in the Netherlands, from which she obtained her MSc degree in 2010.
After finishing her master degree she worked as a junior researcher at the 
department of Public Health at the Academic Medical Centre, Amsterdam. 
In 2010 she started a PhD project on methodological aspects of measuring 
quality of hospital care at the department of Public Health of the ErasmusMC 
under the supervision of Prof. Dr. Ewout Steyerberg, Prof. Dr. Niek Klazinga, 
and Dr. Hester Lingsma, which resulted in this thesis. After finishing her PhD 
thesis Claudia Fischer worked as ‘team leader methodology’ at the Dutch 
Institute for Clinical Auditing in the Netherlands. In December 2015 she will 
start to work as a research scientist at Philips Research in Cambridge/UK. 
308
lISt oF PUBlICatIoNS
Peer reviewed journals
Fischer C, Lingsma HF, Hardwick R, Cromwell D, Steyerberg EW, Groene O. 
Risk adjustment models for short-term outcomes after surgical resection 
for oesophago-gastric cancer patients. British Journal of Surgery. 2015: In 
press.
Fischer C, Steyerberg EW, Fonarow GC, Ganiats TG, Lingsma HF. A system-
atic review and meta-analysis on the association between quality of hospi-
tal care and readmission rates in patients with heart failure. American Heart 
Journal. 2015: In press. 
Fischer C, Lingsma H, van Leersum N, Tollenaar RA, Wouters MW, Steyerberg 
EW. Comparing colon cancer outcomes: The impact of low hospital case 
volume and case-mix adjustment. European Journal of Surgical Oncology. 
2015, 41(8):1045-53.
Fischer C, Lingsma H, Marang van de Mheen P, Kringos DS, Klazinga NS, Stey-
erberg EW. Is the readmission rate a valid quality indicator? A review of the 
evidence. PloS One. 2014: 9 (11).
Aghaei HA, Ravaghi H, Kringos DS, Ogbu UC, Fischer C, Azami SR, Klazinga 
NS. Using quality measures for quality improvement: the perspective of hos-
pital staff. PLoS One. 2014: 23;9(1).
Anema HA, van der Veer SN, Kievit J, Krol-Warmerdam E, Fischer C, Steyer-
berg E, Dongelmans DA, Reidinga AC, Klazinga NS, de Keizer NF. Influences 
of definition ambiguity on hospital indicator scores: examples from The Neth-
erlands. European Journal of Public Health. 2014: 24(1):73-8.
Anema HA, Kievit J, Fischer C, Steyerberg EW, Klazinga NS. Influences of hos-
pital information systems, indicator data collection and computation on re-
ported Dutch hospital performance indicator scores. BMC Health Services 
Research. 2013: 13(1):212.
Fischer C, Anema H, Klazinga N. The validity of indicators for assessing qual-
ity of care: A review of the European literature on the readmission rate. Euro-
pean Journal of Public Health. 2011: 1-8. (Received the editor’s choice)
li
st
 o
f p
ub
lic
at
io
ns
309
Klazinga N, Fischer C, ten Asbroek A. Health services research activities re-
lated to performance indicators and benchmarking in Europe. Journal of 
Health Services Research and Policy. 2011: 16 Suppl 2:38-47.
Fischer C, Brug J, Tak N, Yngve A, te Velde S. Differences in fruit and veg-
etable intake and their determinants among 11-year-old schoolchildren 
between 2003 and 2009. International Journal of Behavioral Nutrition and 
Physical Activity. 2011: 8:141. 
Fischer C, Yıldırım M, Salmon J, Chinapaw M. Comparing different acceler-
ometer cut points for sedentary time in children. Pediatrics exercise science. 
2012: 24(2):220-8.
Reports
Kringos DS, Fischer C, Lingsma HF, Marang-van de Mheen PK, Steyerberg EW, 
Klazinga NS. Onderzoek naar de bruikbaarheid van informatie over herop-
names en heroperaties uit het DBC Informatiesysteem (DIS) voor het gener-
eren van kwaliteitsindicatoren. 
Kringos DS, Anema HA, ten Asbroek AHA, Fischer C, Botje D, Kievit J, Steyer-
berg EW, Klazinga NS. Beperkt Zicht; Onderzoek naar de betrouwbaarheid, 
validiteit en bruikbaarheid van prestatie-indicatoren over de kwaliteit van 
de Nederlandse ziekenhuiszorg. Amsterdam: Nederlandse Federatie van 
Universitair Medische Centra (NFU). December 2012. ISBN: 978 90 9027307 3. 
99 p.
Policy Briefs
HSR Europe (2011). Policybrief-health-services-research. Retrieved January 
08, 2015, from http://www.nivel.nl/sites/default/files/bestanden/Policybrief-
health-services-research.pdf.
310
Ph
D 
Po
rt
fo
lio
PHD PoRtFolIo
Summary of PhD training and teaching activities
Name of PhD student: Claudia Fischer
Erasmus MC department: Public Health
PhD period: 2010 - 2015
Promotors: Prof.dr. E.W.Steyerberg
 Prof.dr. N.S.Klazinga
Copromotor: Dr. H.F.Lingsma
   year Workload
    (eCtS)
 1. PhD training
General academic skills
Workshop grant proposal 2014 0.3
Project and time management course 2012 1.4
Research skills
Master of Public Health, Netherlands Institute for health Sciences (Nihes)  2011-2013 70
Rotterdam, the Netherlands
Master Policy and Politics, institute of Health Policy & Management 2011 5
Seminars and workshops
SMDM core course: introduction to medical decision analysis  06/2014 0.3
(Decision-Analytic Modeling)
Seminars department of Public Health, Erasmus MC 2010-2015 3.6
Meetings clinical decision making, department of Public Health, Erasmus MC 2010-2015 1.8
Presentations at national and international conferences
Presentations within Erasmus MC 2010-2015 5
National conferences
Dutch Institute of Clinical Audit (DICA) congress, Amsterdam 06/2013 1
NCVG, Amsterdam 11/2010 1
International meetings and conferences
Health is Wealth (Liverpool Health Partners), Liverpool 01/2015 0.9
ISQUA, Rio de Janeiro 10/2014 0.9
Young Expert Panel on Health, Microsoft Innovation Centre, institutional  06/2014 0.3
workshop at the WHO, Brussels
SMDM, Antwerp 06/2014 0.9
Seminar ‘Social Europe-Solidarity in health’, European Parliament, Brussels 01/2014 0.3
International QUIRN meeting, Lisbon 05/2013 0.3
European Health Forum, Gastein 10/2012 0.9
Digital Futures workshop (DG INFSO) Brussels 04/2012 0.6
Young Researchers Meeting, FAHRE, Porto 03/2012 0.3
European Health Forum, Gastein 10/2011 0.9
SMDM, Oslo 10/2011 0.9
ISQUA, Hong Kong 06/2011 0.9
Academy Health Annual Research Meeting, Seattle  04/2011 0.9
EUPHA, Amsterdam 05/2010  0.6
EGEA, Brussels 05/2010  0.6
Health Services Research Working Conference, the Hague 04/2010 0.3
311
 2. teaching activies 2010-2015
lecturing
Master thesis supervision of medical and health policy students, ErasmusMC 2013 1.4
Leading workgroups on quality of care, medical master students,  2012-2013 0.2
Amsterdam Medical Centre, University of Amsterdam;
Supervising medical bachelor students on public health research project;  2012-2013 1.2
ErasmusMC
Guest lecturer, study course “between health care process and health care  2011-2012  0.1
policy”, Quality indicators for medical/ medical informatics students at 
Amsterdam Medical Centre, University of Amsterdam;
ISQUA = International society for quality in health care 
WHO = World Health Origination
SMDM = society for medical decision making
NCVG = nederlands congress for volksgezondheid
EUPHA = European public health association
FAHRE= Strengthening Euopean Food and Health Research


